
<html lang="en"     class="pb-page"  data-request-id="68fd481f-03a3-45d8-9535-6fabadb6891a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm9004708;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2010.53.issue-1"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Heat Shock Protein 90: Inhibitors in Clinical Trials" /></meta><meta name="dc.Creator" content="Marco A.  Biamonte" /></meta><meta name="dc.Creator" content="Ryan  Van de Water" /></meta><meta name="dc.Creator" content="Joseph W.  Arndt" /></meta><meta name="dc.Creator" content="Robert H.  Scannevin" /></meta><meta name="dc.Creator" content="Daniel  Perret" /></meta><meta name="dc.Creator" content="Wen-Cherng  Lee" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 16, 2009" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9004708" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9004708" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9004708" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9004708" /></link>
        
    
    

<title>Heat Shock Protein 90: Inhibitors in Clinical Trials | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9004708" /></meta><meta property="og:title" content="Heat Shock Protein 90: Inhibitors in Clinical Trials" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9004708"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9004708">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9004708&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9004708&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9004708&amp;href=/doi/10.1021/jm9004708" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 3-17</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901774n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm9005912" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm100114u"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco+A.++Biamonte">Marco A. Biamonte</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ryan++Van+de+Water">Ryan Van de Water</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+W.++Arndt">Joseph W. Arndt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+H.++Scannevin">Robert H. Scannevin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Perret">Daniel Perret</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wen-Cherng++Lee">Wen-Cherng Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Biogen Idec, 5200 Research Place, San Diego, California 92122</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Biogen Idec, Cambridge, Massachusetts 02142</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: (858) 401-5082. Fax: (858) 795-9642. E-mail: <a href="/cdn-cgi/l/email-protection#ec818d9e8f83c28e858d8183829889ac8e85838b89828588898fc28f8381"><span class="__cf_email__" data-cfemail="6b060a1908044509020a0604051f0e2b0902040c0e05020f0e0845080406">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9004708&amp;href=/doi/10.1021%2Fjm9004708" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 3–17</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 16, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 April 2009</li><li><span class="item_label"><b>Published</b> online</span>16 September 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9004708" title="DOI URL">https://doi.org/10.1021/jm9004708</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMarco%2BA.%2BBiamonte%252C%2BRyan%2BVan%2Bde%2BWater%252C%2BJoseph%2BW.%2BArndt%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D1%26contentID%3Djm9004708%26title%3DHeat%2BShock%2BProtein%2B90%253A%2BInhibitors%2Bin%2BClinical%2BTrials%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D17%26publicationDate%3DJanuary%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9004708"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">7531</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">203</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9004708" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Heat Shock Protein 90: Inhibitors in Clinical Trials&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;A. Biamonte&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;Van de Water&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;W. Arndt&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;H. Scannevin&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Perret&quot;},{&quot;first_name&quot;:&quot;Wen-Cherng&quot;,&quot;last_name&quot;:&quot;Lee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;3-17&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9004708&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9004708&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9004708" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9004708&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9004708" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9004708&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9004708" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9004708&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9004708&amp;href=/doi/10.1021/jm9004708" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9004708" /></input><a href="/doi/pdf/10.1021/jm9004708" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26pmid%3D20055425%26genre%3Darticle%26aulast%3DBiamonte%26date%3D2010%26atitle%3DHeat%2BShock%2BProtein%2B90%253A%2BInhibitors%2Bin%2BClinical%2BTrials%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D1%26spage%3D3%26epage%3D17%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The function of the heat shock proteins (HSPs<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>)<div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: ADP, adenosine diphosphate; AML, acute myeloid leukemia; AMP-PNP, adenylyl imidodiphosphate; ATP, adenosine triphosphate; AUC, total area under the drug concentration−time curve; <i>C</i><sub>max</sub>, maximum plasma drug concentration during a dosing interval; Cl, total clearance of drug in plasma; CLL, chronic lymphocytic leukemia; DTT, 1,4-dithio-<span class="smallcaps smallerCapital">dl</span>-threitol; EPL, egg phospholipid; FDG, 2-fluoro-2-deoxy-<span class="smallcaps smallerCapital">d</span>-glucose; FP, fluorescence polarization; GIST, gastrointestinal stromal tumors; HSP, heat shock protein; MTD, maximum tolerated dose; NCI, National Cancer Institute; NHL, non-Hodgkin’s lymphoma; NSCLC, non-small-cell lung cancer; PET, positron emitted tomography; PGP, P-glycoprotein; PMSE, phospholipon−miglyol−soybean oil emulsion; RECIST, response evaluaton criteria in solid tumors; <i>T</i><sub>max</sub>, time after dosing when at maximum plasma drug concentration; TCEP, tris(2-carboxyethyl)phosphine; TFAA, trifluoroacetic anhydride; TGI, tumor growth inhibition; <i>V</i>, volume of distribution.</p></div> is to fold and maintain the proper conformation of other proteins, referred to as “clients”. HSPs are therefore molecular chaperones. They are overexpressed when a cell is subjected to a transient increase in temperature or to other stresses, such as oxidants or radiations, to assist in refolding denatured client proteins.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In addition to mediating critical cellular stress responses, HSPs also play a routine homeostatic role in regulating client protein folding under nonstressed conditions.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Molecular chaperones are among the most abundant of cellular proteins, constituting 5−10% of all proteins in the cell,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> including HSP90, which even under basal, nonstressed conditions comprises approximately 1% of the cellular protein population.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90α is an inducible form overexpressed in cancer cells, while HSP90β is the constitutive form. Both HSP90α and HSP90β are found in the cytoplasm. There are also two paralogues: Grp94, localized in the endoplasmic reticulum lumen, and TRAP1, confined to mitochondria.</div><div class="NLM_p">Inhibition of HSP90 causes client proteins to adopt aberrant conformations, and these abnormally folded proteins are rapidly eliminated by the cell via ubiquitination and proteasome degradation. Of the 280 reported HSP90 clients, 48 are involved in cell growth and various signaling cascades. Several HSP90 clients are notorious oncogenes (Raf-1, Akt, cdk4, Src, Flt-3, hTert, c-Met, etc.), and five are clinically validated cancer targets: HER-2/neu (Herceptin (trastuzumab)), Bcr-Abl (Gleevec (imatinib mesylate)), estrogen receptor (tamoxifen), androgen receptor (Casodex (bicalutamide)), and VEGF, the vascular endothelial growth factor receptor (Sutent (sunitinib)).<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a></div><div class="NLM_p">Some client proteins are particularly responsive to HSP90 inhibitors and undergo rapid degradation at low concentrations of the inhibitor. The more sensitive clients are usually those involved in growth signaling, but some mutated proteins found in tumor cells (mutant p53, imatinib-resistant Bcr-Abl)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> are also particularly dependent on HSP90 to preserve their conformation and function. The most sensitive client appears to be HER2 and is followed by mutant EGFR > Raf-1 > Akt > mutant BRAF > wild-type EGFR.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Since inhibition of HSP90 can lead to the degradation of a large number of oncogenic proteins, HSP90 has become a target of interest for oncology. A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway. It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found. This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> but this assertion has been challenged.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Furthermore, the activity of HSP90 is regulated by proteins called cochaperones, and tumor cells, which have higher levels of given cochaperones, exhibit higher levels of HSP90 activity compared to noncancerous cells.<a onclick="showRef(event, 'ref11 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref14">(11, 14)</a></div><div class="NLM_p last">It has been debated if HSP90, being implicated with so many clients, could provide an acceptable therapeutic index. Empirical evidence supports the pursuit of HSP90 inhibitors. Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins. In cell cultures, HSP90 inhibitors kill tumor cells at concentrations much lower than those required to kill normal cells. In mice, efficacy can be observed at nontoxic doses, and in humans, the first signs of clinical benefit are emerging. It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Assays</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43458" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43458" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To exert its function, HSP90 needs to bind ATP in a pocket located in the N-terminal domain. The natural product geldanamycin (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>1</b>) and all the inhibitors discussed herein bind to that same pocket. Since geldanamycin was the first HSP90 inhibitor discovered, binding assays have typically relied on monitoring the displacement from HSP90 of a geldanamycin-based probe, usually a fluorescently labeled version of geldanamycin.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> It has only recently come to light that geldanamycin and its derivatives exist in vivo in both the quinone (<b>1</b>) and the hydroquinone (<b>2</b>) forms, with the latter binding HSP90 much more tightly (0.05 vs 2 μM).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Controlling the redox state of the binding assay is therefore critical to obtain accurate and meaningful binding data. This can be done by incorporation of a reducing agent such as 1,4-dithio-<span class="smallcaps smallerCapital">dl</span>-threitol (DTT; see below). The effect of the quinone reduction, now demonstrated in multiple assay formats, needs to be reconciled with previous literature data. Binding data obtained prior to 2004 typically do not incorporate a reducing agent and if so are probably unreliable.</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Geldanamycin in equilibrium between the quinone and hydroquinone forms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Fluorescence polarization (FP) assays have come to the forefront as a convenient format in which to screen potential HSP90 inhibitors.<a onclick="showRef(event, 'ref13 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref13 ref18 ref19 ref20 ref21">(13, 18-21)</a> They offer the advantage of being “mix and read” homogeneous assays that are amenable to high-throughput compound screening.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> These assays utilize fluorescently labeled derivatives of geldanamycin and monitor the reduction of polarization when competitive inhibitors are present and displace the fluorescent geldanamycin probe on HSP90. As alluded to above, controlling the redox state of the assay has proved to be essential, since the geldanamycin-based probes bind more tightly when they are in their hydroquinone form. Howes et al.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> reported binding constants of 281 nM for geldanamycin (<b>1</b>) and 1270 nM for 17-allyl-17-desmethoxygeldanamycin (17-AAG, <b>3</b>); however, reducing agents were not included in the assay buffers. Gooljarsingh et al.,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Du et al.,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Kim et al.,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and Onuoha et al.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> all described a time-dependent improvement in binding affinity of fluorescently labeled geldanamycin for HSP90. A commonality in these assays was the inclusion of a reducing agent (typically DTT, 1,4-dithio-<span class="smallcaps smallerCapital">dl</span>-threitol) in the assay buffer so that over time the assay constituents were reduced. The effect of reduction was thoroughly examined in this assay format by Onuoha et al.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> in which preincubation of the fluorescent geldanamycin probe with the reducing agent TCEP (tris(2-carboxyethyl)phosphine) abolished the time-dependent effect on binding and revealed high affinity for HSP90 even with short incubation times. Onuoha et al.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> also demonstrated that in the absence of reducing agents, the binding did not increase with time, and low affinity binding was observed even with 24 h incubation times.</div><div class="NLM_p last">Functional, cell-based assays provide additional information, since they take into account the effects of HSP90 cochaperones that are not present in recombinant protein binding assays and add additional compound selection filters such as cell permeability. Furthermore, if the cell-culture medium contains serum proteins, protein-binding effects are implicitly taken into account. One such assay monitors the effect of HSP90 inhibitors on the degradation of the HSP90 client HER2 in breast-cancer MCF7 cells. HER2 is a receptor located on the surface of cells, and its expression can be easily monitored with extracellular-directed fluorescent antibodies and flow cytometry. We have found this assay to be reliable and reproducible.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In summary, the combination of a binding assay and a cell-based assay offers the best assessment of HSP90 inhibitors in vitro.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">3 Design and Synthesis of HSP90 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Of the 12 HSP90 inhibitors that are in clinical trials, the structures of the following 6 have been disclosed (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>): 17-allylamino-17-desmethoxygeldanamycin (17-AAG, <b>3</b>)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and its hydroquinone (IPI-504, <b>4</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> 17-(dimethylaminoethylamino)-17-desmethoxygeldanamycin (17-DMAG, <b>5</b>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> the purine BIIB021 (<b>6</b>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> the resorcinol NVP-AUY922 (<b>7</b>),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and the benzamide SNX-5422 (<b>8</b>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> a glycine prodrug of SNX-2112 (<b>9</b>). At the time of writing, it appears that there are six additional compounds in clinical trials, but their structures have not been made public. We now give a brief overview of the design of inhibitors <b>3</b>−<b>9</b>.</div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Six HSP90 inhibitors in clinical trials of which the structures have been disclosed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">3.1 17-AAG, Oxidized Form (<b>3</b>)</h3><div class="NLM_p last">Ansamycins <b>3</b>−<b>5</b> are all derived from geldanamycin (<b>1</b>), which was first isolated in 1970 by scientists at Upjohn by fermentation of <i>Streptomyces hygroscopicus</i>.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> The structure of geldanamycin was elucidated 1 year later.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Geldanamycin was originally of interest for its antibiotic properties, but the high reactivity of the 17-MeO group made it unsuitable for drug development. The 17-MeO group is easily displaced with amines at room temperature, and treatment of geldanamycin with allylamine provides the more stable 17-AAG quantitatively in less than 1 h. 17-AAG was first reported in 1980 in a patent application by Kaken Chemicals, Tokyo, claiming its antitumor properties,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>and later in 1995 by Pfizer.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Initially, the activity of 17-AAG was poorly understood, and 17-AAG was mistaken to be an inhibitor of the HER2 kinase. Only after 1994 was 17-AAG recognized to actually inhibit HSP90, thereby inducing HER2 degradation and giving the erroneous impression of direct inhibition of HER2.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> 17-AAG entered clinical trials in 1999.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">3.2 17-AAG, Reduced Form (<b>4</b>)</h3><div class="NLM_p last">17-AAG is notoriously insoluble and difficult to formulate. As mentioned earlier, 17-AAG is partially converted in vivo to its hydroquinone form, which also inhibits HSP90 effectively. Infinity Pharmaceuticals reduced 17-AAG with Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub> and isolated the resulting hydroquinone as the HCl salt <b>4</b>, which is far more water-soluble than the parent 17-AAG (250 vs. 0.02 mg/mL, respectively). The hydrochloride <b>4</b> is stable at −20 °C but not at room temperature.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> It entered clinical trials in January 2005.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.3 17-DMAG (<b>5</b>)</h3><div class="NLM_p last">Another way to increase the solubility of the geldanamycin analogues was to attach an ionizable amino group. 17-DMAG (<b>5</b>), the <i>N</i>,<i>N</i>-dimethylethylamino analogue of 17-AAG, proved to be potent and to have improved water solubility. Kosan put 17-DMAG in clinical trials in August 2006 but discontinued it in 2008 to “commit resources to the development of 17-AAG for the treatment of breast cancer as a result of a comparative analysis with 17-AAG based on several factors, including clinical experience to date, strength of intellectual property protection and risk, and time to commercialization”.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.4 Purine <b>6</b></h3><div class="NLM_p">Using structure-based drug design, researchers at the Memorial Sloane Kettering Institute developed chimeric molecules by purposely combining the structural aspects of ATP (adenine ring) and 17-AAG (aromatic ring), which led to the discovery of PU3 (<b>10</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), the first fully synthetic inhibitor of HSP90.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The weakly active <b>10</b> (40 μM in a HER2 degradation assay) was optimized independently by Conforma Therapeutics<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37-39)</a> (<b>11</b>,<b> 12</b>) and Memorial Sloan-Kettering Institute<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (<b>13</b>) to give compounds with potencies ranging from 30 to 100 nM in the HER2 degradation assay. Compounds <b>11</b>−<b>13</b> are also orally active, contrary to 17-AAG, but high doses are required for efficacy in xenograft models (>100 mg/kg).</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Early synthetic inhibitors of HSP90 and proposed pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although compounds <b>11</b> and <b>12</b> were not sufficiently potent to be further developed, they served to establish a pharmacophore model highlighting two key features, illustrated with compound <b>14</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>): (1) a NH<sub>2</sub>−C═N fragment able to bind the purine pocket of HSP90, thus mimicking the NH<sub>2</sub>−C═N fragment of ATP and (2) an aromatic ring located exactly six bonds away (5 Å) from the NH<sub>2</sub> group. In addition, a purine scaffold, rich in basic nitrogen atoms and offering multiple possibilities for hydrogen bonding, also seemed to be necessary.</div><div class="NLM_p">On the basis of this pharmacophore model, the two key features were “rotated” around the purine ring to give the new guanine series <b>16</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Series <b>16</b> preserves the 5 Å distance (6-bonds) between the NH<sub>2</sub> and the aryl group, but the aryl group is connected to the scaffold via N-9 rather than C-8. This connectivity notably simplified the synthesis of the new series, which culminated with the discovery of <b>6</b>, assembled in a single step from inexpensive commercial reagents (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Purine <b>6</b> entered clinical trials in 2005 as an oral drug for hematological and solid tumors.</div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Pharmacophore hypothesis (<b>15</b>), transposition of key binding elements to generate a new series (<b>16</b>), and synthesis of clinical candidate <b>6</b> (Conforma-Biogen Idec).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.5 Resorcinol <b>7</b></h3><div class="NLM_p">Researchers at Vernalis (which started a collaboration with Novartis in 2004) adopted a structure-guided approach in designing HSP90 inhibitors. Vernalis screened for compounds able to bind HSP90 and identified as a starting point resorcinol <b>19</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), a motif also found in the natural product and HSP90 inhibitor radicicol (see later, <b>39</b>). Further optimization led to <b>20</b>, where the amide group was key in forming a new interaction with the protein (Gly97).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Finally, introduction of a solubilizing group and minor structural modifications led to the clinical candidate <b>7</b>.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The medicinal chemistry route was a 12-step synthesis (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Resorcinol <b>7</b> entered clinical trials in September 2007 as an intravenous infusion.</div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Lead evolution of clinical candidate <b>7</b> (Vernalis-Novartis).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Synthesis of clinical candidate <b>7</b> (Vernalis-Novartis).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.6 Benzamide <b>8</b> and Its Active Metabolite <b>9</b></h3><div class="NLM_p">To identify HSP90 inhibitors, Serenex (acquired by Pfizer in 2008) has developed an ATP-affinity column. When cell lysates were loaded on the column, approximately 2000 ATP-binding proteins were captured. Using a mass spectrometry platform, Serenex screened for compounds that would selectively displace HSP90 from the column and identified compounds <b>27</b>, <b>28</b>, and the benzamide <b>9</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Benzamide <b>9</b> has variable oral bioavailability and produces polymorphic crystal forms unsuitable for development.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> These issues were resolved with the glycine prodrug <b>8</b>. Prodrug <b>8</b> has been in clinical trials since May 2007 as an oral inhibitor of HSP90. The medicinal chemistry route for preparing benzamide <b>9</b> involves five steps.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Early Serenex HSP90 inhibitors <b>27</b> and <b>28</b> and synthesis of <b>9</b>, the active metabolite of clinical candidate <b>8</b> (Serenex-Pfizer).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">3.7 Other Inhibitors</h3><div class="NLM_p">The structures of the six other clinical HSP90 inhibitors have not been disclosed yet. Of note, however, is the work of Kyowa Hakko and Biotica Technology. 17-AAG is known to be hepatotoxic, an effect that has been ascribed to its quinone ring reacting at C-19 with glutathione under physiological conditions (<i>T</i><sub>1/2</sub> = 9.8 h for 17-AAG, 26 min for 17-DMAG).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Kyowa Hakko prepared geldanamycin derivatives devoid of quinones by reacting 17-AAG and analogous quinones (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>, <b>35</b>) with MeMgBr, followed by Zn(BH<sub>4</sub>)<sub>2</sub> to obtain 4-methylphenol derivatives of type <b>36</b>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Biotica Technology focused on the HSP90 inhibitor macbecin (<b>37</b>) and genetically engineered the microorganism that secretes it, <i>Actinosynemma pretiosum.</i><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Deletion of the genes responsible for the C-21 monooxidation and the four susbequent biosynthetic steps (C4,5-desaturation, C15-hydroxylation, and C11/C15-O-methylation) yielded a new strain that produced exclusively phenol <b>38</b> at >200 mg/L. Phenol <b>38</b> (<i>K</i><sub>d</sub> = 3 nM) had in mice a “therapeutic index” 3 times higher that 17-AAG, suggesting that the quinone ring of 17-AAG is indeed responsible for toxicity.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">Several years earlier, in 1996, Kyowa Hakko disclosed another natural product, radicicol (<b>39</b>), and its oxime derivatives (<b>40</b>),<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> but did not pursue further clinical studies. Finally, efforts directed at finding novel HSP90 inhibitors have been thoroughly reviewed elsewhere.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Other inhibitors of HSP90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">4 Structural Biology of HSP90 and Comparison of Ligand Binding Modes</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The activity of HSP90 is regulated by a sophisticated process that involves HSP90 dimerization, ATP/ADP binding and hydrolysis, and formation of complexes with cochaperones. In cells, HSP90 is present as a dimer. Crystal structures of several full length HSP90s, from yeast, <i>E. coli</i>, and an endoplasmic reticulum paralogue, have been solved, and their structural biology has been recently reviewed.<a onclick="showRef(event, 'ref2 ref49 ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref2 ref49 ref50 ref51 ref52">(2, 49-52)</a> HSP90s share a common architecture and are divided into three functional domains (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>A): (a) an N-terminal domain that comprises an ATP-binding pocket,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (b) a middle domain that regulates the interaction with substrate client proteins and also contains residues critical for ATPase activity,<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> and (c) a C-terminal domain that regulates HSP90 dimerization and contains a second nucleotide-binding site.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> The binding of ATP, its hydrolysis, and the resultant ADP binding drive a series of conformational changes in the N-terminal domain ATP lid (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>B).<a onclick="showRef(event, 'ref49 ref58'); return false;" href="javascript:void(0);" class="ref ref49 ref58">(49, 58)</a> The structure of the entire dimer is affected, and the hydrophobic faces of HSP90 shift from an open conformation able to bind a client protein to one in which they get buried internally, thereby facilitating client release.</div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Crystal structure of the yeast HSP90 dimer, in complex with p23/Sba1. Nonhydrolyzable ATP analogue is in red: N = N-terminal domain; M = middle domain; C = C-terminal domain. (B) Close-up of ATP-driven lid closure in N domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Beyond complex intramolecular conformational changes, HSP90 exerts its functional activity in vivo through the interactions with cochaperone molecules, of which over a dozen have been identified (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). The cochaperones HSP70 and HSP40 are both required for loading client proteins on HSP90 and for substrate maturation,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and their interaction is regulated via the action of Hop/Sti1.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Other cochaperones such as Hip, Aha1, and Cdc37 are also present in the pre-ATP-bound HSP90−client complex. Upon binding of ATP, these cochaperones are dissociated from the HSP90 complex and are replaced by others, such as p23/Sba1 and immunophillins, to form the mature refolding complex. Upon release of the client, the mature complex is dissociated so the chaperone sequence can recycle and bind new client proteins. When an inhibitor such as geldanamycin is bound in the HSP90 ATP-pocket, the cycle is interrupted and the misfolded client is tagged with ubiquitin via the action of Hip and flagged for degradation by the 26S proteasome. Hip binds to HSP70<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and HSP90<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and appears to be an E3 ligase responsible for ubiquitinylation of client proteins.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a> Hip can also activate the release of the transcription factor HSF1, which turns on the cellular stress response and protects against programmed cell death.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><figure id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. HSP90 cycle: GM = geldanamycin analogue; 40 = HSP40; 70 = HSP70; IP = immunophillin; HIP = HSP70-interacting protein; HOP = HSP70/HSP90 organizing protein. Cdc37 and Aha1 are not shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Comparison of HSP90 inhibitor binding modes: (A) ADP (carbon atoms in teal, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1byq">1byq</a>) superimposed on active site electrostatic surface representation; (B) 17-DMAG (carbon atoms in white, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1osf">1osf</a>); (C) radicicol (<b>39</b>) (carbon atoms in slate blue, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1bgq">1bgq</a>); (D) purine <b>10</b> (carbon atoms in orange, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uym">1uym</a>); (E) resorcinol <b>7</b> (carbon atoms in light green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2vci">2vci</a>); (F) compound <b>28</b>, an analogue of benzamide <b>9</b> (carbon atoms in cyan, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3d0b">3d0b</a>). Active site water molecules (red spheres) and hydrogen bonds (dashes) are also indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The number of X-ray crystal structures of HSP90 has increased dramatically with presently over 100 HSP90 structures in the Protein Data Bank. They include apo and binary complexes with ADP, the ATP-analogue AMP-PNP (adenylyl imidodiphosphate), small-molecule inhibitors, and protein−protein complexes with cochaperones. Comparisons of the binding modes of the inhibitors and of ADP reveal certain common features (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). For instance, examination of the purine binding pocket of the ADP cocrystal structure (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>A) exposes two critical hydrogen bonds: the first one is observed between the NH<sub>2</sub> group of adenine and residue D93, and the second is observed between N-1 of adenine and T184 via a bridging water molecule (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>A).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Interestingly, the hydrogen bonds with D93 and T184 are conserved features with all the known HSP90 inhibitors, including 17-AAG and its analogue 17-DMAG (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>B),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the resorcinol containing moieties of radicicol (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>C) and Novartis-Vernalis resorcinol <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>E),<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> the purine scaffold of <b>10</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>D), and carbazolone <b>28</b>, an analogue of Serenex-Pfizer benzamide <b>9</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>F).</div><div class="NLM_p">Nonetheless, important disparity in how these HSP90 inhibitors bind to the ATP-binding cleft also exists. For example, in the 17-DMAG cocrystal structure, the N106 that interacts with the sugar of ADP is pushed out of the active site to accommodate the methoxy moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>B). The loss of this interaction is more than offset by several additional H-bonds that are picked up between K58 and a hydroxyl, between the K112 and a quinone oxygen, and between the G135 carbonyl and the cis amide nitrogen of 17-DMAG.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> While the Novartis-Vernalis resorcinol <b>7</b><a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> and radicicol (<b>39</b>) share similarity in their active site binding footprint, an additional H-bonding interaction with the C-5 ethylamide residue of <b>7</b> with G97 is not seen in the radicicol cocrystal structure (Figures <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>C,E). It was shown that the ethylamide is critical to gain additional potency. Furthermore, Serenex-Pfizer benzamide <b>9</b> is expected to bind as in the published crystal structure of the related tetrahydro-4<i>H</i>-carbazol-4-one <b>28</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3d0b">3d0b</a>) which makes additional hydrophobic interactions with the aryl binding pocket formed by L103, L107, F138, V150, and W162 of HSP90.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> This binding mode resembles that seen for 8-benzylpurine <b>10</b> in which L107 and its associated helix are displaced by the trimethoxybenzyl moiety of <b>10</b>, inducing it into an extended helix conformation. Interestingly, several distinct structural conformations have been observed in this region of HSP90 involving residues 104−111 (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> This area of HSP90 has been shown to unwind to form open, closed, or intermediate conformations, as seen in the cocrystal structures of ADP, 17-AAG, radicicol, Vernalis’ resorcinol <b>7</b>, and Vernalis’ naphthalene <b>41</b> (a preclinical inhibitor, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2bz5">2bz5</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>), indicating considerable plasticity in this region of the structure.</div><figure id="fig12" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Conformational flexibility observed in HSP90 N-terminal domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig13" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Vernalis preclinical inhibitor <b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">5 Preclinical Biological Data and Clinical Data</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> summarizes the binding data and cell-based activities of the clinical inhibitors and of 17-AG, an active metabolite of 17-AAG. All the compounds have similar potencies in the HER2 degradation assay, with IC<sub>50</sub> values ranging from 7 to 35 nM. This section describes the preclinical data of each inhibitor.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Constants and HER2 Degradation Values</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th class="colsep1 rowsep1" colspan="2" align="center"><i>K</i><sub>i</sub> [nM]<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th align="center"> </th></tr><tr valign="top"><th align="center">inhibitor</th><th align="center">reducing conditions (+TCEP)</th><th align="center">nonreducing conditions (−TCEP)</th><th align="center">HER2 degradation<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> [nM]</th></tr></thead><tbody><tr valign="top"><td align="left">17-AAG</td><td align="left">9.0 ± 4.7</td><td align="left">530 ± 170</td><td align="left">12 ± 5</td></tr><tr valign="top"><td align="left">17-AG</td><td align="left">3.0 ± 1.8</td><td align="left">21 ± 8</td><td align="left">12 ± 3</td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left">13 ± 3.5</td><td align="left">26 ± 18</td><td align="left">38 ± 10</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">0.064 ± 0.058<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td align="left">0.069 ± 0.047<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td align="left">7 ± 1</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">1.1 ± 0.4</td><td align="left">2.8 ± 2.1</td><td align="left">22 ± 3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">All <i>K</i><sub>i</sub> values from Infinity.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">All HER2 degradation values from Biogen Idec.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Note that the laboratory that developed <b>7</b> reports for its own compound a substantially different <i>K</i><sub>i</sub> = 9 nM.</p></div></div></div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">5.1 Geldanamycin Analogues</h3><div class="NLM_p">17-AAG binds HSP90 with an affinity of the order of 500 nM as the quinone form and 9 nM as the hydroquinone form (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). When incubated with MCF7 breast-cancer cell lines, 17-AAG induces HER2 degradation with an IC<sub>50</sub> of 12 nM. 17-AAG also degrades other client proteins and up-regulates HSP70, while nonclients (e.g., PI3K) remain unaffected, a signature of HSP90 inhibition. Note that HSP70 protects cells against insults. Thus, induction of the cytoprotective HSP70, an unavoidable side effect of HSP90 inhibition, is somewhat counterproductive because HSP90 inhibitors are meant to damage cancer cells.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Inhibition of HSP90 also leads to a slight HSP90 upregulation. The up-regulation of HSP70 (and to a lesser extent of HSP90) has caused concerns that it would be challenging to maintain an effective dosing schedule in the clinic.</div><div class="NLM_p">Importantly, 17-AAG is a P-glycoprotein substrate and is less effective in PGP expressing tumor cell lines. Loss of the NQ01 gene, which is required for the bioreduction of 17-AAG to the more potent hydroquinone form, has also been proposed to be a mechanism of resistance. In cells, 17-AAG works in synergy with other cancer therapeutics, such as paclitaxel (Taxol, in a sequence-dependent manner),<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> cisplatin,<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> bortezomib (Velcade),<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> and trastuzumab.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> In vivo, 17-AAG is rapidly metabolized to not only 17-desmethoxy-17-aminogeldanamycin (17-AG) but also acrolein, thus making it a dubious choice for a therapeutic agent. It is noted that the metabolite 17-AG is essentially as potent as its parent 17-AAG.</div><div class="NLM_p">The pharmacokinetic properties of 17-AAG were examined by administering the compound in a DMSO/egg phospholipid formulation to A2780 tumor-bearing mice, ip, at 80 mg/kg.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Over the first 3 h, 17-AAG accumulates in the liver (liver/plasma ≈ 10) but not in the tumor (tumor/plasma ≈ 0.5). However, 17-AAG is retained for over 24 h in the tumor, while it is cleared rapidly from plasma and liver (other organs not reported). Additional parameters are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The half-life of 17-AAG is 0.9 h in plasma and liver but is 7.5 h in the tumor. The metabolite 17-AG behaves similarly, with short half-lives in plasma and liver (1.2 and 1.8 h, respectively) and longer half-lives in the tumor (13 h).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Mouse PK Parameter of 17-AAG Administered ip, 80 mg/kg, in DMSO/Egg Phospholipid</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">analyte</th><th align="center">tissue</th><th align="center" char="."><i>C</i><sub>max</sub> [μM]</th><th align="center" char=".">AUC [μM·h]</th><th align="center" char="."><i>V<sub>z</sub></i> [L]</th><th align="center" char=".">Cl [L/h]</th><th align="center" char="."><i>T</i><sub>1/2</sub> [h]</th></tr></thead><tbody><tr valign="top"><td align="left">17-AAG</td><td align="left">plasma</td><td align="char" char=".">35</td><td align="char" char=".">68</td><td align="char" char=".">0.05</td><td align="char" char=".">0.04</td><td align="char" char=".">0.88</td></tr><tr valign="top"><td align="left">17-AAG</td><td align="left">tumor</td><td align="char" char=".">15</td><td align="char" char=".">80</td><td align="char" char=".">0.34</td><td align="char" char=".">0.03</td><td align="char" char=".">7.5</td></tr><tr valign="top"><td align="left">17-AAG</td><td align="left">liver</td><td align="char" char=".">126</td><td align="char" char=".">263</td><td align="char" char=".">0.01</td><td align="char" char=".">0.01</td><td align="char" char=".">0.86</td></tr><tr valign="top"><td align="left">17-AG</td><td align="left">plasma</td><td align="char" char=".">4.8</td><td align="char" char=".">15</td><td align="char" char=".">0.18</td><td align="char" char=".">0.11</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td align="left">17-AG</td><td align="left">tumor</td><td align="char" char=".">3.5</td><td align="char" char=".">43</td><td align="char" char=".">0.49</td><td align="char" char=".">0.03</td><td align="char" char=".">13.7</td></tr><tr valign="top"><td align="left">17-AG</td><td align="left">liver</td><td align="char" char=".">18</td><td align="char" char=".">59</td><td align="char" char=".">0.06</td><td align="char" char=".">0.02</td><td align="char" char=".">1.8</td></tr></tbody></table></div></div><div class="NLM_p">In xenograft models, with the same DMSO/egg phospholipid formulation, 17-AAG is administered to mice typically ip at 80 mg/kg twice weekly, leading to tumor growth inhibition of about 70−90%.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Synergistic effects between 17-AAG and paclitaxel have been noted in vivo.<a onclick="showRef(event, 'ref10 ref73'); return false;" href="javascript:void(0);" class="ref ref10 ref73">(10, 73)</a> In gefitinib-resistant EGFR (epidermal growth factor receptor) xenograft models, the combination of 17-AAG and paclitaxel was significantly more effective than either drug alone. While the drugs given individually inhibited tumor growth by ∼50%, the combination gave partial regressions.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Note that mutated forms of EGFR are highly sensitive to HSP90 inhibition and are found in 10−25% of the nonsmall cell lung cancers.</div><div class="NLM_p">The clinical trials involving 17-AAG have been recently reviewed.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> A central theme with 17-AAG is its lack of solubility, which led to increasingly sophisticated formulations. The first formulation was introduced in 1999 by the NCI and consisted of a DMSO/egg-phospholipid vehicle for intravenous administeration. In a phase I study, only minimal efficacy was observed and hepatoxicity (transaminitis) did occur. In addition, the DMSO caused anorexia and odors of dimethyl sulfide in patients.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The maximum tolerated dose (MTD) was schedule dependent, ranging from 56 mg/m<sup>2</sup> on a daily basis to 220 mg/m<sup>2</sup> when given every 3 days (a 70 kg human being corresponds to 2 m<sup>2</sup>). On daily dosing, hepatic toxicity was dose limiting, and intermittent schedules were recommended.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> The human PK parameters (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) indicate that at 220 mg/m<sup>2</sup> 17-AAG gave an initial <i>C</i><sub>max</sub> = 7.5 μM that exceeded the cell-based potency (HER2 degradation IC<sub>50</sub> = 12 nM). 17-AAG had a <i>T</i><sub>1/2</sub> of 3.8 ± 2.2 h (4 times longer than in mice) and was rapidly cleared with Cl = 42 L/h (human hepatic blood flow = 90 L/h). The active metabolite 17-AG was present in equal amounts as 17-AAG, based on the plasma AUC (∼22 μM·h).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> An independent work gave similar parameters.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Human Pharmacokinetic Parameters of 17-AAG, Administered at a Dose of 220 mg/m<sup>2</sup> in DMSO/Egg Phospholipid<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">analyte</th><th align="center"><i>C</i><sub>max</sub> [μM]</th><th align="center"><i>T</i><sub>max</sub> [h]</th><th align="center"><i>T</i><sub>1/2</sub> [h]</th><th align="center">AUC [μM·h]</th><th align="center">Cl [L/h]</th><th align="center"><i>V</i><sub>dss</sub> [L]</th></tr></thead><tbody><tr valign="top"><td align="left">17-AAG</td><td align="left">7.5 ± 3.3</td><td align="left"> </td><td align="left">3.8 ± 2.2</td><td align="left">22 ± 10</td><td align="left">42 ± 20<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td><td align="left">140 ± 60<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td></tr><tr valign="top"><td align="left">17-AG</td><td align="left">3.0 ± 1.2</td><td align="left">1.7 ± 0.5</td><td align="left">6.9 ± 4.3</td><td align="left">21 ± 13</td><td align="left"> </td><td align="left">230 ± 110<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">All values from Solit et al.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> except where noted.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">The clearance was converted from (L/h)/m<sup>2</sup> to L/h assuming patients of 2 m<sup>2</sup>.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last">Value from Banerji et al.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></p></div></div></div><div class="NLM_p">In spite of the rapid clearance of 17-AAG in humans, its pharmacodynamic effects lasted for at least 24 h, as judged by c-Raf-1 inhibition, cdk4 depletion, and HSP70 induction in peripheral blood leukocytes.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> This illustrates an important point pertaining to HSP90 inhibitors. Though they may be short-lived, they rapidly induce the degradation of the relevant clients and the cell requires 24−48 h to resynthesize them. A continuous inhibition of HSP90 is therefore not necessary, and compounds with short half-lives can provide a long-lasting pharmacodynamic effect.</div><div class="NLM_p">Kosan Pharmaceuticals developed a DMSO-free formulation of 17-AAG (KOS-953).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The Kosan formulation contained cremophor, which can induce hypersensitivity reactions and anaphylaxis and requires premedication with antihistamines and steroids. Patients were treated with up to 450 mg/m<sup>2</sup> of drug on a weekly schedule, and the dose was limited not because of toxicity but because of constraints on volume and formulation.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Importantly, the combination of 17-AAG and trastuzumab induced regressions of 21−25% in HER2 positive breast tumors, even if patients had failed trastuzumab therapy. These are some of the strongest clinical data supporting 17-AAG. Equally significant is that multiple myeloma patients, even if refractory to bortezomib, still responded to the combination of bortezomib and 17-AAG.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Responses were also observed in metastatic melanoma. The cremophor-based formulation has recently been modified to an injectable suspension that does not require steroid premedication.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">Conforma Therapeutics developed an oil-in-water nanoemulsion of 17-AAG (CNF1010). Clinical trials were initiated in 2005. This oil-in-water formulation of 17-AAG is not currently pursued by Biogen Idec.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><div class="NLM_p">Infinity Pharmaceuticals formulated 17-AAG in its hydroquinone form, trapped as a HCl salt (<b>4</b>). This makes sense, since 17-AAG is in equilibrium with its reduced hydroquinone in vitro (liver microsomes) and in vivo. For instance, iv injection of 17-AAG to mice leads to 5 times more hydroquinone than 17-AAG. In xenograft models, <b>4</b> is typically dosed iv at 100 mg/kg (300 mg/m<sup>2</sup>) twice weekly and induces tumor growth inhibitions on the order of 70%. Coadministration of bortezomib at 0.3 mg/m<sup>2</sup> iv had a synergistic effect and led to 100% TGI.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Hydroquinone <b>4</b> entered clinical trials in 2005 and gave promising results in gastrointestinal stromal tumors (GIST) on a twice weekly schedule (400 mg/m<sup>2</sup>).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Positron emitted tomography (PET) imaging was performed with 18-fluorodeoxyglucose to measure the metabolic activity of the tumors. Fifteen of 18 patients achieved stable diseases, and four partial responses were observed. This study prompted a phase III trial in GIST, which was initiated in August 2008. The trial was suspended when safety data from the first 46 patients enrolled in the study showed a higher than anticipated mortality rate. A preliminary review of the data suggests that the patients had more advanced disease, as evidenced by a greater percentage of patients having received three or more prior therapies and longer time since initial diagnosis.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div><div class="NLM_p last">17-DMAG was developed by the NCI and Kosan as a more soluble analogue of 17-AAG. 17-DMAG can be formulated in 5% dextrose in water, is 50% orally bioavailable in mice,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and can also be administered iv. The maximum tolerated dose upon iv injection is 12 mg/m<sup>2</sup> (rats) and 8 mg/m<sup>2</sup> (dogs). In rats and dogs, the drug-related toxicities are gastrointestinal, hepatic, and bone-marrow related. Dogs also show signs of renal and gallbladder toxicities. The highest concentrations are found in the liver of rats, with progressively lower concentrations in the spleen, lung, and plasma. Only minimal amounts are found in the heart, and none is found in the brain.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> 17-DMAG entered clinical trials in 2005, and showed 2 complete responses among 12 patients suffering of acute myeloid leukemia (AML).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Nevertheless, 17-DMAG was discontinued at the beginning of 2008.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">5.2 Purine <b>6</b></h3><div class="NLM_p">Purine <b>6</b> developed by Conforma Therapeutics and later by Biogen Idec was the first fully synthetic HSP90 inhibitor to reach the clinic (2005). In a fluorescent polarization assay, the binding affinity (<i>K</i><sub>i</sub> value) of <b>6</b> for HSP90α was 1.7 ± 0.4 nM, compared to 4.6 ± 0.5 nM for 17-AAG.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Purine <b>6</b> did not inhibit a panel of 10 kinases at 10 μM. In MCF7 cells, <b>6</b> degrades HER2 with an IC<sub>50</sub> of 38 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and induces the characteristic response of HSP90 inhibitors: degradation of HSP90 clients, up-regulation of HSP70, and no effect on PI3K, which is not a client of HSP90 (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig14" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Effect of purine <b>6</b> on protein levels in MCF7 cells (A) as a function of concentration after 24 h and (B) as a function of time at 400 nM. Reprinted with permission from <contrib-group person-group-type="allauthors">Lundgren, K.; Zhang, H.; Brekken, J.; Huser, N.; Powell, R. E.; Timple, N.; Busch, D. J.; Neely, L.; Sensintaffar, J. L.; Yang, Y.-C.; McKenzie, A.; Friedman, J.; Scannevin, R.; Kamal, A.; Hong, K.; Kasibhatla, S. R.; Boehm, M. F.; Burrows, F. J.</contrib-group>BIIB021, an orally available, fully synthetic small molecule inhibitor of the heat shock protein HSP90.  <cite>Mol. Cancer Ther.</cite> <span class="NLM_year">2009</span>, <em>8</em>, 921−929, Figure 1.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The mouse pharmacokinetic parameters were evaluated with an oral dose of <b>6</b> dissolved in 0.1 N HCl (100 mg/kg) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Purine <b>6</b> was orally bioavailable and rapidly absorbed, peaking in the plasma after 0.1 h, with <i>C</i><sub>max</sub> = 31 μM. Purine <b>6</b> was rapidly cleared, with <i>T</i><sub>1/2</sub> = 0.8 h. Despite the short half-life of <b>6</b> in serum, <b>6</b> was measurable in tumors at 24 and 48 h. More importantly, the pharmacological effect lasted for approximately 24 h. Just as with 17-AAG, the rapidly cleared <b>6</b> induced a durable pharmacodynamic response.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Mouse Oral Pharmacokinetic Properties of Purine <b>6</b> Dosed at 100 mg/kg in 0.1 N HCl</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center" char="."><i>C</i><sub>max</sub> [μM]</th><th align="center" char="."><i>T</i><sub>max</sub> [h]</th><th align="center" char=".">AUC [μM·h]</th><th align="center" char="."><i>T</i><sub>1/2</sub> [h]</th><th align="center" char=".">HLM,<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a>% parent remaining at 1 h</th></tr></thead><tbody><tr valign="top"><td align="left"><b>6</b></td><td align="char" char=".">31</td><td align="char" char=".">0.1</td><td align="char" char=".">15</td><td align="char" char=".">0.8</td><td align="char" char=".">86</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Drug incubated for 1 h with human liver microsomes (HLM) at 37 °C.</p></div></div></div><div class="NLM_p">For xenograft models, the human stomach carcinoma N87 tumor cell line was selected because of its relatively high HER2 expression. Tumor fragments were implanted subcutaneously, and treatment started once the tumor size reached 80−100 mm<sup>3</sup>. Following oral dosing of <b>6</b> as a methanesulfonic acid salt at 125 mg/kg (equivalent to 96 mg/kg free base) on a 5-days/week schedule for 5 weeks, 87% tumor growth inhibition was observed (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Purine <b>6</b> was well tolerated exhibiting no treatment-related toxicity at these doses other than minimal weight loss (3−5%) over the course of the study. Purine <b>6</b> performed at least as well at 17-AAG (70% TGI, <i>p</i> = 0.02) given ip in PMSE<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> at 90 mg/kg. Decreasing the dose of <b>6</b> 4-fold led to an erosion of efficacy, with TGI ≈ 50% (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>). Other tumors also responded well to <b>6</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Summary of Tumor Growth Inhibition with Purine <b>6</b><a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">tumor model</th><th align="center" char=".">dose (mg/kg)</th><th align="center">weekly schedule</th><th align="center">tumor type</th><th align="center" char=".">% TGI</th><th align="center" char="."><i>p</i></th></tr></thead><tbody><tr valign="top"><td align="left">N87</td><td align="char" char=".">125</td><td align="left">qdx5</td><td align="left">gastric</td><td align="char" char=".">87</td><td align="char" char=".">0.0001</td></tr><tr valign="top"><td align="left">BT474</td><td align="char" char=".">120</td><td align="left">qdx5</td><td align="left">breast</td><td align="char" char=".">94</td><td align="char" char=".">0.00005</td></tr><tr valign="top"><td align="left">CWR22</td><td align="char" char=".">120</td><td align="left">qdx5</td><td align="left">prostate</td><td align="char" char=".">85</td><td align="char" char=".">0.02</td></tr><tr valign="top"><td align="left">U87</td><td align="char" char=".">75</td><td align="left">bidx5</td><td align="left">glioblastoma</td><td align="char" char=".">70</td><td align="char" char=".">0.02</td></tr><tr valign="top"><td align="left">SKOV3</td><td align="char" char=".">124</td><td align="left">qdx5</td><td align="left">ovarian</td><td align="char" char=".">67</td><td align="char" char=".">0.003</td></tr><tr valign="top"><td align="left">Panc-1</td><td align="char" char=".">124</td><td align="left">qdx5</td><td align="left">pancreatic</td><td align="char" char=".">51</td><td align="char" char=".">0.002</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">qdx5 = daily, 5 days on and 2 days off. bidx5 = twice daily, 5 days on and 2 days off. Reprinted with permission from <contrib-group person-group-type="allauthors">Lundgren, K.; Zhang, H.; Brekken, J.; Huser, N.; Powell, R. E.; Timple, N.; Busch, D. J.; Neely, L.; Sensintaffar, J. L.; Yang, Y.-C.; McKenzie, A.; Friedman, J.; Scannevin, R.; Kamal, A.; Hong, K.; Kasibhatla, S. R.; Boehm, M. F.; Burrows, F. J.</contrib-group>BIIB021, an orally available, fully synthetic small molecule inhibitor of the heat shock protein HSP90.  <cite>Mol. Cancer Ther.</cite> <span class="NLM_year">2009</span>, <em>8</em>, 921−929, Table 2B.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div></div></div><figure id="fig15" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0001.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Growth of N87 tumor xenografts in athymic mice treated with purine <b>6</b> orally, 5 days/week. Reprinted with permission from <contrib-group person-group-type="allauthors">Lundgren, K.; Zhang, H.; Brekken, J.; Huser, N.; Powell, R. E.; Timple, N.; Busch, D. J.; Neely, L.; Sensintaffar, J. L.; Yang, Y.-C.; McKenzie, A.; Friedman, J.; Scannevin, R.; Kamal, A.; Hong, K.; Kasibhatla, S. R.; Boehm, M. F.; Burrows, F. J.</contrib-group>BIIB021, an orally available, fully synthetic small molecule inhibitor of the heat shock protein HSP90.  <cite>Mol. Cancer Ther.</cite> <span class="NLM_year">2009</span>, <em>8</em>, 921−929, Figure 2A.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">5.3 Resorcinol <b>7</b></h3><div class="NLM_p">Resorcinol <b>7</b>, discovered by Vernalis and subsequently developed by Novartis, was the third fully synthetic inhibitor to reach clinic clinical trials (2007).<a onclick="showRef(event, 'ref27 ref67 ref91 ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref27 ref67 ref91 ref92 ref93">(27, 67, 91-93)</a> In a binding assay with the HSP90α and HSP90β isoforms, <b>7</b> demonstrated an IC<sub>50</sub> of 7.8 and 21 nM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The <i>K</i><sub>i</sub> values for HSP90α and HSP90β were found to be 9.0 and 8.2 nM, respectively. Resorcinol <b>7</b> demonstrated selectivity versus the HSP90 family members Grp94 (IC<sub>50</sub> = 85 nM) and TRAP1 (IC<sub>50</sub> = 535 nM) and was selective versus a panel of 13 kinases at 10 μM. In MCF7 cells, <b>7</b> degrades HER2 with an IC<sub>50</sub> of 7 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and inhibits the proliferation of 29 different human tumor cell lines, with GI<sub>50</sub> values ranging from 2 to 40 nM. It is not a P-glycoprotein substrate.<a onclick="showRef(event, 'ref27 ref67'); return false;" href="javascript:void(0);" class="ref ref27 ref67">(27, 67)</a></div><div class="NLM_p">The percent parent remaining of <b>7</b> after being treated with mouse and human liver microsomes for 30 min was found to be 31% and 41%, respectively. The main metabolites identified in mouse plasma were the glucuronide, a deethylated product, likely the primary amide, and an oxidation product. However, the glucuronide is estimated to account for ∼95% of the plasma metabolites.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_p">In PK studies,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> athymic mice bearing WM266.4 human melanoma xenografts were dosed iv with 50 mg/kg of <b>7</b>, formulated in DMSO/Tween-20/saline (10:5:85) (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The plasma AUC was 15 μM·h. The drug was rapidly cleared, with Cl = 143 mL/h (compared to the mouse liver blood flow of 108 mL/h) and <i>T</i><sub>1/2</sub> = 1−2 h. However, as is observed with other HSP90 inhibitors, the compound showed increased concentrations in tumors and other tissues, with a ratio of the compound in tumor/plasma greater than 4. More importantly, <b>7</b> is cleared much more slowly from tumors, with an observed clearance of 20−40 mL/h and a half-life of 15 h. Intraperitoneal administration gave comparable parameters (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), justifying the use of ip dosing in animal models.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Mouse PK Parameters of Resorcinol <b>7</b> Administered iv, 50 mg/kg</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">route</th><th align="center">tissue</th><th align="center" char="."><i>C</i><sub>max</sub> [μM]</th><th align="center" char=".">AUC [μM·h]</th><th align="center" char="."><i>V</i><sub><i>z</i></sub> [L]</th><th align="center" char=".">Cl [L/h]</th><th align="center"><i>T</i><sub>1/2</sub> [h]</th></tr></thead><tbody><tr valign="top"><td align="left">iv</td><td align="left">plasma</td><td align="char" char=".">49</td><td align="char" char=".">15</td><td align="char" char=".">0.875</td><td align="char" char=".">0.143</td><td align="left">1−2</td></tr><tr valign="top"><td align="left">iv</td><td align="left">tumor</td><td align="char" char=".">14</td><td align="char" char=".">70</td><td align="char" char=".">0.440</td><td align="char" char=".">0.020</td><td align="left">15</td></tr><tr valign="top"><td align="left">ip</td><td align="left">plasma</td><td align="char" char=".">53</td><td align="char" char=".">26</td><td align="char" char=".">0.077</td><td align="char" char=".">0.082</td><td align="left">1−2</td></tr><tr valign="top"><td align="left">ip</td><td align="left">tumor</td><td align="char" char=".">6</td><td align="char" char=".">36</td><td align="char" char=".">0.883</td><td align="char" char=".">0.041</td><td align="left">15</td></tr></tbody></table></div></div><div class="NLM_p">Regarding the pharmacodynamics, when mice with WM266.4 melanoma xenografts were treated with five daily ip doses (50 mg/kg) of <b>7</b>, a concentration range of 6.8−7.7 μM <b>7</b> in tumors was found over the 24 h period after the last dose. In addition the HSP90 clients HER2, p-ERK1/2, p-AKT, AKT, and HIF-1α were reduced versus controls to 7−35%, 65−83%, 13−51%, 57−65%, and 60−85%, respectively. HSP70 was found to have increased by 247−281% of controls. The MTD for mice was 50 (mg/kg)/day. Increasing the dose to 70 (mg/kg)/day caused ∼10% body weight loss after day 8. With a 50 (mg/kg)/day dose given ip throughout the entire study a tumor growth inhibition of 46% was observed. In addition, <b>7</b> was tested in established colon, glioblastoma, breast, ovarian, and prostate xenografts and demonstrated a therapeutic response in all cases. Most notably, tumor regressions were observed in the BT474 high HER2 breast cancer model (5/12 tumors, TGI = 79%) and the U87MG glioblastoma model (average regressions of 58%).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_p last">In a phase I/II trial, resorcinol <b>7</b> is administered intrave-nously as a 1 h infusion on a once a week schedule. The maximum dose reported to date is 54 mg/m<sup>2</sup>. In general, asthenia/fatigue, nausea, and diarrhea were the most commonly reported adverse events. Reversible visual symptoms grades 1 and 2 were reported at 40 and 54 mg/m<sup>2</sup>. Grade 3 dose-limiting toxicities were atrial flutter/fibrillation (1 of 12 patients at 22 mg/m<sup>2</sup>), diarrhea (1 of 13 patients at 40 mg/m<sup>2</sup>), anorexia combined with fatigue (1 of 13 patients at 40 mg/m<sup>2</sup>), and asthenia (i.e., weakness, 1 of 9 patients at 54 mg/m<sup>2</sup>).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> At 40 mg/m<sup>2</sup>, HSP70 was up-regulated 4−19 fold and a 20% reduction in soluble HER2 was achieved in 74% of patients.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Exploratory FDG-PET scans scans have demonstrated partial metabolic reponses in a number of patients, but no complete or partial response as per RECIST criteria has been reported in this study.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">5.4 Benzamides <b>8</b> and <b>9</b><a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96, 97)</a></h3><div class="NLM_p">Benzamide <b>8</b>, a glycine prodrug of <b>9</b> originated at Serenex and developed by Pfizer, entered clinical trials in 2007. The reason for developing a prodrug was that <b>9</b> has a variable oral bioavailability, due at least in part to crystal polymorphism and poor solubility.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">In a FP-binding assay, <b>9</b> has a <i>K</i><sub>i</sub> of 1 nM, and in a cell-based HER2-degradation assay <b>9</b> has an IC<sub>50</sub> of 20 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Benzamide <b>9</b> also binds to Grp94 and TRAP1 but not to any other of the 2000 ATP-binding proteins contained in the Serenex platform. In a panel of breast, lung, and ovarian cancer cell lines, <b>9</b> inhibited cell proliferation with GI<sub>50</sub> values ranging from 10 to 50 nM. In contrast to 17-AAG, the sensitivity of cancer cell lines to <b>9</b> in vitro did not correlate with the level of HER2 expression.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Benzamide <b>9</b> was also cytotoxic in drug-sensitive and drug-resistant multiple myeloma cell-lines with IC<sub>50</sub> values of 19−186 nM at 48 h.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Thus, <b>9</b> proved to be potent in both HER2 driven (breast) and Akt driven (multiple myeloma) cell lines. In contrast, 17-AAG was less cytotoxic in multiple myeloma, with GI<sub>50</sub> values of 100−500 nM.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><div class="NLM_p">Benzamide <b>9</b> was administered to mice as its glycine prodrug <b>8</b> dissolved in 1% carboxymethyl cellulose and 0.5% Tween-80 at 10 mg/mL. Mice bearing human multiple myeloma MM.1S xenografts were treated with oral doses of 20 and 40 mg/kg on a 3×/week schedule, and <b>8</b> almost completely halted tumor growth. Results suggested that <b>8</b> inhibited cell growth and also acted on the bone marrow microenvironment by blocking osteoclastogenesis, a common complication of multiple myeloma, and angiogenesis.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><div class="NLM_p">Pharmacokinetic data on <b>8</b>, the clinical prodrug of benzamide <b>9</b>, are not available. However, preclinical data have been published on SNX-5542 (<b>42</b>),<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> another prodrug of benzamide <b>9</b>. The structure of <b>42</b> has not been released. Also, the preclinical prodrug SNX-5542 should not be confused with the clinical prodrug SNX-5422. Prodrug <b>42</b> was formulated in 5% dextrose in water. Chronic treatment of mice with <b>42</b> at oral doses of 100 mg/kg or greater was associated with weight loss, and several mice died after 1 week of treatment, but <b>42</b> was well tolerated at a dose of 50 mg/kg, without weight loss or other gross toxicities. Judging from the published figure,<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> the active metabolite <b>9</b> has a plasma <i>T</i><sub>1/2</sub> ≈ 3 h. Metabolite <b>9</b> accumulates preferentially in tumor tissues and has a longer half-life in tumors (<i>T</i><sub>1/2</sub> ≈ 10 h). For instance, at 24 h, there was a >10-fold excess of drug found in tumor tissue (5 μM) compared with that in lung, small intestine, liver, skin, uterus, and kidney. The drug concentrations in muscle, brain, and heart were negligible (<0.1 μM) at this time point, a noteworthy point as cardiac toxicity has been a potential concern with this class of agents given the role played by chaperones in the maturation of the cardiac potassium channel hERG. Despite persistently high levels of metabolite <b>9</b> (1.8 μM) in the tumor, HER2 expression rose to baseline levels 48 h after dosing.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div><div class="NLM_p last">In mice, at a dose of 50 mg/kg (five times per week), <b>42</b> caused ∼50% tumor regressions in BT474 xenografts. The effect was durable, with no evidence of tumor regrowth noted 5 weeks after the last dose on day 35. In a H1650 xenograft, <b>42</b> did not cause regressions but still inhibited tumor growth (TGI ≈ 80%) and outperformed 17-AAG (TGI ≈ 30%, 100 mg/kg MWF).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">6 Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As mentioned earlier, there are 12 HSP90 inhibitors in clinical trials (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), but the structures have been disclosed for only 6 of them: 17-AAG (quinone and hydroquinone forms), 17-DMAG, purine <b>6</b>, resorcinol <b>7</b>, and benzamide <b>8</b>. These six clinical inhibitors all have potencies on the order of 7−35 nM in a cell-based assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>) and half-lives of 1−3 h in the plasma of rodents. These inhibitors may distribute preferentially to the tumors and may have longer half-lives in the tumors than in the plasma, as in the case of 17-AAG and the active metabolite of <b>8</b>. In murine xenograft models, all compounds are required to be given at high doses (50−100 mg/kg) in order to achieve efficacy. Tumor growth can be inhibited, but regressions are rare and limited to the most sensitive cell-lines such as the high HER2 expressing BT474. In rodents, synergistic effects with paclitaxel have been published. The most advanced HSP90 inhibitors are 17-AAG and its hydroquinone <b>4</b>, currently in a phase III study in GIST, followed by purine <b>6</b>, entering phase II for the same indication. Clinical results have been published for 17-AAG, which is active in GIST as a single agent, in HER2 positive metastatic breast cancer in combination with trastuzumab, and in multiple myeloma in combination with bortezomib.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Current Clinical Trials Involving HSP90 Inhibitors (July 2009)<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">molecule</th><th align="center">company</th><th align="center">ROA</th><th align="center">indications</th><th align="center">phase</th></tr></thead><tbody><tr valign="top"><td class="colsep1" colspan="5" align="center">Synthetic (Non-Geldanamycin Analogues)</td></tr><tr valign="top"><td align="left">BIIB021</td><td align="left">Biogen Idec</td><td align="left">oral</td><td align="left">GIST</td><td align="left">II</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">breast, CLL, solid tumors</td><td align="left">I</td></tr><tr valign="top"><td align="left">SNX-5422</td><td align="left">Serenex/Pfizer</td><td align="left">oral</td><td align="left">cancer</td><td align="left">I</td></tr><tr valign="top"><td align="left">AV-142</td><td align="left">Aveo</td><td align="left">oral</td><td align="left">cancer</td><td align="left">I</td></tr><tr valign="top"><td align="left">MPC-3100</td><td align="left">Myriad Genetics</td><td align="left">oral</td><td align="left">cancer</td><td align="left">I</td></tr><tr valign="top"><td align="left">BIIB028</td><td align="left">Biogen Idec</td><td align="left">iv</td><td align="left">cancer</td><td align="left">I</td></tr><tr valign="top"><td align="left">AUY-922</td><td align="left">Vernalis, Novartis</td><td align="left">iv</td><td align="left">breast, solid tumors</td><td align="left">I</td></tr><tr valign="top"><td align="left">STA-9090</td><td align="left">Synta</td><td align="left">iv</td><td align="left">cancer</td><td align="left">I</td></tr><tr valign="top"><td align="left">KW-2478</td><td align="left">Kyowa Hakko</td><td align="left">iv</td><td align="left">leukemia, multiple myeloma, CLL, NHL</td><td align="left">I</td></tr><tr valign="top" class="rowsep1"><td class="rowsep1" align="left">AT-13387</td><td class="rowsep1" align="left">Astex</td><td class="rowsep1" align="left">iv</td><td class="rowsep1" align="left">cancer</td><td class="rowsep1" align="left">I</td></tr><tr valign="top"><td class="colsep1" colspan="5" align="center">17-AAG (Geldanamycin Analogues)</td></tr><tr valign="top"><td align="left">KOS-953 (tanespimycin)</td><td align="left">Kosan/BMS</td><td align="left">iv</td><td align="left">multiple myeloma</td><td align="left">III</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">breast, renal, thyroid, ovarian, pancreas</td><td align="left">II</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">pediactric solid tumors</td><td align="left">I</td></tr><tr valign="top"><td align="left">IPI-504 (retaspimycin)</td><td align="left">Infinity</td><td align="left">iv</td><td align="left">GIST</td><td align="left">III</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">NSCLC, breast</td><td align="left">II</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">sarcoma, multiple myeloma</td><td align="left">I</td></tr><tr valign="top"><td align="left">IPI-493</td><td align="left">Infinity</td><td align="left">oral</td><td align="left">solid tumors</td><td align="left">I</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">Source: <a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a>. Acronyms: GIST (gastrointestinal stromal tumor), CLL (chronic lymphocytic leukemia), NHL (non-Hodgkin’s lymphoma), NSCLC (non-small-cell lung cancer).</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Summary of Preclinical Data: Cell-Based Potency, Half-Life in Mice (Plasma), and Typical Dosing Regimen To Observe Efficacy in Murine Xenograft Models</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">drug</th><th align="left">company</th><th align="center" char=".">HER2 [nM]</th><th align="center"><i>T</i><sub>1/2</sub> in mice [h]</th><th align="center">typical dose regimen in mice</th></tr></thead><tbody><tr valign="top"><td align="left">17-AAG</td><td align="left">Kosan/BMS, Infinity</td><td align="char" char=".">12</td><td align="left">1</td><td align="left">ip, 100 mg/kg, 3×/week</td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left">Biogen Idec</td><td align="char" char=".">38</td><td align="left">1</td><td align="left">po, 100 mg/kg, 5×/week</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">Vernalis-Novartis</td><td align="char" char=".">7</td><td align="left">1</td><td align="left">ip or iv, 30−50 mg/kg, (3−5)×/week</td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="left">Serenex-Pfizer</td><td align="char" char=".">20</td><td align="left"> </td><td align="left">po, 20−40 mg/kg, 3×/week</td></tr><tr valign="top"><td align="left"><b>42</b></td><td align="left">Serenex-Pfizer</td><td align="char" char=".">20</td><td align="left">∼3</td><td align="left">po, 50 mg/kg, 5×/week</td></tr></tbody></table></div></div><div class="NLM_p last">The field of HSP90 inhibition started 10 years ago and was pioneered by academic institutions. At that time the chances of HSP90 inhibition leading to acceptable efficacy/safety margins were unclear. Small companies willing to take high risks followed on, and now a number of major pharmaceutical companies have HSP90 programs either via partnerships or acquisitions. One can expect ever more potent HSP90 inhibitors to emerge, with improved pharmacokinetic properties and possibly different tissue distributions. Nononcology indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson’s disease, Alzheimer’s disease, and fungal infections. For the time being, however, the focus is oncology. HSP90 inhibitors should not be expected to be magic bullets but should rather be viewed as an additional tool in the arsenal of the oncologist. Still, promising clinical results have been reported, and because HSP90 plays a role in so many pathways, HSP90 inhibitors are ideally suited for combination therapies. Moving forward, the challenge will be to design the best clinical trial, with the right combination and for the right indication.</div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52373" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52373" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco A. Biamonte</span> - <span class="hlFld-Affiliation affiliation">Biogen Idec, 5200 Research Place, San Diego, California 92122</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a6cbc7d4c5c988c4cfc7cbc9c8d2c3e6c4cfc9c1c3c8cfc2c3c588c5c9cb"><span class="__cf_email__" data-cfemail="a9c4c8dbcac687cbc0c8c4c6c7ddcce9cbc0c6ceccc7c0cdccca87cac6c4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan Van de Water</span> - <span class="hlFld-Affiliation affiliation">Biogen Idec, 5200 Research Place, San Diego, California 92122</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph W. Arndt</span> - <span class="hlFld-Affiliation affiliation">Biogen Idec, Cambridge,  Massachusetts 02142</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert H. Scannevin</span> - <span class="hlFld-Affiliation affiliation">Biogen Idec, Cambridge,  Massachusetts 02142</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Perret</span> - <span class="hlFld-Affiliation affiliation">Biogen Idec, 5200 Research Place, San Diego, California 92122</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wen-Cherng Lee</span> - <span class="hlFld-Affiliation affiliation">Biogen Idec, Cambridge,  Massachusetts 02142</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm9004708" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Marco A. Biamonte</b> graduated from the Swiss Institute of Technology, Lausanne, Switzerland (1990). After completing a Ph.D. in total synthesis with Dr. Jim Staunton and Dr. Ian Paterson at the University of Cambridge, U.K. (1995), he performed postdoctoral studies in carbohydrate chemistry in the laboratories of Prof. Andrea Vasella at the Swiss Institute of Technology, Zürich, Switzerland (ETH-Z, 1998). Marco has worked as a medicinal chemist at Serono Pharmaceuticals, Conforma Therapeutics, and Biogen Idec. He is currently leading chemistry efforts on novel inhibitors of the heat shock protein 90.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ryan Van de Water</b> completed a B.S. at the University of California, San Diego, in 1998. He then received a Ph.D. from the University of California, Santa Barbara, with Dr. Thomas Pettus in 2003, where he worked on new synthetic methods and natural product synthesis. After completing postdoctoral research with Dr. Samuel Danishefsky in natural product synthesis, he joined Conforma Therapeutics in 2005, which was subsequently acquired by Biogen Idec. He is currently a medicinal chemist working on HSP90 inhibitors.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Joseph W. Arndt</b> earned his Ph.D. in Chemistry from The Ohio State University where he studied reaction mechanisms of metalloproteins. He pursued postdoctoral studies in the laboratory of Professor Raymond Stevens at The Scripps Research Institute where he led structural and functional studies on botulinum neurotoxins. In 2006 he joined the Protein Crystallography Group at Biogen Idec, where he championed structural biology support for several biologic and small molecule programs including HSP90. His scientific interests include structure-based drug design, antibody engineering, and modulating protein−protein interactions.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Robert H. Scannevin</b> graduated with a Ph.D. from the State University of New York at Stony Brook (1997). He completed his thesis project in the laboratory of Dr. James S. Trimmer, working on the molecular mechanisms of potassium channel localization. He went on to complete his postdoctoral training in the laboratory of Dr. Richard L. Huganir at Johns Hopkins University School of Medicine (2000) where he characterized novel glutamate receptor interacting molecules and their effects on subcellular trafficking. Robert has worked in molecular drug discovery since early 2001 for Wyeth, Johnson and Johnson, and Biogen Idec. He currently leads a biology research group focusing on discovering therapeutics for multiple sclerosis and Alzheimer’s disease.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Daniel Perret</b> received his M.B.A. from the Rady School of Management in 2006 and his M.S. in Bioengineering from the University of Technology at Compiegne, France. He joined Biogen Idec in 2001 as a Research Scientist and subsequently served as Senior Analyst, Market Research, and Area Business Manager from 2006 to 2008. Prior to joining Biogen Idec Daniel has worked in oncology research and development at Sanofi-Aventis and Genentech. He is currently leading the market research and competitive intelligence activities for the early stage oncology pipeline at Biogen Idec.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Wen-Cherng Lee</b> graduated with a degree in Chemistry from the National Taiwan University in 1983 and remained as a full-time teaching assistant from 1985 to 1987. He completed his Ph.D. thesis under the guidance of Professor Stephen Martin at the University of Texas, Austin. After postdoctoral work with Professor Masamune at the Massachussetts Institute of Technology (MIT), Dr. Lee joined Biogen in 1993 and worked on several small-molecule drug discovery projects. Currently, he is an Associate Director in the medicinal chemistry department.</p></figure></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84205" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84205" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 97 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Soo, E. T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, G. W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lwin, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bay, B.-H.</span><span> </span><span class="NLM_article-title">Heat shock proteins as novel targets in cancer</span> <span class="citation_source-journal">In Vivo</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=311-316&author=E.+T.+L.+Sooauthor=G.+W.+C.+Yipauthor=Z.+M.+Lwinauthor=S.+D.+Kumarauthor=B.-H.+Bay&title=Heat+shock+proteins+as+novel+targets+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoo%26aufirst%3DE.%2BT.%2BL.%26aulast%3DYip%26aufirst%3DG.%2BW.%2BC.%26aulast%3DLwin%26aufirst%3DZ.%2BM.%26aulast%3DKumar%26aufirst%3DS.%2BD.%26aulast%3DBay%26aufirst%3DB.-H.%26atitle%3DHeat%2520shock%2520proteins%2520as%2520novel%2520targets%2520in%2520cancer%26jtitle%3DIn%2520Vivo%26date%3D2008%26volume%3D22%26spage%3D311%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span> </span><span class="NLM_article-title">Structure and mechanism of the HSP90 molecular chaperone machinery</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1146%2Fannurev.biochem.75.103004.142738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16756493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2006&pages=271-294&author=L.+H.+Pearlauthor=C.+Prodromou&title=Structure+and+mechanism+of+the+HSP90+molecular+chaperone+machinery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of the Hsp90 molecular chaperone machinery</span></div><div class="casAuthors">Pearl, Laurence H.; Prodromou, Chrisostomos</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">271-294</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) is a mol. chaperone essential for activating many signaling proteins in the eukaryotic cell.  Biochem. and structural anal. of Hsp90 has revealed a complex mechanism of ATPase-coupled conformational changes and interactions with cochaperone proteins, which facilitate activation of Hsp90's diverse "clientele.".  Despite recent progress, key aspects of the ATPase-coupled mechanism of Hsp90 remain controversial, and the nature of the changes, engendered by Hsp90 in client proteins, is largely unknown.  Here, the authors discuss present knowledge of Hsp90 structure and function gleaned from crystallog. studies of individual domains and recent progress in obtaining a structure for the ATP-bound conformation of the intact dimeric chaperone.  Addnl., the authors describe the roles of the plethora of cochaperones with which Hsp90 cooperates and growing insights into their biochem. mechanisms, which come from crystal structures of Hsp90-cochaperone complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Aa7D8Mk_qbVg90H21EOLACvtfcHk0ljdkgPNgpbYwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D&md5=a954553202a2a81fce297ac6a8378c67</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.75.103004.142738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.75.103004.142738%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520the%2520HSP90%2520molecular%2520chaperone%2520machinery%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2006%26volume%3D75%26spage%3D271%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="note"><p class="first last">This number is cited in several papers but without reference.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Welch, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feramisco, J. R.</span><span> </span><span class="NLM_article-title">Purification of the major mammalian heat shock proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">14949</span><span class="NLM_x">–</span> <span class="NLM_lpage">14959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=14949-14959&author=W.+J.+Welchauthor=J.+R.+Feramisco&title=Purification+of+the+major+mammalian+heat+shock+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DW.%2BJ.%26aulast%3DFeramisco%26aufirst%3DJ.%2BR.%26atitle%3DPurification%2520of%2520the%2520major%2520mammalian%2520heat%2520shock%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26spage%3D14949%26epage%3D14959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Messaoudi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrat, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brion, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alami, M.</span><span> </span><span class="NLM_article-title">Recent advances in HSP90 inhibitors as antitumor agents</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=761-782&author=S.+Messaoudiauthor=J.+F.+Peyratauthor=J.+D.+Brionauthor=M.+Alami&title=Recent+advances+in+HSP90+inhibitors+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMessaoudi%26aufirst%3DS.%26aulast%3DPeyrat%26aufirst%3DJ.%2BF.%26aulast%3DBrion%26aufirst%3DJ.%2BD.%26aulast%3DAlami%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520in%2520HSP90%2520inhibitors%2520as%2520antitumor%2520agents%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D761%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Sausville, E. A.</span><span> </span><span class="NLM_article-title">Heat Shock Protein-90 Directed Therapeutics and Target Validation</span>. In  <span class="citation_source-book">Cancer Drug Design and Discovery</span>; <span class="NLM_contrib-group">Neidle, S.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">336</span>− <span class="NLM_lpage">350</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FB978-012369448-5.50017-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=336-350&author=E.+A.+Sausvilleauthor=S.+Neidle&title=Cancer+Drug+Design+and+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-012369448-5.50017-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012369448-5.50017-3%26sid%3Dliteratum%253Aachs%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DHeat%2520Shock%2520Protein-90%2520Directed%2520Therapeutics%2520and%2520Target%2520Validation%26btitle%3DCancer%2520Drug%2520Design%2520and%2520Discovery%26aulast%3DNeidle%26aufirst%3DS.%26pub%3DElsevier%26date%3D2008%26spage%3D336%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1517%2F13543776.14.6.837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=837-847&author=B.+W.+Dymockauthor=M.+J.+Drysdaleauthor=E.+McDonaldauthor=P.+Workman&title=Inhibitors+of+HSP90+and+other+chaperones+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span></div><div class="casAuthors">Dymock, Brian W.; Drysdale, Martin J.; McDonald, Edward; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-847</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Mol. chaperones are proteins that ensure the appropriate folding, stability and function of other proteins in the cell.  There is increasing evidence that mol. chaperones are not only important in normal cell homeostasis and response to stresses, such as heat shock, but can also be involved in disease pathol.  In particular, HSP90 has emerged as an important potential drug target in oncol.  This is because it is essential for the stability of a long list of client proteins', including ErbB2/human epithelial growth factor receptor (HER)2, Raf-1, Akt/protein kinase B (PKB), Polo-1, Met, mutant p53 and human telomerase reverse transcriptase (hTERT), as well as the estrogen and androgen receptor.  Inhibition of HSP90 leads to depletion of these oncogenic clients by the ubiquitin proteasome pathway, thereby providing a simultaneous combinatorial attack on all of the hallmark phenotypic traits of cancer cells.  Because of the rapid progress made, this review focuses on the patents dealing with the discovery and application of small mol. inhibitors of HSP90, although limited coverage of other applications in the area of HSP90 and addnl. chaperones is also included.  Pioneering work with natural products, namely geldanamycin and related ansamycin antibiotics together with radicicol macrocycle derivs., established the therapeutic potential of inhibiting the essential N-terminal ATPase of HSP90 by competing at the nucleotide binding site.  A geldanamycin analog, 17-(desmethoxy), 17-allylamino geldanamycin (17AAG), is completing Phase I clin. trials with promising initial results.  The use of high-throughput screening and rational design based on X-ray crystal structures of HSP90 has led to the discovery of small mol. HSP90 inhibitors based on purine and pyrazole scaffolds.  The continued progression of these various compd. classes into clin. trials should help to establish proof of concept for inhibition of HSP90 as a viable therapeutic approach for the treatment of cancer and potentially other diseases.  This would in turn validate protein folding as a strategy for drug development and encourage addnl. chaperones to be explored as mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ19fmQE-bzbVg90H21EOLACvtfcHk0lj3QJOJj5tIwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D&md5=68f468698084591e41c9c0a337542ca1</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.6.837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.6.837%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520HSP90%2520and%2520other%2520chaperones%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D837%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Isaacs, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanping, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 as a molecular target for cancer therapeutics</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS1535-6108%2803%2900029-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=12676580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=213-217&author=J.+S.+Isaacsauthor=X.+Wanpingauthor=L.+Neckers&title=Heat+shock+protein+90+as+a+molecular+target+for+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90 as a molecular target for cancer therapeutics</span></div><div class="casAuthors">Isaacs, Jennifer S.; Xu, Wanping; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-217</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review on the study of heat shock protein 90 (Hsp90) inhibitors for cancer therapeutics.  It discusses the mechanism of Hsp90 inhibition, function of Hsp90, and translation of Hsp90 inhibition to clin. use in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_CXl57WSP3bVg90H21EOLACvtfcHk0lj3QJOJj5tIwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOrtb8%253D&md5=e02c28786774a7e975632231e9919208</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900029-1%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DJ.%2BS.%26aulast%3DWanping%26aufirst%3DX.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DHeat%2520shock%2520protein%252090%2520as%2520a%2520molecular%2520target%2520for%2520cancer%2520therapeutics%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D213%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1517%2F14712598.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11772336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=3-24&author=A.+Maloneyauthor=P.+Workman&title=HSP90+as+a+new+therapeutic+target+for+cancer+therapy%3A+the+story+unfolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span></div><div class="casAuthors">Maloney, Alison; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review. Current anticancer drug-development strategies involve identifying novel mol. targets which are crucial for tumorigenesis.  The mol. chaperone heat-shock protein (HSP) 90 is of interest as an anticancer drug target because of its importance in maintaining the conformation, stability and function of key oncogenic client proteins involved in signal transduction pathways leading to proliferation, cell cycle progression, and apoptosis, as well as other features of the malignant phenotype such as invasion, angiogenesis and metastasis.  The natural-product HSP90 inhibitors geldanamycin and radicicol exert their antitumor effect by inhibiting the intrinsic ATPase activity of HSP90, resulting in degrdn. of HSP90 client proteins via the ubiquitin proteosome pathway.  Anticancer selectivity may derive from the simultaneous combinatorial effects of HSP90 inhibitors on multiple cancer targets and pathways. 17-Allylamino-17-demethoxygeldanamycin (17AAG) showed good activity and cancer selectivity in preclin. models and has now progressed to Phase I clin. trials in cancer patients with encouraging initial results.  Phase II trials including combination studies with cytotoxic agents are now being planned and these should allow the therapeutic activity of 17AAG to be detd.  Second-generation HSP90 inhibitors may be designed to overcome some of the drawbacks of 17AAG, including limited oral bioavailability and soly.  They could also be engineered to target specific functions of HSP90, which may not only provide greater mol. selectivity and clin. benefit but may also increase understanding of the complex functions of this mol. chaperone.  HSP90 inhibitors provide proof of concept for drugs directed at HSP90 and protein folding and this principle may be applicable to other medical conditions involving protein aggregation and stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxpya4HhGPu7Vg90H21EOLACvtfcHk0lj3QJOJj5tIwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D&md5=b0542acde22286a95578e3ef4dac0d8e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1517%2F14712598.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHSP90%2520as%2520a%2520new%2520therapeutic%2520target%2520for%2520cancer%2520therapy%253A%2520the%2520story%2520unfolds%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2002%26volume%3D2%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Richter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">HSP90: chaperoning signal transduction</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1002%2Fjcp.1131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11473354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvVGnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2001&pages=281-290&author=K.+Richterauthor=J.+Buchner&title=HSP90%3A+chaperoning+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90: chaperoning signal transduction</span></div><div class="casAuthors">Richter, Klaus; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-290</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review with 120 refs.  Hsp90 is an ATP-dependent mol. chaperone involved in the folding and activation of an unknown no. of substrate proteins.  These substrate proteins include protein kinases and transcription factors.  Consistent with this task, Hsp90 is an essential protein in all eukaryotes.  The interaction of Hsp90 with its substrate proteins involves the transient formation of multiprotein complexes with a set of highly conserved partner proteins.  The specific function of each component in the processing of substrates is still unknown.  Large ATP-dependent conformational changes of Hsp90 occur during the hydrolysis reaction and these changes are thought to drive the chaperone cycle.  Natural inhibitors of the ATPase activity, like geldanamycin and radicicol, block the processing of Hsp90 substrate proteins.  As many of these substrates are crit. elements in signal transduction, Hsp90 seems to introduce an addnl. level of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8NDhXhxYLZbVg90H21EOLACvtfcHk0lgZT2WskUJ5tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvVGnsro%253D&md5=2347e8946c70d42aa18ea58dd2def6b7</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1002%2Fjcp.1131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.1131%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DHSP90%253A%2520chaperoning%2520signal%2520transduction%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2001%26volume%3D188%26spage%3D281%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">Therapeutic and diagnostic implications of HSP90 activation</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=283-290&author=A.+Kamalauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=Therapeutic+and+diagnostic+implications+of+HSP90+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DTherapeutic%2520and%2520diagnostic%2520implications%2520of%2520HSP90%2520activation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D283%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Gorre, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellwood-Yen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">3041</span><span class="NLM_x">–</span> <span class="NLM_lpage">3044</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2002&pages=3041-3044&author=M.+E.+Gorreauthor=K.+Ellwood-Yenauthor=G.+Chiosisauthor=N.+Rosenauthor=C.+L.+Sawyers&title=BCR-ABL+point+mutants+isolated+from+patients+with+imatinib+mesylate-resistant+chronic+myeloid+leukemia+remain+sensitive+to+inhibitors+of+the+BCR-ABL+chaperone+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGorre%26aufirst%3DM.%2BE.%26aulast%3DEllwood-Yen%26aufirst%3DK.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DBCR-ABL%2520point%2520mutants%2520isolated%2520from%2520patients%2520with%2520imatinib%2520mesylate-resistant%2520chronic%2520myeloid%2520leukemia%2520remain%2520sensitive%2520to%2520inhibitors%2520of%2520the%2520BCR-ABL%2520chaperone%2520heat%2520shock%2520protein%252090%26jtitle%3DBlood%26date%3D2002%26volume%3D100%26spage%3D3041%26epage%3D3044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sawai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandarlapaty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span> </span><span class="NLM_article-title">Inhibition of HSP90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to Paclitaxel</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=589-596&author=A.+Sawaiauthor=S.+Chandarlapatyauthor=H.+Greulichauthor=M.+Gonenauthor=Q.+Yeauthor=C.+L.+Arteagaauthor=W.+Sellersauthor=N.+Rosenauthor=D.+B.+Solit&title=Inhibition+of+HSP90+down-regulates+mutant+epidermal+growth+factor+receptor+%28EGFR%29+expression+and+sensitizes+EGFR+mutant+tumors+to+Paclitaxel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSawai%26aufirst%3DA.%26aulast%3DChandarlapaty%26aufirst%3DS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DGonen%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26atitle%3DInhibition%2520of%2520HSP90%2520down-regulates%2520mutant%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520expression%2520and%2520sensitizes%2520EGFR%2520mutant%2520tumors%2520to%2520Paclitaxel%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D589%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of HSP90 confers tumour selectivity on HSP90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+HSP90+confers+tumour+selectivity+on+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0lgZT2WskUJ5tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520HSP90%2520confers%2520tumour%2520selectivity%2520on%2520HSP90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Altered states: selectively drugging the HSP90 cancer chaperone</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=47-51&author=P.+Workman&title=Altered+states%3A+selectively+drugging+the+HSP90+cancer+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DAltered%2520states%253A%2520selectively%2520drugging%2520the%2520HSP90%2520cancer%2520chaperone%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D47%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gooljarsingh, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grooms, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnamon, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerrigan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, T.</span><span> </span><span class="NLM_article-title">A biochemical rationale for the anticancer effects of HSP90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">7625</span><span class="NLM_x">–</span> <span class="NLM_lpage">7630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1073%2Fpnas.0602650103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16684877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVGlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=7625-7630&author=L.+T.+Gooljarsinghauthor=C.+Fernandesauthor=K.+Yanauthor=H.+Zhangauthor=M.+Groomsauthor=K.+Johansonauthor=R.+H.+Sinnamonauthor=R.+B.+Kirpatrickauthor=J.+Kerriganauthor=T.+Lewis&title=A+biochemical+rationale+for+the+anticancer+effects+of+HSP90+inhibitors%3A+slow%2C+tight+binding+inhibition+by+geldanamycin+and+its+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues</span></div><div class="casAuthors">Gooljarsingh, Lata T.; Fernandes, Christine; Yan, Kang; Zhang, Hong; Grooms, Michael; Johanson, Kyung; Sinnamon, Robert H.; Kirkpatrick, Robert B.; Kerrigan, John; Lewis, Tia; Arnone, Marc; King, Alastair J.; Lai, Zhihong; Copeland, Robert A.; Tummino, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7625-7630</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Heat shock protein (Hsp)90 is emerging as an important therapeutic target for the treatment of cancer.  Two analogs of the Hsp90 inhibitor geldanamycin are currently in clin. trials.  Geldanamycin (GA) and its analogs have been reported to bind purified Hsp90 with low micromolar potency, in stark contrast to their low nanomolar antiproliferative activity in cell culture and their potent antitumor activity in animal models.  Several models have been proposed to account for the ≈100-fold-greater potency in cell culture, including that GA analogs bind with greater affinity to a five-protein Hsp90 complex than to Hsp90 alone.  We have detd. that GA and the fluorescent analog BODIPY-GA (BDGA) both demonstrate slow, tight binding to purified Hsp90.  BDGA, used to characterize the kinetics of ligand-Hsp90 interactions, was found to bind Hsp90α with koff = 2.5×10-3 min-1, t1/2 = 4.6 h, and Ki* = 10 nM.  It was found that BDGA binds to a functional multiprotein Hsp90 complex with kinetics and affinity identical to that of Hsp90 alone.  Also, BDGA binds to Hsp90 from multiple cell lyzates in a time-dependent manner with similar kinetics.  Therefore, our results indicate that the high potency of GA in cell culture and in vivo can be accounted for by its time-dependent, tight binding to Hsp90 alone.  In the broader context, these studies highlight the essentiality of detailed biochem. characterization of drug-target interactions for the effective translation of in vitro pharmacol. to cellular and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYOm9dd7WlmLVg90H21EOLACvtfcHk0lg6mxK-VPj1fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVGlurY%253D&md5=10e3cc3af47d06242dd621b8c64b3b34</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0602650103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0602650103%26sid%3Dliteratum%253Aachs%26aulast%3DGooljarsingh%26aufirst%3DL.%2BT.%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGrooms%26aufirst%3DM.%26aulast%3DJohanson%26aufirst%3DK.%26aulast%3DSinnamon%26aufirst%3DR.%2BH.%26aulast%3DKirpatrick%26aufirst%3DR.%2BB.%26aulast%3DKerrigan%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DT.%26atitle%3DA%2520biochemical%2520rationale%2520for%2520the%2520anticancer%2520effects%2520of%2520HSP90%2520inhibitors%253A%2520slow%252C%2520tight%2520binding%2520inhibition%2520by%2520geldanamycin%2520and%2520its%2520analogues%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D7625%26epage%3D7630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Dickey, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klosak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ash, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoraka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlatkovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahman, N. S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span> </span><span class="NLM_article-title">The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=648-658&author=C.+A.+Dickeyauthor=A.+Kamalauthor=K.+Lundgrenauthor=N.+Klosakauthor=R.+M.+Baileyauthor=J.+Dunmoreauthor=P.+Ashauthor=S.+Shorakaauthor=J.+Zlatkovicauthor=C.+B.+Eckmanauthor=C.+Pattersonauthor=D.+W.+Dicksonauthor=N.+S.+Nahmanauthor=M.+Huttonauthor=F.+Burrowsauthor=L.+Petrucelli&title=The+high-affinity+HSP90-CHIP+complex+recognizes+and+selectively+degrades+phosphorylated+tau+client+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DKlosak%26aufirst%3DN.%26aulast%3DBailey%26aufirst%3DR.%2BM.%26aulast%3DDunmore%26aufirst%3DJ.%26aulast%3DAsh%26aufirst%3DP.%26aulast%3DShoraka%26aufirst%3DS.%26aulast%3DZlatkovic%26aufirst%3DJ.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26aulast%3DPatterson%26aufirst%3DC.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DNahman%26aufirst%3DN.%2BS.%26aulast%3DHutton%26aufirst%3DM.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DPetrucelli%26aufirst%3DL.%26atitle%3DThe%2520high-affinity%2520HSP90-CHIP%2520complex%2520recognizes%2520and%2520selectively%2520degrades%2520phosphorylated%2520tau%2520client%2520proteins%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D648%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of the HSP90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980403y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=260-266&author=S.+M.+Roeauthor=C.+Prodromouauthor=R.+O%E2%80%99Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=Structural+basis+for+inhibition+of+the+HSP90+molecular+chaperone+by+the+antitumor+antibiotics+radicicol+and+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm980403y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980403y%26sid%3Dliteratum%253Aachs%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520the%2520HSP90%2520molecular%2520chaperone%2520by%2520the%2520antitumor%2520antibiotics%2520radicicol%2520and%2520geldanamycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D260%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Stebbins, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Crystal structure of an HSP90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS0092-8674%2800%2980203-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=9108479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaK2sXislCitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1997&pages=239-250&author=C.+E.+Stebbinsauthor=A.+A.+Russoauthor=C.+Schneiderauthor=N.+Rosenauthor=F.+U.+Hartlauthor=N.+P.+Pavletich&title=Crystal+structure+of+an+HSP90-geldanamycin+complex%3A+targeting+of+a+protein+chaperone+by+an+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent</span></div><div class="casAuthors">Stebbins, Charles E.; Russo, Alicia A.; Schneider, Christine; Rosen, Neal; Hartl, F. Ulrich; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-250</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Hsp90 chaperone is required for the activation of several families of eukaryotic protein kinases and nuclear hormone receptors, many of which are proto-oncogenic and play a prominent role in cancer.  The geldanamycin antibiotic has antiproliferative and anti-tumor effects, as it binds to Hsp90, inhibits the Hsp90-mediated conformational maturation/refolding reaction, and results in the degrdn. of Hsp90 substrates.  The structure of the geldanamycin-binding domain of Hsp90 (residues 9-232) reveals a pronounced pocket, 15 Å deep. that is highly conserved across species.  Geldanamycin binds inside this pocket, adopting a compact structure similar to that of a polypeptide chain in a turn conformation.  This, and the pocket's similarity to substrate-binding sites, suggest that the pocket binds a portion of the polypeptide substrate and participates in the conformational maturation/refolding reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvnmleAOFITbVg90H21EOLACvtfcHk0lg6mxK-VPj1fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXislCitLo%253D&md5=54a56450c509727e070f4db20a9d7b1a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980203-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980203-2%26sid%3Dliteratum%253Aachs%26aulast%3DStebbins%26aufirst%3DC.%2BE.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DSchneider%26aufirst%3DC.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DCrystal%2520structure%2520of%2520an%2520HSP90-geldanamycin%2520complex%253A%2520targeting%2520of%2520a%2520protein%2520chaperone%2520by%2520an%2520antitumor%2520agent%26jtitle%3DCell%26date%3D1997%26volume%3D89%26spage%3D239%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzasalma, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnakov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrabrant, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaner, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnakova, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masucci, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckman, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galemmo, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. L.</span><span> </span><span class="NLM_article-title">Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5678</span><span class="NLM_x">–</span> <span class="NLM_lpage">5685</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0524969" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=5678-5685&author=A.+C.+Maroneyauthor=J.+J.+Maruganauthor=T.+M.+Mezzasalmaauthor=A.+N.+Barnakovauthor=T.+A.+Garrabrantauthor=L.+E.+Weanerauthor=W.+J.+Jonesauthor=L.+A.+Barnakovaauthor=H.+K.+Koblishauthor=M.+J.+Toddauthor=J.+A.+Masucciauthor=I.+C.+Deckmanauthor=R.+A.+Galemmoauthor=D.+L.+Johnson&title=Dihydroquinone+ansamycins%3A+toward+resolving+the+conflict+between+low+in+vitro+affinity+and+high+cellular+potency+of+geldanamycin+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fbi0524969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0524969%26sid%3Dliteratum%253Aachs%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DMezzasalma%26aufirst%3DT.%2BM.%26aulast%3DBarnakov%26aufirst%3DA.%2BN.%26aulast%3DGarrabrant%26aufirst%3DT.%2BA.%26aulast%3DWeaner%26aufirst%3DL.%2BE.%26aulast%3DJones%26aufirst%3DW.%2BJ.%26aulast%3DBarnakova%26aufirst%3DL.%2BA.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DTodd%26aufirst%3DM.%2BJ.%26aulast%3DMasucci%26aufirst%3DJ.%2BA.%26aulast%3DDeckman%26aufirst%3DI.%2BC.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BL.%26atitle%3DDihydroquinone%2520ansamycins%253A%2520toward%2520resolving%2520the%2520conflict%2520between%2520low%2520in%2520vitro%2520affinity%2520and%2520high%2520cellular%2520potency%2520of%2520geldanamycin%2520derivatives%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D5678%26epage%3D5685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">High-throughput screening fluorescence polarization assay for tumor-specific HSP90</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1177%2F1087057107306067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=17942784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12rs7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=915-924&author=Y.+Duauthor=K.+Moulickauthor=A.+Rodinaauthor=J.+Aguirreauthor=S.+Feltsauthor=R.+Dingledineauthor=H.+Fuauthor=G.+Chiosis&title=High-throughput+screening+fluorescence+polarization+assay+for+tumor-specific+HSP90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening fluorescence polarization assay for tumor-specific Hsp90</span></div><div class="casAuthors">Du, Yuhong; Moulick, Kamalika; Rodina, Anna; Aguirre, Julia; Felts, Sara; Dingledine, Raymond; Fu, Haian; Chiosis, Gabriella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">915-924</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that has emerged as an important target in cancer and several other diseases, such as neurodegenerative diseases, nerve injuries, inflammation, and infection.  Discovery of novel agents that inhibit Hsp90 and have druglike properties is therefore a major focus in several academic and industrial labs.  In this study, the authors describe the development and optimization in a 384-well format of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization, which measures competitive binding of red-shifted fluorescently labeled geldanamycin (GM-cy3B) to Hsp90 found in the NCI-N417 small-cell lung carcinoma cells.  The authors demonstrate that GM-cy3B binds with high affinity and specificity to cellular Hsp90.  The assay results in excellent signal-to-noise ratios (>10) and Z' values (>0.75) at tracer concns. greater than 4 nM and 1 μg/well of total NCI-N417 protein, indicating a robust assay.  It also equilibrates after 5 h of incubation at room temp. and remains stable for up to 24 h.  Furthermore, it is a simple mix-and-read format that is cost-effective and uses only low amts. of fluorophore and cell lysates.  A study using more than 15,000 compds. from the National Institutes of Health Mol. Libraries Screening Center Network was performed to validate its performance in a high-throughput screening format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8tjbDItT49rVg90H21EOLACvtfcHk0lgSzQMfQCRuQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12rs7rO&md5=e47f199e1c11d828056f6007d3f38eab</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1177%2F1087057107306067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057107306067%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DDingledine%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHigh-throughput%2520screening%2520fluorescence%2520polarization%2520assay%2520for%2520tumor-specific%2520HSP90%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2007%26volume%3D12%26spage%3D915%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">A fluorescence polarization assay for inhibitors of HSP90</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2006&pages=202-213&author=R.+Howesauthor=X.+Barrilauthor=B.+W.+Dymockauthor=K.+Grantauthor=C.+J.+Northfieldauthor=A.+G.+Robertsonauthor=A.+Surgenorauthor=J.+Wayneauthor=L.+Wrightauthor=K.+Jamesauthor=T.+Matthewsauthor=K.+M.+Cheungauthor=E.+McDonaldauthor=P.+Workmanauthor=M.+J.+Drysdale&title=A+fluorescence+polarization+assay+for+inhibitors+of+HSP90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWayne%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DA%2520fluorescence%2520polarization%2520assay%2520for%2520inhibitors%2520of%2520HSP90%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D350%26spage%3D202%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huezo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Development of a fluorescence polarization assay for the molecular chaperone HSP90</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1177%2F1087057104265995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=15296636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=375-381&author=J.+Kimauthor=S.+Feltsauthor=L.+Llaugerauthor=H.+Heauthor=H.+Huezoauthor=N.+Rosenauthor=G.+Chiosis&title=Development+of+a+fluorescence+polarization+assay+for+the+molecular+chaperone+HSP90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span></div><div class="casAuthors">Kim, Joungnam; Felts, Sara; Llauger, Laura; He, Huazhong; Huezo, Henri; Rosen, Neal; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone with essential functions in maintaining transformation, and there is increasing interest in developing Hsp90 inhibitors as cancer therapeutics.  In this study, the authors describe the development and optimization of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization.  The assay is based on the competition of fluorescently (BODIPY) labeled geldanamycin (GM) for binding to purified recombinant Hsp90α (GM is a natural product that binds to the ATP/ADP pocket in the amino terminal of Hsp90).  The authors show that GM-BODIPY binds Hsp90α with high affinity.  Even at low Hsp90α concns. (30 nM), the measured polarization value is close to the max. assay range of 160 mP, making measurements very sensitive.  Its performance, as judged by signal-to-noise ratios (> 10) and Z and Z' values (> 0.5), suggests that this is a robust and reliable assay.  GM, PU24FCl, ADP, and ATP, all known to bind to the Hsp90 pocket, compete with GM-BODIPY for binding to Hsp90α with EC50s in agreement with reported values.  These data demonstrate that the Hsp90-FP-based assay can be used for high-throughput screening in aiding the identification of novel Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTTKuW5DgFIbVg90H21EOLACvtfcHk0lgSzQMfQCRuQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D&md5=e6e13d80237b2b5c65a78d20d2f3c4bc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1177%2F1087057104265995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104265995%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520fluorescence%2520polarization%2520assay%2520for%2520the%2520molecular%2520chaperone%2520HSP90%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2004%26volume%3D9%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Onuoha, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulstock, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengerova, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. E.</span><span> </span><span class="NLM_article-title">Mechanistic studies on HSP90 inhibition by ansamycin derivatives</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2007&pages=287-297&author=S.+C.+Onuohaauthor=S.+R.+Mukundauthor=E.+T.+Coulstockauthor=B.+Sengerovaauthor=J.+Shawauthor=S.+H.+McLaughlinauthor=S.+E.+Jackson&title=Mechanistic+studies+on+HSP90+inhibition+by+ansamycin+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnuoha%26aufirst%3DS.%2BC.%26aulast%3DMukund%26aufirst%3DS.%2BR.%26aulast%3DCoulstock%26aufirst%3DE.%2BT.%26aulast%3DSengerova%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DS.%2BH.%26aulast%3DJackson%26aufirst%3DS.%2BE.%26atitle%3DMechanistic%2520studies%2520on%2520HSP90%2520inhibition%2520by%2520ansamycin%2520derivatives%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D372%26spage%3D287%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timple, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neely, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">BIIB021, an orally available, fully synthetic small molecule inhibitor of the heat shock protein HSP90</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1535-7163.MCT-08-0758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=19372565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=921-929&author=K.+Lundgrenauthor=H.+Zhangauthor=J.+Brekkenauthor=N.+Huserauthor=R.+E.+Powellauthor=N.+Timpleauthor=D.+J.+Buschauthor=L.+Neelyauthor=J.+L.+Sensintaffarauthor=Y.-C.+Yangauthor=A.+McKenzieauthor=J.+Friedmanauthor=R.+Scannevinauthor=A.+Kamalauthor=K.+Hongauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=BIIB021%2C+an+orally+available%2C+fully+synthetic+small+molecule+inhibitor+of+the+heat+shock+protein+HSP90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90</span></div><div class="casAuthors">Lundgren, Karen; Zhang, Hong; Brekken, John; Huser, Nanni; Powell, Rachel E.; Timple, Noel; Busch, David J.; Neely, Laura; Sensintaffar, John L.; Yang, Yong-ching; McKenzie, Andres; Friedman, Jessica; Scannevin, Robert; Kamal, Adeela; Hong, Kevin; Kasibhatla, Srinivas R.; Boehm, Marcus F.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">921-929</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of heat shock protein 90 (Hsp90) results in the degrdn. of oncoproteins that drive malignant progression, inducing cell death, making Hsp90 a target of substantial interest for cancer therapy.  BIIB021 is a novel, fully synthetic inhibitor of Hsp90 that binds competitively with geldanamycin in the ATP-binding pocket of Hsp90.  In tumor cells, BIIB021 induced the degrdn. of Hsp90 client proteins including HER-2, AKT, and Raf-1 and up-regulated expression of the heat shock proteins Hsp70 and Hsp27.  BIIB021 treatment resulted in growth inhibition and cell death in cell lines from a variety of tumor types at nanomolar concns.  Oral administration of BIIB021 led to the degrdn. of Hsp90 client proteins measured in tumor tissue and resulted in the inhibition of tumor growth in several human tumor xenograft models.  Studies to investigate the antitumor effects of BIIB021 showed activity on both daily and intermittent dosing schedules, providing dose schedule flexibility for clin. studies.  Assays measuring the HER-2 protein in tumor tissue and the HER-2 extracellular domain in plasma were used to show interdiction of the Hsp90 pathway and utility as potential biomarkers in clin. trials for BIIB021.  Together, these data show that BIIB021 is a promising new oral inhibitor of Hsp90 with antitumor activity in preclin. models.[Mol Cancer Ther 2009;8(4):921-9].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSbI2RYG4aF7Vg90H21EOLACvtfcHk0lgut4zYUGnv5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D&md5=271e2311ab807bc74b2ac66b81e514e1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0758%26sid%3Dliteratum%253Aachs%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DPowell%26aufirst%3DR.%2BE.%26aulast%3DTimple%26aufirst%3DN.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DNeely%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.-C.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DBIIB021%252C%2520an%2520orally%2520available%252C%2520fully%2520synthetic%2520small%2520molecule%2520inhibitor%2520of%2520the%2520heat%2520shock%2520protein%2520HSP90%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D921%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Schnur, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallaschun, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dee, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzzi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiOrio, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacci, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span> </span><span class="NLM_article-title">erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3813</span><span class="NLM_x">–</span> <span class="NLM_lpage">3820</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00019a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3813-3820&author=R.+C.+Schnurauthor=M.+L.+Cormanauthor=R.+J.+Gallaschunauthor=B.+A.+Cooperauthor=M.+F.+Deeauthor=J.+L.+Dotyauthor=M.+L.+Muzziauthor=C.+I.+DiOrioauthor=E.+G.+Barbacciauthor=P.+E.+Millerauthor=V.+A.+Pollackauthor=D.+M.+Savageauthor=D.+E.+Sloanauthor=L.+R.+Pustilnikauthor=J.+D.+Moyerauthor=M.+P.+Moyer&title=erbB-2+oncogene+inhibition+by+geldanamycin+derivatives%3A+synthesis%2C+mechanism+of+action%2C+and+structure-activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm00019a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00019a011%26sid%3Dliteratum%253Aachs%26aulast%3DSchnur%26aufirst%3DR.%2BC.%26aulast%3DCorman%26aufirst%3DM.%2BL.%26aulast%3DGallaschun%26aufirst%3DR.%2BJ.%26aulast%3DCooper%26aufirst%3DB.%2BA.%26aulast%3DDee%26aufirst%3DM.%2BF.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DMuzzi%26aufirst%3DM.%2BL.%26aulast%3DDiOrio%26aufirst%3DC.%2BI.%26aulast%3DBarbacci%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DP.%2BE.%26aulast%3DPollack%26aufirst%3DV.%2BA.%26aulast%3DSavage%26aufirst%3DD.%2BM.%26aulast%3DSloan%26aufirst%3DD.%2BE.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26atitle%3DerbB-2%2520oncogene%2520inhibition%2520by%2520geldanamycin%2520derivatives%253A%2520synthesis%252C%2520mechanism%2520of%2520action%252C%2520and%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3813%26epage%3D3820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibbits, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of HSP90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4606</span><span class="NLM_x">–</span> <span class="NLM_lpage">4615</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4606-4615&author=J.+Geauthor=E.+Normantauthor=J.+R.+Porterauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=Y.+Gaoauthor=A.+T.+Georgesauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+Pattersonauthor=J.+R.+Sydorauthor=T.+T.+Tibbitsauthor=J.+K.+Tongauthor=J.+Adamsauthor=V.+J.+Palombella&title=Design%2C+synthesis%2C+and+biological+evaluation+of+hydroquinone+derivatives+of+17-amino-17-demethoxygeldanamycin+as+potent%2C+water-soluble+inhibitors+of+HSP90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm0603116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603116%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DGeorges%26aufirst%3DA.%2BT.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DTibbits%26aufirst%3DT.%2BT.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520hydroquinone%2520derivatives%2520of%252017-amino-17-demethoxygeldanamycin%2520as%2520potent%252C%2520water-soluble%2520inhibitors%2520of%2520HSP90%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4606%26epage%3D4615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagattuta, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamburger, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiseman, J. L.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, tissue distribution and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1007%2Fs00280-001-0380-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11855755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=7-19&author=M.+J.+Egorinauthor=T.+F.+Lagattutaauthor=D.+R.+Hamburgerauthor=J.+M.+Coveyauthor=K.+D.+Whiteauthor=S.+M.+Musserauthor=J.+L.+Eiseman&title=Pharmacokinetics%2C+tissue+distribution+and+metabolism+of+17-%28dimethylaminoethylamino%29-17-demethoxygeldanamycin+%28NSC+707545%29+in+CD2F1+mice+and+Fischer+344+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, tissue distribution and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats</span></div><div class="casAuthors">Egorin, Merrill J.; Lagattuta, Theodore F.; Hamburger, Deborah R.; Covey, Joseph M.; White, Kevin D.; Musser, Steven M.; Eiseman, Julie L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-19</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Female CD2F1 mice or male Fischer 344 rats were subjected to a study to define the plasma pharmacokinetics, tissue distribution, and urinary excretion of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17DMAG) after i.v. delivery and to define the bioavailability of 17DMAG after i.p. and oral delivery.  The biliary excretion of 17DMAG after i.v. delivery to rats and any of its metabolites obsd. in plasma, tissue, urine, or bile were also evaluated.  17DMAG, when given i.p., had excellent bioavailability and good bioavailability when given orally.  17DMAG was widely distributed to tissues and was quant. metabolized much less than is 17-(allylamino)-17-demethoxygeldanamycin.  The pharmacokinetic and metabolite results are relevant to the design of addnl. preclin. studies as well as to contemplated clin. trials of 17DMAG and could be useful in their interpretation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol_we5KxwJLbVg90H21EOLACvtfcHk0lhNfe7Omcnmcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFClurs%253D&md5=3ee6e9929fa7cd8ce301ab8a24f11fa0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00280-001-0380-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-001-0380-8%26sid%3Dliteratum%253Aachs%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DLagattuta%26aufirst%3DT.%2BF.%26aulast%3DHamburger%26aufirst%3DD.%2BR.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DWhite%26aufirst%3DK.%2BD.%26aulast%3DMusser%26aufirst%3DS.%2BM.%26aulast%3DEiseman%26aufirst%3DJ.%2BL.%26atitle%3DPharmacokinetics%252C%2520tissue%2520distribution%2520and%2520metabolism%2520of%252017-%2528dimethylaminoethylamino%2529-17-demethoxygeldanamycin%2520%2528NSC%2520707545%2529%2520in%2520CD2F1%2520mice%2520and%2520Fischer%2520344%2520rats%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2002%26volume%3D49%26spage%3D7%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050752%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2767-2778&author=S.+R.+Kasibhatlaauthor=K.+Hongauthor=M.+A.+Biamonteauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=R.+E.+Loughauthor=J.+Brekkenauthor=K.+Lundgrenauthor=R.+Greckoauthor=G.+A.+Timonyauthor=Y.+Ranauthor=R.+Mansfieldauthor=L.+C.+Fritzauthor=E.+Ulmauthor=F.+J.+Burrowsauthor=M.+F.+Boehm&title=Rationally+designed+high-affinity+2-amino-6-halopurine+heat+shock+protein+90+inhibitors+that+exhibit+potent+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm050752%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050752%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DUlm%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3DRationally%2520designed%2520high-affinity%25202-amino-6-halopurine%2520heat%2520shock%2520protein%252090%2520inhibitors%2520that%2520exhibit%2520potent%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2767%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4,5-Diarylisoxazole HSP90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.-M.+J.+Cheungauthor=I.+Collinsauthor=N.+G.+M.+Daviesauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-Diarylisoxazole+HSP90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-Diarylisoxazole%2520HSP90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, K. H.; Eaves, J.; Veal, J.; Barta, T.; Lifeng, G.; Hinkley, L.; Hanson, G.</span><span> </span><span class="NLM_article-title">Tetrahydroindolone and Tetrahydroindazolone Derivatives</span>. WO 2006/091963<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=K.+H.+Huang&author=J.+Eaves&author=J.+Veal&author=T.+Barta&author=G.+Lifeng&author=L.+Hinkley&author=G.+Hanson&title=Tetrahydroindolone+and+Tetrahydroindazolone+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26atitle%3DTetrahydroindolone%2520and%2520Tetrahydroindazolone%2520Derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huang, K. H.; Eaves, J.; Veal, J.; Hall, S. E.; Barta, T. E.; Hanson, G. J.</span><span> </span><span class="NLM_article-title">Cyclohexylamino Benzene, Pyridine, and Pyridazine Derivatives</span>. US 2007/0207984,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=K.+H.+Huang&author=J.+Eaves&author=J.+Veal&author=S.+E.+Hall&author=T.+E.+Barta&author=G.+J.+Hanson&title=Cyclohexylamino+Benzene%2C+Pyridine%2C+and+Pyridazine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26atitle%3DCyclohexylamino%2520Benzene%252C%2520Pyridine%252C%2520and%2520Pyridazine%2520Derivatives%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Boer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wnuk, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D. H.</span><span> </span><span class="NLM_article-title">Geldanamycin, a new antibiotic</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1970&pages=442-447&author=C.+De+Boerauthor=P.+A.+Meulmanauthor=R.+J.+Wnukauthor=D.+H.+Peterson&title=Geldanamycin%2C+a+new+antibiotic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBoer%26aufirst%3DC.%26aulast%3DMeulman%26aufirst%3DP.%2BA.%26aulast%3DWnuk%26aufirst%3DR.%2BJ.%26aulast%3DPeterson%26aufirst%3DD.%2BH.%26atitle%3DGeldanamycin%252C%2520a%2520new%2520antibiotic%26jtitle%3DJ.%2520Antibiot.%26date%3D1970%26volume%3D23%26spage%3D442%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">De Boer, C.; Peterson, D. H.</span><span> </span><span class="NLM_article-title">Antibiotic Geldanamycin</span>. US 3595955,<span class="NLM_x"> </span><span class="NLM_year">1971</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1971&author=C.+De+Boer&author=D.+H.+Peterson&title=Antibiotic+Geldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBoer%26aufirst%3DC.%26atitle%3DAntibiotic%2520Geldanamycin%26date%3D1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gallaschun, R. J.; Moyer, M. P.; Schnur, R. C.</span><span> </span><span class="NLM_article-title">Ansamycin Derivatives as Antioncogene and Anticancer Agents</span>. WO 9501342,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=R.+J.+Gallaschun&author=M.+P.+Moyer&author=R.+C.+Schnur&title=Ansamycin+Derivatives+as+Antioncogene+and+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGallaschun%26aufirst%3DR.%2BJ.%26atitle%3DAnsamycin%2520Derivatives%2520as%2520Antioncogene%2520and%2520Anticancer%2520Agents%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Whitesell, L.; Neckers, L.; Trepel, J.; Myers, C.</span><span> </span><span class="NLM_article-title">Tumoricidal Activity of Benzoquinonoid Ansamycins against Prostate Cancer and Primitive Neural Malignancies</span>. WO 9408578,<span class="NLM_x"> </span><span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&author=L.+Whitesell&author=L.+Neckers&author=J.+Trepel&author=C.+Myers&title=Tumoricidal+Activity+of+Benzoquinonoid+Ansamycins+against+Prostate+Cancer+and+Primitive+Neural+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26atitle%3DTumoricidal%2520Activity%2520of%2520Benzoquinonoid%2520Ansamycins%2520against%2520Prostate%2520Cancer%2520and%2520Primitive%2520Neural%2520Malignancies%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">424</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29e&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1007%2Fs002800050817" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=1998&pages=273-279&author=T.+W.+Schulteauthor=L.+M.+Neckers&title=The+benzoquinone+ansamycin+17-allylamino-17-demethoxygeldanamycin+binds+to+HSP90+and+shares+important+biologic+activities+with+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29e&amp;dbid=16384&amp;doi=10.1007%2Fs002800050817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800050817%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DThe%2520benzoquinone%2520ansamycin%252017-allylamino-17-demethoxygeldanamycin%2520binds%2520to%2520HSP90%2520and%2520shares%2520important%2520biologic%2520activities%2520with%2520geldanamycin%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1998%26volume%3D424%26spage%3D273%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><div class="note"><p class="first last">For a recent total synthesis: </p></div><span class="NLM_contrib-group">Qin, H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panek, J. S.</span><span> </span><span class="NLM_article-title">Total synthesis of the HSP90 inhibitor geldanamycin</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2479</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol800749w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=2477-2479&author=H.-L.+Qinauthor=J.+S.+Panek&title=Total+synthesis+of+the+HSP90+inhibitor+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of the Hsp90 Inhibitor Geldanamycin</span></div><div class="casAuthors">Qin, Hua-Li; Panek, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2477-2479</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An enantioselective synthesis of the Hsp90 inhibitor geldanamycin (I) was achieved in 20 linear steps and 2.0% overall yield from 2-methoxyhydroquinone.  The synthesis is highlighted by a regio- and stereoselective hydroboration reaction; a Sc(OTf)3/Et3SiH-mediated pyran ring-opening reaction; an enantioselective crotylation to simultaneously install the C8-C9 (E)-trisubstituted olefin, the C10 and C11 stereocenters; a chelation-controlled asym. metalated acetylide addn.; and an intramol. copper(I)-mediated aryl amidation reaction to close the 19-membered macrolactam.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSqIH-BMiIm7Vg90H21EOLACvtfcHk0lgOn0xLihByJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsbs%253D&md5=5551b7fe64071cd24303cdf6e95e6ca6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol800749w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol800749w%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DH.-L.%26aulast%3DPanek%26aufirst%3DJ.%2BS.%26atitle%3DTotal%2520synthesis%2520of%2520the%2520HSP90%2520inhibitor%2520geldanamycin%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D2477%26epage%3D2479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Rinehart, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slomp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grostic, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldanamycin, I.</span><span> </span><span class="NLM_article-title">Structure assignment</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">7591</span><span class="NLM_x">–</span> <span class="NLM_lpage">7593</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00729a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaE3MXmsVWqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1970&pages=7591-7593&author=K.+L.+Rinehartauthor=K.+Sasakiauthor=G.+Slompauthor=M.+F.+Grosticauthor=E.+C.+Olsonauthor=I.+Geldanamycin&title=Structure+assignment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Geldanamycin.  I.  Structure assignment</span></div><div class="casAuthors">Rinehart, Kenneth L., Jr.; Sasaki, Kazuya; Slomp, George; Grostic, Marvin F.; Olson, Edward C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7591-3</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Structure I was assigned to geldanamycin, a yellow antibiotic isolated from Streptomyces hygroscopicus var geldanus.  Zn-HOAc redn. of I gave a colorless compd. which was air oxidized back to I.  Reductive acetylation gave diacetyldihydrogeldana-mycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa7gfjSwgY67Vg90H21EOLACvtfcHk0lgOn0xLihByJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXmsVWqtg%253D%253D&md5=0337b67e216c32203383ed66f5fd485d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja00729a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00729a018%26sid%3Dliteratum%253Aachs%26aulast%3DRinehart%26aufirst%3DK.%2BL.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DSlomp%26aufirst%3DG.%26aulast%3DGrostic%26aufirst%3DM.%2BF.%26aulast%3DOlson%26aufirst%3DE.%2BC.%26aulast%3DGeldanamycin%26aufirst%3DI.%26atitle%3DStructure%2520assignment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1970%26volume%3D92%26spage%3D7591%26epage%3D7593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Sasaki, K.; Inoue, Y.</span><span> </span><span class="NLM_article-title">Geldanamycin Derivative and Antitumor Agent Containing It</span>. DE 3006097,<span class="NLM_x"> </span><span class="NLM_year">1980</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&author=K.+Sasaki&author=Y.+Inoue&title=Geldanamycin+Derivative+and+Antitumor+Agent+Containing+It"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DK.%26atitle%3DGeldanamycin%2520Derivative%2520and%2520Antitumor%2520Agent%2520Containing%2520It%26date%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Whitesell, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">8324</span><span class="NLM_x">–</span> <span class="NLM_lpage">8328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1073%2Fpnas.91.18.8324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=8078881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8324-8328&author=L+Whitesellauthor=E.+G.+Mimnaughauthor=B.+De+Costaauthor=C.+E.+Myersauthor=L.+M.+Neckers&title=Inhibition+of+heat+shock+protein+HSP90-pp60v-src+heteroprotein+complex+formation+by+benzoquinone+ansamycins%3A+essential+role+for+stress+proteins+in+oncogenic+transformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span></div><div class="casAuthors">Whitesell, Luke; Mimnaugh, Edward G.; De Costa, Brian; Myers, Charles E.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8324-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The mol. mechanisms by which oncogenic tyrosine kinases induce cellular transformation are unclear.  Herbimycin A, geldanamycin, and certain other benzoquinone ansamycins display an unusual capacity to revert tyrosine kinase-induced oncogenic transformation.  As an approach to the study of v-src-mediated transformation, the authors examd. ansamycin action in transformed cells and found that drug-induced reversion could be achieved without direct inhibition of src phosphorylating activity.  To identify mechanisms other than kinase inhibition for drug-mediated reversion, the authors prepd. a solid phase-immobilized geldanamycin deriv. and affinity pptd. the mol. targets with which the drug interacted.  In a range of cell lines, immobilized geldanamycin bound elements of a major class of heat shock protein (HSP90) in a stable and pharmacol. specific manner.  Consistent with these binding data, the authors found that sol. geldanamycin and herbimycin A inhibited specifically the formation of a previously described src-HSP90 heteroprotein complex.  A related benzoquinone ansamycin that failed to revert transformed cells did not inhibit the formation of this complex.  These results demonstrate that HSP participation in multimol. complex formation is required for src-mediated transformation and can provide a target for drug modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTW8DJOglQLVg90H21EOLACvtfcHk0linNG8noE1tyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D&md5=18f1cad01698df44adaa05ef3da9f850</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8324%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL%26aulast%3DMimnaugh%26aufirst%3DE.%2BG.%26aulast%3DDe%2BCosta%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DC.%2BE.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%2520HSP90-pp60v-src%2520heteroprotein%2520complex%2520formation%2520by%2520benzoquinone%2520ansamycins%253A%2520essential%2520role%2520for%2520stress%2520proteins%2520in%2520oncogenic%2520transformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D8324%26epage%3D8328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E.</span><span> </span><span class="NLM_article-title">Geldanamycin as a potential anticancer agent: its molecular target and biochemical activity</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=361-373&author=L.+Neckersauthor=T.+W.+Schulteauthor=E.+Mimnaugh&title=Geldanamycin+as+a+potential+anticancer+agent%3A+its+molecular+target+and+biochemical+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DMimnaugh%26aufirst%3DE.%26atitle%3DGeldanamycin%2520as%2520a%2520potential%2520anticancer%2520agent%253A%2520its%2520molecular%2520target%2520and%2520biochemical%2520activity%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1999%26volume%3D17%26spage%3D361%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span>Press Release, February 28, 2008: <a href="http://phx.corporate-ir.net/phoenix.zhtml?c=121014&amp;p=irol-newsArticle&amp;ID=1113760&amp;highlight=" class="extLink">http://phx.corporate-ir.net/phoenix.zhtml?c=121014&p=irol-newsArticle&ID=1113760&highlight=</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Press+Release%2C+February+28%2C+2008%3A+http%3A%2F%2Fphx.corporate-ir.net%2Fphoenix.zhtml%3Fc%3D121014%26p%3Dirol-newsArticle%26ID%3D1113760%26highlight%3D."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timaul, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munster, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">A small molecule designed to bind to the adenine nucleotide pocket of HSP90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS1074-5521%2801%2900015-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11306353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVCitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=289-299&author=G.+Chiosisauthor=M.+N.+Timaulauthor=B.+Lucasauthor=P.+N.+Munsterauthor=F.+F.+Zhengauthor=L.+Sepp-Lorenzinoauthor=N.+Rosen&title=A+small+molecule+designed+to+bind+to+the+adenine+nucleotide+pocket+of+HSP90+causes+Her2+degradation+and+the+growth+arrest+and+differentiation+of+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells</span></div><div class="casAuthors">Chiosis, Gabriela; Timaul, Merna N.; Lucas, Brian; Munster, Pamela N.; Zheng, Fuzhong F.; Sepp-Lorenzino, Laura; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">289-299</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: The Hsp90s contain a conserved pocket that binds ATP/ADP and plays an important role in the regulation of chaperone function.  Occupancy of this pocket by several natural products (geldanamycin (GM) and radicicol) alters Hsp90 function and results in the degrdn. of a subset of proteins (i.e. steroid receptors, Her2, Raf).  We have used the structural features of this pocket to design a small mol. inhibitor of Hsp90.  Results: The designed small mol. PU3 competes with GM for Hsp90 binding with a relative affinity of 15-20 μM.  PU3 induces degrdn. of proteins, including Her2, in a manner similar to GM.  Furthermore, PU3 inhibits the growth of breast cancer cells causing retinoblastoma protein hypophosphorylation, G1 arrest and differentiation.  Conclusions: PU3 is representative of a novel class of synthetic compds. that binds to Hsp90 and inhibits the proliferation of cancer cells.  These reagents could provide a new strategy for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwVErTsVLPMrVg90H21EOLACvtfcHk0linNG8noE1tyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVCitbs%253D&md5=6a51b7e8c95c320fa27f62d9f9f645f5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900015-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900015-1%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DTimaul%26aufirst%3DM.%2BN.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMunster%26aufirst%3DP.%2BN.%26aulast%3DZheng%26aufirst%3DF.%2BF.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DA%2520small%2520molecule%2520designed%2520to%2520bind%2520to%2520the%2520adenine%2520nucleotide%2520pocket%2520of%2520HSP90%2520causes%2520Her2%2520degradation%2520and%2520the%2520growth%2520arrest%2520and%2520differentiation%2520of%2520breast%2520cancer%2520cells%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D289%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kasibhatla, S. R.; Hong, K.; Zhang, L.; Biamonte, M. A.; Boehm, M. F.; Shi, J.; Fan, J.</span><span> </span><span class="NLM_article-title">Preparation of Purine Analogs as Heat Shock Protein 90 (HSP90) Inhibitors</span>. WO 03/037860,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=S.+R.+Kasibhatla&author=K.+Hong&author=L.+Zhang&author=M.+A.+Biamonte&author=M.+F.+Boehm&author=J.+Shi&author=J.+Fan&title=Preparation+of+Purine+Analogs+as+Heat+Shock+Protein+90+%28HSP90%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DPreparation%2520of%2520Purine%2520Analogs%2520as%2520Heat%2520Shock%2520Protein%252090%2520%2528HSP90%2529%2520Inhibitors%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span> </span><span class="NLM_article-title">Orally active purine-based inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=817-828&author=M.+A.+Biamonteauthor=J.+Shiauthor=K.+Hongauthor=D.+C.+Hurstauthor=L.+Zhangauthor=J.+Fanauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=A.+A.+Maldonadoauthor=J.+L.+Sensintaffarauthor=Y.-C.+Yangauthor=A.+Kamalauthor=R.+E.+Loughauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=G.+A.+Timonyauthor=M.+F.+Boehmauthor=S.+R.+Kasibhatla&title=Orally+active+purine-based+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0503087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503087%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DHurst%26aufirst%3DD.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DMaldonado%26aufirst%3DA.%2BA.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.-C.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DOrally%2520active%2520purine-based%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D817%26epage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Brazidec, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">7′-Substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5352</span><span class="NLM_x">–</span> <span class="NLM_lpage">5362</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051146h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5352-5362&author=L.+Zhangauthor=J.+Fanauthor=K.+Vuauthor=K.+Hongauthor=J.-Y.+Le+Brazidecauthor=J.+Shiauthor=M.+Biamonteauthor=D.+J.+Buschauthor=R.+E.+Loughauthor=R.+Greckoauthor=Y.+Ranauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=R.+Mansfieldauthor=G.+A.+Timonyauthor=E.+H.+Ulmauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehm&title=7%E2%80%B2-Substituted+benzothiazolothio-+and+pyridinothiazolothio-purines+as+potent+heat+shock+protein+90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm051146h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051146h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DVu%26aufirst%3DK.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DLe%2BBrazidec%26aufirst%3DJ.-Y.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DBiamonte%26aufirst%3DM.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DUlm%26aufirst%3DE.%2BH.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3D7%25E2%2580%25B2-Substituted%2520benzothiazolothio-%2520and%2520pyridinothiazolothio-purines%2520as%2520potent%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5352%26epage%3D5362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Evaluation of 8-arylsulfanyl, 8- arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2892</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049012b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2892-2905&author=L.+Llaugerauthor=H.+Heauthor=J.+Kimauthor=J.+Aguirreauthor=N.+Rosenauthor=U.+Petersauthor=P.+Daviesauthor=G.+Chiosis&title=Evaluation+of+8-arylsulfanyl%2C+8-+arylsulfoxyl%2C+and+8-arylsulfonyl+adenine+derivatives+as+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm049012b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049012b%26sid%3Dliteratum%253Aachs%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DEvaluation%2520of%25208-arylsulfanyl%252C%25208-%2520arylsulfoxyl%252C%2520and%25208-arylsulfonyl%2520adenine%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2892%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">Novel, potent small-molecule inhibitors of the molecular chaperone HSP90 discovered through structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4212</span><span class="NLM_x">–</span> <span class="NLM_lpage">4215</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050355z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4212-4215&author=B.+W.+Dymockauthor=X.+Barrilauthor=P.+A.+Broughauthor=J.+E.+Cansfieldauthor=A.+Masseyauthor=E.+McDonaldauthor=R.+E.+Hubbardauthor=A.+Surgenorauthor=S.+D.+Roughleyauthor=P.+Webbauthor=P.+Workmanauthor=L.+Wrightauthor=M.+J.+Drysdale&title=Novel%2C+potent+small-molecule+inhibitors+of+the+molecular+chaperone+HSP90+discovered+through+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Potent Small-Molecule Inhibitors of the Molecular Chaperone Hsp90 Discovered through Structure-Based Design</span></div><div class="casAuthors">Dymock, Brian W.; Barril, Xavier; Brough, Paul A.; Cansfield, Julie E.; Massey, Andrew; McDonald, Edward; Hubbard, Roderick E.; Surgenor, Allan; Roughley, Stephen D.; Webb, Paul; Workman, Paul; Wright, Lisa; Drysdale, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4212-4215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The crystal structure of a previously reported screening hit 1 (CCT018159) bound to the N terminal domain of mol. chaperone Hsp90 has been used to design 5-amide analogs.  These exhibit enhanced potency against the target in binding and functional assays with accompanying appropriate cellular pharmacodynamic changes.  Compd. 11 (VER-49009) compares favorably with the clin. evaluated 17-AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZR4ICeTnHxbVg90H21EOLACvtfcHk0lh3sILMvGSQLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D&md5=3a854d5f6fd1eb0e292292b2a8d22401</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm050355z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050355z%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DNovel%252C%2520potent%2520small-molecule%2520inhibitors%2520of%2520the%2520molecular%2520chaperone%2520HSP90%2520discovered%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4212%26epage%3D4215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Hall, S.</span><span> </span><span class="NLM_article-title">Discovery and Pre-Clinical Profile of SNX-5422: An Orally Active Hsp90 Inhibitor in Phase 1 Trials for Solid and Hematological Tumors</span>. Presented at the AACR Annual Meeting,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract 2449.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+Hall&title=Discovery+and+Pre-Clinical+Profile+of+SNX-5422%3A+An+Orally+Active+Hsp90+Inhibitor+in+Phase+1+Trials+for+Solid+and+Hematological+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520Pre-Clinical%2520Profile%2520of%2520SNX-5422%253A%2520An%2520Orally%2520Active%2520Hsp90%2520Inhibitor%2520in%2520Phase%25201%2520Trials%2520for%2520Solid%2520and%2520Hematological%2520Tumors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Cysyk, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barchi, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strong, J. M.</span><span> </span><span class="NLM_article-title">Reaction of geldanamycin and C17-substituted analogs with glutathione: product implications and pharmacological implications</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx050237e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=376-381&author=R.+L.+Cysykauthor=R.+J.+Parkerauthor=J.+J.+Barchiauthor=P.+S.+Steegauthor=N.+R.+Hartmanauthor=J.+M.+Strong&title=Reaction+of+geldanamycin+and+C17-substituted+analogs+with+glutathione%3A+product+implications+and+pharmacological+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Ftx050237e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx050237e%26sid%3Dliteratum%253Aachs%26aulast%3DCysyk%26aufirst%3DR.%2BL.%26aulast%3DParker%26aufirst%3DR.%2BJ.%26aulast%3DBarchi%26aufirst%3DJ.%2BJ.%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DHartman%26aufirst%3DN.%2BR.%26aulast%3DStrong%26aufirst%3DJ.%2BM.%26atitle%3DReaction%2520of%2520geldanamycin%2520and%2520C17-substituted%2520analogs%2520with%2520glutathione%253A%2520product%2520implications%2520and%2520pharmacological%2520implications%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2006%26volume%3D19%26spage%3D376%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Yamaguchi, S.; Nakashima, T.; Kanda, Y.</span><span> </span><span class="NLM_article-title">Preparation of Benzenoid Ansamycin Derivatives as HSP90 Family Protein Inhibitors for Treatment of Tumor</span>. WO 2007/001049,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=S.+Yamaguchi&author=T.+Nakashima&author=Y.+Kanda&title=Preparation+of+Benzenoid+Ansamycin+Derivatives+as+HSP90+Family+Protein+Inhibitors+for+Treatment+of+Tumor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Benzenoid%2520Ansamycin%2520Derivatives%2520as%2520HSP90%2520Family%2520Protein%2520Inhibitors%2520for%2520Treatment%2520of%2520Tumor%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Zhang, M. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nur-E-Alam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vousden, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaitatzis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radzom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, C. J.</span><span> </span><span class="NLM_article-title">Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5494</span><span class="NLM_x">–</span> <span class="NLM_lpage">5497</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8006068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5494-5497&author=M.+Q.+Zhangauthor=S.+Gaisserauthor=M.+Nur-E-Alamauthor=L.+S.+Sheehanauthor=W.+A.+Vousdenauthor=N.+Gaitatzisauthor=G.+Peckauthor=N.+J.+Coatesauthor=S.+J.+Mossauthor=M.+Radzomauthor=T.+A.+Fosterauthor=R.+M.+Sheridanauthor=M.+A.+Gregoryauthor=S.+M.+Roeauthor=C.+Prodromouauthor=L.+Pearlauthor=S.+M.+Boydauthor=B.+Wilkinsonauthor=C.+J.+Martin&title=Optimizing+natural+products+by+biosynthetic+engineering%3A+discovery+of+nonquinone+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm8006068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006068%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BQ.%26aulast%3DGaisser%26aufirst%3DS.%26aulast%3DNur-E-Alam%26aufirst%3DM.%26aulast%3DSheehan%26aufirst%3DL.%2BS.%26aulast%3DVousden%26aufirst%3DW.%2BA.%26aulast%3DGaitatzis%26aufirst%3DN.%26aulast%3DPeck%26aufirst%3DG.%26aulast%3DCoates%26aufirst%3DN.%2BJ.%26aulast%3DMoss%26aufirst%3DS.%2BJ.%26aulast%3DRadzom%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DT.%2BA.%26aulast%3DSheridan%26aufirst%3DR.%2BM.%26aulast%3DGregory%26aufirst%3DM.%2BA.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DBoyd%26aufirst%3DS.%2BM.%26aulast%3DWilkinson%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DC.%2BJ.%26atitle%3DOptimizing%2520natural%2520products%2520by%2520biosynthetic%2520engineering%253A%2520discovery%2520of%2520nonquinone%2520Hsp90%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5494%26epage%3D5497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Agatsuma, T.; Saitoh, Y.; Yamashita, Y.; Mizukami, T.; Akinaga, S.; Gomi, K.; Akasaka, K.; Takahashi, I.</span><span> </span><span class="NLM_article-title">Preparation of Radicicol Derivatives as Tyrosine Kinase Inhibitors</span>. WO 96/33989,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=T.+Agatsuma&author=Y.+Saitoh&author=Y.+Yamashita&author=T.+Mizukami&author=S.+Akinaga&author=K.+Gomi&author=K.+Akasaka&author=I.+Takahashi&title=Preparation+of+Radicicol+Derivatives+as+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAgatsuma%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Radicicol%2520Derivatives%2520as%2520Tyrosine%2520Kinase%2520Inhibitors%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Ikuina, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amishiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakata, C.</span><span> </span><span class="NLM_article-title">Synthesis and antitumor activity of novel <i>O</i>-carbamoylmethyloxime derivatives of radicicol</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2534</span><span class="NLM_x">–</span> <span class="NLM_lpage">2541</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030110r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2534-2541&author=Y.+Ikuinaauthor=N.+Amishiroauthor=M.+Miyataauthor=H.+Narumiauthor=H.+Ogawaauthor=T.+Akiyamaauthor=Y.+Shiotsuauthor=S.+Akinagaauthor=C.+Murakata&title=Synthesis+and+antitumor+activity+of+novel+O-carbamoylmethyloxime+derivatives+of+radicicol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm030110r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030110r%26sid%3Dliteratum%253Aachs%26aulast%3DIkuina%26aufirst%3DY.%26aulast%3DAmishiro%26aufirst%3DN.%26aulast%3DMiyata%26aufirst%3DM.%26aulast%3DNarumi%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DMurakata%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520antitumor%2520activity%2520of%2520novel%2520O-carbamoylmethyloxime%2520derivatives%2520of%2520radicicol%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2534%26epage%3D2541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of HSP90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.2174%2F156802608784911644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18673171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVant7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=859-868&author=M.+J.+Drysdaleauthor=P.+A.+Brough&title=Medicinal+chemistry+of+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of Hsp90 inhibitors</span></div><div class="casAuthors">Drysdale, Martin J.; Brough, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">859-868</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp90) inhibitors are an increasingly interesting and important class of compds. where the first in class, natural product derived inhibitors such as 17-allylaminogeldanamycin (17-AAG), are entering late stage clin. development.  Recently the emergence of synthetic, small mol. inhibitors has been described and both NVP-AUY922 and BIIB021 have entered clin. development.  The medicinal chem. of these and other published small mol. Hsp90 inhibitors is described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_sn_Ez1pvv7Vg90H21EOLACvtfcHk0lgFd4AEFduMGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVant7Y%253D&md5=3e85f368ba92e36692b957c6e73d44a8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F156802608784911644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608784911644%26sid%3Dliteratum%253Aachs%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DMedicinal%2520chemistry%2520of%2520HSP90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D859%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Shiau, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southworth, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agard, D. A</span><span> </span><span class="NLM_article-title">Structural analysis of <i>E. coli</i> hsp90 reveals dramatic nucleotide-dependent conformational rearrangements</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=329-340&author=A.+K.+Shiauauthor=S.+F.+Harrisauthor=D.+R.+Southworthauthor=D.+A+Agard&title=Structural+analysis+of+E.+coli+hsp90+reveals+dramatic+nucleotide-dependent+conformational+rearrangements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DSouthworth%26aufirst%3DD.%2BR.%26aulast%3DAgard%26aufirst%3DD.%2BA%26atitle%3DStructural%2520analysis%2520of%2520E.%2520coli%2520hsp90%2520reveals%2520dramatic%2520nucleotide-dependent%2520conformational%2520rearrangements%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D329%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Ali, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Crystal structure of an HSP90-nucleotide-p23/Sba1 closed chaperone complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1017</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1038%2Fnature04716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16625188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1agtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=1013-1017&author=M.+M.+Aliauthor=S.+M.+Roeauthor=C.+K.+Vaughanauthor=P.+Meyerauthor=B.+Panaretouauthor=P.+W.+Piperauthor=C.+Prodromouauthor=L.+H.+Pearl&title=Crystal+structure+of+an+HSP90-nucleotide-p23%2FSba1+closed+chaperone+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex</span></div><div class="casAuthors">Ali, Maruf M. U.; Roe, S. Mark; Vaughan, Cara K.; Meyer, Phillipe; Panaretou, Barry; Piper, Peter W.; Prodromou, Chrisostomos; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7087</span>),
    <span class="NLM_cas:pages">1013-1017</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hsp90 (heat shock protein of 90 kDa) is a ubiquitous mol. chaperone responsible for the assembly and regulation of many eukaryotic signaling systems and is an emerging target for rational chemotherapy of many cancers.  Although the structures of isolated domains of Hsp90 have been detd., the arrangement and ATP-dependent dynamics of these in the full Hsp90 dimer have been elusive and contentious.  Here we present the crystal structure of full-length yeast Hsp90 in complex with an ATP analog and the co-chaperone p23/Sba1.  The structure reveals the complex architecture of the closed' state of the Hsp90 chaperone, the extensive interactions between domains and between protein chains, the detailed conformational changes in the amino-terminal domain that accompany ATP binding, and the structural basis for stabilization of the closed state by p23/Sba1.  Contrary to expectations, the closed Hsp90 would not enclose its client proteins but provides a bipartite binding surface whose formation and disruption are coupled to the chaperone ATPase cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcaj34ODndPbVg90H21EOLACvtfcHk0lhh4GgFcctBzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1agtLw%253D&md5=15ea0bcf7cbf297b3f4a7005c7798fb0</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnature04716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04716%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DM.%2BM.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DVaughan%26aufirst%3DC.%2BK.%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520an%2520HSP90-nucleotide-p23%252FSba1%2520closed%2520chaperone%2520complex%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D1013%26epage%3D1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=41-56&author=D.+E.+Dollinsauthor=J.+J.+Warrenauthor=R.+M.+Immorminoauthor=D.+T.+Gewirth&title=Structures+of+GRP94-nucleotide+complexes+reveal+mechanistic+differences+between+the+hsp90+chaperones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DWarren%26aufirst%3DJ.%2BJ.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructures%2520of%2520GRP94-nucleotide%2520complexes%2520reveal%2520mechanistic%2520differences%2520between%2520the%2520hsp90%2520chaperones%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D28%26spage%3D41%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Wandinger, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">The HSP90 chaperone machinery</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">18473</span><span class="NLM_x">–</span> <span class="NLM_lpage">18477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=18473-18477&author=S.+K.+Wandingerauthor=K.+Richterauthor=J.+Buchner&title=The+HSP90+chaperone+machinery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWandinger%26aufirst%3DS.%2BK.%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DThe%2520HSP90%2520chaperone%2520machinery%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D18473%26epage%3D18477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Identification and structural characterization of the ATP/ADP-binding site in the HSP90 molecular chaperone</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS0092-8674%2800%2980314-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=9230303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaK2sXkslShtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=65-75&author=C.+Prodromouauthor=S.+M.+Roeauthor=R.+O%27Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=Identification+and+structural+characterization+of+the+ATP%2FADP-binding+site+in+the+HSP90+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone</span></div><div class="casAuthors">Prodromou, Chrisostomos; Roe, S. Mark; O'Brien, Ronan; Ladbury, John E.; Piper, Peter W.; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-75</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hsp90 mol. chaperones in eukaryotic cells play essential roles in the folding and activation of a range of client proteins involved in cell cycle regulation, steroid hormone responsiveness, and signal transduction.  The biochem. mechanism of Hsp90 is poorly understood, and the involvement of ATP in particular is controversial.  Crystal structures of complexes between the n-terminal domain of the yeast Hsp90 chaperone and ADP ATP unambiguously identify a specific adenine nucleotide binding site homologous to the ATP-binding site of DNA gyrase B.  This site is the same as that identified for the antitumor agent geldanamycin, suggesting that geldanamycin acts by blocking the binding of nucleotides to Hsp90 and not the binding of incompletely folded client polypeptides as previously suggested.  These results finally resolve the question of the direct involvement of ATP in Hsp90 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFYXzazhDOZLVg90H21EOLACvtfcHk0lhh4GgFcctBzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslShtLc%253D&md5=54dd6b1b47538c3fe4eca43904850df6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980314-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980314-1%26sid%3Dliteratum%253Aachs%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DO%2527Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DIdentification%2520and%2520structural%2520characterization%2520of%2520the%2520ATP%252FADP-binding%2520site%2520in%2520the%2520HSP90%2520molecular%2520chaperone%26jtitle%3DCell%26date%3D1997%26volume%3D90%26spage%3D65%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Meyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS1097-2765%2803%2900065-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=12667448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVWkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=647-658&author=P.+Meyerauthor=C.+Prodromouauthor=B.+Huauthor=C.+Vaughanauthor=S.+M.+Roeauthor=B.+Panaretouauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=Structural+and+functional+analysis+of+the+middle+segment+of+hsp90%3A+implications+for+ATP+hydrolysis+and+client+protein+and+cochaperone+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional analysis of the middle segment of Hsp90: Implications for ATP hydrolysis and client protein and cochaperone interactions</span></div><div class="casAuthors">Meyer, Philippe; Prodromou, Chrisostomos; Hu, Bin; Vaughan, Cara; Roe, S. Mark; Panaretou, Barry; Piper, Peter W.; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">647-658</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activation of client proteins by the Hsp90 mol. chaperone is dependent on binding and hydrolysis of ATP, which drives a mol. clamp via transient dimerization of the N-terminal domains.  The crystal structure of the middle segment of yeast Hsp90 reveals considerable evolutionary divergence from the equiv. regions of other GHKL protein family members such as MutL and GyrB, including an addnl. domain of new fold.  Using the known structure of the N-terminal nucleotide binding domain, a model for the Hsp90 dimer has been constructed.  From this structure, residues implicated in the ATPase-coupled conformational cycle and in interactions with client proteins and the activating cochaperone Aha1 have been identified, and their roles functionally characterized in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqewICLgiRIuLVg90H21EOLACvtfcHk0lhh4GgFcctBzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVWkt7w%253D&md5=b1635443b8c376b1159ec1353472bf13</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900065-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900065-0%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DVaughan%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DStructural%2520and%2520functional%2520analysis%2520of%2520the%2520middle%2520segment%2520of%2520hsp90%253A%2520implications%2520for%2520ATP%2520hydrolysis%2520and%2520client%2520protein%2520and%2520cochaperone%2520interactions%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26spage%3D647%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span> </span><span class="NLM_article-title">Modulation of Akt kinase activity by binding to HSP90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">10832</span><span class="NLM_x">–</span> <span class="NLM_lpage">10837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10832-10837&author=S.+Satoauthor=N.+Fujitaauthor=T.+Tsuruo&title=Modulation+of+Akt+kinase+activity+by+binding+to+HSP90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DN.%26aulast%3DTsuruo%26aufirst%3DT.%26atitle%3DModulation%2520of%2520Akt%2520kinase%2520activity%2520by%2520binding%2520to%2520HSP90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D10832%26epage%3D10837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiau, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agard, D. A.</span><span> </span><span class="NLM_article-title">The crystal structure of the carboxy-terminal dimerization domain of htpG, the <i>Escherichia coli</i> HSP90, reveals a potential substrate binding site</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1087-1097&author=S.+F.+Harrisauthor=A.+K.+Shiauauthor=D.+A.+Agard&title=The+crystal+structure+of+the+carboxy-terminal+dimerization+domain+of+htpG%2C+the+Escherichia+coli+HSP90%2C+reveals+a+potential+substrate+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26atitle%3DThe%2520crystal%2520structure%2520of%2520the%2520carboxy-terminal%2520dimerization%2520domain%2520of%2520htpG%252C%2520the%2520Escherichia%2520coli%2520HSP90%252C%2520reveals%2520a%2520potential%2520substrate%2520binding%2520site%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D1087%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Minami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahara, I.</span><span> </span><span class="NLM_article-title">The carboxy-terminal region of mammalian HSP90 is required for its dimerization and function in vivo</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=8289821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaK2cXhvVGlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=1459-1464&author=Y.+Minamiauthor=Y.+Kimuraauthor=H.+Kawasakiauthor=K.+Suzukiauthor=I.+Yahara&title=The+carboxy-terminal+region+of+mammalian+HSP90+is+required+for+its+dimerization+and+function+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The carboxy-terminal region of mammalian HSP90 is required for its dimerization and function in vivo</span></div><div class="casAuthors">Minami, Yasufumi; Kimura, Yoko; Kawasaki, Hiroshi; Suzuki, Koichi; Yahara, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1459-64</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">The majority of mouse HSP90 exists as α-α and β-β homodimers.  Truncation of the 15-kDa carboxy-terminal region of mouse HSP90 by digestion with the Ca2+-dependent protease m-calpain caused dissocn. of the dimer.  When expressed in a reticulocyte lysate, the full-length human HSP90α formed a dimeric form.  A plasmid harboring human HSP90α cDNA was constructed so that the carboxy-terminal 49 amino acid residues were removed when translated in vitro.  This carboxy-terminally truncated human HSP90α was found to exist as a monomer.  In contrast, loss of the 118 amino acid residues from the amino terminus of human HSP90α did not affect its in vitro dimerization.  Introduction of an expression plasmid harboring the full-length human HSP90α complements the lethality caused by the double mutations of two HSP90-related genes, hsp82 and hsc82, in a haploid strain of Saccharomyces cerevisiae.  The carboxy-terminally truncated human HSP90α neither formed dimers in yeast cells nor rescued the lethal double mutant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm54tIR10nNLVg90H21EOLACvtfcHk0lgyMmDs7o2oqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhvVGlsbc%253D&md5=151905625b933abd7e18dea113da7eb7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinami%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DKawasaki%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DYahara%26aufirst%3DI.%26atitle%3DThe%2520carboxy-terminal%2520region%2520of%2520mammalian%2520HSP90%2520is%2520required%2520for%2520its%2520dimerization%2520and%2520function%2520in%2520vivo%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1994%26volume%3D14%26spage%3D1459%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Richter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainzl, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">Intrinsic inhibition of the HSP90 ATPase activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">11301</span><span class="NLM_x">–</span> <span class="NLM_lpage">11311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1074%2Fjbc.M510142200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16461354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFWjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=11301-11311&author=K.+Richterauthor=S.+Moserauthor=F.+Hagnauthor=R.+Friedrichauthor=O.+Hainzlauthor=M.+Hellerauthor=S.+Schleeauthor=H.+Kesslerauthor=J.+Reinsteinauthor=J.+Buchner&title=Intrinsic+inhibition+of+the+HSP90+ATPase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic Inhibition of the Hsp90 ATPase Activity</span></div><div class="casAuthors">Richter, Klaus; Moser, Sandra; Hagn, Franz; Friedrich, Rainer; Hainzl, Otmar; Heller, Markus; Schlee, Sandra; Kessler, Horst; Reinstein, Jochen; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">11301-11311</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mol. chaperone Hsp90 is required for the folding and activation of a large no. of substrate proteins.  These are involved in essential cellular processes ranging from signal transduction to viral replication.  For the activation of its substrates, Hsp90 binds and hydrolyzes ATP, which is the key driving force for conformational conversions within the dimeric chaperone.  Dimerization of Hsp90 is mediated by a C-terminal dimerization site.  In addn., there is a transient ATP-induced dimerization of the two N-terminal ATP-binding domains.  The resulting ring-like structure is thought to be the ATPase-active conformation.  Hsp90 is a slow ATPase with a turnover no. of 1 ATP/min for the yeast protein.  A key question for understanding the mol. mechanism of Hsp90 is how ATP hydrolysis is regulated and linked to conformational changes.  In this study, we analyzed the activation process structurally and biochem. with a view to identify the conformational limitations of the ATPase reaction cycle.  We showed that the first 24 amino acids stabilize the N-terminal domain in a rigid state.  Their removal confers flexibility specifically to the region between amino acids 98 and 120.  Most surprisingly, the deletion of this structure results in the complete loss of ATPase activity and in increased N-terminal dimerization.  Complementation assays using heterodimeric Hsp90 show that this rigid lid acts as an intrinsic kinetic inhibitor of the Hsp90 ATPase cycle preventing N-terminal dimerization in the ground state.  On the other hand, this structure acts in concert with the 24 N-terminal amino acids of the other N-terminal domain to form an activated ATPase and thus regulates the turnover no. of Hsp90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU8XaKrwQtkrVg90H21EOLACvtfcHk0lgyMmDs7o2oqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFWjtr4%253D&md5=a25cf0f740198a58603f724d3158f79c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M510142200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M510142200%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DMoser%26aufirst%3DS.%26aulast%3DHagn%26aufirst%3DF.%26aulast%3DFriedrich%26aufirst%3DR.%26aulast%3DHainzl%26aufirst%3DO.%26aulast%3DHeller%26aufirst%3DM.%26aulast%3DSchlee%26aufirst%3DS.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DReinstein%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DIntrinsic%2520inhibition%2520of%2520the%2520HSP90%2520ATPase%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D11301%26epage%3D11311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Wegele, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">Hsp70 and HSP90, a relay team for protein folding</span> <span class="citation_source-journal">Rev. Physiol. Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1007%2Fs10254-003-0021-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=14740253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFWqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2004&pages=1-44&author=H.+Wegeleauthor=L.+Mullerauthor=J.+Buchner&title=Hsp70+and+HSP90%2C+a+relay+team+for+protein+folding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp70 and Hsp90 - a relay team for protein folding</span></div><div class="casAuthors">Wegele, H.; Mueller, L.; Buchner, J.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews of Physiology, Biochemistry and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-44</span>CODEN:
                <span class="NLM_cas:coden">RPBEA5</span>;
        ISSN:<span class="NLM_cas:issn">0303-4240</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Mol. chaperones are a functionally defined set of proteins which assist the structure formation of proteins in vivo.  Without certain protective mechanisms, such as binding nascent polypeptide chains by mol. chaperones, cellular protein concns. would lead to misfolding and aggregation.  In the mammalian system, mol. chaperones Hsp70 and Hsp90 are involved in the folding and maturation of key regulatory proteins, like steroid hormone receptors, transcription factors, and kinases, some of which are involved in cancer progression.  Hsp70 and Hsp90 form a multichaperone complex, in which both are connected by a 3rd protein called Hop.  The connection of and the interplay between the 2 chaperone machineries is of crucial importance for cell viability.  This review provides a detailed view of the Hsp70 and Hsp90 machineries, their cofactors, and their mode of regulation.  It summarizes the current knowledge in the field, including the ATP-dependent regulation of the Hsp70/Hsp90 multichaperone cycle and elucidates the complex interplay and their synergistic interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjgKipZ7s6ZbVg90H21EOLACvtfcHk0libiOSu4OCwaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFWqtrg%253D&md5=4095fcaa6fe7424050fabee5200b37b3</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs10254-003-0021-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10254-003-0021-1%26sid%3Dliteratum%253Aachs%26aulast%3DWegele%26aufirst%3DH.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DHsp70%2520and%2520HSP90%252C%2520a%2520relay%2520team%2520for%2520protein%2520folding%26jtitle%3DRev.%2520Physiol.%2520Biochem.%2520Pharmacol.%26date%3D2004%26volume%3D151%26spage%3D1%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Onuoha, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulstock, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossmann, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. E.</span><span> </span><span class="NLM_article-title">Structural studies on the co-chaperone Hop and its complexes with HSP90</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2008&pages=732-744&author=S.+C.+Onuohaauthor=E.+T.+Coulstockauthor=J.+G.+Grossmannauthor=S.+E.+Jackson&title=Structural+studies+on+the+co-chaperone+Hop+and+its+complexes+with+HSP90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnuoha%26aufirst%3DS.%2BC.%26aulast%3DCoulstock%26aufirst%3DE.%2BT.%26aulast%3DGrossmann%26aufirst%3DJ.%2BG.%26aulast%3DJackson%26aufirst%3DS.%2BE.%26atitle%3DStructural%2520studies%2520on%2520the%2520co-chaperone%2520Hop%2520and%2520its%2520complexes%2520with%2520HSP90%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D379%26spage%3D732%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Ballinger, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span> </span><span class="NLM_article-title">Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4535</span><span class="NLM_x">–</span> <span class="NLM_lpage">4545</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1128%2FMCB.19.6.4535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=10330192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaK1MXjt1yisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=4535-4545&author=C.+A.+Ballingerauthor=P.+Connellauthor=Y.+Wuauthor=Z.+Huauthor=L.+J.+Thompsonauthor=L.+Y.+Yinauthor=C.+Patterson&title=Identification+of+CHIP%2C+a+novel+tetratricopeptide+repeat-containing+protein+that+interacts+with+heat+shock+proteins+and+negatively+regulates+chaperone+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions</span></div><div class="casAuthors">Ballinger, Carol A.; Connell, Patrice; Wu, Yaxu; Hu, Zhaoyong; Thompson, Larry J.; Yin, Li-Yan; Patterson, Cam</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4535-4545</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The chaperone function of the mammalian 70-kDa heat shock proteins Hsc70 and Hsp70 is modulated by phys. interactions with four previously identified chaperone cofactors: Hsp40, BAG-1, the Hsc70-interacting protein Hip, and the Hsc70-hsp90-organizing protein Hop.  Hip and Hop interact with Hsc70 via a tetratricopeptide repeat domain.  In a search for addnl. tetratricopeptide repeat-contg. proteins, the authors have identified a novel 35-kDa cytoplasmic protein, carboxyl terminus of Hsc70-interacting protein (CHIP).  CHIP is highly expressed in adult striated muscle in vivo and is expressed broadly in vitro in tissue culture.  Hsc70 and Hsp70 were identified as potential interaction partners for this protein in a yeast two-hybrid screen.  In vitro binding assays demonstrated direct interactions between CHIP and both Hsc70 and Hsp70, and complexes contg. CHIP and Hsc70 were identified in immunoppts. of human skeletal muscle cells in vivo.  Using glutathione S-transferase fusions, the authors found that CHIP interacted with the carboxy-terminal residues 540 to 650 of Hsc70, whereas Hsc70 interacted with the amino-terminal residues 1 to 197 (contg. the tetratricopeptide domain and an adjacent charged domain) of CHIP.  Recombinant CHIP inhibited Hsp40-stimulated ATPase activity of Hsc70 and Hsp70, suggesting that CHIP blocks the forward reaction of the Hsc70-Hsp70 substrate-binding cycle.  Consistent with this observation, both luciferase refolding and substrate binding in the presence of Hsp40 and Hsp70 were inhibited by CHIP.  Taken together, these results indicate that CHIP decreases net ATPase activity and reduces chaperone efficiency, and they implicate CHIP in the neg. regulation of the forward reaction of the Hsc70-Hsp70 substrate-binding cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryOQ7k2PDUhLVg90H21EOLACvtfcHk0libiOSu4OCwaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjt1yisL8%253D&md5=d1baaf9ca0c3d91a169fcb31e3dec763</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1128%2FMCB.19.6.4535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.19.6.4535%26sid%3Dliteratum%253Aachs%26aulast%3DBallinger%26aufirst%3DC.%2BA.%26aulast%3DConnell%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DThompson%26aufirst%3DL.%2BJ.%26aulast%3DYin%26aufirst%3DL.%2BY.%26aulast%3DPatterson%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520CHIP%252C%2520a%2520novel%2520tetratricopeptide%2520repeat-containing%2520protein%2520that%2520interacts%2520with%2520heat%2520shock%2520proteins%2520and%2520negatively%2520regulates%2520chaperone%2520functions%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D4535%26epage%3D4545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Connell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinger, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohfeld, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span> </span><span class="NLM_article-title">The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1038%2F35070170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11146632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslGqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=93-96&author=P.+Connellauthor=C.+A.+Ballingerauthor=J.+Jiangauthor=Y.+Wuauthor=L.+J.+Thompsonauthor=J.+Hohfeldauthor=C.+Patterson&title=The+co-chaperone+CHIP+regulates+protein+triage+decisions+mediated+by+heat-shock+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins</span></div><div class="casAuthors">Connell, Patrice; Ballinger, Carol A.; Jiang, Jihong; Wu, Yaxu; Thompson, Larry J.; Hohfeld, Jorg; Patterson, Cam</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-96</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To maintain quality control in cells, mechanisms distinguish among improperly folded peptides, mature and functional proteins, and proteins to be targeted for degrdn.  The mol. chaperones, including heat-shock protein Hsp90, have the ability to recognize misfolded proteins and assist in their conversion to a functional conformation.  Disruption of Hsp90 heterocomplexes by the Hsp90 inhibitor geldanamycin leads to substrate degrdn. through the ubiquitin-proteasome pathway, implicating this system in protein triage decisions.  We previously identified CHIP (carboxyl terminus of Hsc70-interacting protein) to be an interaction partner of Hsc70 (ref. 4).  CHIP also interacts directly with a tetratricopeptide repeat acceptor site of Hsp90, incorporating into Hsp90 heterocomplexes and eliciting release of the regulatory cofactor p23.  Here we show that CHIP abolishes the steroid-binding activity and transactivation potential of the glucocorticoid receptor, a well-characterized Hsp90 substrate, even though it has little effect on its synthesis.  Instead, CHIP induces ubiquitination of the glucocorticoid receptor and degrdn. through the proteasome.  By remodelling Hsp90 heterocomplexes to favor substrate degrdn., CHIP modulates protein triage decisions that regulate the balance between protein folding and degrdn. for chaperone substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLcICHJwNISLVg90H21EOLACvtfcHk0libiOSu4OCwaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslGqsQ%253D%253D&md5=575a74b738bee74e5e5d4d9a27bc6a04</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2F35070170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35070170%26sid%3Dliteratum%253Aachs%26aulast%3DConnell%26aufirst%3DP.%26aulast%3DBallinger%26aufirst%3DC.%2BA.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DThompson%26aufirst%3DL.%2BJ.%26aulast%3DHohfeld%26aufirst%3DJ.%26aulast%3DPatterson%26aufirst%3DC.%26atitle%3DThe%2520co-chaperone%2520CHIP%2520regulates%2520protein%2520triage%2520decisions%2520mediated%2520by%2520heat-shock%2520proteins%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2001%26volume%3D3%26spage%3D93%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Meacham, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyr, D. M.</span><span> </span><span class="NLM_article-title">The Hsp70 co-chaperone CHIP targets immature CFTR for proteasomal degradation</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1038%2F35050509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11146634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslGqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=100-105&author=G.+C.+Meachamauthor=C.+Pattersonauthor=W.+Zhangauthor=J.+M.+Youngerauthor=D.+M.+Cyr&title=The+Hsp70+co-chaperone+CHIP+targets+immature+CFTR+for+proteasomal+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation</span></div><div class="casAuthors">Meacham, Geoffrey C.; Patterson, Cam; Zhang, Wenyue; Younger, J. Michael; Cyr, Douglas M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-105</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The folding of both wild-type and mutant forms of the cystic-fibrosis transmembrane-conductance regulator (CFTR), a plasma-membrane chloride-ion channel, is inefficient.  Most nascent CFTR is retained in the endoplasmic reticulum and degraded by the ubiquitin proteasome pathway.  Aberrant folding and defective trafficking of CFTRΔF508 is the principal cause of cystic fibrosis, but how the endoplasmic-reticulum quality-control system targets CFTR for degrdn. remains unknown.  CHIP is a cytosolic U-box protein that interacts with Hsc70 through a set of tetratricorepeat motifs.  The U-box represents a modified form of the ring-finger motif that is found in ubiquitin ligases and that defines the E4 family of polyubiquitination factors.  Here the authors show that CHIP functions with Hsc70 to sense the folded state of CFTR and targets aberrant forms for proteasomal degrdn. by promoting their ubiquitination.  The U-box appeared essential for this process because overexpression of CHIPΔU-box inhibited the action of endogenous CHIP and blocked CFTR ubiquitination and degrdn.  CHIP is a co-chaperone that converts Hsc70 from a protein-folding machine into a degrdn. factor that functions in endoplasmic-reticulum quality control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR2XvF2JH4WLVg90H21EOLACvtfcHk0libiOSu4OCwaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslGqtw%253D%253D&md5=65875810d882127157d1c23452e2b327</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2F35050509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050509%26sid%3Dliteratum%253Aachs%26aulast%3DMeacham%26aufirst%3DG.%2BC.%26aulast%3DPatterson%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYounger%26aufirst%3DJ.%2BM.%26aulast%3DCyr%26aufirst%3DD.%2BM.%26atitle%3DThe%2520Hsp70%2520co-chaperone%2520CHIP%2520targets%2520immature%2520CFTR%2520for%2520proteasomal%2520degradation%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2001%26volume%3D3%26spage%3D100%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Murata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span> </span><span class="NLM_article-title">CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1093%2Fembo-reports%2Fkve246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11743028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Ciug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=1133-1138&author=S.+Murataauthor=Y.+Minamiauthor=M.+Minamiauthor=T.+Chibaauthor=K.+Tanaka&title=CHIP+is+a+chaperone-dependent+E3+ligase+that+ubiquitylates+unfolded+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein</span></div><div class="casAuthors">Murata, Shigeo; Minami, Yasufumi; Minami, Michiko; Chiba, Tomoki; Tanaka, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1133-1138</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The ubiquitin-proteasome system catalyzes the immediate destruction of misfolded or impaired proteins generated in cells, but how this proteolytic machinery recognizes abnormality of cellular proteins for selective elimination remains elusive.  Here, we report that the C-terminus of Hsc70-interacting protein (CHIP) with a U-box domain is an E3 ubiquitin-ligase collaborating with mol. chaperones Hsp90 and Hsc70.  Thermally denatured firefly luciferase was multiubiquitylated by CHIP in the presence of E1 and E2 (Ubc4 or UbcH5c) in vitro, only when the unfolded substrate was captured by Hsp90 or Hsc70 and Hsp40.  No ubiquitylating activity was detected in CHIP lacking the U-box region.  CHIP efficiently ubiquitylated denatured luciferase trapped by the C-terminal region of Hsp90, which contains a CHIP binding site.  CHIP also showed self-ubiquitylating activity independent of target ubiquitylation.  Our results indicate that CHIP can be regarded as "a quality-control E3" that selectively ubiquitylates unfolded protein(s) by collaborating with mol. chaperones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRqke0yhJ4NbVg90H21EOLACvtfcHk0libZNA3JpiGxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Ciug%253D%253D&md5=06a57e11ed0a550cf5a2392dd58b94f2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1093%2Fembo-reports%2Fkve246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fembo-reports%252Fkve246%26sid%3Dliteratum%253Aachs%26aulast%3DMurata%26aufirst%3DS.%26aulast%3DMinami%26aufirst%3DY.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DCHIP%2520is%2520a%2520chaperone-dependent%2520E3%2520ligase%2520that%2520ubiquitylates%2520unfolded%2520protein%26jtitle%3DEMBO%2520Rep.%26date%3D2001%26volume%3D2%26spage%3D1133%26epage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Dai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madamanchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span> </span><span class="NLM_article-title">CHIP activates HSF1 and confers protection against apoptosis and cellular stress</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5446</span><span class="NLM_x">–</span> <span class="NLM_lpage">5458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=5446-5458&author=Q.+Daiauthor=C.+Zhangauthor=Y.+Wuauthor=H.+McDonoughauthor=R.+A.+Whaleyauthor=V.+Godfreyauthor=H.+H.+Liauthor=N.+Madamanchiauthor=W.+Xuauthor=L.+Neckersauthor=D.+Cyrauthor=C.+Patterson&title=CHIP+activates+HSF1+and+confers+protection+against+apoptosis+and+cellular+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMcDonough%26aufirst%3DH.%26aulast%3DWhaley%26aufirst%3DR.%2BA.%26aulast%3DGodfrey%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DH.%2BH.%26aulast%3DMadamanchi%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DCyr%26aufirst%3DD.%26aulast%3DPatterson%26aufirst%3DC.%26atitle%3DCHIP%2520activates%2520HSF1%2520and%2520confers%2520protection%2520against%2520apoptosis%2520and%2520cellular%2520stress%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D5446%26epage%3D5458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Obermann, W. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sondermann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">In vivo function of HSP90 is dependent on ATP binding and ATP hydrolysis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1998&pages=901-910&author=W.+M.+J.+Obermannauthor=H.+Sondermannauthor=A.+A.+Russoauthor=N.+P.+Pavletichauthor=F.+U.+Hartl&title=In+vivo+function+of+HSP90+is+dependent+on+ATP+binding+and+ATP+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObermann%26aufirst%3DW.%2BM.%2BJ.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DIn%2520vivo%2520function%2520of%2520HSP90%2520is%2520dependent%2520on%2520ATP%2520binding%2520and%2520ATP%2520hydrolysis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1998%26volume%3D143%26spage%3D901%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandon, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalusa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2850</span><span class="NLM_x">–</span> <span class="NLM_lpage">2860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2850-2860&author=S.+A.+Ecclesauthor=A.+Masseyauthor=F.+I.+Raynaudauthor=S.+Y.+Sharpauthor=G.+Boxauthor=M.+Valentiauthor=L.+Pattersonauthor=A.+D.+Brandonauthor=S.+Gowanauthor=F.+Boxallauthor=W.+Aherneauthor=M.+Rowlandsauthor=A.+Hayesauthor=V.+Martinsauthor=F.+Urbanauthor=K.+Boxallauthor=C.+Prodromouauthor=L.+Pearlauthor=K.+Jamesauthor=T.+P.+Matthewsauthor=K.+M.+Cheungauthor=A.+Kalusaauthor=K.+Jonesauthor=E.+McDonaldauthor=X.+Barrilauthor=P.+A.+Broughauthor=J.+E.+Cansfieldauthor=B.+Dymockauthor=M.+J.+Drysdaleauthor=H.+Finchauthor=R.+Howesauthor=R.+E.+Hubbardauthor=A.+Surgenorauthor=P.+Webbauthor=M.+Woodauthor=L.+Wrightauthor=P.+Workman&title=NVP-AUY922%3A+a+novel+heat+shock+protein+90+inhibitor+active+against+xenograft+tumor+growth%2C+angiogenesis%2C+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DPatterson%26aufirst%3DL.%26aulast%3DBrandon%26aufirst%3DA.%2BD.%26aulast%3DGowan%26aufirst%3DS.%26aulast%3DBoxall%26aufirst%3DF.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DRowlands%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DUrban%26aufirst%3DF.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DKalusa%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DNVP-AUY922%253A%2520a%2520novel%2520heat%2520shock%2520protein%252090%2520inhibitor%2520active%2520against%2520xenograft%2520tumor%2520growth%252C%2520angiogenesis%252C%2520and%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2850%26epage%3D2860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Barta, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenks, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabasz, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span> </span><span class="NLM_article-title">Discovery of benzamide tetrahydro-4<i>H</i>-carbazol-4-ones as novel small molecule inhibitors of HSP90</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3517</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2Fj.bmcl.2008.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18511277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFSns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3517-3521&author=T.+E.+Bartaauthor=J.+M.+Vealauthor=J.+W.+Riceauthor=J.+M.+Partridgeauthor=R.+P.+Faddenauthor=W.+Maauthor=M.+Jenksauthor=L.+F.+Gengauthor=G.+J.+Hansonauthor=K.+H.+Huangauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=J.+Ottoauthor=S.+E.+Hall&title=Discovery+of+benzamide+tetrahydro-4H-carbazol-4-ones+as+novel+small+molecule+inhibitors+of+HSP90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90</span></div><div class="casAuthors">Barta, Thomas E.; Veal, James M.; Rice, John W.; Partridge, Jeffrey M.; Fadden, R. Patrick; Ma, Wei; Jenks, Matthew; Geng, Lifeng; Hanson, Gunnar J.; Huang, Kenneth H.; Barabasz, Amy F.; Foley, Briana E.; Otto, James; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3517-3521</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Hsp90 maintains the conformational stability of multiple proteins implicated in oncogenesis and has emerged as a target for chemotherapy.  We report here the discovery of a novel small mol. scaffold that inhibits Hsp90.  X-ray data show that the scaffold binds competitively at the ATP site on Hsp90.  Cellular proliferation and client assays demonstrate that members of the series are able to inhibit Hsp90 at nanomolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC-Wjx_IUjKbVg90H21EOLACvtfcHk0lhOxMyEX-LhYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFSns74%253D&md5=f965e9a2cfd0d44a57bb1949cd87de63</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%2BF.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520benzamide%2520tetrahydro-4H-carbazol-4-ones%2520as%2520novel%2520small%2520molecule%2520inhibitors%2520of%2520HSP90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3517%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Structure−activity relationships in purine-based inhibitor binding to HSP90 isoforms</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2Fj.chembiol.2004.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=15217611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=775-785&author=L.+Wrightauthor=X.+Barrilauthor=B.+Dymockauthor=L.+Sheridanauthor=A.+Surgenorauthor=M.+Beswickauthor=M.+Drysdaleauthor=A.+Collierauthor=A.+Masseyauthor=N.+Daviesauthor=A.+Finkauthor=C.+Fromontauthor=W.+Aherneauthor=K.+Boxallauthor=S.+Sharpauthor=P.+Workmanauthor=R.+E.+Hubbard&title=Structure%E2%88%92activity+relationships+in+purine-based+inhibitor+binding+to+HSP90+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms</span></div><div class="casAuthors">Wright, Lisa; Barril, Xavier; Dymock, Brian; Sheridan, Louisa; Surgenor, Allan; Beswick, Mandy; Drysdale, Martin; Collier, Adam; Massey, Andy; Davies, Nick; Fink, Alex; Fromont, Christophe; Aherne, Wynne; Boxall, Kathy; Sharp, Swee; Workman, Paul; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-785</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the chaperone protein HSP90 is a potential strategy for treatment of cancers.  We have detd. structures of the HSP90α N-terminal domain complexed with the purine-based inhibitor, PU3, and analogs with enhanced potency both in enzyme and cell-based assays.  The compds. induce upregulation of HSP70 and downregulation of the known HSP90 client proteins Raf-1, CDK4, and ErbB2, confirming that the mols. inhibit cell growth by a mechanism dependent on HSP90 inhibition.  We have also detd. the first structure of the N-terminal domain of HSP90β, complexed with PU3.  The structures allow a detailed rationale to be developed for the obsd. affinity of the PU3 class of compds. for HSP90 and also provide a structural framework for design of compds. with improved binding affinity and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Z11Wd4hiXrVg90H21EOLACvtfcHk0lhOxMyEX-LhYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D&md5=dd2146dba0f4b3198d5bc7023e645812</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DSheridan%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBeswick%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DCollier%26aufirst%3DA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DN.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520in%2520purine-based%2520inhibitor%2520binding%2520to%2520HSP90%2520isoforms%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D775%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Fritz, C. C.; Ge, J.; Hafeez, N.; Tillotson, B.; Depew, K.; Coco, J.; Basuki, J.; Lim, A.; Patterson, J.; Porter, J. R.; Palombella, V.; Normant, E.</span> (Infinity Pharmaceuticals) <span> </span><span class="NLM_article-title">Comparison of the Cellular and Biochemical Properties of Ansamycin and Non-Ansamycin Based Inhibitors</span>. Presented at the AACR-EORTC Meeting, Geneva,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=C.+C.+Fritz&author=J.+Ge&author=N.+Hafeez&author=B.+Tillotson&author=K.+Depew&author=J.+Coco&author=J.+Basuki&author=A.+Lim&author=J.+Patterson&author=J.+R.+Porter&author=V.+Palombella&author=E.+Normant&title=Comparison+of+the+Cellular+and+Biochemical+Properties+of+Ansamycin+and+Non-Ansamycin+Based+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DFritz%26aufirst%3DC.%2BC.%26atitle%3DComparison%2520of%2520the%2520Cellular%2520and%2520Biochemical%2520Properties%2520of%2520Ansamycin%2520and%2520Non-Ansamycin%2520Based%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">McCollum, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">TenEyck, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensgard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morlan, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballman, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlichman, C.</span><span> </span><span class="NLM_article-title">P-Glycoprotein-mediated resistance to HSP90-directed therapy is eclipsed by the heat shock response</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">7419</span><span class="NLM_x">–</span> <span class="NLM_lpage">7427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=7419-7427&author=A.+K.+McCollumauthor=C.+J.+TenEyckauthor=B.+Stensgardauthor=B.+W.+Morlanauthor=K.+V.+Ballmanauthor=R.+B.+Jenkinsauthor=D.+O.+Toftauthor=C.+Erlichman&title=P-Glycoprotein-mediated+resistance+to+HSP90-directed+therapy+is+eclipsed+by+the+heat+shock+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCollum%26aufirst%3DA.%2BK.%26aulast%3DTenEyck%26aufirst%3DC.%2BJ.%26aulast%3DStensgard%26aufirst%3DB.%26aulast%3DMorlan%26aufirst%3DB.%2BW.%26aulast%3DBallman%26aufirst%3DK.%2BV.%26aulast%3DJenkins%26aufirst%3DR.%2BB.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DErlichman%26aufirst%3DC.%26atitle%3DP-Glycoprotein-mediated%2520resistance%2520to%2520HSP90-directed%2520therapy%2520is%2520eclipsed%2520by%2520the%2520heat%2520shock%2520response%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D7419%26epage%3D7427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nguyen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mixon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrump, D. S.</span><span> </span><span class="NLM_article-title">Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin</span> <span class="citation_source-journal">J. Thorac. Cardiovasc. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1999&pages=908-915&author=D.+M.+Nguyenauthor=A.+Chenauthor=A.+Mixonauthor=D.+S.+Schrump&title=Sequence-dependent+enhancement+of+paclitaxel+toxicity+in+non-small+cell+lung+cancer+by+17-allylamino+17-demethoxygeldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DMixon%26aufirst%3DA.%26aulast%3DSchrump%26aufirst%3DD.%2BS.%26atitle%3DSequence-dependent%2520enhancement%2520of%2520paclitaxel%2520toxicity%2520in%2520non-small%2520cell%2520lung%2520cancer%2520by%252017-allylamino%252017-demethoxygeldanamycin%26jtitle%3DJ.%2520Thorac.%2520Cardiovasc.%2520Surg.%26date%3D1999%26volume%3D118%26spage%3D908%26epage%3D915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit72b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nguyen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabibi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrump, D. S.</span><span> </span><span class="NLM_article-title">Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis</span> <span class="citation_source-journal">Ann. Thorac. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72b&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS0003-4975%2801%2902787-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72b&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11515869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72b&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A280%3ADC%252BD3MvntFamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2001&pages=371-378&author=D.+M.+Nguyenauthor=D.+Lorangauthor=G.+A.+Chenauthor=J.+H.+Stewartauthor=E.+Tabibiauthor=D.+S.+Schrump&title=Enhancement+of+paclitaxel-mediated+cytotoxicity+in+lung+cancer+cells+by+17-allylamino+geldanamycin%3A+in+vitro+and+in+vivo+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72bR"><div class="casContent"><span class="casTitleNuber">72b</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis</span></div><div class="casAuthors">Nguyen D M; Lorang D; Chen G A; Stewart J H 4th; Tabibi E; Schrump D S</div><div class="citationInfo"><span class="NLM_cas:title">The Annals of thoracic surgery</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">371-8; discussion 378-9</span>
        ISSN:<span class="NLM_cas:issn">0003-4975</span>.
    </div><div class="casAbstract">BACKGROUND:  It has previously been demonstrated that 17-allylamino geldanamycin (17-AAG) enhances paclitaxel-mediated cytotoxicity and downregulates vascular endothelial factor expression in non-small cell lung cancer.  This project was designed to evaluate the tumoricidal and antiangiogeneic effects of 17-AAG and paclitaxel in H358 non-small cell lung cancer cells grown as xenografts in nude mice.  METHODS:  In vitro cytotoxic drug combination effects were evaluated by (4, 5-dimethylthiazo-2-yl)-2, 5-diphenyl tetrazolium bromide-based proliferation assays.  The combinations of 17-AAG and paclitaxel were administered intraperitoneally in nude mice bearing H358 tumor xenografts.  Tumor volumes were measured weekly.  Tumor expression of erbB2, vascular endothelial cell growth factor, von Willebrand factor (tumor microvasculature), and activated caspase 3 (apoptosis) were determined by immunohistochemistry.  RESULTS:  Five- to 22-fold enhancement of paclitaxel cytotoxicity was achieved by paclitaxel + 17-AAG combination that was paralleled with marked induction of apoptosis.  This combination treatment profoundly suppressed tumor growth and significantly prolonged survival of mice bearing H358 xenografts.  Immunohistochemical staining of tumor tissues indicated profound reduction of vascular endothelial cell growth factor expression associated with reduction of microvasculature in tumors treated with 17-AAG.  Apoptotic cells were more abundant in tumors treated with 17-AAG + paclitaxel than in those treated with 17-AAG or paclitaxel alone.  CONCLUSIONS:  Concurrent exposure of H358 cells to 17-AAG and paclitaxel resulted in supraadditive growth inhibition effects in vitro and in vivo.  Analysis of molecular markers of tumor tissues indicated that therapeutic drug levels could be achieved with this chemotherapy regimen leading to significant biological responses.  Moreover, 17-AAG-mediated suppression of vascular endothelial cell growth factor production by tumor cells may contribute to the antitumor effects of this drug combination in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6lhdZxuooAFQKX3ooHxWjfW6udTcc2eYkHWv9IE3Fjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvntFamtQ%253D%253D&md5=fa80347b05cd34e1586c8c4003fcb863</span></div><a href="/servlet/linkout?suffix=cit72b&amp;dbid=16384&amp;doi=10.1016%2FS0003-4975%2801%2902787-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-4975%252801%252902787-4%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DD.%2BM.%26aulast%3DLorang%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DG.%2BA.%26aulast%3DStewart%26aufirst%3DJ.%2BH.%26aulast%3DTabibi%26aufirst%3DE.%26aulast%3DSchrump%26aufirst%3DD.%2BS.%26atitle%3DEnhancement%2520of%2520paclitaxel-mediated%2520cytotoxicity%2520in%2520lung%2520cancer%2520cells%2520by%252017-allylamino%2520geldanamycin%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520analysis%26jtitle%3DAnn.%2520Thorac.%2520Surg.%26date%3D2001%26volume%3D72%26spage%3D371%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit72c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormerod, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rienzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, A. L.</span><span> </span><span class="NLM_article-title">Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72c&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1535-7163.MCT-05-0445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72c&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16731752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72c&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVWnurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1197-1208&author=N.+Sainauthor=B.+Krishnanauthor=M.+G.+Ormerodauthor=A.+De+Rienzoauthor=W.+M.+Liuauthor=S.+B.+Kayeauthor=P.+Workmanauthor=A.+L.+Jackman&title=Potentiation+of+paclitaxel+activity+by+the+HSP90+inhibitor+17-allylamino-17-demethoxygeldanamycin+in+human+ovarian+carcinoma+cell+lines+with+high+levels+of+activated+AKT"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72cR"><div class="casContent"><span class="casTitleNuber">72c</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT</span></div><div class="casAuthors">Sain, Nivedita; Krishnan, Bhavani; Ormerod, Michael G.; De Rienzo, Assunta; Liu, Wai M.; Kaye, Stanley B.; Workman, Paul; Jackman, Ann L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1197-1208</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activation of the phosphatidylinositol-3-kinase (PI3K)/AKT survival pathway is a mechanism of cytotoxic drug resistance in ovarian cancer, and inhibitors of this pathway can sensitize to cytotoxic drugs.  The HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) depletes some proteins involved in PI3K/AKT signaling, e.g., ERBB2, epidermal growth factor receptor (EGFR), and phosphorylated AKT (p-AKT).  17-AAG and paclitaxel were combined (at a fixed 1:1 ratio of their IC50) in four ovarian cancer cell lines that differ in expression of p-AKT, EGFR, and ERBB2.  The EGFR-overexpressing A431 and KB epidermoid cell lines were also included.  Combination indexes (CI) were calcd. using the median-effect equation and interpreted in the context of 17-AAG-mediated inhibition of PI3K signaling.  Synergy was obsd. in IGROV-1- and ERBB2-overexpressing SKOV-3 ovarian cancer cells that express a high level of constitutively activated p-AKT [CI at fraction unaffected (fu)0.5 = 0.50 and 0.53, resp.].  Slight synergy was obsd. in A431 cells (moderate p-AKT/overexpressed EGFR; CI at fu0.5 = 0.76) and antagonism in CH1 (moderate p-AKT), HX62 cells (low p-AKT), and KB cells (low p-AKT/overexpressed EGFR; CI at fu50 = 3.0, 3.5, and 2.0, resp.).  The obsd. effects correlated with changes in the rate of apoptosis induction.  17-AAG induced a decrease in HSP90 client proteins (e.g., C-RAF, ERBB2, and p-AKT) or in downstream markers of their activity (e.g., phosphorylated extracellular signal-regulated kinase or p-AKT) in SKOV-3, IGROV-1, and CH1 cells at IC50 concns.  A non-growth-inhibitory concn. (6 nmol/L) reduced the phosphorylation of AKT (but not extracellular signal-regulated kinase) and sensitized SKOV-3 cells to paclitaxel.  In conclusion, 17-AAG may sensitize a subset of ovarian cancer to paclitaxel, particularly those tumors in which resistance is driven by ERBB2 and/or p-AKT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOIHecJVgN37Vg90H21EOLACvtfcHk0ljW16o2fqg9AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVWnurc%253D&md5=7c6d1770fb9e7a92c31e3379ac8e93a4</span></div><a href="/servlet/linkout?suffix=cit72c&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0445%26sid%3Dliteratum%253Aachs%26aulast%3DSain%26aufirst%3DN.%26aulast%3DKrishnan%26aufirst%3DB.%26aulast%3DOrmerod%26aufirst%3DM.%2BG.%26aulast%3DDe%2BRienzo%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%2BM.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJackman%26aufirst%3DA.%2BL.%26atitle%3DPotentiation%2520of%2520paclitaxel%2520activity%2520by%2520the%2520HSP90%2520inhibitor%252017-allylamino-17-demethoxygeldanamycin%2520in%2520human%2520ovarian%2520carcinoma%2520cell%2520lines%2520with%2520high%2520levels%2520of%2520activated%2520AKT%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1197%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olshen, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to taxol</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">2139</span><span class="NLM_x">–</span> <span class="NLM_lpage">2144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2139-2144&author=D.+B.+Solitauthor=A.+D.+Bassoauthor=A.+B.+Olshenauthor=H.+I.+Scherauthor=N.+Rosen&title=Inhibition+of+heat+shock+protein+90+function+down-regulates+Akt+kinase+and+sensitizes+tumors+to+taxol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DBasso%26aufirst%3DA.%2BD.%26aulast%3DOlshen%26aufirst%3DA.%2BB.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%252090%2520function%2520down-regulates%2520Akt%2520kinase%2520and%2520sensitizes%2520tumors%2520to%2520taxol%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D2139%26epage%3D2144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">McCollum, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukasiewicz, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">TenEyck, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingle, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlichman, C.</span><span> </span><span class="NLM_article-title">Cisplatin abrogates the geldanamycin-induced heat shock response</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3256</span><span class="NLM_x">–</span> <span class="NLM_lpage">3264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1535-7163.MCT-08-0157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18852129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ensb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=3256-3264&author=A.+K.+McCollumauthor=K.+B.+Lukasiewiczauthor=C.+J.+TenEyckauthor=W.+L.+Lingleauthor=D.+O.+Toftauthor=C.+Erlichman&title=Cisplatin+abrogates+the+geldanamycin-induced+heat+shock+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Cisplatin abrogates the geldanamycin-induced heat shock response</span></div><div class="casAuthors">McCollum, Andrea K.; Lukasiewicz, Kara B.; TenEyck, Cynthia J.; Lingle, Wilma L.; Toft, David O.; Erlichman, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3256-3264</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Benzoquinone ansamycin antibiotics such as geldanamycin (GA) bind to the N-terminal ATP-binding domain of heat shock protein (Hsp) 90 and inhibit its chaperone functions.  Despite in vitro and in vivo studies indicating promising antitumor activity, derivs. of GA, including 17-allylaminogeldanamycin (17-AAG), have shown little clin. efficacy as single agents.  Thus, combination studies of 17-AAG and several cancer chemotherapeutics, including cisplatin (CDDP), have begun.  In colony-forming assays, the combination of CDDP and GA or 17-AAG was synergistic and caused increased apoptosis compared with each agent alone.  One measurable response that results from treatment with Hsp90-targeted agents is the induction of a heat shock factor-1 (HSF-1) heat shock response.  Treatment with GA + CDDP revealed that CDDP suppresses up-regulation of HSF-1 transcription, causing decreased levels of stress-inducible proteins such as Hsp27 and Hsp70.  However, CDDP treatment did not prevent trimerization and nuclear localization of HSF-1 but inhibited DNA binding of HSF-1 as shown by chromatin immunopptn.  Melphalan, but not camptothecin, caused similar inhibition of GA-induced HSF-1-mediated Hsp70 up-regulation.  3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt cell survival assays revealed that deletion of Hsp70 caused increased sensitivity to GA (Hsp70+/+ IC50 = 63.7 ± 14.9 nmol/L and Hsp70-/- IC50 = 4.3 ± 2.9 nmol/L), which confirmed that a stress response plays a crit. role in decreasing GA sensitivity.  Our results suggest that the synergy of GA + CDDP is due, in part, to CDDP-mediated abrogation of the heat shock response through inhibition of HSF-1 activity.  Clin. modulation of the HSF-1-mediated heat shock response may enhance the efficacy of Hsp90-directed therapy. [Mol Cancer Ther 2008;7(10):3256-64].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCuOuzH7bdybVg90H21EOLACvtfcHk0ljW16o2fqg9AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ensb%252FN&md5=acf49aa902d3b1da677842424dc40c8d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0157%26sid%3Dliteratum%253Aachs%26aulast%3DMcCollum%26aufirst%3DA.%2BK.%26aulast%3DLukasiewicz%26aufirst%3DK.%2BB.%26aulast%3DTenEyck%26aufirst%3DC.%2BJ.%26aulast%3DLingle%26aufirst%3DW.%2BL.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DErlichman%26aufirst%3DC.%26atitle%3DCisplatin%2520abrogates%2520the%2520geldanamycin-induced%2520heat%2520shock%2520response%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D3256%26epage%3D3264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Duus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahar, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozpuyan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izban, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Masri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maududi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alkan, S.</span><span> </span><span class="NLM_article-title">Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma</span> <span class="citation_source-journal">Leuk. Lymphoma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1369</span><span class="NLM_x">–</span> <span class="NLM_lpage">1378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1080%2F10428190500472123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16923571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWksbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=1369-1378&author=J.+Duusauthor=H.+I.+Baharauthor=G.+Venkataramanauthor=F.+Ozpuyanauthor=K.+F.+Izbanauthor=H.+Al-Masriauthor=T.+Maududiauthor=A.+Toorauthor=S.+Alkan&title=Analysis+of+expression+of+heat+shock+protein-90+%28HSP90%29+and+the+effects+of+HSP90+inhibitor+%2817-AAG%29+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma</span></div><div class="casAuthors">Duus, J.; Bahar, H. I.; Venkataraman, G.; Ozpuyan, F.; Izban, K. F.; Al-Masri, H.; Maududi, T.; Toor, A.; Alkan, S.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1369-1378</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Heat shock protein 90 (HSP90) is required for structural folding and maintenance of conformational integrity of various proteins, including several assocd. with cellular signaling.  Recent studies utilizing 17-allylamino-17-demethoxygeldanamycin (17-AAG), an inhibitor of HSP90, demonstrated an antitumor effect in solid tumors.  To test whether HSP90 could be targeted in multiple myeloma (MM) patients, we first investigated expression of HSP90 by immunofluorescence and flow cytometric anal. in a myeloma cell line (U266) and primary myeloma cells.  Following demonstration of HSP90 expression in myeloma cells, archival samples of 32 MM patients were analyzed by immunoperoxidase staining.  Myeloma cells in all patients showed strong cytoplasmic expression of HSP90 in all samples and 55% also demonstrated concurrent nuclear immunopositivity.  Treatment of U266 and primary MM cells with 17AAG resulted in significantly increased apoptosis compared to untreated control cells.  Anal. of anti-apoptotic BCL2 family proteins and akt in MM cells incubated with 17AAG revealed down-regulation of BCL-2, BCL-XL, MCL-1 and akt.  Furthermore, although a low concn. of bortezomib resulted in no cell death, a combination of 17AAG and bortezomib treatment revealed a synergistic apoptotic effect on the U266 cell line.  These data suggest that targeted inhibition of HSP90 may prove to be a valid and innovative strategy for the development of future therapeutic options for MM patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUx9uyCQeSJ7Vg90H21EOLACvtfcHk0lgYuagS_YiR8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWksbvE&md5=b88b14273842d7de01cceaedf60604eb</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1080%2F10428190500472123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428190500472123%26sid%3Dliteratum%253Aachs%26aulast%3DDuus%26aufirst%3DJ.%26aulast%3DBahar%26aufirst%3DH.%2BI.%26aulast%3DVenkataraman%26aufirst%3DG.%26aulast%3DOzpuyan%26aufirst%3DF.%26aulast%3DIzban%26aufirst%3DK.%2BF.%26aulast%3DAl-Masri%26aufirst%3DH.%26aulast%3DMaududi%26aufirst%3DT.%26aulast%3DToor%26aufirst%3DA.%26aulast%3DAlkan%26aufirst%3DS.%26atitle%3DAnalysis%2520of%2520expression%2520of%2520heat%2520shock%2520protein-90%2520%2528HSP90%2529%2520and%2520the%2520effects%2520of%2520HSP90%2520inhibitor%2520%252817-AAG%2529%2520in%2520multiple%2520myeloma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2006%26volume%3D47%26spage%3D1369%26epage%3D1378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Raja, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clubb, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega-Cava, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakku-Reddi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naramura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, H.</span><span> </span><span class="NLM_article-title">A combination of trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1640</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1535-7163.MCT-07-2409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18769124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1630-1640&author=S.+M.+Rajaauthor=R.+J.+Clubbauthor=M.+Bhattacharyyaauthor=M.+Dimriauthor=H.+Chengauthor=W.+Panauthor=C.+Ortega-Cavaauthor=A.+Lakku-Reddiauthor=M.+Naramuraauthor=V.+Bandauthor=H.+Band&title=A+combination+of+trastuzumab+and+17-AAG+induces+enhanced+ubiquitinylation+and+lysosomal+pathway-dependent+ErbB2+degradation+and+cytotoxicity+in+ErbB2-overexpressing+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells</span></div><div class="casAuthors">Raja, Srikumar M.; Clubb, Robert J.; Bhattacharyya, Mitra; Dimri, Manjari; Cheng, Hao; Pan, Wei; Ortega-Cava, Cesar; Lakku-Reddi, Alagarsamy; Naramura, Mayumi; Band, Vimla; Band, Hamid</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1630-1640</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">ErbB2 (or Her2/Neu) overexpression in breast cancer signifies poorer prognosis, yet it has provided an avenue for targeted therapy as demonstrated by the success of the humanized monoclonal antibody Trastuzumab (Herceptin).  Resistance to Trastuzumab and eventual failure in most cases, however, necessitate alternate ErbB2-targeted therapies.  HSP90 inhibitors such as 17-allylaminodemethoxygeldanamycin (17-AAG), potently downregulate the cell surface ErbB2.  While the precise mechanisms of Trastuzumab or 17-AAG action remain unclear, ubiquitinylation-dependent proteasomal or lysosomal degrdn. of ErbB2 appears to play a substantial role.  As Trastuzumab and 17-AAG induce the recruitment of distinct E3 ubiquitin ligases, Cbl and CHIP resp., to ErbB2, we hypothesized that 17-AAG and Trastuzumab combination could induce a higher level of ubiquitinylation and downregulation of ErbB2 as compared to single drug treatments.  We present biochem. and cell biol. evidence that combined 17-AAG and Trastuzumab treatment of ErbB2-overexpressing breast cancer cell lines leads to enhanced ubiquitinylation, downregulation from the cell surface and lysosomal degrdn. of ErbB2.  Importantly, combined 17-AAG and Trastuzumab treatment induced synergistic growth arrest and cell death specifically in ErbB2-overexpressing but not in ErbB2-low breast cancer cells.  Our results suggest the 17-AAG and Trastuzumab combination as a mechanism-based combinatorial targeted therapy for ErbB2-overexpressing breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Pmjyyf8L7LVg90H21EOLACvtfcHk0lgYuagS_YiR8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktL3L&md5=d7b9f1a2ad114b19bacf6eebb0b8c2ac</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2409%26sid%3Dliteratum%253Aachs%26aulast%3DRaja%26aufirst%3DS.%2BM.%26aulast%3DClubb%26aufirst%3DR.%2BJ.%26aulast%3DBhattacharyya%26aufirst%3DM.%26aulast%3DDimri%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DOrtega-Cava%26aufirst%3DC.%26aulast%3DLakku-Reddi%26aufirst%3DA.%26aulast%3DNaramura%26aufirst%3DM.%26aulast%3DBand%26aufirst%3DV.%26aulast%3DBand%26aufirst%3DH.%26atitle%3DA%2520combination%2520of%2520trastuzumab%2520and%252017-AAG%2520induces%2520enhanced%2520ubiquitinylation%2520and%2520lysosomal%2520pathway-dependent%2520ErbB2%2520degradation%2520and%2520cytotoxicity%2520in%2520ErbB2-overexpressing%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1630%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Banerji, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimshaw, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic−pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models</span> <span class="citation_source-journal">Clin. Cancer. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">7023</span><span class="NLM_x">–</span> <span class="NLM_lpage">7032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1078-0432.CCR-05-0518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16203796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKiurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=7023-7032&author=U.+Banerjiauthor=M.+Waltonauthor=F.+Raynaudauthor=R.+Grimshawauthor=L.+Kellandauthor=M.+Valentiauthor=I.+Judsonauthor=P.+Workman&title=Pharmacokinetic%E2%88%92pharmacodynamic+relationships+for+the+heat+shock+protein+90+molecular+chaperone+inhibitor+17-allylamino%2C+17-demethoxygeldanamycin+in+human+ovarian+cancer+xenograft+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic-Pharmacodynamic Relationships for the Heat Shock Protein 90 Molecular Chaperone Inhibitor 17-Allylamino, 17-Demethoxygeldanamycin in Human Ovarian Cancer Xenograft Models</span></div><div class="casAuthors">Banerji, Udai; Walton, Michael; Raynaud, Florence; Grimshaw, Rachel; Kelland, Lloyd; Valenti, Melani; Judson, Ian; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">19, Pt. 1</span>),
    <span class="NLM_cas:pages">7023-7032</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To establish the pharmacokinetic and pharmacodynamic profile of the heat shock protein 90 (HSP90) inhibitor 17-allylamino, 17-demethoxygeldanamycin (17-AAG) in ovarian cancer xenograft models.  Exptl. Design: The effects of 17-AAG on growth inhibition and the expression of pharmacodynamic biomarkers c-RAF-1, CDK4, and HSP70 were studied in human ovarian cancer cell lines A2780 and CH1.  Corresponding expts. were conducted with established tumor xenografts.  The variability and specificity of pharmacodynamic markers in human peripheral blood lymphocytes (PBL) were studied.  Results: The IC50 values of 17-AAG in A2780 and CH1 cells were 18.3 nmol/L (SD, 2.3) and 410.1 nmol/L (SD, 9.4), resp.  Pharmacodynamic changes indicative of HSP90 inhibition were demonstrable at greater than or equal the IC50 concn. in both cell lines.  Xenograft expts. confirmed tumor growth inhibition in vivo.  Peak concns. of 17-AAG achieved in A2780 and CH1 tumors were 15.6 and 16.5 μmol/L, resp., and there was no significant difference between day 1 and 11 pharmacokinetic profiles.  Reversible changes in pharmacodynamic biomarkers were shown in tumor and murine PBLs in both xenograft models.  Expression of pharmacodynamic markers varied between human PBLs from different human volunteers but not within the same individual.  Pharmacodynamic biomarker changes consistent with HSP90 inhibition were shown in human PBLs exposed ex vivo to 17-AAG but not to selected cytotoxic drugs.  Conclusion: Pharmacokinetic-pharmacodynamic relationships were established for 17-AAG.  This information formed the basis of a pharmacokinetic-pharmacodynamic-driven phase I trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5wCR9QLU4krVg90H21EOLACvtfcHk0lgYuagS_YiR8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKiurjP&md5=1ef1b18dcf4f131d622d5189dff681d2</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0518%26sid%3Dliteratum%253Aachs%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DWalton%26aufirst%3DM.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DGrimshaw%26aufirst%3DR.%26aulast%3DKelland%26aufirst%3DL.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DJudson%26aufirst%3DI.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DPharmacokinetic%25E2%2588%2592pharmacodynamic%2520relationships%2520for%2520the%2520heat%2520shock%2520protein%252090%2520molecular%2520chaperone%2520inhibitor%252017-allylamino%252C%252017-demethoxygeldanamycin%2520in%2520human%2520ovarian%2520cancer%2520xenograft%2520models%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2005%26volume%3D11%26spage%3D7023%26epage%3D7032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Development and application of HSP90 inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2Fj.drudis.2007.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18190862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVWhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=38-43&author=D.+B.+Solitauthor=G.+Chiosis&title=Development+and+application+of+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78aR"><div class="casContent"><span class="casTitleNuber">78a</span><div class="casTitle"><span class="NLM_cas:atitle">Development and application of Hsp90 inhibitors</span></div><div class="casAuthors">Solit, David B.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">38-43</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 has emerged as an important target in several diseases.  The present review will discuss our understanding of the role played by Hsp90 in regulating and maintaining the transformed phenotype in cancers and neurodegenerative diseases, as well as recent findings on its roles in fungal and viral infections.  It will also update the reader on the preclin. development and clin. translation of Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobKuG3vjpdrLVg90H21EOLACvtfcHk0liWf7JG-wt5SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVWhug%253D%253D&md5=a4fa749f37fe96d9f323d437e9afded6</span></div><a href="/servlet/linkout?suffix=cit78a&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2007.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2007.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520and%2520application%2520of%2520HSP90%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D38%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit78b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharaj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Targeting HSP90: small-molecule inhibitors and their clinical development</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2Fj.coph.2008.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18644253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=370-374&author=T.+Taldoneauthor=A.+Gozmanauthor=R.+Maharajauthor=G.+Chiosis&title=Targeting+HSP90%3A+small-molecule+inhibitors+and+their+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78bR"><div class="casContent"><span class="casTitleNuber">78b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90: small-molecule inhibitors and their clinical development</span></div><div class="casAuthors">Taldone, Tony; Gozman, Alexander; Maharaj, Ronnie; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-374</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 multichaperone complex has important roles in the development and progression of malignant transformation.  Several small-mol. inhibitors of Hsp90 of diverse chemotypes have shown potent antitumor activity in a wide-range of malignancies, and are currently in clin. or late-stage preclin. investigation.  This review intends to update the reader on advances made over the past two years in the clin. development of Hsp90 inhibitors in advanced cancers.  It will refer to the two 17-AAG formulations, tanespimycin and IPI-504, and to synthetic small mols., among which are the purine-scaffold Hsp90 inhibitor CNF2024/BIIB021, the isoxazole deriv. VER-52296/NVP-AUY922, and the carbazol-4-one benzamide deriv. SNX-5422, and will present our current knowledge on their clin. performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaxbcGVj_eb7Vg90H21EOLACvtfcHk0liWf7JG-wt5SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7J&md5=2f471b76eec1e93de88ecaa46865db6d</span></div><a href="/servlet/linkout?suffix=cit78b&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DGozman%26aufirst%3DA.%26aulast%3DMaharaj%26aufirst%3DR.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DTargeting%2520HSP90%253A%2520small-molecule%2520inhibitors%2520and%2520their%2520clinical%2520development%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D370%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percy, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikorski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slovin, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLaCruz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span> </span><span class="NLM_article-title">Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span> <span class="citation_source-journal">Clin. Cancer. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">–</span> <span class="NLM_lpage">1782</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1078-0432.CCR-06-1863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=17363532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1775-1782&author=D.+B.+Solitauthor=I.+Percyauthor=C.+Kopilauthor=R.+Sikorskiauthor=M.+J.+Morrisauthor=S.+F.+Slovinauthor=W.+K.+Kellyauthor=A.+DeLaCruzauthor=T.+Curleyauthor=G.+Hellerauthor=S.+Larsonauthor=L.+Schwartzauthor=M.+J.+Egorinauthor=N.+Rosenauthor=H.+I.+Scher&title=Phase+I+trial+of+17-allylamino-17-demethoxygeldanamycin+in+patients+with+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span></div><div class="casAuthors">Solit, David B.; Ivy, S. Percy; Kopil, Catherine; Sikorski, Rachel; Morris, Michael J.; Slovin, Susan F.; Kelly, W. Kevin; DeLaCruz, Anthony; Curley, Tracy; Heller, Glenn; Larson, Steven; Schwartz, Lawrence; Egorin, Merrill J.; Rosen, Neal; Scher, Howard I.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1775-1782</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To define the max. tolerated dose (MTD), toxicities, and pharmacokinetics of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when administered using continuous and intermittent dosing schedules.  Patients with progressive solid tumor malignancies were treated with 17-AAG using an accelerated titrn. dose escalation schema.  The starting dose and schedule were 5 mg/m2 daily for 5 days with cycles repeated every 21 days.  Dosing modifications based on safety, pharmacodynamic modeling, and clin. outcomes led to the evaluation of the following schedules: daily x 3 repeated every 14 days; twice weekly (days 1, 4, 8, and 11) for 2 wk every 3 wk; and twice weekly (days 1 and 4) without interruption.  During cycle 1, blood was collected for pharmacokinetic and pharmacodynamic studies.  Fifty-four eligible patients were treated.  The MTD was schedule dependent: 56 mg/m2 on the daily x 5 schedule; 112 mg/m2 on the daily x 3 schedule; and 220 mg/m2 on the days 1, 4, 8, and 11 every-21-day schedule.  Continuous twice-weekly dosing was deemed too toxic because of delayed hepatotoxicity.  Hepatic toxicity was also dose limiting with the daily x 5 schedule.  Other common toxicities encountered were fatigue, myalgias, and nausea.  This latter adverse effect may have been attributable, in part, to the DMSO-based formulation.  Concns. of 17-AAG above those required for activity in preclin. models could be safely achieved in plasma.  Induction of a heat shock response and down-regulation of Akt and Raf-1 were obsd. in biomarker studies.  The MTD and toxicity profile of 17-AAG were schedule dependent.  Intermittent dosing schedules were less toxic and are recommended for future phase II studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGKeAL9KtMGbVg90H21EOLACvtfcHk0liWf7JG-wt5SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtL4%253D&md5=7de014104bbd48f42ec8faac2e8d92ed</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1863%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DPercy%26aufirst%3DI.%26aulast%3DKopil%26aufirst%3DC.%26aulast%3DSikorski%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DSlovin%26aufirst%3DS.%2BF.%26aulast%3DKelly%26aufirst%3DW.%2BK.%26aulast%3DDeLaCruz%26aufirst%3DA.%26aulast%3DCurley%26aufirst%3DT.%26aulast%3DHeller%26aufirst%3DG.%26aulast%3DLarson%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DL.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DScher%26aufirst%3DH.%2BI.%26atitle%3DPhase%2520I%2520trial%2520of%252017-allylamino-17-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520cancer%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1775%26epage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Banerji, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scurr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judson, I.</span><span> </span><span class="NLM_article-title">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino,17-demethoxygeldanamycin in patients with advanced malignancies</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4152</span><span class="NLM_x">–</span> <span class="NLM_lpage">4161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1200%2FJCO.2005.00.612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=15961763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=4152-4161&author=U.+Banerjiauthor=A.+O%E2%80%99Donnellauthor=M.+Scurrauthor=S.+Paceyauthor=S.+Stapletonauthor=Y.+Asadauthor=L.+Simmonsauthor=A.+Maloneyauthor=F.+Raynaudauthor=M.+Campbellauthor=M+Waltonauthor=S.+Lakhaniauthor=S.+Kayeauthor=P.+Workmanauthor=I.+Judson&title=Phase+I+pharmacokinetic+and+pharmacodynamic+study+of+17-allylamino%2C17-demethoxygeldanamycin+in+patients+with+advanced+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies</span></div><div class="casAuthors">Banerji, Udai; O'Donnell, Anne; Scurr, Michelle; Pacey, Simon; Stapleton, Sarah; Asad, Yasmin; Simmons, Laura; Maloney, Alison; Raynaud, Florence; Campbell, Maeli; Walton, Michael; Lakhani, Sunil; Kaye, Stanley; Workman, Paul; Judson, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4152-4161</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To study the toxicity and pharmacokinetic-pharmacodynamic profile of 17-allylamino, 17-demethoxygeldanamycin (17-AAG) and to recommend a dose for phase II trials.  Patients and Methods: This was a phase I study examg. a once-weekly dosing schedule of 17-AAG.  Thirty patients with advanced malignancies were treated.  Results: The highest dose level reached was 450 mg/m2/wk.  The dose-limiting toxicities (DLTs) encountered were grade 3 diarrhea in three patients (one at 320 mg/m2/wk and two at 450 mg/m2/wk) and grade 3 to 4 hepatotoxicity (AST/ALT) in one patient at 450 mg/m2/wk.  Two of nine DLTs were at the highest dose level.  Two patients with metastatic melanoma had stable disease and were treated for 15 and 41 mo, resp.  The dose vs. area under the curve-relationship for 17-AAG was linear (r2 = .71) over the dose range 10 to 450 mg/m2/wk, with peak plasma concns. of 8,998 μg/L (std. deviation, 2,881) at the highest dose level.  After the demonstration of pharmacodynamic changes in peripheral blood leukocytes, pre- and 24 h post-treatment, tumor biopsies were performed and demonstrated target inhibition (c-RAF-1 inhibition in four of six patients, CDK4 depletion in eight of nine patients and HSP70 induction in eight of nine patients) at the dose levels 320 and 450 mg/m2/wk.  It was not possible to reproducibly demonstrate these changes in biopsies taken 5 days after treatment.  Conclusion: It has been possible to demonstrate that 17-AAG exhibits a tolerable toxicity profile with therapeutic plasma concns. and target inhibition for 24 h after treatment and some indications of clin. activity at the dose level 450 mg/m2/wk.  We recommend this dose for phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaKgFbodgT_bVg90H21EOLACvtfcHk0lg3zpLDfv3aAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D&md5=6ba10e24a68a1d9bd09d87239eea1ca6</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.00.612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.00.612%26sid%3Dliteratum%253Aachs%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DA.%26aulast%3DScurr%26aufirst%3DM.%26aulast%3DPacey%26aufirst%3DS.%26aulast%3DStapleton%26aufirst%3DS.%26aulast%3DAsad%26aufirst%3DY.%26aulast%3DSimmons%26aufirst%3DL.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DWalton%26aufirst%3DM%26aulast%3DLakhani%26aufirst%3DS.%26aulast%3DKaye%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJudson%26aufirst%3DI.%26atitle%3DPhase%2520I%2520pharmacokinetic%2520and%2520pharmacodynamic%2520study%2520of%252017-allylamino%252C17-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520malignancies%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D4152%26epage%3D4161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span>30% propylene glycol, 20% cremophor EL, 50% ethanol to a concentration of 10 mg/mL in the vial, 200 mg/vial.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=30%25+propylene+glycol%2C+20%25+cremophor+EL%2C+50%25+ethanol+to+a+concentration+of+10+mg%2FmL+in+the+vial%2C+200+mg%2Fvial."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopeck, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cropp, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannah, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudis, C. A.</span><span> </span><span class="NLM_article-title">Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer. A dose-escalation study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5410</span><span class="NLM_x">–</span> <span class="NLM_lpage">5417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1200%2FJCO.2007.11.7960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18048823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVCisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=5410-5417&author=S.+Modiauthor=A.+T.+Stopeckauthor=M.+S.+Gordonauthor=D.+Mendelsonauthor=D.+B.+Solitauthor=R.+Bagatellauthor=W.+Maauthor=J.+Whelerauthor=N.+Rosenauthor=L.+Nortonauthor=G.+F.+Croppauthor=R.+G.+Johnsonauthor=A.+L.+Hannahauthor=C.+A.+Hudis&title=Combination+of+trastuzumab+and+tanespimycin+%2817-AAG%2C+KOS-953%29+is+safe+and+active+in+trastuzumab-refractory+HER-2-overexpressing+breast+cancer.+A+dose-escalation+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: a phase I dose-escalation study</span></div><div class="casAuthors">Modi, Shanu; Stopeck, Alison T.; Gordon, Michael S.; Mendelson, David; Solit, David B.; Bagatell, Rochelle; Ma, Weining; Wheler, Jennifer; Rosen, Neal; Norton, Larry; Cropp, Gillian F.; Johnson, Robert G.; Hannah, Alison L.; Hudis, Clifford A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5410-5417</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: This phase I study examd. whether a heat shock protein (Hsp) 90 inhibitor tanespimycin (17-AAG; KOS-953) could be administered safely in combination with trastuzumab at a dose that inhibits Hsp90 function in vivo in lymphocytes.  Patients and Methods: Patients with an advanced solid tumor progressing during std. therapy were eligible.  Patients were treated with weekly trastuzumab followed by i.v. tanespimycin, assessed in escalating dose levels.  Results: Twenty-five patients were enrolled onto four tanespimycin dose levels: 225 (n = 4), 300 (n = 3), 375 (n = 8), and 450 mg/m2 (n = 10).  Dose-limiting toxicity (DLT) was obsd. at the third and fourth cohort (1 patient each): more than 2-wk delay for grade 4 fatigue/grade 2 nausea and anorexia (375 mg/m2); more than 2-wk delay for thrombocytopenia (450 mg/m2).  Drug-related grade 3 toxicity included emesis, increased ALT, hypersensitivity reactions (two patients each), and drug-induced thrombocytopenia (n = 1).  Common mild to moderate toxicities included fatigue, nausea, diarrhea, emesis, headache, rash/pruritus, increased AST/ALT, and anorexia.  Pharmacokinetic anal. demonstrated no difference in tanespimycin kinetics with or without trastuzumab.  Pharmacodynamic testing showed reactive induction of Hsp70 (a marker of Hsp90 inhibition) in lymphocytes at all dose levels.  Antitumor activity was noted (partial response, n = 1; minor response, n = 4; stable disease ≥ 4 mo, n = 4).  Tumor regressions were seen only in patients with human epidermal growth factor receptor 2 (HER-2)-pos. metastatic breast cancer.  Conclusion: Tanespimycin plus trastuzumab is well tolerated and has antitumor activity in patients with HER-2+ breast cancer whose tumors have progressed during treatment with trastuzumab.  These data suggest that Hsp90 function can be inhibited in vivo to a degree sufficient to cause inhibition of tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMOMgqgGMiFbVg90H21EOLACvtfcHk0lg3zpLDfv3aAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVCisQ%253D%253D&md5=a99de102e2458d4428b39a239a06ada4</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.11.7960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.11.7960%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DS.%26aulast%3DStopeck%26aufirst%3DA.%2BT.%26aulast%3DGordon%26aufirst%3DM.%2BS.%26aulast%3DMendelson%26aufirst%3DD.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DWheler%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DCropp%26aufirst%3DG.%2BF.%26aulast%3DJohnson%26aufirst%3DR.%2BG.%26aulast%3DHannah%26aufirst%3DA.%2BL.%26aulast%3DHudis%26aufirst%3DC.%2BA.%26atitle%3DCombination%2520of%2520trastuzumab%2520and%2520tanespimycin%2520%252817-AAG%252C%2520KOS-953%2529%2520is%2520safe%2520and%2520active%2520in%2520trastuzumab-refractory%2520HER-2-overexpressing%2520breast%2520cancer.%2520A%2520dose-escalation%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D5410%26epage%3D5417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span>48th ASH Meeting, Orlando, FL, December 2006.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=48th+ASH+Meeting%2C+Orlando%2C+FL%2C+December+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><a href="http://clinicaltrial.gov/ct/show/NCT00319930" class="extLink">http://clinicaltrial.gov/ct/show/NCT00319930</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fclinicaltrial.gov%2Fct%2Fshow%2FNCT00319930."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayzel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span> </span><span class="NLM_article-title">Development of 17-allylamino-17-demethoxygeldanamycin hydroquionone hydrochloride (IPI-504), an anti-cancer agent directed against HSP90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17408</span><span class="NLM_x">–</span> <span class="NLM_lpage">17413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17408-17413&author=J.+R.+Sydorauthor=E.+Normantauthor=C.+S.+Pienauthor=J.+R.+Porterauthor=J.+Geauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=J.+Hudakauthor=J.+Pattersonauthor=C.+Pendersauthor=M.+Pinkauthor=M.+A.+Readauthor=J.+Sangauthor=C.+Woodwardauthor=Y.+Zhangauthor=D.+S.+Grayzelauthor=J.+Wrightauthor=J.+A.+Barrettauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=J.+K.+Tong&title=Development+of+17-allylamino-17-demethoxygeldanamycin+hydroquionone+hydrochloride+%28IPI-504%29%2C+an+anti-cancer+agent+directed+against+HSP90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DHudak%26aufirst%3DJ.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DPenders%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGrayzel%26aufirst%3DD.%2BS.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26atitle%3DDevelopment%2520of%252017-allylamino-17-demethoxygeldanamycin%2520hydroquionone%2520hydrochloride%2520%2528IPI-504%2529%252C%2520an%2520anti-cancer%2520agent%2520directed%2520against%2520HSP90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17408%26epage%3D17413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span>Presented at the ASCO Annual Meeting,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Presented+at+the+ASCO+Annual+Meeting%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span>Infinity Press Release, April 15,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Infinity+Press+Release%2C+April+15%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Glaze, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiseman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holleran, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, J. E.</span><span> </span><span class="NLM_article-title">Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1007%2Fs00280-005-1000-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=15986212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=637-647&author=E.+R.+Glazeauthor=A.+L.+Lambertauthor=A.+C.+Smithauthor=J.+G.+Pageauthor=W.+D.+Johnsonauthor=D.+L.+McCormickauthor=A.+P.+Brownauthor=B.+S.+Levineauthor=J.+M.+Coveyauthor=M.+J.+Egorinauthor=J.+L.+Eisemanauthor=J.+L.+Holleranauthor=E.+A.+Sausvilleauthor=J.+E.+Tomaszewski&title=Preclinical+toxicity+of+a+geldanamycin+analog%2C+17-%28dimethylaminoethylamino%29-17-demethoxygeldanamycin+%2817-DMAG%29%2C+in+rats+and+dogs%3A+potential+clinical+relevance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance</span></div><div class="casAuthors">Glaze, Elizabeth R.; Lambert, Amy L.; Smith, Adaline C.; Page, John G.; Johnson, William D.; McCormick, David L.; Brown, Alan P.; Levine, Barry S.; Covey, Joseph M.; Egorin, Merrill J.; Eiseman, Julie L.; Holleran, Julianne L.; Sausville, Edward A.; Tomaszewski, Joseph E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">637-647</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: 17-DMAG is a hydrophilic deriv. of the mol. chaperone inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17-AAG; NSC-330507), which is currently being evaluated for the treatment of cancer in clin. trials. 17-DMAG offers a potential advantage over 17-AAG because its aq. soly. eliminates the need for complicated formulations that are currently used for administration of 17-AAG.  In addn., 17-DMAG undergoes only limited metab. compared to 17-AAG.  The present results are from preclin. toxicity studies evaluating 17-DMAG in rats and dogs.  Methods: Doses of 0, 2.4, 12 and 24 mg/m2 per day were administered to rats, while dogs received doses of 0, 8 or 16 mg/m2 per day.  In both species, 17-DMAG was administered i.v. (slow bolus for rats; 1-h infusion for dogs) daily for 5 days.  An addnl. cohort of dogs received 16 mg/m2 per day orally for 5 days.  Clin. observations were noted, and std. hematol. and clin. chem. parameters were monitored.  Selected tissues were evaluated microscopically for drug-related lesions.  Tissue and plasma 17-DMAG concns. were measured by HPLC/MS at selected time-points on days 1 and 5.  Results: Daily i.v. administration of 17-DMAG at doses of 24 mg/m2 per day in rats or 16 mg/m2 per day in dogs produced lethality on day 6, approx. 24 h following the last dose.  Body wt. loss was common in rats and dogs.  Drug-related gastrointestinal, bone marrow and hepatic toxicities were also common in rats and dogs.  Dogs also exhibited signs of renal and gallbladder toxicity.  Plasma concns. of 17-DMAG increased proportionately with dose in rats and disproportionately with dose in dogs.  In rat tissues, however, only fourfold to sixfold increases in 17-DMAG concns. were obsd. with a tenfold increase in dose.  The highest concns. of 17-DMAG were found in the liver of rats, with progressively lower concns. in the spleen, lung, kidney and plasma.  Regardless of the route of administration, higher drug concns. were present in plasma (rat and dog) and tissue (rat) samples obtained on day 5 compared to those obtained on day 1.  Although plasma concns. decreased with time, 17-DMAG was still detected in dog plasma for at least 24 h after drug administration.  Conclusions: With the recent approval of 17-DMAG for clin. use, the data generated from these preclin. studies will provide guidance to clinicians as they administer this drug to their patients.  The MTD of 17-DMAG was 12 mg/m2 per day in rats and 8 mg/m2 per day in dogs; therefore, the recommended starting dose for phase I trial is 1.3 mg/m2 per day for 5 days.  Gastrointestinal and bone marrow toxicity were dose-limiting in rats, and gastrointestinal, renal, gallbladder and bone marrow toxicity were dose-limiting in dogs.  All adverse effects were fully reversible in surviving animals after treatment was complete.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWkzP-n-oIFbVg90H21EOLACvtfcHk0ljXmTAECEzu6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7bP&md5=62fe4552e57e6e2b86326d57d4ab8ff2</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1007%2Fs00280-005-1000-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-005-1000-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlaze%26aufirst%3DE.%2BR.%26aulast%3DLambert%26aufirst%3DA.%2BL.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DPage%26aufirst%3DJ.%2BG.%26aulast%3DJohnson%26aufirst%3DW.%2BD.%26aulast%3DMcCormick%26aufirst%3DD.%2BL.%26aulast%3DBrown%26aufirst%3DA.%2BP.%26aulast%3DLevine%26aufirst%3DB.%2BS.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DEiseman%26aufirst%3DJ.%2BL.%26aulast%3DHolleran%26aufirst%3DJ.%2BL.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DTomaszewski%26aufirst%3DJ.%2BE.%26atitle%3DPreclinical%2520toxicity%2520of%2520a%2520geldanamycin%2520analog%252C%252017-%2528dimethylaminoethylamino%2529-17-demethoxygeldanamycin%2520%252817-DMAG%2529%252C%2520in%2520rats%2520and%2520dogs%253A%2520potential%2520clinical%2520relevance%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D56%26spage%3D637%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Lancet, J.; Gojo, I.; Baer, M.; Burton, M.; Klein, M.; Nowadly, C.; Gorre, M.; Zhong, Z.; Johnson, R. G.; Hannah, A. L.</span><span> </span><span class="NLM_article-title">Phase 1, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of of the Hsp-90 Inhibitor, KOS-1022 (17-DMAG), in Patients with Refractory Hematological Malignancies</span>. Presented at the ASCO Annual Meeting,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>Abstract 2081.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+Lancet&author=I.+Gojo&author=M.+Baer&author=M.+Burton&author=M.+Klein&author=C.+Nowadly&author=M.+Gorre&author=Z.+Zhong&author=R.+G.+Johnson&author=A.+L.+Hannah&title=Phase+1%2C+Pharmacokinetic+%28PK%29+and+Pharmacodynamic+%28PD%29+Study+of+of+the+Hsp-90+Inhibitor%2C+KOS-1022+%2817-DMAG%29%2C+in+Patients+with+Refractory+Hematological+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLancet%26aufirst%3DJ.%26atitle%3DPhase%25201%252C%2520Pharmacokinetic%2520%2528PK%2529%2520and%2520Pharmacodynamic%2520%2528PD%2529%2520Study%2520of%2520of%2520the%2520Hsp-90%2520Inhibitor%252C%2520KOS-1022%2520%252817-DMAG%2529%252C%2520in%2520Patients%2520with%2520Refractory%2520Hematological%2520Malignancies%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span>P = phospholipon 90G (phospholipid surfactant). M = miglyol 812N (short chain triglyceride). S = soybean oil (long chain triglyceride). E = emulsion.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=P+%3D+phospholipon+90G+%28phospholipid+surfactant%29.+M+%3D+miglyol+812N+%28short+chain+triglyceride%29.+S+%3D+soybean+oil+%28long+chain+triglyceride%29.+E+%3D+emulsion."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Cheung, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of HSP90 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3338</span><span class="NLM_x">–</span> <span class="NLM_lpage">3343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3338-3343&author=K.+J.+Cheungauthor=T.+P.+Matthewsauthor=K.+Jamesauthor=M.+G.+Rowlandsauthor=K.+J.+Boxallauthor=S.+Y.+Sharpauthor=A.+Maloneyauthor=S.+M.+Roeauthor=C.+Prodromouauthor=L.+H.+Pearlauthor=G.+W.+Aherneauthor=E.+McDonaldauthor=P.+Workman&title=The+identification%2C+synthesis%2C+protein+crystal+structure+and+in+vitro+biochemical+evaluation+of+a+new+3%2C4-diarylpyrazole+class+of+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DK.%2BJ.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DBoxall%26aufirst%3DK.%2BJ.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DThe%2520identification%252C%2520synthesis%252C%2520protein%2520crystal%2520structure%2520and%2520in%2520vitro%2520biochemical%2520evaluation%2520of%2520a%2520new%25203%252C4-diarylpyrazole%2520class%2520of%2520HSP90%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3338%26epage%3D3343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalusa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1198</span><span class="NLM_x">–</span> <span class="NLM_lpage">1211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1535-7163.MCT-07-0149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=17431102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFanu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1198-1211&author=S.+Y.+Sharpauthor=C.+Prodromouauthor=K.+Boxallauthor=M.+V.+Powersauthor=J.+L.+Holmesauthor=G.+Boxauthor=T.+P.+Matthewsauthor=K.+J.+Cheungauthor=A.+Kalusaauthor=K.+Jamesauthor=A.+Hayesauthor=A.+Hardcastleauthor=B.+Dymockauthor=P.+A.+Broughauthor=X.+Barrilauthor=J.+E.+Cansfieldauthor=L.+Wrightauthor=A.+Surgenorauthor=N.+Foloppeauthor=R.+E.+Hubbardauthor=W.+Aherneauthor=L.+Pearlauthor=K.+Jonesauthor=E.+McDonaldauthor=F.+Raynaudauthor=S.+Ecclesauthor=M.+Drysdaleauthor=P.+Workman&title=Inhibition+of+the+heat+shock+protein+90+molecular+chaperone+in+vitro+and+in+vivo+by+novel%2C+synthetic%2C+potent+resorcinylic+pyrazole%2Fisoxazole+amide+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues</span></div><div class="casAuthors">Sharp, Swee Y.; Prodromou, Chrisostomos; Boxall, Kathy; Powers, Marissa V.; Holmes, Joanna L.; Box, Gary; Matthews, Thomas P.; Cheung, Kwai-Ming J.; Kalusa, Andrew; James, Karen; Hayes, Angela; Hardcastle, Anthea; Dymock, Brian; Brough, Paul A.; Barril, Xavier; Cansfield, Julie E.; Wright, Lisa; Surgenor, Allan; Foloppe, Nicolas; Hubbard, Roderick E.; Aherne, Wynne; Pearl, Laurence; Jones, Keith; McDonald, Edward; Raynaud, Florence; Eccles, Sue; Drysdale, Martin; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1198-1211</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Although the heat shock protein 90 (HSP90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) shows clin. promise, potential limitations encourage development of alternative chemotypes.  We discovered the 3,4-diarylpyrazole resorcinol CCT018159 by high-throughput screening and used structure-based design to generate more potent pyrazole amide analogs, exemplified by VER-49009.  Here, we describe the detailed biol. properties of VER-49009 and the corresponding isoxazole VER-50589.  X-ray crystallog. showed a virtually identical HSP90 binding mode.  However, the dissocn. const. (Kd) of VER-50589 was 4.5±2.2 nmol/L compared with 78.0±10.4 nmol/L for VER-49009, attributable to higher enthalpy for VER-50589 binding.  A competitive binding assay gave a lower IC50 of 21±4 nmol/L for VER-50589 compared with 47±9 nmol/L for VER-49009.  Cellular uptake of VER-50589 was 4-fold greater than for VER-49009.  Mean cellular antiproliferative GI50 values for VER-50589 and VER-49009 for a human cancer cell line panel were 78±15 and 685±119 nmol/L, resp., showing a 9-fold potency gain for the isoxazole.  Unlike 17-AAG, but as with CCT018159, cellular potency of these analogs was independent of NAD(P)H:quinone oxidoreductase 1/DT-diaphorase and P-glycoprotein expression.  Consistent with HSP90 inhibition, VER-50589 and VER-49009 caused induction of HSP72 and HSP27 alongside depletion of client proteins, including C-RAF, B-RAF, and survivin, and the protein arginine methyltransferase PRMT5.  Both caused cell cycle arrest and apoptosis.  Extent and duration of pharmacodynamic changes in an orthotopic human ovarian carcinoma model confirmed the superiority of VER-50589 over VER-49009.  VER-50589 accumulated in HCT116 human colon cancer xenografts at levels above the cellular GI50 for 24 h, resulting in 30% growth inhibition.  The results indicate the therapeutic potential of the resorcinylic pyrazole/isoxazole amide analogs as HSP90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdCmDXnfwFjrVg90H21EOLACvtfcHk0ljikoPUJ7bEHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFanu7Y%253D&md5=58678b76ed7fbda4d21942c69346946c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0149%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DCheung%26aufirst%3DK.%2BJ.%26aulast%3DKalusa%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHardcastle%26aufirst%3DA.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520the%2520heat%2520shock%2520protein%252090%2520molecular%2520chaperone%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520novel%252C%2520synthetic%252C%2520potent%2520resorcinylic%2520pyrazole%252Fisoxazole%2520amide%2520analogues%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1198%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radimerski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span> </span><span class="NLM_article-title">NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">R33</span><div class="note"><p class="first last"> (12 pages)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=R33&author=M.+R.+Jensenauthor=J.+Schoepferauthor=T.+Radimerskiauthor=A.+Masseyauthor=C.+T.+Guyauthor=J.+Brueggenauthor=C.+Quadtauthor=A.+Bucklerauthor=R.+Cozensauthor=M.+J.+Drysdaleauthor=C.+Garcia-Echeverriaauthor=P.+Chene&title=NVP-AUY922%3A+a+small+molecule+HSP90+inhibitor+with+potent+antitumor+activity+in+preclinical+breast+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DRadimerski%26aufirst%3DT.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DGuy%26aufirst%3DC.%2BT.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DQuadt%26aufirst%3DC.%26aulast%3DBuckler%26aufirst%3DA.%26aulast%3DCozens%26aufirst%3DR.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DChene%26aufirst%3DP.%26atitle%3DNVP-AUY922%253A%2520a%2520small%2520molecule%2520HSP90%2520inhibitor%2520with%2520potent%2520antitumor%2520activity%2520in%2520preclinical%2520breast%2520cancer%2520models%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2008%26volume%3D10%26spage%3DR33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Sessa, C.; Sharma, S.; Britten, C.; Vogelzang, N.; Bhalla, K.; Mita, M.; Pluard, T.; Stiegler, P.; Quadt, C.; Shapiro, G. I.</span><span> </span><span class="NLM_article-title">A Phase I Dose-Escalation Study of AUY922, a Novel HSP90 Inhibitor, in Patients with Advanced Solid Malignancies</span>. Presented at the ASCO Annual Meeting,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Abstract 3532.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+Sessa&author=S.+Sharma&author=C.+Britten&author=N.+Vogelzang&author=K.+Bhalla&author=M.+Mita&author=T.+Pluard&author=P.+Stiegler&author=C.+Quadt&author=G.+I.+Shapiro&title=A+Phase+I+Dose-Escalation+Study+of+AUY922%2C+a+Novel+HSP90+Inhibitor%2C+in+Patients+with+Advanced+Solid+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSessa%26aufirst%3DC.%26atitle%3DA%2520Phase%2520I%2520Dose-Escalation%2520Study%2520of%2520AUY922%252C%2520a%2520Novel%2520HSP90%2520Inhibitor%252C%2520in%2520Patients%2520with%2520Advanced%2520Solid%2520Malignancies%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Ida, S.; Motwani, M.; Jensen, M.; Wang, J.; Huseinovic, N.; Stiegler, P.; Wang, X.; Quadt, C.</span><span> </span><span class="NLM_article-title">Pharmacodynamics and Pharmacokinetics of AUY922 in a Phase I/II Study of Patients with Solid Tumors</span>. Presented at the ASCO Annual Meeting,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Abstract 3533.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Ida&author=M.+Motwani&author=M.+Jensen&author=J.+Wang&author=N.+Huseinovic&author=P.+Stiegler&author=X.+Wang&author=C.+Quadt&title=Pharmacodynamics+and+Pharmacokinetics+of+AUY922+in+a+Phase+I%2FII+Study+of+Patients+with+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DIda%26aufirst%3DS.%26atitle%3DPharmacodynamics%2520and%2520Pharmacokinetics%2520of%2520AUY922%2520in%2520a%2520Phase%2520I%252FII%2520Study%2520of%2520Patients%2520with%2520Solid%2520Tumors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Chandarlapaty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawai, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silinski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span> </span><span class="NLM_article-title">SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1078-0432.CCR-07-1667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18172276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslGq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=240-248&author=S.+Chandarlapatyauthor=A+Sawaiauthor=Q.+Yeauthor=A.+Scottauthor=M.+Silinskiauthor=K.+Huangauthor=P.+Faddenauthor=J.+Partridgeauthor=S.+Hallauthor=P.+Steedauthor=L.+Nortonauthor=N.+Rosenauthor=D.+B.+Solit&title=SNX2112%2C+a+synthetic+heat+shock+protein+90+inhibitor%2C+has+potent+antitumor+activity+against+HER+kinase-dependent+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase-Dependent Cancers</span></div><div class="casAuthors">Chandarlapaty, Sarat; Sawai, Ayana; Ye, Qing; Scott, Anisa; Silinski, Melanie; Huang, Ken; Fadden, Pat; Partdrige, Jeff; Hall, Steven; Steed, Paul; Norton, Larry; Rosen, Neal; Solit, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-248</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The heat shock protein 90 (Hsp90) chaperone plays an important role in transformation by regulating the conformational maturation and stability of oncogenic kinases and transcription factors.  Ansamycins, such as 17-(allylamino)-17-demethoxygeldanmycin (17-AAG), inhibit Hsp90 function; induce the degrdn. of Hsp90 client proteins such as HER2, and have shown activity in early clin. trials.  However, the utility of these drugs has been limited by their hepatotoxicity, poor soly., and poorly tolerated formulations.  Exptl. Design: We detd. the pharmacodynamic and antitumor properties of a novel, synthetic Hsp90 inhibitor, SNX-2112, in cell culture and xenograft models of HER kinase-dependent cancers.  RESULTS: We show in a panel of tumor cell lines that SNX-2112 and its prodrug SNX-5542 are Hsp90 inhibitors with properties and potency similar to that of 17-AAG, including: degrdn. of HER2, mutant epidermal growth factor receptor, and other client proteins, inhibition of extracellular signal-regulated kinase and Akt activation, and induction of a Rb-dependent G1 arrest with subsequent apoptosis.  SNX-5542 can be administered to mice orally on a daily schedule.  Following oral administration, SNX-5542 is rapidly converted to SNX-2112, which accumulates in tumors relative to normal tissues.  A single dose of SNX-5542 causes HER2 degrdn. and inhibits its downstream signaling for up to 24 h, and daily dosing results in regression of HER2-dependent xenografts.  SNX-5542 also shows greater activity than 17-AAG in a non-small cell lung cancer xenograft model expressing mutant EGFR.  CONCLUSIONS: These results suggest that Hsp90 inhibition with SNX-2112 (delivered as a prodrug) may represent a promising therapeutic strategy for tumors whose growth and survival is dependent on Hsp90 clients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqER6BYKwq_PLVg90H21EOLACvtfcHk0li7B5vPEK3QIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslGq&md5=d0aff2ef77885c47803acd1d6cb446c5</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1667%26sid%3Dliteratum%253Aachs%26aulast%3DChandarlapaty%26aufirst%3DS.%26aulast%3DSawai%26aufirst%3DA%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DSilinski%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DFadden%26aufirst%3DP.%26aulast%3DPartridge%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DS.%26aulast%3DSteed%26aufirst%3DP.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26atitle%3DSNX2112%252C%2520a%2520synthetic%2520heat%2520shock%2520protein%252090%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520activity%2520against%2520HER%2520kinase-dependent%2520cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D240%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Okawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabasz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiziltepe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enatsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">846</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=846-855&author=Y.+Okawaauthor=T.+Hideshimaauthor=P.+Steedauthor=S.+Valletauthor=S.+Hallauthor=K.+Huangauthor=J.+Riceauthor=A.+Barabaszauthor=B.+Foleyauthor=H.+Ikedaauthor=N.+Rajeauthor=T.+Kiziltepeauthor=H.+Yasuiauthor=S.+Enatsuauthor=K.+C.+Anderson&title=SNX-2112%2C+a+selective+Hsp90+inhibitor%2C+potently+inhibits+tumor+cell+growth%2C+angiogenesis%2C+and+osteoclastogenesis+in+multiple+myeloma+and+other+hematologic+tumors+by+abrogating+signaling+via+Akt+and+ERK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkawa%26aufirst%3DY.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DBarabasz%26aufirst%3DA.%26aulast%3DFoley%26aufirst%3DB.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DKiziltepe%26aufirst%3DT.%26aulast%3DYasui%26aufirst%3DH.%26aulast%3DEnatsu%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DSNX-2112%252C%2520a%2520selective%2520Hsp90%2520inhibitor%252C%2520potently%2520inhibits%2520tumor%2520cell%2520growth%252C%2520angiogenesis%252C%2520and%2520osteoclastogenesis%2520in%2520multiple%2520myeloma%2520and%2520other%2520hematologic%2520tumors%2520by%2520abrogating%2520signaling%2520via%2520Akt%2520and%2520ERK%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D846%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':[],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29a','cit29b','cit29c','cit29d','cit29e'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72a','cit72b','cit72c'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78a','cit78b'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 203 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chihoko Yoshimura, Satoru Nagatoishi, Daisuke Kuroda, Yasuo Kodama, Takao Uno, Makoto Kitade, Khoontee Chong-Takata, Hiromi Oshiumi, Hiromi Muraoka, Satoshi Yamashita, Yuichi Kawai, Shuichi Ohkubo, <span class="NLM_string-name hlFld-ContribAuthor">Kouhei Tsumoto</span>. </span><span class="cited-content_cbyCitation_article-title">Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2669-2677. <a href="https://doi.org/10.1021/acs.jmedchem.0c01715" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01715</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01715%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThermodynamic%252BDissection%252Bof%252BPotency%252Band%252BSelectivity%252Bof%252BCytosolic%252BHsp90%252BInhibitors%26aulast%3DYoshimura%26aufirst%3DChihoko%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29102020%26date%3D23022021%26volume%3D64%26issue%3D5%26spage%3D2669%26epage%3D2677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sanket J. Mishra, Weiya Liu, Kristin Beebe, Monimoy Banerjee, Caitlin N. Kent, Vitumbiko Munthali, John Koren, III, John A Taylor, III, Leonard M. Neckers, Jeffrey Holzbeierlein, <span class="NLM_string-name hlFld-ContribAuthor">Brian S. J. Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1545-1557. <a href="https://doi.org/10.1021/acs.jmedchem.0c01700" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01700%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDevelopment%252Bof%252BHsp90%2525CE%2525B2-Selective%252BInhibitors%252Bto%252BOvercome%252BDetriments%252BAssociated%252Bwith%252Bpan-Hsp90%252BInhibition%26aulast%3DMishra%26aufirst%3DSanket%2BJ.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28092020%26date%3D11012021%26volume%3D64%26issue%3D3%26spage%3D1545%26epage%3D1557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Margaret J. Hilton, Christopher M. Brackett, Brandon Q. Mercado, Brian S. J. Blagg, <span class="NLM_string-name hlFld-ContribAuthor">Scott J. Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Catalysis-Enabled Access to Cryptic Geldanamycin Oxides. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2020,</strong> <em>6 </em>
                                    (3)
                                     , 426-435. <a href="https://doi.org/10.1021/acscentsci.0c00024" title="DOI URL">https://doi.org/10.1021/acscentsci.0c00024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.0c00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.0c00024%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DCatalysis-Enabled%252BAccess%252Bto%252BCryptic%252BGeldanamycin%252BOxides%26aulast%3DHilton%26aufirst%3DMargaret%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08012020%26date%3D24022020%26volume%3D6%26issue%3D3%26spage%3D426%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Li Li, Lei Wang, Qi-Dong You, <span class="NLM_string-name hlFld-ContribAuthor">Xiao-Li Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1798-1822. <a href="https://doi.org/10.1021/acs.jmedchem.9b00940" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00940%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeat%252BShock%252BProtein%252B90%252BInhibitors%25253A%252BAn%252BUpdate%252Bon%252BAchievements%25252C%252BChallenges%25252C%252Band%252BFuture%252BDirections%26aulast%3DLi%26aufirst%3DLi%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D13062019%26date%3D12112019%26date%3D30102019%26volume%3D63%26issue%3D5%26spage%3D1798%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lei Wang, Jingsheng Jiang, Lixiao Zhang, Qiuyue Zhang, Jianrui Zhou, Li Li, Xiaoli Xu, <span class="NLM_string-name hlFld-ContribAuthor">Qidong You</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Small Molecules Targeting the Protein–Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 1281-1297. <a href="https://doi.org/10.1021/acs.jmedchem.9b01659" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01659%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BSmall%252BMolecules%252BTargeting%252Bthe%252BProtein%2525E2%252580%252593Protein%252BInteraction%252Bof%252BHeat%252BShock%252BProtein%252B90%252B%252528Hsp90%252529%252Band%252BCell%252BDivision%252BCycle%252B37%252Bas%252BOrally%252BActive%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BColorectal%252BCancer%26aulast%3DWang%26aufirst%3DLei%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D13102019%26date%3D24012020%26date%3D14012020%26volume%3D63%26issue%3D3%26spage%3D1281%26epage%3D1297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Takao Uno, Yuichi Kawai, Satoshi Yamashita, Hiromi Oshiumi, Chihoko Yoshimura, Takashi Mizutani, Tatsuya Suzuki, Khoon Tee Chong, Kazuhiko Shigeno, Mitsuru Ohkubo, Yasuo Kodama, Hiromi Muraoka, Kaoru Funabashi, Koichi Takahashi, Shuichi Ohkubo, <span class="NLM_string-name hlFld-ContribAuthor">Makoto Kitade</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 531-551. <a href="https://doi.org/10.1021/acs.jmedchem.8b01085" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01085%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-Ethyl-4-%2525283-isopropyl-4-%2525284-%2525281-methyl-1H-pyrazol-4-yl%252529-1H-imidazol-1-yl%252529-1H-pyrazolo%25255B3%25252C4-b%25255Dpyridin-1-yl%252529benzamide%252B%252528TAS-116%252529%252Bas%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BAvailable%252BHSP90%252BInhibitor%26aulast%3DUno%26aufirst%3DTakao%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D10072018%26date%3D21122018%26date%3D07122018%26volume%3D62%26issue%3D2%26spage%3D531%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Hui-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Hui  Jin</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Min  Jia</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Chao  Bao</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, and <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10498-10519. <a href="https://doi.org/10.1021/acs.jmedchem.6b00912" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00912%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BTetrahydropyrido%25255B4%25252C3-d%25255Dpyrimidines%252Bas%252BPotent%252BInhibitors%252Bof%252BChaperone%252BHeat%252BShock%252BProtein%252B90%26aulast%3DJiang%26aufirst%3DFen%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17062016%26date%3D22112016%26date%3D08122016%26date%3D09112016%26volume%3D59%26issue%3D23%26spage%3D10498%26epage%3D10519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica A.  Hall</span>, <span class="hlFld-ContribAuthor ">Sahithi  Seedarala</span>, <span class="hlFld-ContribAuthor ">Huiping  Zhao</span>, <span class="hlFld-ContribAuthor ">Gaurav  Garg</span>, <span class="hlFld-ContribAuthor ">Suman  Ghosh</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Novobiocin Analogues That Inhibit the MAPK Pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 925-933. <a href="https://doi.org/10.1021/acs.jmedchem.5b01354" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01354%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovobiocin%252BAnalogues%252BThat%252BInhibit%252Bthe%252BMAPK%252BPathway%26aulast%3DHall%26aufirst%3DJessica%2BA.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D01092015%26date%3D27012016%26date%3D11022016%26date%3D08012016%26volume%3D59%26issue%3D3%26spage%3D925%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mercy  Anyika</span>, <span class="hlFld-ContribAuthor ">Mason  McMullen</span>, <span class="hlFld-ContribAuthor ">Leah K.  Forsberg</span>, <span class="hlFld-ContribAuthor ">Rick T.  Dobrowsky</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Noviomimetics as C-Terminal Hsp90 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , 67-71. <a href="https://doi.org/10.1021/acsmedchemlett.5b00331" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00331</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00331%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252BNoviomimetics%252Bas%252BC-Terminal%252BHsp90%252BInhibitors%26aulast%3DAnyika%26aufirst%3DMercy%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D12082015%26date%3D07122015%26date%3D09122015%26date%3D14012016%26volume%3D7%26issue%3D1%26spage%3D67%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Xianglin    Shi </span><span class="hlFld-ContribAuthor "> William F.    Kiesman </span><span class="hlFld-ContribAuthor "> Donald G.    Walker </span>. </span><span class="cited-content_cbyCitation_article-title">Development of Hsp90 Inhibitors for the Treatment of HER-2 Positive Solid Cancers. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 69-100. <a href="https://doi.org/10.1021/bk-2016-1239.ch003" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch003%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BHsp90%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BHER-2%252BPositive%252BSolid%252BCancers%26aulast%3DShi%26aufirst%3DXianglin%26date%3D2016%26date%3D2016%26spage%3D69%26epage%3D100%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Glenn C.  Micalizio</span> and <span class="hlFld-ContribAuthor ">Sarah B.  Hale</span>  . </span><span class="cited-content_cbyCitation_article-title">Reaction Design, Discovery, and Development as a Foundation to Function-Oriented Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2015,</strong> <em>48 </em>
                                    (3)
                                     , 663-673. <a href="https://doi.org/10.1021/ar500408e" title="DOI URL">https://doi.org/10.1021/ar500408e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ar500408e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Far500408e%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DReaction%252BDesign%25252C%252BDiscovery%25252C%252Band%252BDevelopment%252Bas%252Ba%252BFoundation%252Bto%252BFunction-Oriented%252BSynthesis%26aulast%3DMicalizio%26aufirst%3DGlenn%2BC.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D11112014%26date%3D10022015%26date%3D17032015%26volume%3D48%26issue%3D3%26spage%3D663%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard  Pirard</span> and <span class="hlFld-ContribAuthor ">Peter  Ertl</span>  . </span><span class="cited-content_cbyCitation_article-title">Evaluation of a Semi-Automated Workflow for Fragment Growing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (1)
                                     , 180-193. <a href="https://doi.org/10.1021/ci5006355" title="DOI URL">https://doi.org/10.1021/ci5006355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci5006355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci5006355%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEvaluation%252Bof%252Ba%252BSemi-Automated%252BWorkflow%252Bfor%252BFragment%252BGrowing%26aulast%3DPirard%26aufirst%3DBernard%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D22102014%26date%3D06012015%26date%3D26012015%26date%3D16122014%26volume%3D55%26issue%3D1%26spage%3D180%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Meng</span>, <span class="hlFld-ContribAuthor ">Dadong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zuoquan  Xie</span>, <span class="hlFld-ContribAuthor ">Ting  Yu</span>, <span class="hlFld-ContribAuthor ">Shuchao  Wu</span>, <span class="hlFld-ContribAuthor ">Lorenza  Wyder</span>, <span class="hlFld-ContribAuthor ">Urs  Regenass</span>, <span class="hlFld-ContribAuthor ">Kurt  Hilpert</span>, <span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, and <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9832-9843. <a href="https://doi.org/10.1021/jm5010144" title="DOI URL">https://doi.org/10.1021/jm5010144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5010144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5010144%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252B4%25252C5-Diarylisoxazoles%252Bas%252BPotent%252BDual%252BInhibitors%252Bof%252BPyruvate%252BDehydrogenase%252BKinase%252Band%252BHeat%252BShock%252BProtein%252B90%26aulast%3DMeng%26aufirst%3DTao%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D25042014%26date%3D26112014%26date%3D11122014%26date%3D10112014%26volume%3D57%26issue%3D23%26spage%3D9832%26epage%3D9843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rohit  Bhat</span>, <span class="hlFld-ContribAuthor ">Sreedhar R.  Tummalapalli</span>, and <span class="hlFld-ContribAuthor ">David P.  Rotella</span>  . </span><span class="cited-content_cbyCitation_article-title">Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (21)
                                     , 8718-8728. <a href="https://doi.org/10.1021/jm500823a" title="DOI URL">https://doi.org/10.1021/jm500823a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500823a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500823a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252Bthe%252BDiscovery%252Band%252BDevelopment%252Bof%252BHeat%252BShock%252BProtein%252B90%252B%252528Hsp90%252529%252BInhibitors%26aulast%3DBhat%26aufirst%3DRohit%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D30052014%26date%3D29082014%26date%3D13112014%26date%3D20082014%26volume%3D57%26issue%3D21%26spage%3D8718%26epage%3D8728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin T.  Ernst</span>, <span class="hlFld-ContribAuthor ">Timothy  Neubert</span>, <span class="hlFld-ContribAuthor ">Michael  Liu</span>, <span class="hlFld-ContribAuthor ">Samuel  Sperry</span>, <span class="hlFld-ContribAuthor ">Harmon  Zuccola</span>, <span class="hlFld-ContribAuthor ">Amy  Turnbull</span>, <span class="hlFld-ContribAuthor ">Beth  Fleck</span>, <span class="hlFld-ContribAuthor ">William  Kargo</span>, <span class="hlFld-ContribAuthor ">Lisa  Woody</span>, <span class="hlFld-ContribAuthor ">Peggy  Chiang</span>, <span class="hlFld-ContribAuthor ">Dao  Tran</span>, <span class="hlFld-ContribAuthor ">Weichao  Chen</span>, <span class="hlFld-ContribAuthor ">Phillip  Snyder</span>, <span class="hlFld-ContribAuthor ">Timothy  Alcacio</span>, <span class="hlFld-ContribAuthor ">Azin  Nezami</span>, <span class="hlFld-ContribAuthor ">James  Reynolds</span>, <span class="hlFld-ContribAuthor ">Khisal  Alvi</span>, <span class="hlFld-ContribAuthor ">Lance  Goulet</span>, and <span class="hlFld-ContribAuthor ">Dean  Stamos</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Novel HSP90α/β Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration of Potential Utility in Treating CNS Disorders such as Huntington’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (8)
                                     , 3382-3400. <a href="https://doi.org/10.1021/jm500042s" title="DOI URL">https://doi.org/10.1021/jm500042s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500042s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500042s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BNovel%252BHSP90%2525CE%2525B1%25252F%2525CE%2525B2%252BIsoform%252BSelective%252BInhibitors%252BUsing%252BStructure-Based%252BDrug%252BDesign.%252BDemonstration%252Bof%252BPotential%252BUtility%252Bin%252BTreating%252BCNS%252BDisorders%252Bsuch%252Bas%252BHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DErnst%26aufirst%3DJustin%2BT.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08012014%26date%3D10042014%26date%3D24042014%26date%3D27032014%26volume%3D57%26issue%3D8%26spage%3D3382%26epage%3D3400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maurizio  Taddei</span>, <span class="hlFld-ContribAuthor ">Serena  Ferrini</span>, <span class="hlFld-ContribAuthor ">Luca  Giannotti</span>, <span class="hlFld-ContribAuthor ">Massimo  Corsi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Manetti</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>, <span class="hlFld-ContribAuthor ">Loredana  Vesci</span>, <span class="hlFld-ContribAuthor ">Ferdinando M.  Milazzo</span>, <span class="hlFld-ContribAuthor ">Domenico  Alloatti</span>, <span class="hlFld-ContribAuthor ">Mario B.  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Massimo  Castorina</span>, <span class="hlFld-ContribAuthor ">Maria L.  Cervoni</span>, <span class="hlFld-ContribAuthor ">Marcella  Barbarino</span>, <span class="hlFld-ContribAuthor ">Rosanna  Foderà</span>, <span class="hlFld-ContribAuthor ">Valeria  Carollo</span>, <span class="hlFld-ContribAuthor ">Claudio  Pisano</span>, <span class="hlFld-ContribAuthor ">Silvia  Armaroli</span>, and <span class="hlFld-ContribAuthor ">Walter  Cabri</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (6)
                                     , 2258-2274. <a href="https://doi.org/10.1021/jm401536b" title="DOI URL">https://doi.org/10.1021/jm401536b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401536b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401536b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BNew%252BHsp90%252BInhibitors%252BBased%252Bon%252Ba%252B1%25252C4%25252C5-Trisubstituted%252B1%25252C2%25252C3-Triazole%252BScaffold%26aulast%3DTaddei%26aufirst%3DMaurizio%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D02102013%26date%3D17032014%26date%3D27032014%26date%3D03032014%26volume%3D57%26issue%3D6%26spage%3D2258%26epage%3D2274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Flavio  Ballante</span>, <span class="hlFld-ContribAuthor ">Antonia  Caroli</span>, <span class="hlFld-ContribAuthor ">Richard B.  Wickersham, III</span>, and <span class="hlFld-ContribAuthor ">Rino  Ragno</span>  . </span><span class="cited-content_cbyCitation_article-title">Hsp90 Inhibitors, Part 1: Definition of 3-D QSAutogrid/R Models as a Tool for Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (3)
                                     , 956-969. <a href="https://doi.org/10.1021/ci400759t" title="DOI URL">https://doi.org/10.1021/ci400759t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400759t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400759t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DHsp90%252BInhibitors%25252C%252BPart%252B1%25253A%252BDefinition%252Bof%252B3-D%252BQSAutogrid%25252FR%252BModels%252Bas%252Ba%252BTool%252Bfor%252BVirtual%252BScreening%26aulast%3DBallante%26aufirst%3DFlavio%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D22122013%26date%3D04032014%26date%3D24032014%26date%3D24022014%26volume%3D54%26issue%3D3%26spage%3D956%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khaled A.  Shaaban</span>, <span class="hlFld-ContribAuthor ">Xiachang  Wang</span>, <span class="hlFld-ContribAuthor ">Sherif I.  Elshahawi</span>, <span class="hlFld-ContribAuthor ">Larissa V.  Ponomareva</span>, <span class="hlFld-ContribAuthor ">Manjula  Sunkara</span>, <span class="hlFld-ContribAuthor ">Gregory C.  Copley</span>, <span class="hlFld-ContribAuthor ">James C.  Hower</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Morris</span>, <span class="hlFld-ContribAuthor ">Madan K.  Kharel</span>, and <span class="hlFld-ContribAuthor ">Jon S.  Thorson</span>  . </span><span class="cited-content_cbyCitation_article-title">Herbimycins D–F, Ansamycin Analogues from Streptomyces sp. RM-7-15. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2013,</strong> <em>76 </em>
                                    (9)
                                     , 1619-1626. <a href="https://doi.org/10.1021/np400308w" title="DOI URL">https://doi.org/10.1021/np400308w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/np400308w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fnp400308w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DHerbimycins%252BD%2525E2%252580%252593F%25252C%252BAnsamycin%252BAnalogues%252Bfrom%252BStreptomyces%252Bsp.%252BRM-7-15%26aulast%3DShaaban%26aufirst%3DKhaled%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D12042013%26date%3D15082013%26date%3D27092013%26volume%3D76%26issue%3D9%26spage%3D1619%26epage%3D1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Pallav D.  Patel</span>, <span class="hlFld-ContribAuthor ">Maulik  Patel</span>, <span class="hlFld-ContribAuthor ">Hardik J.  Patel</span>, <span class="hlFld-ContribAuthor ">Christopher E.  Evans</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Stefan  Ochiana</span>, <span class="hlFld-ContribAuthor ">Smit K.  Shah</span>, <span class="hlFld-ContribAuthor ">Mohammad  Uddin</span>, <span class="hlFld-ContribAuthor ">Daniel  Gewirth</span>, and <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>  . </span><span class="cited-content_cbyCitation_article-title">Experimental and Structural Testing Module to Analyze Paralogue-Specificity and Affinity in the Hsp90 Inhibitors Series. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 6803-6818. <a href="https://doi.org/10.1021/jm400619b" title="DOI URL">https://doi.org/10.1021/jm400619b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400619b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400619b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExperimental%252Band%252BStructural%252BTesting%252BModule%252Bto%252BAnalyze%252BParalogue-Specificity%252Band%252BAffinity%252Bin%252Bthe%252BHsp90%252BInhibitors%252BSeries%26aulast%3DTaldone%26aufirst%3DTony%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26042013%26date%3D21082013%26date%3D12092013%26volume%3D56%26issue%3D17%26spage%3D6803%26epage%3D6818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elinor  Meiby</span>, <span class="hlFld-ContribAuthor ">Heather  Simmonite</span>, <span class="hlFld-ContribAuthor ">Loic  le Strat</span>, <span class="hlFld-ContribAuthor ">Ben  Davis</span>, <span class="hlFld-ContribAuthor ">Natalia  Matassova</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Moore</span>, <span class="hlFld-ContribAuthor ">Michael  Mrosek</span>, <span class="hlFld-ContribAuthor ">James  Murray</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>, and <span class="hlFld-ContribAuthor ">Sten  Ohlson</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment Screening by Weak Affinity Chromatography: Comparison with Established Techniques for Screening against HSP90. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2013,</strong> <em>85 </em>
                                    (14)
                                     , 6756-6766. <a href="https://doi.org/10.1021/ac400715t" title="DOI URL">https://doi.org/10.1021/ac400715t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ac400715t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fac400715t%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DFragment%252BScreening%252Bby%252BWeak%252BAffinity%252BChromatography%25253A%252BComparison%252Bwith%252BEstablished%252BTechniques%252Bfor%252BScreening%252Bagainst%252BHSP90%26aulast%3DMeiby%26aufirst%3DElinor%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08032013%26date%3D10062013%26date%3D27062013%26date%3D16072013%26date%3D10062013%26volume%3D85%26issue%3D14%26spage%3D6756%26epage%3D6766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias R.  Bauer</span>, <span class="hlFld-ContribAuthor ">Tamer M.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Simon M.  Vogel</span>, and <span class="hlFld-ContribAuthor ">Frank M.  Boeckler</span>  . </span><span class="cited-content_cbyCitation_article-title">Evaluation and Optimization of Virtual Screening Workflows with DEKOIS 2.0 – A Public Library of Challenging Docking Benchmark Sets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (6)
                                     , 1447-1462. <a href="https://doi.org/10.1021/ci400115b" title="DOI URL">https://doi.org/10.1021/ci400115b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400115b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400115b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEvaluation%252Band%252BOptimization%252Bof%252BVirtual%252BScreening%252BWorkflows%252Bwith%252BDEKOIS%252B2.0%252B%2525E2%252580%252593%252BA%252BPublic%252BLibrary%252Bof%252BChallenging%252BDocking%252BBenchmark%252BSets%26aulast%3DBauer%26aufirst%3DMatthias%2BR.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19022013%26date%3D12062013%26date%3D24062013%26date%3D25052013%26volume%3D53%26issue%3D6%26spage%3D1447%26epage%3D1462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Russell R. A.  Kitson</span> and <span class="hlFld-ContribAuthor ">Christopher J.  Moody</span>  . </span><span class="cited-content_cbyCitation_article-title">Learning from Nature: Advances in Geldanamycin- and Radicicol-Based Inhibitors of Hsp90. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (11)
                                     , 5117-5141. <a href="https://doi.org/10.1021/jo4002849" title="DOI URL">https://doi.org/10.1021/jo4002849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo4002849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo4002849%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLearning%252Bfrom%252BNature%25253A%252BAdvances%252Bin%252BGeldanamycin-%252Band%252BRadicicol-Based%252BInhibitors%252Bof%252BHsp90%26aulast%3DKitson%26aufirst%3DRussell%2BR.%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06022013%26date%3D26032013%26date%3D07062013%26date%3D15032013%26volume%3D78%26issue%3D11%26spage%3D5117%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiping  Zhao</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Moroni</span>, <span class="hlFld-ContribAuthor ">Bin  Yan</span>, <span class="hlFld-ContribAuthor ">Giorgio  Colombo</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (1)
                                     , 57-62. <a href="https://doi.org/10.1021/ml300275g" title="DOI URL">https://doi.org/10.1021/ml300275g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300275g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300275g%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3D-QSAR-Assisted%252BDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BNovobiocin%252BAnalogues%26aulast%3DZhao%26aufirst%3DHuiping%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07092012%26date%3D23112012%26date%3D29112012%26date%3D10012013%26volume%3D4%26issue%3D1%26spage%3D57%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Se-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Ashok  Bajji</span>, <span class="hlFld-ContribAuthor ">Rajendra  Tangallapally</span>, <span class="hlFld-ContribAuthor ">Benjamin  Markovitz</span>, <span class="hlFld-ContribAuthor ">Richard  Trovato</span>, <span class="hlFld-ContribAuthor ">Mark  Shenderovich</span>, <span class="hlFld-ContribAuthor ">Vijay  Baichwal</span>, <span class="hlFld-ContribAuthor ">Paul  Bartel</span>, <span class="hlFld-ContribAuthor ">Daniel  Cimbora</span>, <span class="hlFld-ContribAuthor ">Rena  McKinnon</span>, <span class="hlFld-ContribAuthor ">Rosann  Robinson</span>, <span class="hlFld-ContribAuthor ">Damon  Papac</span>, <span class="hlFld-ContribAuthor ">Daniel  Wettstein</span>, <span class="hlFld-ContribAuthor ">Robert  Carlson</span>, and <span class="hlFld-ContribAuthor ">Kraig M.  Yager</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7480-7501. <a href="https://doi.org/10.1021/jm3004619" title="DOI URL">https://doi.org/10.1021/jm3004619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3004619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3004619%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525282S%252529-1-%25255B4-%2525282-%25257B6-Amino-8-%25255B%2525286-bromo-1%25252C3-benzodioxol-5-yl%252529sulfanyl%25255D-9H-purin-9-yl%25257Dethyl%252529piperidin-1-yl%25255D-2-hydroxypropan-1-one%252B%252528MPC-3100%252529%25252C%252Ba%252BPurine-Based%252BHsp90%252BInhibitor%26aulast%3DKim%26aufirst%3DSe-Ho%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D02042012%26date%3D31082012%26date%3D13092012%26date%3D22082012%26volume%3D55%26issue%3D17%26spage%3D7480%26epage%3D7501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiandong  Shi</span>, <span class="hlFld-ContribAuthor ">Ryan  Van de Water</span>, <span class="hlFld-ContribAuthor ">Kevin  Hong</span>, <span class="hlFld-ContribAuthor ">Ryan B.  Lamer</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Weichert</span>, <span class="hlFld-ContribAuthor ">Cristina M.  Sandoval</span>, <span class="hlFld-ContribAuthor ">Srinivas R.  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Marcus F.  Boehm</span>, <span class="hlFld-ContribAuthor ">Jianhua  Chao</span>, <span class="hlFld-ContribAuthor ">Karen  Lundgren</span>, <span class="hlFld-ContribAuthor ">Noelito  Timple</span>, <span class="hlFld-ContribAuthor ">Rachel  Lough</span>, <span class="hlFld-ContribAuthor ">Gerardo  Ibanez</span>, <span class="hlFld-ContribAuthor ">Christina  Boykin</span>, <span class="hlFld-ContribAuthor ">Francis J.  Burrows</span>, <span class="hlFld-ContribAuthor ">Marilyn R.  Kehry</span>, <span class="hlFld-ContribAuthor ">Theodore J.  Yun</span>, <span class="hlFld-ContribAuthor ">Erin K.  Harning</span>, <span class="hlFld-ContribAuthor ">Christine  Ambrose</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Thompson</span>, <span class="hlFld-ContribAuthor ">Sarah A.  Bixler</span>, <span class="hlFld-ContribAuthor ">Anthone  Dunah</span>, <span class="hlFld-ContribAuthor ">Pamela  Snodgrass-Belt</span>, <span class="hlFld-ContribAuthor ">Joseph  Arndt</span>, <span class="hlFld-ContribAuthor ">Istvan J.  Enyedy</span>, <span class="hlFld-ContribAuthor ">Ping  Li</span>, <span class="hlFld-ContribAuthor ">Victor S.  Hong</span>, <span class="hlFld-ContribAuthor ">Andres  McKenzie</span>, and <span class="hlFld-ContribAuthor ">Marco A.  Biamonte</span>  . </span><span class="cited-content_cbyCitation_article-title">EC144 Is a Potent Inhibitor of the Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7786-7795. <a href="https://doi.org/10.1021/jm300810x" title="DOI URL">https://doi.org/10.1021/jm300810x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300810x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300810x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEC144%252BIs%252Ba%252BPotent%252BInhibitor%252Bof%252Bthe%252BHeat%252BShock%252BProtein%252B90%26aulast%3DShi%26aufirst%3DJiandong%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D08062012%26date%3D31082012%26date%3D13092012%26volume%3D55%26issue%3D17%26spage%3D7786%26epage%3D7795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam S.  Duerfeldt</span>, <span class="hlFld-ContribAuthor ">Laura B.  Peterson</span>, <span class="hlFld-ContribAuthor ">Jason C.  Maynard</span>, <span class="hlFld-ContribAuthor ">Chun Leung  Ng</span>, <span class="hlFld-ContribAuthor ">Davide  Eletto</span>, <span class="hlFld-ContribAuthor ">Olga  Ostrovsky</span>, <span class="hlFld-ContribAuthor ">Heather E.  Shinogle</span>, <span class="hlFld-ContribAuthor ">David S.  Moore</span>, <span class="hlFld-ContribAuthor ">Yair  Argon</span>, <span class="hlFld-ContribAuthor ">Christopher V.  Nicchitta</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Grp94 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2012,</strong> <em>134 </em>
                                    (23)
                                     , 9796-9804. <a href="https://doi.org/10.1021/ja303477g" title="DOI URL">https://doi.org/10.1021/ja303477g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja303477g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDevelopment%252Bof%252Ba%252BGrp94%252Binhibitor%26aulast%3DDuerfeldt%26aufirst%3DAdam%2BS.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D11042012%26date%3D29052012%26date%3D13062012%26volume%3D134%26issue%3D23%26spage%3D9796%26epage%3D9804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura B.  Peterson</span>, <span class="hlFld-ContribAuthor ">Jeffrey D.  Eskew</span>, <span class="hlFld-ContribAuthor ">George A.  Vielhauer</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">The hERG Channel Is Dependent upon the Hsp90α Isoform for Maturation and Trafficking. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2012,</strong> <em>9 </em>
                                    (6)
                                     , 1841-1846. <a href="https://doi.org/10.1021/mp300138n" title="DOI URL">https://doi.org/10.1021/mp300138n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp300138n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp300138n%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DThe%252BhERG%252BChannel%252BIs%252BDependent%252Bupon%252Bthe%252BHsp90%2525CE%2525B1%252BIsoform%252Bfor%252BMaturation%252Band%252BTrafficking%26aulast%3DPeterson%26aufirst%3DLaura%2BB.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D09032012%26date%3D23042012%26date%3D11042012%26date%3D03052012%26date%3D04062012%26volume%3D9%26issue%3D6%26spage%3D1841%26epage%3D1846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone  Eichner</span>, <span class="hlFld-ContribAuthor ">Timo  Eichner</span>, <span class="hlFld-ContribAuthor ">Heinz G.  Floss</span>, <span class="hlFld-ContribAuthor ">Jörg  Fohrer</span>, <span class="hlFld-ContribAuthor ">Edgar  Hofer</span>, <span class="hlFld-ContribAuthor ">Florenz  Sasse</span>, <span class="hlFld-ContribAuthor ">Carsten  Zeilinger</span>, and <span class="hlFld-ContribAuthor ">Andreas  Kirschning</span>  . </span><span class="cited-content_cbyCitation_article-title">Broad Substrate Specificity of the Amide Synthase in S. hygroscopicus—New 20-Membered Macrolactones Derived from Geldanamycin. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2012,</strong> <em>134 </em>
                                    (3)
                                     , 1673-1679. <a href="https://doi.org/10.1021/ja2087147" title="DOI URL">https://doi.org/10.1021/ja2087147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja2087147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja2087147%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DBroad%252BSubstrate%252BSpecificity%252Bof%252Bthe%252BAmide%252BSynthase%252Bin%252BS.%252Bhygroscopicus%2525E2%252580%252594New%252B20-Membered%252BMacrolactones%252BDerived%252Bfrom%252BGeldanamycin%26aulast%3DEichner%26aufirst%3DSimone%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D15092011%26date%3D10012012%26date%3D25012012%26date%3D05122011%26volume%3D134%26issue%3D3%26spage%3D1673%26epage%3D1679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riccardo  Baruchello</span>, <span class="hlFld-ContribAuthor ">Daniele  Simoni</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Grisolia</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Barbato</span>, <span class="hlFld-ContribAuthor ">Paolo  Marchetti</span>, <span class="hlFld-ContribAuthor ">Riccardo  Rondanin</span>, <span class="hlFld-ContribAuthor ">Stefania  Mangiola</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>, <span class="hlFld-ContribAuthor ">Tiziana  Brunetti</span>, <span class="hlFld-ContribAuthor ">Domenico  Alloatti</span>, <span class="hlFld-ContribAuthor ">Grazia  Gallo</span>, <span class="hlFld-ContribAuthor ">Andrea  Ciacci</span>, <span class="hlFld-ContribAuthor ">Loredana  Vesci</span>, <span class="hlFld-ContribAuthor ">Massimo  Castorina</span>, <span class="hlFld-ContribAuthor ">Ferdinando M.  Milazzo</span>, <span class="hlFld-ContribAuthor ">Maria L.  Cervoni</span>, <span class="hlFld-ContribAuthor ">Mario B.  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Marcella  Barbarino</span>, <span class="hlFld-ContribAuthor ">Rosanna  Foderà</span>, <span class="hlFld-ContribAuthor ">Claudio  Pisano</span>, and <span class="hlFld-ContribAuthor ">Walter  Cabri</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel 3,4-Isoxazolediamides as Potent Inhibitors of Chaperone Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8592-8604. <a href="https://doi.org/10.1021/jm201155e" title="DOI URL">https://doi.org/10.1021/jm201155e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201155e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201155e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B3%25252C4-Isoxazolediamides%252Bas%252BPotent%252BInhibitors%252Bof%252BChaperone%252BHeat%252BShock%252BProtein%252B90%26aulast%3DBaruchello%26aufirst%3DRiccardo%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D30082011%26date%3D23112011%26date%3D22122011%26date%3D09112011%26volume%3D54%26issue%3D24%26spage%3D8592%26epage%3D8604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James E. H.  Day</span>, <span class="hlFld-ContribAuthor ">Swee Y.  Sharp</span>, <span class="hlFld-ContribAuthor ">Martin G.  Rowlands</span>, <span class="hlFld-ContribAuthor ">Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">William  Lewis</span>, <span class="hlFld-ContribAuthor ">S. Mark  Roe</span>, <span class="hlFld-ContribAuthor ">Chrisostomos  Prodromou</span>, <span class="hlFld-ContribAuthor ">Laurence H.  Pearl</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, and <span class="hlFld-ContribAuthor ">Christopher J.  Moody</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting the Hsp90 Molecular Chaperone with Novel Macrolactams. Synthesis, Structural, Binding, and Cellular Studies. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2011,</strong> <em>6 </em>
                                    (12)
                                     , 1339-1347. <a href="https://doi.org/10.1021/cb200196e" title="DOI URL">https://doi.org/10.1021/cb200196e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb200196e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb200196e%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DTargeting%252Bthe%252BHsp90%252BMolecular%252BChaperone%252Bwith%252BNovel%252BMacrolactams.%252BSynthesis%25252C%252BStructural%25252C%252BBinding%25252C%252Band%252BCellular%252BStudies%26aulast%3DDay%26aufirst%3DJames%2BE.%2BH.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D11112010%26date%3D20092011%26date%3D04102011%26date%3D16122011%26date%3D20092011%26volume%3D6%26issue%3D12%26spage%3D1339%26epage%3D1347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Genaro  Pimienta</span>, <span class="hlFld-ContribAuthor ">Kristina M.  Herbert</span>, and <span class="hlFld-ContribAuthor ">Lynne  Regan</span>  . </span><span class="cited-content_cbyCitation_article-title">A Compound That Inhibits the HOP–Hsp90 Complex Formation and Has Unique Killing Effects in Breast Cancer Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2011,</strong> <em>8 </em>
                                    (6)
                                     , 2252-2261. <a href="https://doi.org/10.1021/mp200346y" title="DOI URL">https://doi.org/10.1021/mp200346y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp200346y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp200346y%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DA%252BCompound%252BThat%252BInhibits%252Bthe%252BHOP%2525E2%252580%252593Hsp90%252BComplex%252BFormation%252Band%252BHas%252BUnique%252BKilling%252BEffects%252Bin%252BBreast%252BCancer%252BCell%252BLines%26aulast%3DPimienta%26aufirst%3DGenaro%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D13032011%26date%3D01092011%26date%3D28082011%26date%3D05102011%26date%3D05122011%26date%3D01092011%26volume%3D8%26issue%3D6%26spage%3D2252%26epage%3D2261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François  Vallée</span>, <span class="hlFld-ContribAuthor ">Chantal  Carrez</span>, <span class="hlFld-ContribAuthor ">Fabienne  Pilorge</span>, <span class="hlFld-ContribAuthor ">Alain  Dupuy</span>, <span class="hlFld-ContribAuthor ">Annick  Parent</span>, <span class="hlFld-ContribAuthor ">Luc  Bertin</span>, <span class="hlFld-ContribAuthor ">Fabienne  Thompson</span>, <span class="hlFld-ContribAuthor ">Paul  Ferrari</span>, <span class="hlFld-ContribAuthor ">Florence  Fassy</span>, <span class="hlFld-ContribAuthor ">Annabelle  Lamberton</span>, <span class="hlFld-ContribAuthor ">Anne  Thomas</span>, <span class="hlFld-ContribAuthor ">Rosalia  Arrebola</span>, <span class="hlFld-ContribAuthor ">Stéphane  Guerif</span>, <span class="hlFld-ContribAuthor ">Alexandre  Rohaut</span>, <span class="hlFld-ContribAuthor ">Victor  Certal</span>, <span class="hlFld-ContribAuthor ">Jean-Marie  Ruxer</span>, <span class="hlFld-ContribAuthor ">Cécile  Delorme</span>, <span class="hlFld-ContribAuthor ">Alain  Jouanen</span>, <span class="hlFld-ContribAuthor ">Jacques  Dumas</span>, <span class="hlFld-ContribAuthor ">Claudine  Grépin</span>, <span class="hlFld-ContribAuthor ">Cécile  Combeau</span>, <span class="hlFld-ContribAuthor ">Hélène  Goulaouic</span>, <span class="hlFld-ContribAuthor ">Norbert  Dereu</span>, <span class="hlFld-ContribAuthor ">Vincent  Mikol</span>, <span class="hlFld-ContribAuthor ">Patrick  Mailliet</span>, and <span class="hlFld-ContribAuthor ">Hervé  Minoux</span>  . </span><span class="cited-content_cbyCitation_article-title">Tricyclic Series of Heat Shock Protein 90 (Hsp90) Inhibitors Part I: Discovery of Tricyclic Imidazo[4,5-c]pyridines as Potent Inhibitors of the Hsp90 Molecular Chaperone. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (20)
                                     , 7206-7219. <a href="https://doi.org/10.1021/jm200784m" title="DOI URL">https://doi.org/10.1021/jm200784m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200784m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200784m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTricyclic%252BSeries%252Bof%252BHeat%252BShock%252BProtein%252B90%252B%252528Hsp90%252529%252BInhibitors%252BPart%252BI%25253A%252BDiscovery%252Bof%252BTricyclic%252BImidazo%25255B4%25252C5-c%25255Dpyridines%252Bas%252BPotent%252BInhibitors%252Bof%252Bthe%252BHsp90%252BMolecular%252BChaperone%26aulast%3DVall%25C3%25A9e%26aufirst%3DFran%25C3%25A7ois%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D17062011%26date%3D05102011%26date%3D27102011%26volume%3D54%26issue%3D20%26spage%3D7206%26epage%3D7219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhaskar Reddy  Kusuma</span>, <span class="hlFld-ContribAuthor ">Laura B.  Peterson</span>, <span class="hlFld-ContribAuthor ">Huiping  Zhao</span>, <span class="hlFld-ContribAuthor ">George  Vielhauer</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Holzbeierlein</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting the Heat Shock Protein 90 Dimer with Dimeric Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (18)
                                     , 6234-6253. <a href="https://doi.org/10.1021/jm200553w" title="DOI URL">https://doi.org/10.1021/jm200553w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200553w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200553w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252BHeat%252BShock%252BProtein%252B90%252BDimer%252Bwith%252BDimeric%252BInhibitors%26aulast%3DKusuma%26aufirst%3DBhaskar%2BReddy%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D04052011%26date%3D23082011%26date%3D22092011%26volume%3D54%26issue%3D18%26spage%3D6234%26epage%3D6253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert L.  Matts</span>, <span class="hlFld-ContribAuthor ">Anshuman  Dixit</span>, <span class="hlFld-ContribAuthor ">Laura B.  Peterson</span>, <span class="hlFld-ContribAuthor ">Liang  Sun</span>, <span class="hlFld-ContribAuthor ">Sudhakar  Voruganti</span>, <span class="hlFld-ContribAuthor ">Palgunan  Kalyanaraman</span>, <span class="hlFld-ContribAuthor ">Steve D.  Hartson</span>, <span class="hlFld-ContribAuthor ">Gennady M.  Verkhivker</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Elucidation of the Hsp90 C-Terminal Inhibitor Binding Site. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2011,</strong> <em>6 </em>
                                    (8)
                                     , 800-807. <a href="https://doi.org/10.1021/cb200052x" title="DOI URL">https://doi.org/10.1021/cb200052x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb200052x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb200052x%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DElucidation%252Bof%252Bthe%252BHsp90%252BC-Terminal%252BInhibitor%252BBinding%252BSite%26aulast%3DMatts%26aufirst%3DRobert%2BL.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D09112010%26date%3D06052011%26date%3D17052011%26date%3D19082011%26date%3D06052011%26volume%3D6%26issue%3D8%26spage%3D800%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen D.  Roughley</span> and <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>  . </span><span class="cited-content_cbyCitation_article-title">How Well Can Fragments Explore Accessed Chemical Space? A Case Study from Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (12)
                                     , 3989-4005. <a href="https://doi.org/10.1021/jm200350g" title="DOI URL">https://doi.org/10.1021/jm200350g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200350g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200350g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252BWell%252BCan%252BFragments%252BExplore%252BAccessed%252BChemical%252BSpace%25253F%252BA%252BCase%252BStudy%252Bfrom%252BHeat%252BShock%252BProtein%252B90%26aulast%3DRoughley%26aufirst%3DStephen%2BD.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D25032011%26date%3D24052011%26date%3D23062011%26date%3D11052011%26volume%3D54%26issue%3D12%26spage%3D3989%26epage%3D4005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Massey</span>. </span><span class="cited-content_cbyCitation_article-title">ATPases as Drug Targets: Insights from Heat Shock Proteins 70 and 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (20)
                                     , 7280-7286. <a href="https://doi.org/10.1021/jm100342z" title="DOI URL">https://doi.org/10.1021/jm100342z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100342z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100342z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DATPases%252Bas%252BDrug%252BTargets%25253A%252BInsights%252Bfrom%252BHeat%252BShock%252BProteins%252B70%252Band%252B90%26aulast%3DMassey%26aufirst%3DAndrew%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D16032010%26date%3D07072010%26date%3D28102010%26volume%3D53%26issue%3D20%26spage%3D7280%26epage%3D7286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioannis S.  Vizirianakis</span>, <span class="hlFld-ContribAuthor ">Maria  Chatzopoulou</span>, <span class="hlFld-ContribAuthor ">Ioannis D.  Bonovolias</span>, <span class="hlFld-ContribAuthor ">Ioannis  Nicolaou</span>, <span class="hlFld-ContribAuthor ">Vassilis J.  Demopoulos</span>, and <span class="hlFld-ContribAuthor ">Asterios S.  Tsiftsoglou</span>  . </span><span class="cited-content_cbyCitation_article-title">Toward the Development of Innovative Bifunctional Agents To Induce Differentiation and To Promote Apoptosis in Leukemia: Clinical Candidates and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (19)
                                     , 6779-6810. <a href="https://doi.org/10.1021/jm100189a" title="DOI URL">https://doi.org/10.1021/jm100189a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100189a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100189a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DToward%252Bthe%252BDevelopment%252Bof%252BInnovative%252BBifunctional%252BAgents%252BTo%252BInduce%252BDifferentiation%252Band%252BTo%252BPromote%252BApoptosis%252Bin%252BLeukemia%25253A%252BClinical%252BCandidates%252Band%252BPerspectives%26aulast%3DVizirianakis%26aufirst%3DIoannis%2BS.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D12022010%26date%3D20072010%26date%3D14102010%26volume%3D53%26issue%3D19%26spage%3D6779%26epage%3D6810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Morra</span>, <span class="hlFld-ContribAuthor ">Marco A. C.  Neves</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Plescia</span>, <span class="hlFld-ContribAuthor ">Shinji  Tsustsumi</span>, <span class="hlFld-ContribAuthor ">Len  Neckers</span>, <span class="hlFld-ContribAuthor ">Gennady  Verkhivker</span>, <span class="hlFld-ContribAuthor ">Dario C.  Altieri</span>, and <span class="hlFld-ContribAuthor ">Giorgio  Colombo</span>  . </span><span class="cited-content_cbyCitation_article-title">Dynamics-Based Discovery of Allosteric Inhibitors: Selection of New Ligands for the C-terminal Domain of Hsp90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2010,</strong> <em>6 </em>
                                    (9)
                                     , 2978-2989. <a href="https://doi.org/10.1021/ct100334n" title="DOI URL">https://doi.org/10.1021/ct100334n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ct100334n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fct100334n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DDynamics-Based%252BDiscovery%252Bof%252BAllosteric%252BInhibitors%25253A%252BSelection%252Bof%252BNew%252BLigands%252Bfor%252Bthe%252BC-terminal%252BDomain%252Bof%252BHsp90%26aulast%3DMorra%26aufirst%3DGiulia%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D17%252006%25202010%26date%3D30082010%26date%3D14092010%26volume%3D6%26issue%3D9%26spage%3D2978%26epage%3D2989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Woodhead</span>, <span class="hlFld-ContribAuthor ">Hayley  Angove</span>, <span class="hlFld-ContribAuthor ">Maria G.  Carr</span>, <span class="hlFld-ContribAuthor ">Gianni  Chessari</span>, <span class="hlFld-ContribAuthor ">Miles  Congreve</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Coyle</span>, <span class="hlFld-ContribAuthor ">Jose  Cosme</span>, <span class="hlFld-ContribAuthor ">Brent  Graham</span>, <span class="hlFld-ContribAuthor ">Philip J.  Day</span>, <span class="hlFld-ContribAuthor ">Robert  Downham</span>, <span class="hlFld-ContribAuthor ">Lynsey  Fazal</span>, <span class="hlFld-ContribAuthor ">Ruth  Feltell</span>, <span class="hlFld-ContribAuthor ">Eva  Figueroa</span>, <span class="hlFld-ContribAuthor ">Martyn  Frederickson</span>, <span class="hlFld-ContribAuthor ">Jonathan  Lewis</span>, <span class="hlFld-ContribAuthor ">Rachel  McMenamin</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Murray</span>, <span class="hlFld-ContribAuthor ">M. Alistair  O’Brien</span>, <span class="hlFld-ContribAuthor ">Lina  Parra</span>, <span class="hlFld-ContribAuthor ">Sahil  Patel</span>, <span class="hlFld-ContribAuthor ">Theresa  Phillips</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>, <span class="hlFld-ContribAuthor ">Sharna  Rich</span>, <span class="hlFld-ContribAuthor ">Donna-Michelle  Smith</span>, <span class="hlFld-ContribAuthor ">Gary  Trewartha</span>, <span class="hlFld-ContribAuthor ">Mladen  Vinkovic</span>, <span class="hlFld-ContribAuthor ">Brian  Williams</span> and <span class="hlFld-ContribAuthor ">Alison J.-A.  Woolford</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (16)
                                     , 5956-5969. <a href="https://doi.org/10.1021/jm100060b" title="DOI URL">https://doi.org/10.1021/jm100060b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100060b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525282%25252C4-Dihydroxy-5-isopropylphenyl%252529-%25255B5-%2525284-methylpiperazin-1-ylmethyl%252529-1%25252C3-dihydroisoindol-2-yl%25255Dmethanone%252B%252528AT13387%252529%25252C%252Ba%252BNovel%252BInhibitor%252Bof%252Bthe%252BMolecular%252BChaperone%252BHsp90%252Bby%252BFragment%252BBased%252BDrug%252BDesign%26aulast%3DWoodhead%26aufirst%3DAndrew%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D15012010%26date%3D28072010%26date%3D26082010%26volume%3D53%26issue%3D16%26spage%3D5956%26epage%3D5969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gudrun M.  Spitzer</span>, <span class="hlFld-ContribAuthor ">Mathias  Heiss</span>, <span class="hlFld-ContribAuthor ">Martina  Mangold</span>, <span class="hlFld-ContribAuthor ">Patrick  Markt</span>, <span class="hlFld-ContribAuthor ">Johannes  Kirchmair</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wolber</span> and <span class="hlFld-ContribAuthor ">Klaus R.  Liedl</span>. </span><span class="cited-content_cbyCitation_article-title">One Concept, Three Implementations of 3D Pharmacophore-Based Virtual Screening: Distinct Coverage of Chemical Search Space. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2010,</strong> <em>50 </em>
                                    (7)
                                     , 1241-1247. <a href="https://doi.org/10.1021/ci100136b" title="DOI URL">https://doi.org/10.1021/ci100136b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci100136b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci100136b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DOne%252BConcept%25252C%252BThree%252BImplementations%252Bof%252B3D%252BPharmacophore-Based%252BVirtual%252BScreening%25253A%252BDistinct%252BCoverage%252Bof%252BChemical%252BSearch%252BSpace%26aulast%3DSpitzer%26aufirst%3DGudrun%2BM.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D9%252004%25202010%26date%3D28062010%26date%3D26072010%26volume%3D50%26issue%3D7%26spage%3D1241%26epage%3D1247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iwona E.  Wrona</span>, <span class="hlFld-ContribAuthor ">Alexander  Gozman</span>, <span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span> and <span class="hlFld-ContribAuthor ">James S.  Panek</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Reblastatin, Autolytimycin, and Non-Benzoquinone Analogues: Potent Inhibitors of Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2010,</strong> <em>75 </em>
                                    (9)
                                     , 2820-2835. <a href="https://doi.org/10.1021/jo1000109" title="DOI URL">https://doi.org/10.1021/jo1000109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo1000109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo1000109%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BReblastatin%25252C%252BAutolytimycin%25252C%252Band%252BNon-Benzoquinone%252BAnalogues%25253A%252BPotent%252BInhibitors%252Bof%252BHeat%252BShock%252BProtein%252B90%26aulast%3DWrona%26aufirst%3DIwona%2BE.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D11012010%26date%3D14042010%26date%3D07052010%26volume%3D75%26issue%3D9%26spage%3D2820%26epage%3D2835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shicheng  Xu</span>, <span class="hlFld-ContribAuthor ">Anping  Guo</span>, <span class="hlFld-ContribAuthor ">Nan-nan  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Dai</span>, <span class="hlFld-ContribAuthor ">Huan-aoyu  Yang</span>, <span class="hlFld-ContribAuthor ">Wenqin  Xie</span>, <span class="hlFld-ContribAuthor ">Mengjie  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of Grp94 selective inhibitors based on Phe199 induced fit mechanism and their anti-inflammatory effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113604. <a href="https://doi.org/10.1016/j.ejmech.2021.113604" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113604%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252BGrp94%252Bselective%252Binhibitors%252Bbased%252Bon%252BPhe199%252Binduced%252Bfit%252Bmechanism%252Band%252Btheir%252Banti-inflammatory%252Beffects%26aulast%3DXu%26aufirst%3DShicheng%26date%3D2021%26volume%3D223%26spage%3D113604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Albert A.  Antolin</span>, <span class="hlFld-ContribAuthor ">Paul A.  Clarke</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Bissan  Al-Lazikani</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of kinase polypharmacology across HSP90 drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>5 </em><a href="https://doi.org/10.1016/j.chembiol.2021.05.004" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DEvolution%252Bof%252Bkinase%252Bpolypharmacology%252Bacross%252BHSP90%252Bdrug%252Bdiscovery%26aulast%3DAntolin%26aufirst%3DAlbert%2BA.%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Qiuyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the HSP90–CDC37–kinase chaperone cycle: A promising therapeutic strategy for cancer. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>95 </em><a href="https://doi.org/10.1002/med.21807" title="DOI URL">https://doi.org/10.1002/med.21807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21807%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252Bthe%252BHSP90%2525E2%252580%252593CDC37%2525E2%252580%252593kinase%252Bchaperone%252Bcycle%25253A%252BA%252Bpromising%252Btherapeutic%252Bstrategy%252Bfor%252Bcancer%26aulast%3DWang%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Nordeman</span>, <span class="hlFld-ContribAuthor ">Z.P.  Jayendra</span>, <span class="hlFld-ContribAuthor ">E.  Briard</span>, <span class="hlFld-ContribAuthor ">S.C.  Li</span>, <span class="hlFld-ContribAuthor ">M.  Larhed</span>, <span class="hlFld-ContribAuthor ">G.  Antoni</span>, <span class="hlFld-ContribAuthor ">S.  Estrada</span>, <span class="hlFld-ContribAuthor ">R.K.  Selvaraju</span>, <span class="hlFld-ContribAuthor ">O.  Åberg</span>, <span class="hlFld-ContribAuthor ">M.R.  Jensen</span>, <span class="hlFld-ContribAuthor ">P.  Stålberg</span>, <span class="hlFld-ContribAuthor ">B.  Skogseid</span>, <span class="hlFld-ContribAuthor ">A.  Monazzam</span>. </span><span class="cited-content_cbyCitation_article-title">18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligand. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>157 </em>, 105647. <a href="https://doi.org/10.1016/j.ejps.2020.105647" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105647%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3D18F-Radiolabeling%252Band%252BPreliminary%252BEvaluation%252Bof%252Ba%252BHSP90%252Bligand%26aulast%3DNordeman%26aufirst%3DP.%26date%3D2021%26volume%3D157%26spage%3D105647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khanh T.  Do</span>, <span class="hlFld-ContribAuthor ">Geraldine  O’Sullivan Coyne</span>, <span class="hlFld-ContribAuthor ">John L.  Hays</span>, <span class="hlFld-ContribAuthor ">Jeffrey G.  Supko</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Liu</span>, <span class="hlFld-ContribAuthor ">Kristin  Beebe</span>, <span class="hlFld-ContribAuthor ">Len  Neckers</span>, <span class="hlFld-ContribAuthor ">Jane B.  Trepel</span>, <span class="hlFld-ContribAuthor ">Min-Jung  Lee</span>, <span class="hlFld-ContribAuthor ">Tomoko  Smyth</span>, <span class="hlFld-ContribAuthor ">Courtney  Gannon</span>, <span class="hlFld-ContribAuthor ">Jennifer  Hedglin</span>, <span class="hlFld-ContribAuthor ">Alona  Muzikansky</span>, <span class="hlFld-ContribAuthor ">Susana  Campos</span>, <span class="hlFld-ContribAuthor ">John  Lyons</span>, <span class="hlFld-ContribAuthor ">Percy  Ivy</span>, <span class="hlFld-ContribAuthor ">James H.  Doroshow</span>, <span class="hlFld-ContribAuthor ">Alice P.  Chen</span>, <span class="hlFld-ContribAuthor ">Geoffrey I.  Shapiro</span>. </span><span class="cited-content_cbyCitation_article-title">Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2020,</strong> <em>86 </em>
                                    (6)
                                     , 815-827. <a href="https://doi.org/10.1007/s00280-020-04176-z" title="DOI URL">https://doi.org/10.1007/s00280-020-04176-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-020-04176-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-020-04176-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DPhase%252B1%252Bstudy%252Bof%252Bthe%252BHSP90%252Binhibitor%252Bonalespib%252Bin%252Bcombination%252Bwith%252BAT7519%25252C%252Ba%252Bpan-CDK%252Binhibitor%25252C%252Bin%252Bpatients%252Bwith%252Badvanced%252Bsolid%252Btumors%26aulast%3DDo%26aufirst%3DKhanh%2BT.%26date%3D2020%26date%3D2020%26volume%3D86%26issue%3D6%26spage%3D815%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pragya  Prasanna</span>, <span class="hlFld-ContribAuthor ">Arun  Upadhyay</span>, . </span><span class="cited-content_cbyCitation_article-title">Heat Shock Proteins as the Druggable Targets in Leishmaniasis: Promises and Perils. </span><span class="cited-content_cbyCitation_journal-name">Infection and Immunity</span><span> <strong>2020,</strong> <em>89 </em>
                                    (2)
                                     <a href="https://doi.org/10.1128/IAI.00559-20" title="DOI URL">https://doi.org/10.1128/IAI.00559-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/IAI.00559-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FIAI.00559-20%26sid%3Dliteratum%253Aachs%26jtitle%3DInfection%2520and%2520Immunity%26atitle%3DHeat%252BShock%252BProteins%252Bas%252Bthe%252BDruggable%252BTargets%252Bin%252BLeishmaniasis%25253A%252BPromises%252Band%252BPerils%26aulast%3DPrasanna%26aufirst%3DPragya%26date%3D2020%26date%3D2021%26volume%3D89%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Xu</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of protein fate decision by small molecules: targeting molecular chaperone machinery. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (10)
                                     , 1904-1925. <a href="https://doi.org/10.1016/j.apsb.2020.01.018" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.01.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.01.018%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DModulation%252Bof%252Bprotein%252Bfate%252Bdecision%252Bby%252Bsmall%252Bmolecules%25253A%252Btargeting%252Bmolecular%252Bchaperone%252Bmachinery%26aulast%3DWang%26aufirst%3DLei%26date%3D2020%26volume%3D10%26issue%3D10%26spage%3D1904%26epage%3D1925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sayan  Dutta Gupta</span>, <span class="hlFld-ContribAuthor ">Cheol Ho  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent update on discovery and development of Hsp90 inhibitors as senolytic agents. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2020,</strong> <em>161 </em>, 1086-1098. <a href="https://doi.org/10.1016/j.ijbiomac.2020.06.115" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.06.115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.06.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.06.115%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DRecent%252Bupdate%252Bon%252Bdiscovery%252Band%252Bdevelopment%252Bof%252BHsp90%252Binhibitors%252Bas%252Bsenolytic%252Bagents%26aulast%3DDutta%2BGupta%26aufirst%3DSayan%26date%3D2020%26volume%3D161%26spage%3D1086%26epage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingyue  Ji</span>, <span class="hlFld-ContribAuthor ">Zhuorong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry strategies toward host targeting antiviral agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (5)
                                     , 1519-1557. <a href="https://doi.org/10.1002/med.21664" title="DOI URL">https://doi.org/10.1002/med.21664</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21664%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMedicinal%252Bchemistry%252Bstrategies%252Btoward%252Bhost%252Btargeting%252Bantiviral%252Bagents%26aulast%3DJi%26aufirst%3DXingyue%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D5%26spage%3D1519%26epage%3D1557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Skrzypczak</span>, <span class="hlFld-ContribAuthor ">Krystian  Pyta</span>, <span class="hlFld-ContribAuthor ">Piotr  Ruszkowski</span>, <span class="hlFld-ContribAuthor ">Maria  Gdaniec</span>, <span class="hlFld-ContribAuthor ">Franz  Bartl</span>, <span class="hlFld-ContribAuthor ">Piotr  Przybylski</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112624. <a href="https://doi.org/10.1016/j.ejmech.2020.112624" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112624%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bstructure%252Band%252Banticancer%252Bactivity%252Bof%252Bnew%252Bgeldanamycin%252Bamine%252Banalogs%252Bcontaining%252BC%25252817%252529-%252Bor%252BC%25252820%252529-%252Bflexible%252Band%252Brigid%252Barms%252Bas%252Bwell%252Bas%252Bclosed%252Bor%252Bopen%252Bansa-bridges%26aulast%3DSkrzypczak%26aufirst%3DNatalia%26date%3D2020%26volume%3D202%26spage%3D112624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-Mei  Li</span>, <span class="hlFld-ContribAuthor ">Bohan  Li</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Sun</span>, <span class="hlFld-ContribAuthor ">Hui  Ma</span>, <span class="hlFld-ContribAuthor ">Meilin  Zhu</span>, <span class="hlFld-ContribAuthor ">Yiquan  Dai</span>, <span class="hlFld-ContribAuthor ">Tao  Ma</span>, <span class="hlFld-ContribAuthor ">Yu  Li</span>, <span class="hlFld-ContribAuthor ">Young-Soo  Hong</span>, <span class="hlFld-ContribAuthor ">Cheng-Zhu  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Enzymatic biosynthesis and biological evaluation of novel 17-AAG glucoside as potential anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (15)
                                     , 127282. <a href="https://doi.org/10.1016/j.bmcl.2020.127282" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127282%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEnzymatic%252Bbiosynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B17-AAG%252Bglucoside%252Bas%252Bpotential%252Banti-cancer%252Bagents%26aulast%3DLi%26aufirst%3DHong-Mei%26date%3D2020%26volume%3D30%26issue%3D15%26spage%3D127282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong‐yan  Zhai</span>, <span class="hlFld-ContribAuthor ">Qun‐fang  Zhou</span>, <span class="hlFld-ContribAuthor ">Jian‐ping  Dou</span>, <span class="hlFld-ContribAuthor ">Fang‐yi  Liu</span>, <span class="hlFld-ContribAuthor ">Xin‐yuan  Zhu</span>, <span class="hlFld-ContribAuthor ">Jie  Yu</span>, <span class="hlFld-ContribAuthor ">Ping  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatic Microwave Ablation–Induced Tumor Destruction and Animal End Point Survival Can Be Improved by Suppression of Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ultrasound in Medicine</span><span> <strong>2020,</strong> <em>39 </em>
                                    (6)
                                     , 1223-1232. <a href="https://doi.org/10.1002/jum.15212" title="DOI URL">https://doi.org/10.1002/jum.15212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jum.15212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjum.15212%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ultrasound%2520in%2520Medicine%26atitle%3DHepatic%252BMicrowave%252BAblation%2525E2%252580%252593Induced%252BTumor%252BDestruction%252Band%252BAnimal%252BEnd%252BPoint%252BSurvival%252BCan%252BBe%252BImproved%252Bby%252BSuppression%252Bof%252BHeat%252BShock%252BProtein%252B90%26aulast%3DZhai%26aufirst%3DHong%25E2%2580%2590yan%26date%3D2020%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D1223%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jackee  Sanchez</span>, <span class="hlFld-ContribAuthor ">Trever R.  Carter</span>, <span class="hlFld-ContribAuthor ">Mark S.  Cohen</span>, <span class="hlFld-ContribAuthor ">Brian S.J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">Old and New Approaches to Target the Hsp90 Chaperone. </span><span class="cited-content_cbyCitation_journal-name">Current Cancer Drug Targets</span><span> <strong>2020,</strong> <em>20 </em>
                                    (4)
                                     , 253-270. <a href="https://doi.org/10.2174/1568009619666191202101330" title="DOI URL">https://doi.org/10.2174/1568009619666191202101330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568009619666191202101330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568009619666191202101330%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Cancer%2520Drug%2520Targets%26atitle%3DOld%252Band%252BNew%252BApproaches%252Bto%252BTarget%252Bthe%252BHsp90%252BChaperone%26aulast%3DSanchez%26aufirst%3DJackee%26date%3D2020%26volume%3D20%26issue%3D4%26spage%3D253%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Lundsten</span>, <span class="hlFld-ContribAuthor ">Diana  Spiegelberg</span>, <span class="hlFld-ContribAuthor ">Nakul R.  Raval</span>, <span class="hlFld-ContribAuthor ">Marika  Nestor</span>. </span><span class="cited-content_cbyCitation_article-title">The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2020,</strong> <em>47 </em>
                                    (4)
                                     , 980-990. <a href="https://doi.org/10.1007/s00259-019-04673-1" title="DOI URL">https://doi.org/10.1007/s00259-019-04673-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-019-04673-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-019-04673-1%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DThe%252Bradiosensitizer%252BOnalespib%252Bincreases%252Bcomplete%252Bremission%252Bin%252B177Lu-DOTATATE-treated%252Bmice%252Bbearing%252Bneuroendocrine%252Btumor%252Bxenografts%26aulast%3DLundsten%26aufirst%3DSara%26date%3D2020%26date%3D2020%26volume%3D47%26issue%3D4%26spage%3D980%26epage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shulei  Zhu</span>, <span class="hlFld-ContribAuthor ">Yalei  Li</span>, <span class="hlFld-ContribAuthor ">Yushu  Huang</span>, <span class="hlFld-ContribAuthor ">Minmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaofan  Gu</span>, <span class="hlFld-ContribAuthor ">Yang  He</span>, <span class="hlFld-ContribAuthor ">Hongchun  Liu</span>, <span class="hlFld-ContribAuthor ">Mingliang  Ma</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Optimized HSP90 mediated fluorescent probes for cancer-specific bioimaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry B</span><span> <strong>2020,</strong> <em>8 </em>
                                    (9)
                                     , 1878-1896. <a href="https://doi.org/10.1039/C9TB02505G" title="DOI URL">https://doi.org/10.1039/C9TB02505G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9TB02505G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9TB02505G%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520B%26atitle%3DOptimized%252BHSP90%252Bmediated%252Bfluorescent%252Bprobes%252Bfor%252Bcancer-specific%252Bbioimaging%26aulast%3DZhu%26aufirst%3DShulei%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D9%26spage%3D1878%26epage%3D1896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yurina  Saito</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Yuuki  Obata</span>, <span class="hlFld-ContribAuthor ">Toshirou  Nishida</span>, <span class="hlFld-ContribAuthor ">Shuichi  Ohkubo</span>, <span class="hlFld-ContribAuthor ">Fumio  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Satoshi  Serada</span>, <span class="hlFld-ContribAuthor ">Minoru  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Tomoharu  Ohkawara</span>, <span class="hlFld-ContribAuthor ">Takahiko  Nishigaki</span>, <span class="hlFld-ContribAuthor ">Takahito  Sugase</span>, <span class="hlFld-ContribAuthor ">Masahiro  Koh</span>, <span class="hlFld-ContribAuthor ">Tomo  Ishida</span>, <span class="hlFld-ContribAuthor ">Koji  Tanaka</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Tomoki  Makino</span>, <span class="hlFld-ContribAuthor ">Yukinori  Kurokawa</span>, <span class="hlFld-ContribAuthor ">Kiyokazu  Nakajima</span>, <span class="hlFld-ContribAuthor ">Makoto  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Seiichi  Hirota</span>, <span class="hlFld-ContribAuthor ">Tetsuji  Naka</span>, <span class="hlFld-ContribAuthor ">Masaki  Mori</span>, <span class="hlFld-ContribAuthor ">Yuichiro  Doki</span>. </span><span class="cited-content_cbyCitation_article-title">TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2020,</strong> <em>122 </em>
                                    (5)
                                     , 658-667. <a href="https://doi.org/10.1038/s41416-019-0688-y" title="DOI URL">https://doi.org/10.1038/s41416-019-0688-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-019-0688-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-019-0688-y%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DTAS-116%252Binhibits%252Boncogenic%252BKIT%252Bsignalling%252Bon%252Bthe%252BGolgi%252Bin%252Bboth%252Bimatinib-na%2525C3%2525AFve%252Band%252Bimatinib-resistant%252Bgastrointestinal%252Bstromal%252Btumours%26aulast%3DSaito%26aufirst%3DYurina%26date%3D2020%26date%3D2019%26volume%3D122%26issue%3D5%26spage%3D658%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  Buc Calderon</span>, <span class="hlFld-ContribAuthor ">Raphaël  Beck</span>, <span class="hlFld-ContribAuthor ">Christophe  Glorieux</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting hsp90 family members: A strategy to improve cancer cell death. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2019,</strong> <em>164 </em>, 177-187. <a href="https://doi.org/10.1016/j.bcp.2019.04.010" title="DOI URL">https://doi.org/10.1016/j.bcp.2019.04.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2019.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2019.04.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DTargeting%252Bhsp90%252Bfamily%252Bmembers%25253A%252BA%252Bstrategy%252Bto%252Bimprove%252Bcancer%252Bcell%252Bdeath%26aulast%3DBuc%2BCalderon%26aufirst%3DPedro%26date%3D2019%26volume%3D164%26spage%3D177%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiajia  Dai</span>, <span class="hlFld-ContribAuthor ">Ao  Chen</span>, <span class="hlFld-ContribAuthor ">Meilin  Zhu</span>, <span class="hlFld-ContribAuthor ">Xin  Qi</span>, <span class="hlFld-ContribAuthor ">Wei  Tang</span>, <span class="hlFld-ContribAuthor ">Ming  Liu</span>, <span class="hlFld-ContribAuthor ">Dehai  Li</span>, <span class="hlFld-ContribAuthor ">Qianqun  Gu</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Penicisulfuranol A, a novel C-terminal inhibitor disrupting molecular chaperone function of Hsp90 independent of ATP binding domain. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2019,</strong> <em>163 </em>, 404-415. <a href="https://doi.org/10.1016/j.bcp.2019.03.012" title="DOI URL">https://doi.org/10.1016/j.bcp.2019.03.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2019.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2019.03.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DPenicisulfuranol%252BA%25252C%252Ba%252Bnovel%252BC-terminal%252Binhibitor%252Bdisrupting%252Bmolecular%252Bchaperone%252Bfunction%252Bof%252BHsp90%252Bindependent%252Bof%252BATP%252Bbinding%252Bdomain%26aulast%3DDai%26aufirst%3DJiajia%26date%3D2019%26volume%3D163%26spage%3D404%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tae-Min  Cho</span>, <span class="hlFld-ContribAuthor ">Ji Young  Kim</span>, <span class="hlFld-ContribAuthor ">Yoon-Jae  Kim</span>, <span class="hlFld-ContribAuthor ">Daeil  Sung</span>, <span class="hlFld-ContribAuthor ">Eunhye  Oh</span>, <span class="hlFld-ContribAuthor ">Seojin  Jang</span>, <span class="hlFld-ContribAuthor ">Lee  Farrand</span>, <span class="hlFld-ContribAuthor ">Van-Hai  Hoang</span>, <span class="hlFld-ContribAuthor ">Cong-Truong  Nguyen</span>, <span class="hlFld-ContribAuthor ">Jihyae  Ann</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>, <span class="hlFld-ContribAuthor ">Jae Hong  Seo</span>. </span><span class="cited-content_cbyCitation_article-title">C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2019,</strong> <em>447 </em>, 141-153. <a href="https://doi.org/10.1016/j.canlet.2019.01.029" title="DOI URL">https://doi.org/10.1016/j.canlet.2019.01.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2019.01.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2019.01.029%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DC-terminal%252BHSP90%252Binhibitor%252BL80%252Belicits%252Banti-metastatic%252Beffects%252Bin%252Btriple-negative%252Bbreast%252Bcancer%252Bvia%252BSTAT3%252Binhibition%26aulast%3DCho%26aufirst%3DTae-Min%26date%3D2019%26volume%3D447%26spage%3D141%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianhua  Liu</span>, <span class="hlFld-ContribAuthor ">Yumei  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Guo</span>, <span class="hlFld-ContribAuthor ">Songjie  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">DFT study of the solvation effect on an antiangiogenic deguelin analogue's structure and properties. </span><span class="cited-content_cbyCitation_journal-name">Chemical Data Collections</span><span> <strong>2019,</strong> <em>20 </em>, 100185. <a href="https://doi.org/10.1016/j.cdc.2019.100185" title="DOI URL">https://doi.org/10.1016/j.cdc.2019.100185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cdc.2019.100185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cdc.2019.100185%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Data%2520Collections%26atitle%3DDFT%252Bstudy%252Bof%252Bthe%252Bsolvation%252Beffect%252Bon%252Ban%252Bantiangiogenic%252Bdeguelin%252Banalogue%252527s%252Bstructure%252Band%252Bproperties%26aulast%3DLiu%26aufirst%3DJianhua%26date%3D2019%26volume%3D20%26spage%3D100185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Gao</span>, <span class="hlFld-ContribAuthor ">Zihao  Yuan</span>, <span class="hlFld-ContribAuthor ">Zhen  Ma</span>, <span class="hlFld-ContribAuthor ">Zhao  Li</span>, <span class="hlFld-ContribAuthor ">Simeng  Yu</span>, <span class="hlFld-ContribAuthor ">Yunfeng  Li</span>, <span class="hlFld-ContribAuthor ">Chongbo  He</span>. </span><span class="cited-content_cbyCitation_article-title">Genome-wide comparative analysis of the
              SHSP
              ,
              HSP60/10
              and
              HSP90
              genes reveals differential heat stress responses in estivation of the sea cucumber
              Apostichopus japonicus. </span><span class="cited-content_cbyCitation_journal-name">Aquaculture Research</span><span> <strong>2019,</strong> <em>50 </em>
                                    (4)
                                     , 1117-1130. <a href="https://doi.org/10.1111/are.13986" title="DOI URL">https://doi.org/10.1111/are.13986</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/are.13986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fare.13986%26sid%3Dliteratum%253Aachs%26jtitle%3DAquaculture%2520Research%26atitle%3DGenome-wide%252Bcomparative%252Banalysis%252Bof%252Bthe%252BSHSP%252B%25252C%252BHSP60%25252F10%252Band%252BHSP90%252Bgenes%252Breveals%252Bdifferential%252Bheat%252Bstress%252Bresponses%252Bin%252Bestivation%252Bof%252Bthe%252Bsea%252Bcucumber%252BApostichopus%252Bjaponicus%26aulast%3DGao%26aufirst%3DLei%26date%3D2019%26date%3D2019%26volume%3D50%26issue%3D4%26spage%3D1117%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chien-Yu  Huang</span>, <span class="hlFld-ContribAuthor ">Po-Li  Wei</span>, <span class="hlFld-ContribAuthor ">Jin-Wun  Wang</span>, <span class="hlFld-ContribAuthor ">Precious Takondwa  Makondi</span>, <span class="hlFld-ContribAuthor ">Ming-Te  Huang</span>, <span class="hlFld-ContribAuthor ">Hsin-An  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-Jia  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Glucose-Regulated Protein 94 Modulates the Response of Osteosarcoma to Chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Disease Markers</span><span> <strong>2019,</strong> <em>2019 </em>, 1-10. <a href="https://doi.org/10.1155/2019/4569718" title="DOI URL">https://doi.org/10.1155/2019/4569718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2019/4569718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2019%2F4569718%26sid%3Dliteratum%253Aachs%26jtitle%3DDisease%2520Markers%26atitle%3DGlucose-Regulated%252BProtein%252B94%252BModulates%252Bthe%252BResponse%252Bof%252BOsteosarcoma%252Bto%252BChemotherapy%26aulast%3DHuang%26aufirst%3DChien-Yu%26date%3D2019%26volume%3D2019%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 Inhibitors Blocking Multiple Oncogenic Signaling Pathways for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 397-429. <a href="https://doi.org/10.1007/978-3-030-03952-3_20" title="DOI URL">https://doi.org/10.1007/978-3-030-03952-3_20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-03952-3_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-03952-3_20%26sid%3Dliteratum%253Aachs%26atitle%3DHSP90%252BInhibitors%252BBlocking%252BMultiple%252BOncogenic%252BSignaling%252BPathways%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DJiang%26aufirst%3DFen%26date%3D2019%26date%3D2019%26spage%3D397%26epage%3D429%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProteins%252Bin%252BSignaling%252BPathways%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.%2BA.%26date%3D2019%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Hu</span>, <span class="hlFld-ContribAuthor ">Xiao J.  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao T.  Yang</span>, <span class="hlFld-ContribAuthor ">Ying Y.  Tang</span>, <span class="hlFld-ContribAuthor ">Lin Y.  Hu</span>, <span class="hlFld-ContribAuthor ">Dong  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Screening Technique for Heat Shock Protein 90 Inhibitors from Natural Products. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 411-439. <a href="https://doi.org/10.1007/978-3-030-23158-3_19" title="DOI URL">https://doi.org/10.1007/978-3-030-23158-3_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-23158-3_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-23158-3_19%26sid%3Dliteratum%253Aachs%26atitle%3DScreening%252BTechnique%252Bfor%252BHeat%252BShock%252BProtein%252B90%252BInhibitors%252Bfrom%252BNatural%252BProducts%26aulast%3DHu%26aufirst%3DYue%26date%3D2019%26date%3D2019%26spage%3D411%26epage%3D439%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProtein%252B90%252Bin%252BHuman%252BDiseases%252Band%252BDisorders%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.%2BA.%26date%3D2019%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geraldine  O’Sullivan Coyne</span>, <span class="hlFld-ContribAuthor ">Cecilia  Monge</span>, <span class="hlFld-ContribAuthor ">Alice P.  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Role of HSP90 Inhibitors in the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 125-143. <a href="https://doi.org/10.1007/978-3-030-23158-3_6" title="DOI URL">https://doi.org/10.1007/978-3-030-23158-3_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-23158-3_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-23158-3_6%26sid%3Dliteratum%253Aachs%26atitle%3DRole%252Bof%252BHSP90%252BInhibitors%252Bin%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DO%25E2%2580%2599Sullivan%2BCoyne%26aufirst%3DGeraldine%26date%3D2019%26date%3D2019%26spage%3D125%26epage%3D143%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProtein%252B90%252Bin%252BHuman%252BDiseases%252Band%252BDisorders%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.%2BA.%26date%3D2019%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuj  Khandelwal</span>, <span class="hlFld-ContribAuthor ">Caitlin N.  Kent</span>, <span class="hlFld-ContribAuthor ">Maurie  Balch</span>, <span class="hlFld-ContribAuthor ">Shuxia  Peng</span>, <span class="hlFld-ContribAuthor ">Sanket J.  Mishra</span>, <span class="hlFld-ContribAuthor ">Junpeng  Deng</span>, <span class="hlFld-ContribAuthor ">Victor W.  Day</span>, <span class="hlFld-ContribAuthor ">Weiya  Liu</span>, <span class="hlFld-ContribAuthor ">Chitra  Subramanian</span>, <span class="hlFld-ContribAuthor ">Mark  Cohen</span>, <span class="hlFld-ContribAuthor ">Jeffery M.  Holzbeierlein</span>, <span class="hlFld-ContribAuthor ">Robert  Matts</span>, <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-017-02013-1" title="DOI URL">https://doi.org/10.1038/s41467-017-02013-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-017-02013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-017-02013-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DStructure-guided%252Bdesign%252Bof%252Ban%252BHsp90%2525CE%2525B2%252BN-terminal%252Bisoform-selective%252Binhibitor%26aulast%3DKhandelwal%26aufirst%3DAnuj%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinubabu  Maddela</span>, <span class="hlFld-ContribAuthor ">Ajitha  Makula</span>, <span class="hlFld-ContribAuthor ">Mario D.  Galigniana</span>, <span class="hlFld-ContribAuthor ">Della G. T.  Parambi</span>, <span class="hlFld-ContribAuthor ">Fernando  Federicci</span>, <span class="hlFld-ContribAuthor ">Gisela  Mazaira</span>, <span class="hlFld-ContribAuthor ">Omnia M.  Hendawy</span>, <span class="hlFld-ContribAuthor ">Sanal  Dev</span>, <span class="hlFld-ContribAuthor ">Githa E.  Mathew</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Fe
              3
              O
              4
              nanoparticles mediated synthesis of novel spirooxindole-dihydropyrimidinone molecules as Hsp90 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>26 </em>, 1800174. <a href="https://doi.org/10.1002/ardp.201800174" title="DOI URL">https://doi.org/10.1002/ardp.201800174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800174%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DFe%252B3%252BO%252B4%252Bnanoparticles%252Bmediated%252Bsynthesis%252Bof%252Bnovel%252Bspirooxindole-dihydropyrimidinone%252Bmolecules%252Bas%252BHsp90%252Binhibitors%26aulast%3DMaddela%26aufirst%3DSrinubabu%26date%3D2018%26date%3D2018%26volume%3D26%26spage%3D1800174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott  Karney-Grobe</span>, <span class="hlFld-ContribAuthor ">Alexandra  Russo</span>, <span class="hlFld-ContribAuthor ">Erin  Frey</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Milbrandt</span>, <span class="hlFld-ContribAuthor ">Aaron  DiAntonio</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 is a chaperone for DLK and is required for axon injury signaling. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (42)
                                     , E9899-E9908. <a href="https://doi.org/10.1073/pnas.1805351115" title="DOI URL">https://doi.org/10.1073/pnas.1805351115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1805351115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1805351115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DHSP90%252Bis%252Ba%252Bchaperone%252Bfor%252BDLK%252Band%252Bis%252Brequired%252Bfor%252Baxon%252Binjury%252Bsignaling%26aulast%3DKarney-Grobe%26aufirst%3DScott%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D42%26spage%3DE9899%26epage%3DE9908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Campanella</span>, <span class="hlFld-ContribAuthor ">Andrea  Pace</span>, <span class="hlFld-ContribAuthor ">Celeste  Caruso Bavisotto</span>, <span class="hlFld-ContribAuthor ">Paola  Marzullo</span>, <span class="hlFld-ContribAuthor ">Antonella  Marino Gammazza</span>, <span class="hlFld-ContribAuthor ">Silvestre  Buscemi</span>, <span class="hlFld-ContribAuthor ">Antonio  Palumbo Piccionello</span>. </span><span class="cited-content_cbyCitation_article-title">Heat Shock Proteins in Alzheimer’s Disease: Role and Targeting. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (9)
                                     , 2603. <a href="https://doi.org/10.3390/ijms19092603" title="DOI URL">https://doi.org/10.3390/ijms19092603</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19092603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19092603%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DHeat%252BShock%252BProteins%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BRole%252Band%252BTargeting%26aulast%3DCampanella%26aufirst%3DClaudia%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D9%26spage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonja  Schmid</span>, <span class="hlFld-ContribAuthor ">Markus  Götz</span>, <span class="hlFld-ContribAuthor ">Thorsten  Hugel</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Inhibitors on Hsp90′s Conformational Dynamics, Cochaperone and Client Interactions. </span><span class="cited-content_cbyCitation_journal-name">ChemPhysChem</span><span> <strong>2018,</strong> <em>19 </em>
                                    (14)
                                     , 1716-1721. <a href="https://doi.org/10.1002/cphc.201800342" title="DOI URL">https://doi.org/10.1002/cphc.201800342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cphc.201800342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcphc.201800342%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPhysChem%26atitle%3DEffects%252Bof%252BInhibitors%252Bon%252BHsp90%2525E2%252580%2525B2s%252BConformational%252BDynamics%25252C%252BCochaperone%252Band%252BClient%252BInteractions%26aulast%3DSchmid%26aufirst%3DSonja%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D14%26spage%3D1716%26epage%3D1721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hassan  Mellatyar</span>, <span class="hlFld-ContribAuthor ">Sona  Talaei</span>, <span class="hlFld-ContribAuthor ">Younes  Pilehvar-Soltanahmadi</span>, <span class="hlFld-ContribAuthor ">Abolfazl  Barzegar</span>, <span class="hlFld-ContribAuthor ">Abolfazl  Akbarzadeh</span>, <span class="hlFld-ContribAuthor ">Arman  Shahabi</span>, <span class="hlFld-ContribAuthor ">Mazyar  Barekati-Mowahed</span>, <span class="hlFld-ContribAuthor ">Nosratollah  Zarghami</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2018,</strong> <em>102 </em>, 608-617. <a href="https://doi.org/10.1016/j.biopha.2018.03.102" title="DOI URL">https://doi.org/10.1016/j.biopha.2018.03.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2018.03.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2018.03.102%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DTargeted%252Bcancer%252Btherapy%252Bthrough%252B17-DMAG%252Bas%252Ban%252BHsp90%252Binhibitor%25253A%252BOverview%252Band%252Bcurrent%252Bstate%252Bof%252Bthe%252Bart%26aulast%3DMellatyar%26aufirst%3DHassan%26date%3D2018%26volume%3D102%26spage%3D608%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Vanicek</span>, <span class="hlFld-ContribAuthor ">Maren  Podewitz</span>, <span class="hlFld-ContribAuthor ">Jessica  Stubbe</span>, <span class="hlFld-ContribAuthor ">Dennis  Schulze</span>, <span class="hlFld-ContribAuthor ">Holger  Kopacka</span>, <span class="hlFld-ContribAuthor ">Klaus  Wurst</span>, <span class="hlFld-ContribAuthor ">Thomas  Müller</span>, <span class="hlFld-ContribAuthor ">Petra  Lippmann</span>, <span class="hlFld-ContribAuthor ">Simone  Haslinger</span>, <span class="hlFld-ContribAuthor ">Herwig  Schottenberger</span>, <span class="hlFld-ContribAuthor ">Klaus R.  Liedl</span>, <span class="hlFld-ContribAuthor ">Ingo  Ott</span>, <span class="hlFld-ContribAuthor ">Biprajit  Sarkar</span>, <span class="hlFld-ContribAuthor ">Benno  Bildstein</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Electrophilic, Catalytically Active and Redox-Responsive Cobaltoceniumyl and Ferrocenyl Triazolylidene Coinage Metal Complexes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2018,</strong> <em>24 </em>
                                    (15)
                                     , 3742-3753. <a href="https://doi.org/10.1002/chem.201705051" title="DOI URL">https://doi.org/10.1002/chem.201705051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201705051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201705051%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DHighly%252BElectrophilic%25252C%252BCatalytically%252BActive%252Band%252BRedox-Responsive%252BCobaltoceniumyl%252Band%252BFerrocenyl%252BTriazolylidene%252BCoinage%252BMetal%252BComplexes%26aulast%3DVanicek%26aufirst%3DStefan%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D15%26spage%3D3742%26epage%3D3753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Jinan  Wang</span>, <span class="hlFld-ContribAuthor ">Fengbo  Lai</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Laixue  Pang</span>, <span class="hlFld-ContribAuthor ">Weiliang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamics revelation of conformational changes and binding modes of heat shock protein 90 induced by inhibitor associations. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (45)
                                     , 25456-25467. <a href="https://doi.org/10.1039/C8RA05042B" title="DOI URL">https://doi.org/10.1039/C8RA05042B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA05042B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA05042B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDynamics%252Brevelation%252Bof%252Bconformational%252Bchanges%252Band%252Bbinding%252Bmodes%252Bof%252Bheat%252Bshock%252Bprotein%252B90%252Binduced%252Bby%252Binhibitor%252Bassociations%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D45%26spage%3D25456%26epage%3D25467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heike  Fuhrmann-Stroissnigg</span>, <span class="hlFld-ContribAuthor ">Yuan Yuan  Ling</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Sara J.  McGowan</span>, <span class="hlFld-ContribAuthor ">Yi  Zhu</span>, <span class="hlFld-ContribAuthor ">Robert W.  Brooks</span>, <span class="hlFld-ContribAuthor ">Diego  Grassi</span>, <span class="hlFld-ContribAuthor ">Siobhan Q.  Gregg</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Stripay</span>, <span class="hlFld-ContribAuthor ">Akaitz  Dorronsoro</span>, <span class="hlFld-ContribAuthor ">Lana  Corbo</span>, <span class="hlFld-ContribAuthor ">Priscilla  Tang</span>, <span class="hlFld-ContribAuthor ">Christina  Bukata</span>, <span class="hlFld-ContribAuthor ">Nadja  Ring</span>, <span class="hlFld-ContribAuthor ">Mauro  Giacca</span>, <span class="hlFld-ContribAuthor ">Xuesen  Li</span>, <span class="hlFld-ContribAuthor ">Tamara  Tchkonia</span>, <span class="hlFld-ContribAuthor ">James L.  Kirkland</span>, <span class="hlFld-ContribAuthor ">Laura J.  Niedernhofer</span>, <span class="hlFld-ContribAuthor ">Paul D.  Robbins</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of HSP90 inhibitors as a novel class of senolytics. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-017-00314-z" title="DOI URL">https://doi.org/10.1038/s41467-017-00314-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-017-00314-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-017-00314-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DIdentification%252Bof%252BHSP90%252Binhibitors%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bsenolytics%26aulast%3DFuhrmann-Stroissnigg%26aufirst%3DHeike%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Guang  Shan</span>, <span class="hlFld-ContribAuthor ">Han-Guang  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Rui  Wu</span>, <span class="hlFld-ContribAuthor ">Yan-Tao  Wen</span>, <span class="hlFld-ContribAuthor ">Li-Wen  Zhang</span>, <span class="hlFld-ContribAuthor ">You-Min  Ying</span>, <span class="hlFld-ContribAuthor ">Jian-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Zha-Jun  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3- and 29-substituted celastrol derivatives and structure-activity relationship studies of their cytotoxic activities. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (15)
                                     , 3450-3453. <a href="https://doi.org/10.1016/j.bmcl.2017.05.083" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.083%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252B3-%252Band%252B29-substituted%252Bcelastrol%252Bderivatives%252Band%252Bstructure-activity%252Brelationship%252Bstudies%252Bof%252Btheir%252Bcytotoxic%252Bactivities%26aulast%3DShan%26aufirst%3DWei-Guang%26date%3D2017%26volume%3D27%26issue%3D15%26spage%3D3450%26epage%3D3453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhao  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Wenwu  Dong</span>, <span class="hlFld-ContribAuthor ">Zhihong  Wang</span>, <span class="hlFld-ContribAuthor ">Yuan  Qin</span>, <span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 inhibitor NVP-AUY922 induces cell apoptosis by disruption of the survivin in papillary thyroid carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2017,</strong> <em>487 </em>
                                    (2)
                                     , 313-319. <a href="https://doi.org/10.1016/j.bbrc.2017.04.056" title="DOI URL">https://doi.org/10.1016/j.bbrc.2017.04.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2017.04.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2017.04.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DHSP90%252Binhibitor%252BNVP-AUY922%252Binduces%252Bcell%252Bapoptosis%252Bby%252Bdisruption%252Bof%252Bthe%252Bsurvivin%252Bin%252Bpapillary%252Bthyroid%252Bcarcinoma%252Bcells%26aulast%3DLiu%26aufirst%3DJinhao%26date%3D2017%26volume%3D487%26issue%3D2%26spage%3D313%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 771-795. <a href="https://doi.org/10.1007/978-1-59745-458-2_40" title="DOI URL">https://doi.org/10.1007/978-1-59745-458-2_40</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-59745-458-2_40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-59745-458-2_40%26sid%3Dliteratum%253Aachs%26atitle%3DSmall%252BMolecule%252BInhibitors%26aulast%3DChen%26aufirst%3DXin%26date%3D2017%26date%3D2016%26spage%3D771%26epage%3D795%26pub%3DSpringer%2520New%2520York%26atitle%3DThe%252BMolecular%252BBasis%252Bof%252BHuman%252BCancer%26aulast%3DColeman%26aufirst%3DWilliam%2BB.%26date%3D2017%26volume%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Wei-Tao  Fu</span>, <span class="hlFld-ContribAuthor ">Zheng-Yu  Jiang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization and bioevaluation of Cdc37-derived peptides: An insight into Hsp90-Cdc37 protein-protein interaction modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (1)
                                     , 233-240. <a href="https://doi.org/10.1016/j.bmc.2016.10.028" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.10.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.10.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Band%252Bbioevaluation%252Bof%252BCdc37-derived%252Bpeptides%25253A%252BAn%252Binsight%252Binto%252BHsp90-Cdc37%252Bprotein-protein%252Binteraction%252Bmodulators%26aulast%3DWang%26aufirst%3DLei%26date%3D2017%26volume%3D25%26issue%3D1%26spage%3D233%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renjie  Huang</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Ayine-Tora</span>, <span class="hlFld-ContribAuthor ">M. Nasri  Muhammad Rosdi</span>, <span class="hlFld-ContribAuthor ">Yu  Li</span>, <span class="hlFld-ContribAuthor ">Jóhannes  Reynisson</span>, <span class="hlFld-ContribAuthor ">Ivanhoe K.H.  Leung</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual screening and biophysical studies lead to HSP90 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (2)
                                     , 277-281. <a href="https://doi.org/10.1016/j.bmcl.2016.11.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.11.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.11.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DVirtual%252Bscreening%252Band%252Bbiophysical%252Bstudies%252Blead%252Bto%252BHSP90%252Binhibitors%26aulast%3DHuang%26aufirst%3DRenjie%26date%3D2017%26volume%3D27%26issue%3D2%26spage%3D277%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Hui-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Chao  Bao</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Hui  Jin</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Di  Jiang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization and biological evaluation of celastrol derivatives as Hsp90–Cdc37 interaction disruptors with improved druglike properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (21)
                                     , 5431-5439. <a href="https://doi.org/10.1016/j.bmc.2016.08.070" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.08.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.08.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.08.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Band%252Bbiological%252Bevaluation%252Bof%252Bcelastrol%252Bderivatives%252Bas%252BHsp90%2525E2%252580%252593Cdc37%252Binteraction%252Bdisruptors%252Bwith%252Bimproved%252Bdruglike%252Bproperties%26aulast%3DJiang%26aufirst%3DFen%26date%3D2016%26volume%3D24%26issue%3D21%26spage%3D5431%26epage%3D5439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danielle  Roman</span>, <span class="hlFld-ContribAuthor ">James  VerHoeve</span>, <span class="hlFld-ContribAuthor ">Heiko  Schadt</span>, <span class="hlFld-ContribAuthor ">Axel  Vicart</span>, <span class="hlFld-ContribAuthor ">Ursula Junker  Walker</span>, <span class="hlFld-ContribAuthor ">Oliver  Turner</span>, <span class="hlFld-ContribAuthor ">Terrilyn A.  Richardson</span>, <span class="hlFld-ContribAuthor ">Suzanne T.  Wolford</span>, <span class="hlFld-ContribAuthor ">Paul E.  Miller</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Hong  Lu</span>, <span class="hlFld-ContribAuthor ">Mikhail  Akimov</span>, <span class="hlFld-ContribAuthor ">William  Kluwe</span>. </span><span class="cited-content_cbyCitation_article-title">Ocular toxicity of AUY922 in pigmented and albino rats. </span><span class="cited-content_cbyCitation_journal-name">Toxicology and Applied Pharmacology</span><span> <strong>2016,</strong> <em>309 </em>, 55-62. <a href="https://doi.org/10.1016/j.taap.2016.08.025" title="DOI URL">https://doi.org/10.1016/j.taap.2016.08.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.taap.2016.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.taap.2016.08.025%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520and%2520Applied%2520Pharmacology%26atitle%3DOcular%252Btoxicity%252Bof%252BAUY922%252Bin%252Bpigmented%252Band%252Balbino%252Brats%26aulast%3DRoman%26aufirst%3DDanielle%26date%3D2016%26volume%3D309%26spage%3D55%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lixia  Zheng</span>, <span class="hlFld-ContribAuthor ">Shao  Wu</span>, <span class="hlFld-ContribAuthor ">Li  Tan</span>, <span class="hlFld-ContribAuthor ">Huo  Tan</span>, <span class="hlFld-ContribAuthor ">Baodan  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Chitosan-functionalised single-walled carbon nanotube-mediated drug delivery of SNX-2112 in cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomaterials Applications</span><span> <strong>2016,</strong> <em>31 </em>
                                    (3)
                                     , 379-386. <a href="https://doi.org/10.1177/0885328216651183" title="DOI URL">https://doi.org/10.1177/0885328216651183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0885328216651183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0885328216651183%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomaterials%2520Applications%26atitle%3DChitosan-functionalised%252Bsingle-walled%252Bcarbon%252Bnanotube-mediated%252Bdrug%252Bdelivery%252Bof%252BSNX-2112%252Bin%252Bcancer%252Bcells%26aulast%3DZheng%26aufirst%3DLixia%26date%3D2016%26date%3D2016%26volume%3D31%26issue%3D3%26spage%3D379%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuhao  Qu</span>, <span class="hlFld-ContribAuthor ">Varughese A.  Mulamoottil</span>, <span class="hlFld-ContribAuthor ">Akshata  Nayak</span>, <span class="hlFld-ContribAuthor ">Seungyeon  Ryu</span>, <span class="hlFld-ContribAuthor ">Xiyan  Hou</span>, <span class="hlFld-ContribAuthor ">Jayoung  Song</span>, <span class="hlFld-ContribAuthor ">Jinha  Yu</span>, <span class="hlFld-ContribAuthor ">Pramod K.  Sahu</span>, <span class="hlFld-ContribAuthor ">Long Xuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Sun  Choi</span>, <span class="hlFld-ContribAuthor ">Sang Kook  Lee</span>, <span class="hlFld-ContribAuthor ">Lak Shin  Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and anticancer activity of C8-substituted-4′-thionucleosides as potential HSP90 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (16)
                                     , 3418-3428. <a href="https://doi.org/10.1016/j.bmc.2016.05.041" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.05.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.05.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Banticancer%252Bactivity%252Bof%252BC8-substituted-4%2525E2%252580%2525B2-thionucleosides%252Bas%252Bpotential%252BHSP90%252Binhibitors%26aulast%3DQu%26aufirst%3DShuhao%26date%3D2016%26volume%3D24%26issue%3D16%26spage%3D3418%26epage%3D3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A-L  Joly</span>, <span class="hlFld-ContribAuthor ">A  Deepti</span>, <span class="hlFld-ContribAuthor ">A  Seignez</span>, <span class="hlFld-ContribAuthor ">A  Goloudina</span>, <span class="hlFld-ContribAuthor ">S  Hebrard</span>, <span class="hlFld-ContribAuthor ">E  Schmitt</span>, <span class="hlFld-ContribAuthor ">S  Richaud</span>, <span class="hlFld-ContribAuthor ">E  Fourmaux</span>, <span class="hlFld-ContribAuthor ">A  Hammann</span>, <span class="hlFld-ContribAuthor ">A  Collura</span>, <span class="hlFld-ContribAuthor ">M  Svrcek</span>, <span class="hlFld-ContribAuthor ">G  Jego</span>, <span class="hlFld-ContribAuthor ">E  Robinet</span>, <span class="hlFld-ContribAuthor ">E  Solary</span>, <span class="hlFld-ContribAuthor ">O  Demidov</span>, <span class="hlFld-ContribAuthor ">E  Kohli</span>, <span class="hlFld-ContribAuthor ">C  Garrido</span>. </span><span class="cited-content_cbyCitation_article-title">The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2016,</strong> <em>35 </em>
                                    (22)
                                     , 2842-2851. <a href="https://doi.org/10.1038/onc.2015.242" title="DOI URL">https://doi.org/10.1038/onc.2015.242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/onc.2015.242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fonc.2015.242%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DThe%252BHSP90%252Binhibitor%25252C%252B17AAG%25252C%252Bprotects%252Bthe%252Bintestinal%252Bstem%252Bcell%252Bniche%252Band%252Binhibits%252Bgraft%252Bversus%252Bhost%252Bdisease%252Bdevelopment%26aulast%3DJoly%26aufirst%3DA-L%26date%3D2016%26date%3D2015%26volume%3D35%26issue%3D22%26spage%3D2842%26epage%3D2851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manoj  Pandey</span>, <span class="hlFld-ContribAuthor ">Sahdeo  Prasad</span>, <span class="hlFld-ContribAuthor ">Amit  Tyagi</span>, <span class="hlFld-ContribAuthor ">Lokesh  Deb</span>, <span class="hlFld-ContribAuthor ">Jiamin  Huang</span>, <span class="hlFld-ContribAuthor ">Deepkamal  Karelia</span>, <span class="hlFld-ContribAuthor ">Shantu  Amin</span>, <span class="hlFld-ContribAuthor ">Bharat  Aggarwal</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Cell Survival Proteins for Cancer Cell Death. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2016,</strong> <em>9 </em>
                                    (1)
                                     , 11. <a href="https://doi.org/10.3390/ph9010011" title="DOI URL">https://doi.org/10.3390/ph9010011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph9010011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph9010011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DTargeting%252BCell%252BSurvival%252BProteins%252Bfor%252BCancer%252BCell%252BDeath%26aulast%3DPandey%26aufirst%3DManoj%26date%3D2016%26date%3D2016%26volume%3D9%26issue%3D1%26spage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Danuta  Zatorska</span>, <span class="hlFld-ContribAuthor ">Stefan O.  Ochiana</span>, <span class="hlFld-ContribAuthor ">Peter  Smith‐Jones</span>, <span class="hlFld-ContribAuthor ">Jacek  Koziorowski</span>, <span class="hlFld-ContribAuthor ">Mark P.  Dunphy</span>, <span class="hlFld-ContribAuthor ">Pat  Zanzonico</span>, <span class="hlFld-ContribAuthor ">Alexander  Bolaender</span>, <span class="hlFld-ContribAuthor ">Jason S.  Lewis</span>, <span class="hlFld-ContribAuthor ">Steven M.  Larson</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>, <span class="hlFld-ContribAuthor ">Naga Vara Kishore  Pillarsetty</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis of the iodine‐124 labeled Hsp90 inhibitor PU‐H71. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 129-132. <a href="https://doi.org/10.1002/jlcr.3369" title="DOI URL">https://doi.org/10.1002/jlcr.3369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3369%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DRadiosynthesis%252Bof%252Bthe%252Biodine%2525E2%252580%252590124%252Blabeled%252BHsp90%252Binhibitor%252BPU%2525E2%252580%252590H71%26aulast%3DTaldone%26aufirst%3DTony%26date%3D2016%26date%3D2016%26volume%3D59%26issue%3D3%26spage%3D129%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bill X.  Wu</span>, <span class="hlFld-ContribAuthor ">Feng  Hong</span>, <span class="hlFld-ContribAuthor ">Yongliang  Zhang</span>, <span class="hlFld-ContribAuthor ">Ephraim  Ansa-Addo</span>, <span class="hlFld-ContribAuthor ">Zihai  Li</span>. </span><span class="cited-content_cbyCitation_article-title">GRP94/gp96 in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 165-190. <a href="https://doi.org/10.1016/bs.acr.2015.09.001" title="DOI URL">https://doi.org/10.1016/bs.acr.2015.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.acr.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.acr.2015.09.001%26sid%3Dliteratum%253Aachs%26atitle%3DGRP94%25252Fgp96%252Bin%252BCancer%26aulast%3DWu%26aufirst%3DBill%2BX.%26date%3D2016%26spage%3D165%26epage%3D190%26pub%3DElsevier%26atitle%3DHsp90%252Bin%252BCancer%25253A%252BBeyond%252Bthe%252BUsual%252BSuspects%26date%3D2016%26volume%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Torunn  Wendel</span>, <span class="hlFld-ContribAuthor ">Yan  Zhen</span>, <span class="hlFld-ContribAuthor ">Zenhe  Suo</span>, <span class="hlFld-ContribAuthor ">Skjalg  Bruheim</span>, <span class="hlFld-ContribAuthor ">Antoni  Wiedlocha</span>. </span><span class="cited-content_cbyCitation_article-title">The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivo. </span><span class="cited-content_cbyCitation_journal-name">Experimental Cell Research</span><span> <strong>2016,</strong> <em>340 </em>
                                    (2)
                                     , 220-226. <a href="https://doi.org/10.1016/j.yexcr.2015.12.017" title="DOI URL">https://doi.org/10.1016/j.yexcr.2015.12.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yexcr.2015.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yexcr.2015.12.017%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Cell%2520Research%26atitle%3DThe%252Bnovel%252BHSP90%252Binhibitor%252BNVP-AUY922%252Bshows%252Bsynergistic%252Banti-leukemic%252Bactivity%252Bwith%252Bcytarabine%252Bin%252Bvivo%26aulast%3DWendel%26aufirst%3DTorunn%26date%3D2016%26volume%3D340%26issue%3D2%26spage%3D220%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi-Chao  Bao</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>, <span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao-Jin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ke  Guo</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Hao-Peng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Betulinic acid acetate, an antiproliferative natural product, suppresses client proteins of heat shock protein pathways through a CDC37-binding mechanism. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (48)
                                     , 42537-42544. <a href="https://doi.org/10.1039/C6RA04776A" title="DOI URL">https://doi.org/10.1039/C6RA04776A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA04776A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA04776A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DBetulinic%252Bacid%252Bacetate%25252C%252Ban%252Bantiproliferative%252Bnatural%252Bproduct%25252C%252Bsuppresses%252Bclient%252Bproteins%252Bof%252Bheat%252Bshock%252Bprotein%252Bpathways%252Bthrough%252Ba%252BCDC37-binding%252Bmechanism%26aulast%3DBao%26aufirst%3DQi-Chao%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D48%26spage%3D42537%26epage%3D42544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Se-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Rajendra  Tangallapally</span>, <span class="hlFld-ContribAuthor ">In Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Richard  Trovato</span>, <span class="hlFld-ContribAuthor ">Daniel  Parker</span>, <span class="hlFld-ContribAuthor ">J. Scott  Patton</span>, <span class="hlFld-ContribAuthor ">Leslie  Reeves</span>, <span class="hlFld-ContribAuthor ">Chad  Bradford</span>, <span class="hlFld-ContribAuthor ">Daniel  Wettstein</span>, <span class="hlFld-ContribAuthor ">Vijay  Baichwal</span>, <span class="hlFld-ContribAuthor ">Damon  Papac</span>, <span class="hlFld-ContribAuthor ">Ashok  Bajji</span>, <span class="hlFld-ContribAuthor ">Robert  Carlson</span>, <span class="hlFld-ContribAuthor ">Kraig M.  Yager</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an l-alanine ester prodrug of the Hsp90 inhibitor, MPC-3100. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (22)
                                     , 5254-5257. <a href="https://doi.org/10.1016/j.bmcl.2015.09.053" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ban%252Bl-alanine%252Bester%252Bprodrug%252Bof%252Bthe%252BHsp90%252Binhibitor%25252C%252BMPC-3100%26aulast%3DKim%26aufirst%3DSe-Ho%26date%3D2015%26volume%3D25%26issue%3D22%26spage%3D5254%26epage%3D5257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lars Ole  Haustedt</span>, <span class="hlFld-ContribAuthor ">Karsten  Siems</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Natural Products in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 379-429. <a href="https://doi.org/10.1002/9781118771723.ch14" title="DOI URL">https://doi.org/10.1002/9781118771723.ch14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118771723.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118771723.ch14%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BNatural%252BProducts%252Bin%252BDrug%252BDiscovery%26aulast%3DHaustedt%26aufirst%3DLars%2BOle%26date%3D2015%26date%3D2015%26spage%3D379%26epage%3D429%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DSmall%252BMolecule%252BMedicinal%252BChemistry%26aulast%3DCzechtizky%26aufirst%3DWerngard%26date%3D2015%26volume%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristoffer R.  Brandvold</span>, <span class="hlFld-ContribAuthor ">Richard I.  Morimoto</span>. </span><span class="cited-content_cbyCitation_article-title">The Chemical Biology of Molecular Chaperones—Implications for Modulation of Proteostasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2015,</strong> <em>427 </em>
                                    (18)
                                     , 2931-2947. <a href="https://doi.org/10.1016/j.jmb.2015.05.010" title="DOI URL">https://doi.org/10.1016/j.jmb.2015.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2015.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2015.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DThe%252BChemical%252BBiology%252Bof%252BMolecular%252BChaperones%2525E2%252580%252594Implications%252Bfor%252BModulation%252Bof%252BProteostasis%26aulast%3DBrandvold%26aufirst%3DKristoffer%2BR.%26date%3D2015%26volume%3D427%26issue%3D18%26spage%3D2931%26epage%3D2947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoxiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhan  Du</span>, <span class="hlFld-ContribAuthor ">Jie  Luo</span>, <span class="hlFld-ContribAuthor ">Xiao  Wang</span>, <span class="hlFld-ContribAuthor ">Haiying  Li</span>, <span class="hlFld-ContribAuthor ">Yuting  Liu</span>, <span class="hlFld-ContribAuthor ">Yong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiwei  Ma</span>, <span class="hlFld-ContribAuthor ">Weiwei  Xiao</span>, <span class="hlFld-ContribAuthor ">Yifei  Wang</span>, <span class="hlFld-ContribAuthor ">Xueyun  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cancer Research and Clinical Oncology</span><span> <strong>2015,</strong> <em>141 </em>
                                    (8)
                                     , 1405-1416. <a href="https://doi.org/10.1007/s00432-014-1896-8" title="DOI URL">https://doi.org/10.1007/s00432-014-1896-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00432-014-1896-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00432-014-1896-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cancer%2520Research%2520and%2520Clinical%2520Oncology%26atitle%3DInhibition%252Bof%252Bheat%252Bshock%252Bprotein%252B90%252Bsuppresses%252Bsquamous%252Bcarcinogenic%252Bprogression%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Besophageal%252Bcancer%26aulast%3DWang%26aufirst%3DShaoxiang%26date%3D2015%26date%3D2015%26volume%3D141%26issue%3D8%26spage%3D1405%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federico  Riccardi Sirtori</span>, <span class="hlFld-ContribAuthor ">Dannica  Caronni</span>, <span class="hlFld-ContribAuthor ">Maristella  Colombo</span>, <span class="hlFld-ContribAuthor ">Claudio  Dalvit</span>, <span class="hlFld-ContribAuthor ">Mauro  Paolucci</span>, <span class="hlFld-ContribAuthor ">Luca  Regazzoni</span>, <span class="hlFld-ContribAuthor ">Carlo  Visco</span>, <span class="hlFld-ContribAuthor ">Gianpaolo  Fogliatto</span>. </span><span class="cited-content_cbyCitation_article-title">Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2015,</strong> <em>76 </em>, 83-94. <a href="https://doi.org/10.1016/j.ejps.2015.05.001" title="DOI URL">https://doi.org/10.1016/j.ejps.2015.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2015.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2015.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DEstablish%252Ban%252Bautomated%252Bflow%252Binjection%252BESI-MS%252Bmethod%252Bfor%252Bthe%252Bscreening%252Bof%252Bfragment%252Bbased%252Blibraries%25253A%252BApplication%252Bto%252BHsp90%26aulast%3DRiccardi%2BSirtori%26aufirst%3DFederico%26date%3D2015%26volume%3D76%26spage%3D83%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anupama  Singh</span>, <span class="hlFld-ContribAuthor ">Ashok  Singh</span>, <span class="hlFld-ContribAuthor ">Jordan M.  Sand</span>, <span class="hlFld-ContribAuthor ">Samuel J.  Bauer</span>, <span class="hlFld-ContribAuthor ">Bilal Bin  Hafeez</span>, <span class="hlFld-ContribAuthor ">Louise  Meske</span>, <span class="hlFld-ContribAuthor ">Ajit K.  Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Topically Applied Hsp90 Inhibitor 17AAG Inhibits UVR-Induced Cutaneous Squamous Cell Carcinomas. </span><span class="cited-content_cbyCitation_journal-name">Journal of Investigative Dermatology</span><span> <strong>2015,</strong> <em>135 </em>
                                    (4)
                                     , 1098-1107. <a href="https://doi.org/10.1038/jid.2014.460" title="DOI URL">https://doi.org/10.1038/jid.2014.460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/jid.2014.460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fjid.2014.460%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Investigative%2520Dermatology%26atitle%3DTopically%252BApplied%252BHsp90%252BInhibitor%252B17AAG%252BInhibits%252BUVR-Induced%252BCutaneous%252BSquamous%252BCell%252BCarcinomas%26aulast%3DSingh%26aufirst%3DAnupama%26date%3D2015%26volume%3D135%26issue%3D4%26spage%3D1098%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura K.  Buckton</span>, <span class="hlFld-ContribAuthor ">Yao  Wang</span>, <span class="hlFld-ContribAuthor ">Jeanette R.  McConnell</span>, <span class="hlFld-ContribAuthor ">Shelli R.  McAlpine</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluating Dual Hsp90 and Hsp70 Inhibition as a Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 55-80. <a href="https://doi.org/10.1007/7355_2015_96" title="DOI URL">https://doi.org/10.1007/7355_2015_96</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2015_96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2015_96%26sid%3Dliteratum%253Aachs%26atitle%3DEvaluating%252BDual%252BHsp90%252Band%252BHsp70%252BInhibition%252Bas%252Ba%252BCancer%252BTherapy%26aulast%3DBuckton%26aufirst%3DLaura%2BK.%26date%3D2015%26date%3D2015%26spage%3D55%26epage%3D80%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProtein%252BInhibitors%26aulast%3DMcAlpine%26aufirst%3DShelli%2BR.%26date%3D2016%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David A.  Proia</span>, <span class="hlFld-ContribAuthor ">Richard C.  Bates</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 Inhibitor-Based Strategies for Cancer Therapy: Advancing Toward Clinical Impact. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 289-322. <a href="https://doi.org/10.1007/978-3-319-17211-8_15" title="DOI URL">https://doi.org/10.1007/978-3-319-17211-8_15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-17211-8_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-17211-8_15%26sid%3Dliteratum%253Aachs%26atitle%3DHSP90%252BInhibitor-Based%252BStrategies%252Bfor%252BCancer%252BTherapy%25253A%252BAdvancing%252BToward%252BClinical%252BImpact%26aulast%3DProia%26aufirst%3DDavid%2BA.%26date%3D2015%26spage%3D289%26epage%3D322%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProtein-Based%252BTherapies%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.A.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Chao  Bao</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>, <span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Kai  Gu</span>, <span class="hlFld-ContribAuthor ">Zheng-Yu  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiao-Jin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ke  Guo</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Hao-Peng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and identification of Cdc37-derived peptides targeting the Hsp90–Cdc37 protein–protein interaction. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (116)
                                     , 96138-96145. <a href="https://doi.org/10.1039/C5RA20408A" title="DOI URL">https://doi.org/10.1039/C5RA20408A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA20408A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA20408A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiscovery%252Band%252Bidentification%252Bof%252BCdc37-derived%252Bpeptides%252Btargeting%252Bthe%252BHsp90%2525E2%252580%252593Cdc37%252Bprotein%2525E2%252580%252593protein%252Binteraction%26aulast%3DWang%26aufirst%3DLei%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D116%26spage%3D96138%26epage%3D96145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geoffrey I.  Shapiro</span>, <span class="hlFld-ContribAuthor ">Eunice  Kwak</span>, <span class="hlFld-ContribAuthor ">Bruce J.  Dezube</span>, <span class="hlFld-ContribAuthor ">Murray  Yule</span>, <span class="hlFld-ContribAuthor ">John  Ayrton</span>, <span class="hlFld-ContribAuthor ">John  Lyons</span>, <span class="hlFld-ContribAuthor ">Daruka  Mahadevan</span>. </span><span class="cited-content_cbyCitation_article-title">First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2015,</strong> <em>21 </em>
                                    (1)
                                     , 87-97. <a href="https://doi.org/10.1158/1078-0432.CCR-14-0979" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-14-0979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-14-0979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-14-0979%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DFirst-in-Human%252BPhase%252BI%252BDose%252BEscalation%252BStudy%252Bof%252Ba%252BSecond-Generation%252BNon-Ansamycin%252BHSP90%252BInhibitor%25252C%252BAT13387%25252C%252Bin%252BPatients%252Bwith%252BAdvanced%252BSolid%252BTumors%26aulast%3DShapiro%26aufirst%3DGeoffrey%2BI.%26date%3D2015%26date%3D2014%26volume%3D21%26issue%3D1%26spage%3D87%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm9004708&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm9004708%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-1&amp;citedByCount=203&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Geldanamycin in equilibrium between the quinone and hydroquinone forms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Six HSP90 inhibitors in clinical trials of which the structures have been disclosed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Early synthetic inhibitors of HSP90 and proposed pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Pharmacophore hypothesis (<b>15</b>), transposition of key binding elements to generate a new series (<b>16</b>), and synthesis of clinical candidate <b>6</b> (Conforma-Biogen Idec).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Lead evolution of clinical candidate <b>7</b> (Vernalis-Novartis).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Synthesis of clinical candidate <b>7</b> (Vernalis-Novartis).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Early Serenex HSP90 inhibitors <b>27</b> and <b>28</b> and synthesis of <b>9</b>, the active metabolite of clinical candidate <b>8</b> (Serenex-Pfizer).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Other inhibitors of HSP90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Crystal structure of the yeast HSP90 dimer, in complex with p23/Sba1. Nonhydrolyzable ATP analogue is in red: N = N-terminal domain; M = middle domain; C = C-terminal domain. (B) Close-up of ATP-driven lid closure in N domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. HSP90 cycle: GM = geldanamycin analogue; 40 = HSP40; 70 = HSP70; IP = immunophillin; HIP = HSP70-interacting protein; HOP = HSP70/HSP90 organizing protein. Cdc37 and Aha1 are not shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Comparison of HSP90 inhibitor binding modes: (A) ADP (carbon atoms in teal, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1byq">1byq</a>) superimposed on active site electrostatic surface representation; (B) 17-DMAG (carbon atoms in white, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1osf">1osf</a>); (C) radicicol (<b>39</b>) (carbon atoms in slate blue, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1bgq">1bgq</a>); (D) purine <b>10</b> (carbon atoms in orange, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uym">1uym</a>); (E) resorcinol <b>7</b> (carbon atoms in light green, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2vci">2vci</a>); (F) compound <b>28</b>, an analogue of benzamide <b>9</b> (carbon atoms in cyan, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3d0b">3d0b</a>). Active site water molecules (red spheres) and hydrogen bonds (dashes) are also indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Conformational flexibility observed in HSP90 N-terminal domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Vernalis preclinical inhibitor <b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Effect of purine <b>6</b> on protein levels in MCF7 cells (A) as a function of concentration after 24 h and (B) as a function of time at 400 nM. Reprinted with permission from <contrib-group person-group-type="allauthors">Lundgren, K.; Zhang, H.; Brekken, J.; Huser, N.; Powell, R. E.; Timple, N.; Busch, D. J.; Neely, L.; Sensintaffar, J. L.; Yang, Y.-C.; McKenzie, A.; Friedman, J.; Scannevin, R.; Kamal, A.; Hong, K.; Kasibhatla, S. R.; Boehm, M. F.; Burrows, F. J.</contrib-group>BIIB021, an orally available, fully synthetic small molecule inhibitor of the heat shock protein HSP90.  <cite>Mol. Cancer Ther.</cite> <span class="NLM_year">2009</span>, <em>8</em>, 921−929, Figure 1.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/medium/jm-2009-004708_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0001.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Growth of N87 tumor xenografts in athymic mice treated with purine <b>6</b> orally, 5 days/week. Reprinted with permission from <contrib-group person-group-type="allauthors">Lundgren, K.; Zhang, H.; Brekken, J.; Huser, N.; Powell, R. E.; Timple, N.; Busch, D. J.; Neely, L.; Sensintaffar, J. L.; Yang, Y.-C.; McKenzie, A.; Friedman, J.; Scannevin, R.; Kamal, A.; Hong, K.; Kasibhatla, S. R.; Boehm, M. F.; Burrows, F. J.</contrib-group>BIIB021, an orally available, fully synthetic small molecule inhibitor of the heat shock protein HSP90.  <cite>Mol. Cancer Ther.</cite> <span class="NLM_year">2009</span>, <em>8</em>, 921−929, Figure 2A.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm9004708/production/images/large/jm-2009-004708_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004708&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 97 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Soo, E. T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, G. W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lwin, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bay, B.-H.</span><span> </span><span class="NLM_article-title">Heat shock proteins as novel targets in cancer</span> <span class="citation_source-journal">In Vivo</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=311-316&author=E.+T.+L.+Sooauthor=G.+W.+C.+Yipauthor=Z.+M.+Lwinauthor=S.+D.+Kumarauthor=B.-H.+Bay&title=Heat+shock+proteins+as+novel+targets+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoo%26aufirst%3DE.%2BT.%2BL.%26aulast%3DYip%26aufirst%3DG.%2BW.%2BC.%26aulast%3DLwin%26aufirst%3DZ.%2BM.%26aulast%3DKumar%26aufirst%3DS.%2BD.%26aulast%3DBay%26aufirst%3DB.-H.%26atitle%3DHeat%2520shock%2520proteins%2520as%2520novel%2520targets%2520in%2520cancer%26jtitle%3DIn%2520Vivo%26date%3D2008%26volume%3D22%26spage%3D311%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span> </span><span class="NLM_article-title">Structure and mechanism of the HSP90 molecular chaperone machinery</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1146%2Fannurev.biochem.75.103004.142738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16756493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2006&pages=271-294&author=L.+H.+Pearlauthor=C.+Prodromou&title=Structure+and+mechanism+of+the+HSP90+molecular+chaperone+machinery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of the Hsp90 molecular chaperone machinery</span></div><div class="casAuthors">Pearl, Laurence H.; Prodromou, Chrisostomos</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">271-294</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (Hsp90) is a mol. chaperone essential for activating many signaling proteins in the eukaryotic cell.  Biochem. and structural anal. of Hsp90 has revealed a complex mechanism of ATPase-coupled conformational changes and interactions with cochaperone proteins, which facilitate activation of Hsp90's diverse "clientele.".  Despite recent progress, key aspects of the ATPase-coupled mechanism of Hsp90 remain controversial, and the nature of the changes, engendered by Hsp90 in client proteins, is largely unknown.  Here, the authors discuss present knowledge of Hsp90 structure and function gleaned from crystallog. studies of individual domains and recent progress in obtaining a structure for the ATP-bound conformation of the intact dimeric chaperone.  Addnl., the authors describe the roles of the plethora of cochaperones with which Hsp90 cooperates and growing insights into their biochem. mechanisms, which come from crystal structures of Hsp90-cochaperone complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Aa7D8Mk_qbVg90H21EOLACvtfcHk0lh4y_ZsU1JtVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKhs78%253D&md5=a954553202a2a81fce297ac6a8378c67</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.75.103004.142738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.75.103004.142738%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520the%2520HSP90%2520molecular%2520chaperone%2520machinery%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2006%26volume%3D75%26spage%3D271%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="note"><p class="first last">This number is cited in several papers but without reference.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Welch, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feramisco, J. R.</span><span> </span><span class="NLM_article-title">Purification of the major mammalian heat shock proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">14949</span><span class="NLM_x">–</span> <span class="NLM_lpage">14959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=14949-14959&author=W.+J.+Welchauthor=J.+R.+Feramisco&title=Purification+of+the+major+mammalian+heat+shock+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DW.%2BJ.%26aulast%3DFeramisco%26aufirst%3DJ.%2BR.%26atitle%3DPurification%2520of%2520the%2520major%2520mammalian%2520heat%2520shock%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26spage%3D14949%26epage%3D14959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Messaoudi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrat, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brion, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alami, M.</span><span> </span><span class="NLM_article-title">Recent advances in HSP90 inhibitors as antitumor agents</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=761-782&author=S.+Messaoudiauthor=J.+F.+Peyratauthor=J.+D.+Brionauthor=M.+Alami&title=Recent+advances+in+HSP90+inhibitors+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMessaoudi%26aufirst%3DS.%26aulast%3DPeyrat%26aufirst%3DJ.%2BF.%26aulast%3DBrion%26aufirst%3DJ.%2BD.%26aulast%3DAlami%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520in%2520HSP90%2520inhibitors%2520as%2520antitumor%2520agents%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D761%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Sausville, E. A.</span><span> </span><span class="NLM_article-title">Heat Shock Protein-90 Directed Therapeutics and Target Validation</span>. In  <span class="citation_source-book">Cancer Drug Design and Discovery</span>; <span class="NLM_contrib-group">Neidle, S.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">336</span>− <span class="NLM_lpage">350</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FB978-012369448-5.50017-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=336-350&author=E.+A.+Sausvilleauthor=S.+Neidle&title=Cancer+Drug+Design+and+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-012369448-5.50017-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012369448-5.50017-3%26sid%3Dliteratum%253Aachs%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DHeat%2520Shock%2520Protein-90%2520Directed%2520Therapeutics%2520and%2520Target%2520Validation%26btitle%3DCancer%2520Drug%2520Design%2520and%2520Discovery%26aulast%3DNeidle%26aufirst%3DS.%26pub%3DElsevier%26date%3D2008%26spage%3D336%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1517%2F13543776.14.6.837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=837-847&author=B.+W.+Dymockauthor=M.+J.+Drysdaleauthor=E.+McDonaldauthor=P.+Workman&title=Inhibitors+of+HSP90+and+other+chaperones+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HSP90 and other chaperones for the treatment of cancer</span></div><div class="casAuthors">Dymock, Brian W.; Drysdale, Martin J.; McDonald, Edward; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-847</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Mol. chaperones are proteins that ensure the appropriate folding, stability and function of other proteins in the cell.  There is increasing evidence that mol. chaperones are not only important in normal cell homeostasis and response to stresses, such as heat shock, but can also be involved in disease pathol.  In particular, HSP90 has emerged as an important potential drug target in oncol.  This is because it is essential for the stability of a long list of client proteins', including ErbB2/human epithelial growth factor receptor (HER)2, Raf-1, Akt/protein kinase B (PKB), Polo-1, Met, mutant p53 and human telomerase reverse transcriptase (hTERT), as well as the estrogen and androgen receptor.  Inhibition of HSP90 leads to depletion of these oncogenic clients by the ubiquitin proteasome pathway, thereby providing a simultaneous combinatorial attack on all of the hallmark phenotypic traits of cancer cells.  Because of the rapid progress made, this review focuses on the patents dealing with the discovery and application of small mol. inhibitors of HSP90, although limited coverage of other applications in the area of HSP90 and addnl. chaperones is also included.  Pioneering work with natural products, namely geldanamycin and related ansamycin antibiotics together with radicicol macrocycle derivs., established the therapeutic potential of inhibiting the essential N-terminal ATPase of HSP90 by competing at the nucleotide binding site.  A geldanamycin analog, 17-(desmethoxy), 17-allylamino geldanamycin (17AAG), is completing Phase I clin. trials with promising initial results.  The use of high-throughput screening and rational design based on X-ray crystal structures of HSP90 has led to the discovery of small mol. HSP90 inhibitors based on purine and pyrazole scaffolds.  The continued progression of these various compd. classes into clin. trials should help to establish proof of concept for inhibition of HSP90 as a viable therapeutic approach for the treatment of cancer and potentially other diseases.  This would in turn validate protein folding as a strategy for drug development and encourage addnl. chaperones to be explored as mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ19fmQE-bzbVg90H21EOLACvtfcHk0ljDqGtJdPrsrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlyqsL8%253D&md5=68f468698084591e41c9c0a337542ca1</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.6.837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.6.837%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520HSP90%2520and%2520other%2520chaperones%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D837%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Isaacs, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanping, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 as a molecular target for cancer therapeutics</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS1535-6108%2803%2900029-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=12676580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=213-217&author=J.+S.+Isaacsauthor=X.+Wanpingauthor=L.+Neckers&title=Heat+shock+protein+90+as+a+molecular+target+for+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90 as a molecular target for cancer therapeutics</span></div><div class="casAuthors">Isaacs, Jennifer S.; Xu, Wanping; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-217</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review on the study of heat shock protein 90 (Hsp90) inhibitors for cancer therapeutics.  It discusses the mechanism of Hsp90 inhibition, function of Hsp90, and translation of Hsp90 inhibition to clin. use in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_CXl57WSP3bVg90H21EOLACvtfcHk0ljDqGtJdPrsrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOrtb8%253D&md5=e02c28786774a7e975632231e9919208</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900029-1%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DJ.%2BS.%26aulast%3DWanping%26aufirst%3DX.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DHeat%2520shock%2520protein%252090%2520as%2520a%2520molecular%2520target%2520for%2520cancer%2520therapeutics%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D213%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1517%2F14712598.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11772336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=3-24&author=A.+Maloneyauthor=P.+Workman&title=HSP90+as+a+new+therapeutic+target+for+cancer+therapy%3A+the+story+unfolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span></div><div class="casAuthors">Maloney, Alison; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review. Current anticancer drug-development strategies involve identifying novel mol. targets which are crucial for tumorigenesis.  The mol. chaperone heat-shock protein (HSP) 90 is of interest as an anticancer drug target because of its importance in maintaining the conformation, stability and function of key oncogenic client proteins involved in signal transduction pathways leading to proliferation, cell cycle progression, and apoptosis, as well as other features of the malignant phenotype such as invasion, angiogenesis and metastasis.  The natural-product HSP90 inhibitors geldanamycin and radicicol exert their antitumor effect by inhibiting the intrinsic ATPase activity of HSP90, resulting in degrdn. of HSP90 client proteins via the ubiquitin proteosome pathway.  Anticancer selectivity may derive from the simultaneous combinatorial effects of HSP90 inhibitors on multiple cancer targets and pathways. 17-Allylamino-17-demethoxygeldanamycin (17AAG) showed good activity and cancer selectivity in preclin. models and has now progressed to Phase I clin. trials in cancer patients with encouraging initial results.  Phase II trials including combination studies with cytotoxic agents are now being planned and these should allow the therapeutic activity of 17AAG to be detd.  Second-generation HSP90 inhibitors may be designed to overcome some of the drawbacks of 17AAG, including limited oral bioavailability and soly.  They could also be engineered to target specific functions of HSP90, which may not only provide greater mol. selectivity and clin. benefit but may also increase understanding of the complex functions of this mol. chaperone.  HSP90 inhibitors provide proof of concept for drugs directed at HSP90 and protein folding and this principle may be applicable to other medical conditions involving protein aggregation and stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxpya4HhGPu7Vg90H21EOLACvtfcHk0ljDqGtJdPrsrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D&md5=b0542acde22286a95578e3ef4dac0d8e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1517%2F14712598.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHSP90%2520as%2520a%2520new%2520therapeutic%2520target%2520for%2520cancer%2520therapy%253A%2520the%2520story%2520unfolds%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2002%26volume%3D2%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Richter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">HSP90: chaperoning signal transduction</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1002%2Fjcp.1131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11473354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvVGnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2001&pages=281-290&author=K.+Richterauthor=J.+Buchner&title=HSP90%3A+chaperoning+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90: chaperoning signal transduction</span></div><div class="casAuthors">Richter, Klaus; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-290</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review with 120 refs.  Hsp90 is an ATP-dependent mol. chaperone involved in the folding and activation of an unknown no. of substrate proteins.  These substrate proteins include protein kinases and transcription factors.  Consistent with this task, Hsp90 is an essential protein in all eukaryotes.  The interaction of Hsp90 with its substrate proteins involves the transient formation of multiprotein complexes with a set of highly conserved partner proteins.  The specific function of each component in the processing of substrates is still unknown.  Large ATP-dependent conformational changes of Hsp90 occur during the hydrolysis reaction and these changes are thought to drive the chaperone cycle.  Natural inhibitors of the ATPase activity, like geldanamycin and radicicol, block the processing of Hsp90 substrate proteins.  As many of these substrates are crit. elements in signal transduction, Hsp90 seems to introduce an addnl. level of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8NDhXhxYLZbVg90H21EOLACvtfcHk0ljDqGtJdPrsrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvVGnsro%253D&md5=2347e8946c70d42aa18ea58dd2def6b7</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1002%2Fjcp.1131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.1131%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DHSP90%253A%2520chaperoning%2520signal%2520transduction%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2001%26volume%3D188%26spage%3D281%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">Therapeutic and diagnostic implications of HSP90 activation</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=283-290&author=A.+Kamalauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=Therapeutic+and+diagnostic+implications+of+HSP90+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DTherapeutic%2520and%2520diagnostic%2520implications%2520of%2520HSP90%2520activation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D283%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Gorre, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellwood-Yen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">3041</span><span class="NLM_x">–</span> <span class="NLM_lpage">3044</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2002&pages=3041-3044&author=M.+E.+Gorreauthor=K.+Ellwood-Yenauthor=G.+Chiosisauthor=N.+Rosenauthor=C.+L.+Sawyers&title=BCR-ABL+point+mutants+isolated+from+patients+with+imatinib+mesylate-resistant+chronic+myeloid+leukemia+remain+sensitive+to+inhibitors+of+the+BCR-ABL+chaperone+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGorre%26aufirst%3DM.%2BE.%26aulast%3DEllwood-Yen%26aufirst%3DK.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DBCR-ABL%2520point%2520mutants%2520isolated%2520from%2520patients%2520with%2520imatinib%2520mesylate-resistant%2520chronic%2520myeloid%2520leukemia%2520remain%2520sensitive%2520to%2520inhibitors%2520of%2520the%2520BCR-ABL%2520chaperone%2520heat%2520shock%2520protein%252090%26jtitle%3DBlood%26date%3D2002%26volume%3D100%26spage%3D3041%26epage%3D3044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sawai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandarlapaty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span> </span><span class="NLM_article-title">Inhibition of HSP90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to Paclitaxel</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=589-596&author=A.+Sawaiauthor=S.+Chandarlapatyauthor=H.+Greulichauthor=M.+Gonenauthor=Q.+Yeauthor=C.+L.+Arteagaauthor=W.+Sellersauthor=N.+Rosenauthor=D.+B.+Solit&title=Inhibition+of+HSP90+down-regulates+mutant+epidermal+growth+factor+receptor+%28EGFR%29+expression+and+sensitizes+EGFR+mutant+tumors+to+Paclitaxel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSawai%26aufirst%3DA.%26aulast%3DChandarlapaty%26aufirst%3DS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DGonen%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26atitle%3DInhibition%2520of%2520HSP90%2520down-regulates%2520mutant%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520expression%2520and%2520sensitizes%2520EGFR%2520mutant%2520tumors%2520to%2520Paclitaxel%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D589%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of HSP90 confers tumour selectivity on HSP90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+HSP90+confers+tumour+selectivity+on+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0lhSAlcEpu8MHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520HSP90%2520confers%2520tumour%2520selectivity%2520on%2520HSP90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Altered states: selectively drugging the HSP90 cancer chaperone</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=47-51&author=P.+Workman&title=Altered+states%3A+selectively+drugging+the+HSP90+cancer+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DAltered%2520states%253A%2520selectively%2520drugging%2520the%2520HSP90%2520cancer%2520chaperone%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D47%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gooljarsingh, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grooms, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnamon, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerrigan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, T.</span><span> </span><span class="NLM_article-title">A biochemical rationale for the anticancer effects of HSP90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">7625</span><span class="NLM_x">–</span> <span class="NLM_lpage">7630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1073%2Fpnas.0602650103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16684877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVGlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=7625-7630&author=L.+T.+Gooljarsinghauthor=C.+Fernandesauthor=K.+Yanauthor=H.+Zhangauthor=M.+Groomsauthor=K.+Johansonauthor=R.+H.+Sinnamonauthor=R.+B.+Kirpatrickauthor=J.+Kerriganauthor=T.+Lewis&title=A+biochemical+rationale+for+the+anticancer+effects+of+HSP90+inhibitors%3A+slow%2C+tight+binding+inhibition+by+geldanamycin+and+its+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues</span></div><div class="casAuthors">Gooljarsingh, Lata T.; Fernandes, Christine; Yan, Kang; Zhang, Hong; Grooms, Michael; Johanson, Kyung; Sinnamon, Robert H.; Kirkpatrick, Robert B.; Kerrigan, John; Lewis, Tia; Arnone, Marc; King, Alastair J.; Lai, Zhihong; Copeland, Robert A.; Tummino, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7625-7630</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Heat shock protein (Hsp)90 is emerging as an important therapeutic target for the treatment of cancer.  Two analogs of the Hsp90 inhibitor geldanamycin are currently in clin. trials.  Geldanamycin (GA) and its analogs have been reported to bind purified Hsp90 with low micromolar potency, in stark contrast to their low nanomolar antiproliferative activity in cell culture and their potent antitumor activity in animal models.  Several models have been proposed to account for the ≈100-fold-greater potency in cell culture, including that GA analogs bind with greater affinity to a five-protein Hsp90 complex than to Hsp90 alone.  We have detd. that GA and the fluorescent analog BODIPY-GA (BDGA) both demonstrate slow, tight binding to purified Hsp90.  BDGA, used to characterize the kinetics of ligand-Hsp90 interactions, was found to bind Hsp90α with koff = 2.5×10-3 min-1, t1/2 = 4.6 h, and Ki* = 10 nM.  It was found that BDGA binds to a functional multiprotein Hsp90 complex with kinetics and affinity identical to that of Hsp90 alone.  Also, BDGA binds to Hsp90 from multiple cell lyzates in a time-dependent manner with similar kinetics.  Therefore, our results indicate that the high potency of GA in cell culture and in vivo can be accounted for by its time-dependent, tight binding to Hsp90 alone.  In the broader context, these studies highlight the essentiality of detailed biochem. characterization of drug-target interactions for the effective translation of in vitro pharmacol. to cellular and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYOm9dd7WlmLVg90H21EOLACvtfcHk0li_m9aTCg5VXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVGlurY%253D&md5=10e3cc3af47d06242dd621b8c64b3b34</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0602650103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0602650103%26sid%3Dliteratum%253Aachs%26aulast%3DGooljarsingh%26aufirst%3DL.%2BT.%26aulast%3DFernandes%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGrooms%26aufirst%3DM.%26aulast%3DJohanson%26aufirst%3DK.%26aulast%3DSinnamon%26aufirst%3DR.%2BH.%26aulast%3DKirpatrick%26aufirst%3DR.%2BB.%26aulast%3DKerrigan%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DT.%26atitle%3DA%2520biochemical%2520rationale%2520for%2520the%2520anticancer%2520effects%2520of%2520HSP90%2520inhibitors%253A%2520slow%252C%2520tight%2520binding%2520inhibition%2520by%2520geldanamycin%2520and%2520its%2520analogues%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D7625%26epage%3D7630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Dickey, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klosak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ash, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoraka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlatkovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahman, N. S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span> </span><span class="NLM_article-title">The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=648-658&author=C.+A.+Dickeyauthor=A.+Kamalauthor=K.+Lundgrenauthor=N.+Klosakauthor=R.+M.+Baileyauthor=J.+Dunmoreauthor=P.+Ashauthor=S.+Shorakaauthor=J.+Zlatkovicauthor=C.+B.+Eckmanauthor=C.+Pattersonauthor=D.+W.+Dicksonauthor=N.+S.+Nahmanauthor=M.+Huttonauthor=F.+Burrowsauthor=L.+Petrucelli&title=The+high-affinity+HSP90-CHIP+complex+recognizes+and+selectively+degrades+phosphorylated+tau+client+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DKlosak%26aufirst%3DN.%26aulast%3DBailey%26aufirst%3DR.%2BM.%26aulast%3DDunmore%26aufirst%3DJ.%26aulast%3DAsh%26aufirst%3DP.%26aulast%3DShoraka%26aufirst%3DS.%26aulast%3DZlatkovic%26aufirst%3DJ.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26aulast%3DPatterson%26aufirst%3DC.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DNahman%26aufirst%3DN.%2BS.%26aulast%3DHutton%26aufirst%3DM.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DPetrucelli%26aufirst%3DL.%26atitle%3DThe%2520high-affinity%2520HSP90-CHIP%2520complex%2520recognizes%2520and%2520selectively%2520degrades%2520phosphorylated%2520tau%2520client%2520proteins%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D648%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of the HSP90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980403y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=260-266&author=S.+M.+Roeauthor=C.+Prodromouauthor=R.+O%E2%80%99Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=Structural+basis+for+inhibition+of+the+HSP90+molecular+chaperone+by+the+antitumor+antibiotics+radicicol+and+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm980403y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980403y%26sid%3Dliteratum%253Aachs%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520the%2520HSP90%2520molecular%2520chaperone%2520by%2520the%2520antitumor%2520antibiotics%2520radicicol%2520and%2520geldanamycin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D260%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Stebbins, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Crystal structure of an HSP90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS0092-8674%2800%2980203-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=9108479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaK2sXislCitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1997&pages=239-250&author=C.+E.+Stebbinsauthor=A.+A.+Russoauthor=C.+Schneiderauthor=N.+Rosenauthor=F.+U.+Hartlauthor=N.+P.+Pavletich&title=Crystal+structure+of+an+HSP90-geldanamycin+complex%3A+targeting+of+a+protein+chaperone+by+an+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent</span></div><div class="casAuthors">Stebbins, Charles E.; Russo, Alicia A.; Schneider, Christine; Rosen, Neal; Hartl, F. Ulrich; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-250</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Hsp90 chaperone is required for the activation of several families of eukaryotic protein kinases and nuclear hormone receptors, many of which are proto-oncogenic and play a prominent role in cancer.  The geldanamycin antibiotic has antiproliferative and anti-tumor effects, as it binds to Hsp90, inhibits the Hsp90-mediated conformational maturation/refolding reaction, and results in the degrdn. of Hsp90 substrates.  The structure of the geldanamycin-binding domain of Hsp90 (residues 9-232) reveals a pronounced pocket, 15 Å deep. that is highly conserved across species.  Geldanamycin binds inside this pocket, adopting a compact structure similar to that of a polypeptide chain in a turn conformation.  This, and the pocket's similarity to substrate-binding sites, suggest that the pocket binds a portion of the polypeptide substrate and participates in the conformational maturation/refolding reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvnmleAOFITbVg90H21EOLACvtfcHk0li_m9aTCg5VXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXislCitLo%253D&md5=54a56450c509727e070f4db20a9d7b1a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980203-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980203-2%26sid%3Dliteratum%253Aachs%26aulast%3DStebbins%26aufirst%3DC.%2BE.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DSchneider%26aufirst%3DC.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DCrystal%2520structure%2520of%2520an%2520HSP90-geldanamycin%2520complex%253A%2520targeting%2520of%2520a%2520protein%2520chaperone%2520by%2520an%2520antitumor%2520agent%26jtitle%3DCell%26date%3D1997%26volume%3D89%26spage%3D239%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzasalma, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnakov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrabrant, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaner, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnakova, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masucci, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckman, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galemmo, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. L.</span><span> </span><span class="NLM_article-title">Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5678</span><span class="NLM_x">–</span> <span class="NLM_lpage">5685</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0524969" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=5678-5685&author=A.+C.+Maroneyauthor=J.+J.+Maruganauthor=T.+M.+Mezzasalmaauthor=A.+N.+Barnakovauthor=T.+A.+Garrabrantauthor=L.+E.+Weanerauthor=W.+J.+Jonesauthor=L.+A.+Barnakovaauthor=H.+K.+Koblishauthor=M.+J.+Toddauthor=J.+A.+Masucciauthor=I.+C.+Deckmanauthor=R.+A.+Galemmoauthor=D.+L.+Johnson&title=Dihydroquinone+ansamycins%3A+toward+resolving+the+conflict+between+low+in+vitro+affinity+and+high+cellular+potency+of+geldanamycin+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fbi0524969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0524969%26sid%3Dliteratum%253Aachs%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DMezzasalma%26aufirst%3DT.%2BM.%26aulast%3DBarnakov%26aufirst%3DA.%2BN.%26aulast%3DGarrabrant%26aufirst%3DT.%2BA.%26aulast%3DWeaner%26aufirst%3DL.%2BE.%26aulast%3DJones%26aufirst%3DW.%2BJ.%26aulast%3DBarnakova%26aufirst%3DL.%2BA.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DTodd%26aufirst%3DM.%2BJ.%26aulast%3DMasucci%26aufirst%3DJ.%2BA.%26aulast%3DDeckman%26aufirst%3DI.%2BC.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BL.%26atitle%3DDihydroquinone%2520ansamycins%253A%2520toward%2520resolving%2520the%2520conflict%2520between%2520low%2520in%2520vitro%2520affinity%2520and%2520high%2520cellular%2520potency%2520of%2520geldanamycin%2520derivatives%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D5678%26epage%3D5685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">High-throughput screening fluorescence polarization assay for tumor-specific HSP90</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1177%2F1087057107306067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=17942784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12rs7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=915-924&author=Y.+Duauthor=K.+Moulickauthor=A.+Rodinaauthor=J.+Aguirreauthor=S.+Feltsauthor=R.+Dingledineauthor=H.+Fuauthor=G.+Chiosis&title=High-throughput+screening+fluorescence+polarization+assay+for+tumor-specific+HSP90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening fluorescence polarization assay for tumor-specific Hsp90</span></div><div class="casAuthors">Du, Yuhong; Moulick, Kamalika; Rodina, Anna; Aguirre, Julia; Felts, Sara; Dingledine, Raymond; Fu, Haian; Chiosis, Gabriella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">915-924</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that has emerged as an important target in cancer and several other diseases, such as neurodegenerative diseases, nerve injuries, inflammation, and infection.  Discovery of novel agents that inhibit Hsp90 and have druglike properties is therefore a major focus in several academic and industrial labs.  In this study, the authors describe the development and optimization in a 384-well format of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization, which measures competitive binding of red-shifted fluorescently labeled geldanamycin (GM-cy3B) to Hsp90 found in the NCI-N417 small-cell lung carcinoma cells.  The authors demonstrate that GM-cy3B binds with high affinity and specificity to cellular Hsp90.  The assay results in excellent signal-to-noise ratios (>10) and Z' values (>0.75) at tracer concns. greater than 4 nM and 1 μg/well of total NCI-N417 protein, indicating a robust assay.  It also equilibrates after 5 h of incubation at room temp. and remains stable for up to 24 h.  Furthermore, it is a simple mix-and-read format that is cost-effective and uses only low amts. of fluorophore and cell lysates.  A study using more than 15,000 compds. from the National Institutes of Health Mol. Libraries Screening Center Network was performed to validate its performance in a high-throughput screening format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8tjbDItT49rVg90H21EOLACvtfcHk0ljlH_RWeQyNCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12rs7rO&md5=e47f199e1c11d828056f6007d3f38eab</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1177%2F1087057107306067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057107306067%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DDingledine%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHigh-throughput%2520screening%2520fluorescence%2520polarization%2520assay%2520for%2520tumor-specific%2520HSP90%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2007%26volume%3D12%26spage%3D915%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">A fluorescence polarization assay for inhibitors of HSP90</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2006&pages=202-213&author=R.+Howesauthor=X.+Barrilauthor=B.+W.+Dymockauthor=K.+Grantauthor=C.+J.+Northfieldauthor=A.+G.+Robertsonauthor=A.+Surgenorauthor=J.+Wayneauthor=L.+Wrightauthor=K.+Jamesauthor=T.+Matthewsauthor=K.+M.+Cheungauthor=E.+McDonaldauthor=P.+Workmanauthor=M.+J.+Drysdale&title=A+fluorescence+polarization+assay+for+inhibitors+of+HSP90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWayne%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DA%2520fluorescence%2520polarization%2520assay%2520for%2520inhibitors%2520of%2520HSP90%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D350%26spage%3D202%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huezo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Development of a fluorescence polarization assay for the molecular chaperone HSP90</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1177%2F1087057104265995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=15296636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=375-381&author=J.+Kimauthor=S.+Feltsauthor=L.+Llaugerauthor=H.+Heauthor=H.+Huezoauthor=N.+Rosenauthor=G.+Chiosis&title=Development+of+a+fluorescence+polarization+assay+for+the+molecular+chaperone+HSP90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span></div><div class="casAuthors">Kim, Joungnam; Felts, Sara; Llauger, Laura; He, Huazhong; Huezo, Henri; Rosen, Neal; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone with essential functions in maintaining transformation, and there is increasing interest in developing Hsp90 inhibitors as cancer therapeutics.  In this study, the authors describe the development and optimization of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization.  The assay is based on the competition of fluorescently (BODIPY) labeled geldanamycin (GM) for binding to purified recombinant Hsp90α (GM is a natural product that binds to the ATP/ADP pocket in the amino terminal of Hsp90).  The authors show that GM-BODIPY binds Hsp90α with high affinity.  Even at low Hsp90α concns. (30 nM), the measured polarization value is close to the max. assay range of 160 mP, making measurements very sensitive.  Its performance, as judged by signal-to-noise ratios (> 10) and Z and Z' values (> 0.5), suggests that this is a robust and reliable assay.  GM, PU24FCl, ADP, and ATP, all known to bind to the Hsp90 pocket, compete with GM-BODIPY for binding to Hsp90α with EC50s in agreement with reported values.  These data demonstrate that the Hsp90-FP-based assay can be used for high-throughput screening in aiding the identification of novel Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTTKuW5DgFIbVg90H21EOLACvtfcHk0ljlH_RWeQyNCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D&md5=e6e13d80237b2b5c65a78d20d2f3c4bc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1177%2F1087057104265995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104265995%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520fluorescence%2520polarization%2520assay%2520for%2520the%2520molecular%2520chaperone%2520HSP90%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2004%26volume%3D9%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Onuoha, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulstock, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengerova, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. E.</span><span> </span><span class="NLM_article-title">Mechanistic studies on HSP90 inhibition by ansamycin derivatives</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2007&pages=287-297&author=S.+C.+Onuohaauthor=S.+R.+Mukundauthor=E.+T.+Coulstockauthor=B.+Sengerovaauthor=J.+Shawauthor=S.+H.+McLaughlinauthor=S.+E.+Jackson&title=Mechanistic+studies+on+HSP90+inhibition+by+ansamycin+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnuoha%26aufirst%3DS.%2BC.%26aulast%3DMukund%26aufirst%3DS.%2BR.%26aulast%3DCoulstock%26aufirst%3DE.%2BT.%26aulast%3DSengerova%26aufirst%3DB.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DS.%2BH.%26aulast%3DJackson%26aufirst%3DS.%2BE.%26atitle%3DMechanistic%2520studies%2520on%2520HSP90%2520inhibition%2520by%2520ansamycin%2520derivatives%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D372%26spage%3D287%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timple, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neely, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">BIIB021, an orally available, fully synthetic small molecule inhibitor of the heat shock protein HSP90</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1535-7163.MCT-08-0758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=19372565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=921-929&author=K.+Lundgrenauthor=H.+Zhangauthor=J.+Brekkenauthor=N.+Huserauthor=R.+E.+Powellauthor=N.+Timpleauthor=D.+J.+Buschauthor=L.+Neelyauthor=J.+L.+Sensintaffarauthor=Y.-C.+Yangauthor=A.+McKenzieauthor=J.+Friedmanauthor=R.+Scannevinauthor=A.+Kamalauthor=K.+Hongauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehmauthor=F.+J.+Burrows&title=BIIB021%2C+an+orally+available%2C+fully+synthetic+small+molecule+inhibitor+of+the+heat+shock+protein+HSP90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90</span></div><div class="casAuthors">Lundgren, Karen; Zhang, Hong; Brekken, John; Huser, Nanni; Powell, Rachel E.; Timple, Noel; Busch, David J.; Neely, Laura; Sensintaffar, John L.; Yang, Yong-ching; McKenzie, Andres; Friedman, Jessica; Scannevin, Robert; Kamal, Adeela; Hong, Kevin; Kasibhatla, Srinivas R.; Boehm, Marcus F.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">921-929</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of heat shock protein 90 (Hsp90) results in the degrdn. of oncoproteins that drive malignant progression, inducing cell death, making Hsp90 a target of substantial interest for cancer therapy.  BIIB021 is a novel, fully synthetic inhibitor of Hsp90 that binds competitively with geldanamycin in the ATP-binding pocket of Hsp90.  In tumor cells, BIIB021 induced the degrdn. of Hsp90 client proteins including HER-2, AKT, and Raf-1 and up-regulated expression of the heat shock proteins Hsp70 and Hsp27.  BIIB021 treatment resulted in growth inhibition and cell death in cell lines from a variety of tumor types at nanomolar concns.  Oral administration of BIIB021 led to the degrdn. of Hsp90 client proteins measured in tumor tissue and resulted in the inhibition of tumor growth in several human tumor xenograft models.  Studies to investigate the antitumor effects of BIIB021 showed activity on both daily and intermittent dosing schedules, providing dose schedule flexibility for clin. studies.  Assays measuring the HER-2 protein in tumor tissue and the HER-2 extracellular domain in plasma were used to show interdiction of the Hsp90 pathway and utility as potential biomarkers in clin. trials for BIIB021.  Together, these data show that BIIB021 is a promising new oral inhibitor of Hsp90 with antitumor activity in preclin. models.[Mol Cancer Ther 2009;8(4):921-9].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSbI2RYG4aF7Vg90H21EOLACvtfcHk0lhjG97GeiDvJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1amt74%253D&md5=271e2311ab807bc74b2ac66b81e514e1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0758%26sid%3Dliteratum%253Aachs%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DPowell%26aufirst%3DR.%2BE.%26aulast%3DTimple%26aufirst%3DN.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DNeely%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.-C.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DBIIB021%252C%2520an%2520orally%2520available%252C%2520fully%2520synthetic%2520small%2520molecule%2520inhibitor%2520of%2520the%2520heat%2520shock%2520protein%2520HSP90%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D921%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Schnur, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallaschun, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dee, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzzi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiOrio, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacci, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span> </span><span class="NLM_article-title">erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3813</span><span class="NLM_x">–</span> <span class="NLM_lpage">3820</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00019a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3813-3820&author=R.+C.+Schnurauthor=M.+L.+Cormanauthor=R.+J.+Gallaschunauthor=B.+A.+Cooperauthor=M.+F.+Deeauthor=J.+L.+Dotyauthor=M.+L.+Muzziauthor=C.+I.+DiOrioauthor=E.+G.+Barbacciauthor=P.+E.+Millerauthor=V.+A.+Pollackauthor=D.+M.+Savageauthor=D.+E.+Sloanauthor=L.+R.+Pustilnikauthor=J.+D.+Moyerauthor=M.+P.+Moyer&title=erbB-2+oncogene+inhibition+by+geldanamycin+derivatives%3A+synthesis%2C+mechanism+of+action%2C+and+structure-activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm00019a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00019a011%26sid%3Dliteratum%253Aachs%26aulast%3DSchnur%26aufirst%3DR.%2BC.%26aulast%3DCorman%26aufirst%3DM.%2BL.%26aulast%3DGallaschun%26aufirst%3DR.%2BJ.%26aulast%3DCooper%26aufirst%3DB.%2BA.%26aulast%3DDee%26aufirst%3DM.%2BF.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DMuzzi%26aufirst%3DM.%2BL.%26aulast%3DDiOrio%26aufirst%3DC.%2BI.%26aulast%3DBarbacci%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DP.%2BE.%26aulast%3DPollack%26aufirst%3DV.%2BA.%26aulast%3DSavage%26aufirst%3DD.%2BM.%26aulast%3DSloan%26aufirst%3DD.%2BE.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26atitle%3DerbB-2%2520oncogene%2520inhibition%2520by%2520geldanamycin%2520derivatives%253A%2520synthesis%252C%2520mechanism%2520of%2520action%252C%2520and%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3813%26epage%3D3820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibbits, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of HSP90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4606</span><span class="NLM_x">–</span> <span class="NLM_lpage">4615</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4606-4615&author=J.+Geauthor=E.+Normantauthor=J.+R.+Porterauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=Y.+Gaoauthor=A.+T.+Georgesauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+Pattersonauthor=J.+R.+Sydorauthor=T.+T.+Tibbitsauthor=J.+K.+Tongauthor=J.+Adamsauthor=V.+J.+Palombella&title=Design%2C+synthesis%2C+and+biological+evaluation+of+hydroquinone+derivatives+of+17-amino-17-demethoxygeldanamycin+as+potent%2C+water-soluble+inhibitors+of+HSP90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm0603116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603116%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DGeorges%26aufirst%3DA.%2BT.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DTibbits%26aufirst%3DT.%2BT.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520hydroquinone%2520derivatives%2520of%252017-amino-17-demethoxygeldanamycin%2520as%2520potent%252C%2520water-soluble%2520inhibitors%2520of%2520HSP90%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4606%26epage%3D4615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagattuta, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamburger, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiseman, J. L.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, tissue distribution and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1007%2Fs00280-001-0380-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11855755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=7-19&author=M.+J.+Egorinauthor=T.+F.+Lagattutaauthor=D.+R.+Hamburgerauthor=J.+M.+Coveyauthor=K.+D.+Whiteauthor=S.+M.+Musserauthor=J.+L.+Eiseman&title=Pharmacokinetics%2C+tissue+distribution+and+metabolism+of+17-%28dimethylaminoethylamino%29-17-demethoxygeldanamycin+%28NSC+707545%29+in+CD2F1+mice+and+Fischer+344+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, tissue distribution and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats</span></div><div class="casAuthors">Egorin, Merrill J.; Lagattuta, Theodore F.; Hamburger, Deborah R.; Covey, Joseph M.; White, Kevin D.; Musser, Steven M.; Eiseman, Julie L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-19</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Female CD2F1 mice or male Fischer 344 rats were subjected to a study to define the plasma pharmacokinetics, tissue distribution, and urinary excretion of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17DMAG) after i.v. delivery and to define the bioavailability of 17DMAG after i.p. and oral delivery.  The biliary excretion of 17DMAG after i.v. delivery to rats and any of its metabolites obsd. in plasma, tissue, urine, or bile were also evaluated.  17DMAG, when given i.p., had excellent bioavailability and good bioavailability when given orally.  17DMAG was widely distributed to tissues and was quant. metabolized much less than is 17-(allylamino)-17-demethoxygeldanamycin.  The pharmacokinetic and metabolite results are relevant to the design of addnl. preclin. studies as well as to contemplated clin. trials of 17DMAG and could be useful in their interpretation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol_we5KxwJLbVg90H21EOLACvtfcHk0lhjG97GeiDvJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFClurs%253D&md5=3ee6e9929fa7cd8ce301ab8a24f11fa0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00280-001-0380-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-001-0380-8%26sid%3Dliteratum%253Aachs%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DLagattuta%26aufirst%3DT.%2BF.%26aulast%3DHamburger%26aufirst%3DD.%2BR.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DWhite%26aufirst%3DK.%2BD.%26aulast%3DMusser%26aufirst%3DS.%2BM.%26aulast%3DEiseman%26aufirst%3DJ.%2BL.%26atitle%3DPharmacokinetics%252C%2520tissue%2520distribution%2520and%2520metabolism%2520of%252017-%2528dimethylaminoethylamino%2529-17-demethoxygeldanamycin%2520%2528NSC%2520707545%2529%2520in%2520CD2F1%2520mice%2520and%2520Fischer%2520344%2520rats%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2002%26volume%3D49%26spage%3D7%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050752%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2767-2778&author=S.+R.+Kasibhatlaauthor=K.+Hongauthor=M.+A.+Biamonteauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=R.+E.+Loughauthor=J.+Brekkenauthor=K.+Lundgrenauthor=R.+Greckoauthor=G.+A.+Timonyauthor=Y.+Ranauthor=R.+Mansfieldauthor=L.+C.+Fritzauthor=E.+Ulmauthor=F.+J.+Burrowsauthor=M.+F.+Boehm&title=Rationally+designed+high-affinity+2-amino-6-halopurine+heat+shock+protein+90+inhibitors+that+exhibit+potent+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm050752%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050752%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DUlm%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3DRationally%2520designed%2520high-affinity%25202-amino-6-halopurine%2520heat%2520shock%2520protein%252090%2520inhibitors%2520that%2520exhibit%2520potent%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2767%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4,5-Diarylisoxazole HSP90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.-M.+J.+Cheungauthor=I.+Collinsauthor=N.+G.+M.+Daviesauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-Diarylisoxazole+HSP90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-Diarylisoxazole%2520HSP90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, K. H.; Eaves, J.; Veal, J.; Barta, T.; Lifeng, G.; Hinkley, L.; Hanson, G.</span><span> </span><span class="NLM_article-title">Tetrahydroindolone and Tetrahydroindazolone Derivatives</span>. WO 2006/091963<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=K.+H.+Huang&author=J.+Eaves&author=J.+Veal&author=T.+Barta&author=G.+Lifeng&author=L.+Hinkley&author=G.+Hanson&title=Tetrahydroindolone+and+Tetrahydroindazolone+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26atitle%3DTetrahydroindolone%2520and%2520Tetrahydroindazolone%2520Derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huang, K. H.; Eaves, J.; Veal, J.; Hall, S. E.; Barta, T. E.; Hanson, G. J.</span><span> </span><span class="NLM_article-title">Cyclohexylamino Benzene, Pyridine, and Pyridazine Derivatives</span>. US 2007/0207984,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=K.+H.+Huang&author=J.+Eaves&author=J.+Veal&author=S.+E.+Hall&author=T.+E.+Barta&author=G.+J.+Hanson&title=Cyclohexylamino+Benzene%2C+Pyridine%2C+and+Pyridazine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26atitle%3DCyclohexylamino%2520Benzene%252C%2520Pyridine%252C%2520and%2520Pyridazine%2520Derivatives%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Boer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wnuk, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D. H.</span><span> </span><span class="NLM_article-title">Geldanamycin, a new antibiotic</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1970&pages=442-447&author=C.+De+Boerauthor=P.+A.+Meulmanauthor=R.+J.+Wnukauthor=D.+H.+Peterson&title=Geldanamycin%2C+a+new+antibiotic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBoer%26aufirst%3DC.%26aulast%3DMeulman%26aufirst%3DP.%2BA.%26aulast%3DWnuk%26aufirst%3DR.%2BJ.%26aulast%3DPeterson%26aufirst%3DD.%2BH.%26atitle%3DGeldanamycin%252C%2520a%2520new%2520antibiotic%26jtitle%3DJ.%2520Antibiot.%26date%3D1970%26volume%3D23%26spage%3D442%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">De Boer, C.; Peterson, D. H.</span><span> </span><span class="NLM_article-title">Antibiotic Geldanamycin</span>. US 3595955,<span class="NLM_x"> </span><span class="NLM_year">1971</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1971&author=C.+De+Boer&author=D.+H.+Peterson&title=Antibiotic+Geldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBoer%26aufirst%3DC.%26atitle%3DAntibiotic%2520Geldanamycin%26date%3D1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gallaschun, R. J.; Moyer, M. P.; Schnur, R. C.</span><span> </span><span class="NLM_article-title">Ansamycin Derivatives as Antioncogene and Anticancer Agents</span>. WO 9501342,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=R.+J.+Gallaschun&author=M.+P.+Moyer&author=R.+C.+Schnur&title=Ansamycin+Derivatives+as+Antioncogene+and+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGallaschun%26aufirst%3DR.%2BJ.%26atitle%3DAnsamycin%2520Derivatives%2520as%2520Antioncogene%2520and%2520Anticancer%2520Agents%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Whitesell, L.; Neckers, L.; Trepel, J.; Myers, C.</span><span> </span><span class="NLM_article-title">Tumoricidal Activity of Benzoquinonoid Ansamycins against Prostate Cancer and Primitive Neural Malignancies</span>. WO 9408578,<span class="NLM_x"> </span><span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&author=L.+Whitesell&author=L.+Neckers&author=J.+Trepel&author=C.+Myers&title=Tumoricidal+Activity+of+Benzoquinonoid+Ansamycins+against+Prostate+Cancer+and+Primitive+Neural+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26atitle%3DTumoricidal%2520Activity%2520of%2520Benzoquinonoid%2520Ansamycins%2520against%2520Prostate%2520Cancer%2520and%2520Primitive%2520Neural%2520Malignancies%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">424</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29e&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1007%2Fs002800050817" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=1998&pages=273-279&author=T.+W.+Schulteauthor=L.+M.+Neckers&title=The+benzoquinone+ansamycin+17-allylamino-17-demethoxygeldanamycin+binds+to+HSP90+and+shares+important+biologic+activities+with+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29e&amp;dbid=16384&amp;doi=10.1007%2Fs002800050817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800050817%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DThe%2520benzoquinone%2520ansamycin%252017-allylamino-17-demethoxygeldanamycin%2520binds%2520to%2520HSP90%2520and%2520shares%2520important%2520biologic%2520activities%2520with%2520geldanamycin%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1998%26volume%3D424%26spage%3D273%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><div class="note"><p class="first last">For a recent total synthesis: </p></div><span class="NLM_contrib-group">Qin, H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panek, J. S.</span><span> </span><span class="NLM_article-title">Total synthesis of the HSP90 inhibitor geldanamycin</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2479</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol800749w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=2477-2479&author=H.-L.+Qinauthor=J.+S.+Panek&title=Total+synthesis+of+the+HSP90+inhibitor+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of the Hsp90 Inhibitor Geldanamycin</span></div><div class="casAuthors">Qin, Hua-Li; Panek, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2477-2479</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An enantioselective synthesis of the Hsp90 inhibitor geldanamycin (I) was achieved in 20 linear steps and 2.0% overall yield from 2-methoxyhydroquinone.  The synthesis is highlighted by a regio- and stereoselective hydroboration reaction; a Sc(OTf)3/Et3SiH-mediated pyran ring-opening reaction; an enantioselective crotylation to simultaneously install the C8-C9 (E)-trisubstituted olefin, the C10 and C11 stereocenters; a chelation-controlled asym. metalated acetylide addn.; and an intramol. copper(I)-mediated aryl amidation reaction to close the 19-membered macrolactam.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSqIH-BMiIm7Vg90H21EOLACvtfcHk0ljDIYYecHSlFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsbs%253D&md5=5551b7fe64071cd24303cdf6e95e6ca6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol800749w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol800749w%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DH.-L.%26aulast%3DPanek%26aufirst%3DJ.%2BS.%26atitle%3DTotal%2520synthesis%2520of%2520the%2520HSP90%2520inhibitor%2520geldanamycin%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D2477%26epage%3D2479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Rinehart, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slomp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grostic, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldanamycin, I.</span><span> </span><span class="NLM_article-title">Structure assignment</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">7591</span><span class="NLM_x">–</span> <span class="NLM_lpage">7593</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00729a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaE3MXmsVWqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1970&pages=7591-7593&author=K.+L.+Rinehartauthor=K.+Sasakiauthor=G.+Slompauthor=M.+F.+Grosticauthor=E.+C.+Olsonauthor=I.+Geldanamycin&title=Structure+assignment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Geldanamycin.  I.  Structure assignment</span></div><div class="casAuthors">Rinehart, Kenneth L., Jr.; Sasaki, Kazuya; Slomp, George; Grostic, Marvin F.; Olson, Edward C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7591-3</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Structure I was assigned to geldanamycin, a yellow antibiotic isolated from Streptomyces hygroscopicus var geldanus.  Zn-HOAc redn. of I gave a colorless compd. which was air oxidized back to I.  Reductive acetylation gave diacetyldihydrogeldana-mycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa7gfjSwgY67Vg90H21EOLACvtfcHk0ljDIYYecHSlFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXmsVWqtg%253D%253D&md5=0337b67e216c32203383ed66f5fd485d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja00729a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00729a018%26sid%3Dliteratum%253Aachs%26aulast%3DRinehart%26aufirst%3DK.%2BL.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DSlomp%26aufirst%3DG.%26aulast%3DGrostic%26aufirst%3DM.%2BF.%26aulast%3DOlson%26aufirst%3DE.%2BC.%26aulast%3DGeldanamycin%26aufirst%3DI.%26atitle%3DStructure%2520assignment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1970%26volume%3D92%26spage%3D7591%26epage%3D7593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Sasaki, K.; Inoue, Y.</span><span> </span><span class="NLM_article-title">Geldanamycin Derivative and Antitumor Agent Containing It</span>. DE 3006097,<span class="NLM_x"> </span><span class="NLM_year">1980</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&author=K.+Sasaki&author=Y.+Inoue&title=Geldanamycin+Derivative+and+Antitumor+Agent+Containing+It"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DK.%26atitle%3DGeldanamycin%2520Derivative%2520and%2520Antitumor%2520Agent%2520Containing%2520It%26date%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Whitesell, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">8324</span><span class="NLM_x">–</span> <span class="NLM_lpage">8328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1073%2Fpnas.91.18.8324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=8078881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8324-8328&author=L+Whitesellauthor=E.+G.+Mimnaughauthor=B.+De+Costaauthor=C.+E.+Myersauthor=L.+M.+Neckers&title=Inhibition+of+heat+shock+protein+HSP90-pp60v-src+heteroprotein+complex+formation+by+benzoquinone+ansamycins%3A+essential+role+for+stress+proteins+in+oncogenic+transformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span></div><div class="casAuthors">Whitesell, Luke; Mimnaugh, Edward G.; De Costa, Brian; Myers, Charles E.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8324-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The mol. mechanisms by which oncogenic tyrosine kinases induce cellular transformation are unclear.  Herbimycin A, geldanamycin, and certain other benzoquinone ansamycins display an unusual capacity to revert tyrosine kinase-induced oncogenic transformation.  As an approach to the study of v-src-mediated transformation, the authors examd. ansamycin action in transformed cells and found that drug-induced reversion could be achieved without direct inhibition of src phosphorylating activity.  To identify mechanisms other than kinase inhibition for drug-mediated reversion, the authors prepd. a solid phase-immobilized geldanamycin deriv. and affinity pptd. the mol. targets with which the drug interacted.  In a range of cell lines, immobilized geldanamycin bound elements of a major class of heat shock protein (HSP90) in a stable and pharmacol. specific manner.  Consistent with these binding data, the authors found that sol. geldanamycin and herbimycin A inhibited specifically the formation of a previously described src-HSP90 heteroprotein complex.  A related benzoquinone ansamycin that failed to revert transformed cells did not inhibit the formation of this complex.  These results demonstrate that HSP participation in multimol. complex formation is required for src-mediated transformation and can provide a target for drug modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTW8DJOglQLVg90H21EOLACvtfcHk0ljDIYYecHSlFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D&md5=18f1cad01698df44adaa05ef3da9f850</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8324%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL%26aulast%3DMimnaugh%26aufirst%3DE.%2BG.%26aulast%3DDe%2BCosta%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DC.%2BE.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%2520HSP90-pp60v-src%2520heteroprotein%2520complex%2520formation%2520by%2520benzoquinone%2520ansamycins%253A%2520essential%2520role%2520for%2520stress%2520proteins%2520in%2520oncogenic%2520transformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D8324%26epage%3D8328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E.</span><span> </span><span class="NLM_article-title">Geldanamycin as a potential anticancer agent: its molecular target and biochemical activity</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=361-373&author=L.+Neckersauthor=T.+W.+Schulteauthor=E.+Mimnaugh&title=Geldanamycin+as+a+potential+anticancer+agent%3A+its+molecular+target+and+biochemical+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DMimnaugh%26aufirst%3DE.%26atitle%3DGeldanamycin%2520as%2520a%2520potential%2520anticancer%2520agent%253A%2520its%2520molecular%2520target%2520and%2520biochemical%2520activity%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1999%26volume%3D17%26spage%3D361%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span>Press Release, February 28, 2008: <a href="http://phx.corporate-ir.net/phoenix.zhtml?c=121014&amp;p=irol-newsArticle&amp;ID=1113760&amp;highlight=" class="extLink">http://phx.corporate-ir.net/phoenix.zhtml?c=121014&p=irol-newsArticle&ID=1113760&highlight=</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Press+Release%2C+February+28%2C+2008%3A+http%3A%2F%2Fphx.corporate-ir.net%2Fphoenix.zhtml%3Fc%3D121014%26p%3Dirol-newsArticle%26ID%3D1113760%26highlight%3D."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timaul, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munster, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">A small molecule designed to bind to the adenine nucleotide pocket of HSP90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS1074-5521%2801%2900015-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11306353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVCitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=289-299&author=G.+Chiosisauthor=M.+N.+Timaulauthor=B.+Lucasauthor=P.+N.+Munsterauthor=F.+F.+Zhengauthor=L.+Sepp-Lorenzinoauthor=N.+Rosen&title=A+small+molecule+designed+to+bind+to+the+adenine+nucleotide+pocket+of+HSP90+causes+Her2+degradation+and+the+growth+arrest+and+differentiation+of+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells</span></div><div class="casAuthors">Chiosis, Gabriela; Timaul, Merna N.; Lucas, Brian; Munster, Pamela N.; Zheng, Fuzhong F.; Sepp-Lorenzino, Laura; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">289-299</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: The Hsp90s contain a conserved pocket that binds ATP/ADP and plays an important role in the regulation of chaperone function.  Occupancy of this pocket by several natural products (geldanamycin (GM) and radicicol) alters Hsp90 function and results in the degrdn. of a subset of proteins (i.e. steroid receptors, Her2, Raf).  We have used the structural features of this pocket to design a small mol. inhibitor of Hsp90.  Results: The designed small mol. PU3 competes with GM for Hsp90 binding with a relative affinity of 15-20 μM.  PU3 induces degrdn. of proteins, including Her2, in a manner similar to GM.  Furthermore, PU3 inhibits the growth of breast cancer cells causing retinoblastoma protein hypophosphorylation, G1 arrest and differentiation.  Conclusions: PU3 is representative of a novel class of synthetic compds. that binds to Hsp90 and inhibits the proliferation of cancer cells.  These reagents could provide a new strategy for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwVErTsVLPMrVg90H21EOLACvtfcHk0lgXpEREfbhz2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVCitbs%253D&md5=6a51b7e8c95c320fa27f62d9f9f645f5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900015-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900015-1%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DTimaul%26aufirst%3DM.%2BN.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMunster%26aufirst%3DP.%2BN.%26aulast%3DZheng%26aufirst%3DF.%2BF.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DA%2520small%2520molecule%2520designed%2520to%2520bind%2520to%2520the%2520adenine%2520nucleotide%2520pocket%2520of%2520HSP90%2520causes%2520Her2%2520degradation%2520and%2520the%2520growth%2520arrest%2520and%2520differentiation%2520of%2520breast%2520cancer%2520cells%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D289%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kasibhatla, S. R.; Hong, K.; Zhang, L.; Biamonte, M. A.; Boehm, M. F.; Shi, J.; Fan, J.</span><span> </span><span class="NLM_article-title">Preparation of Purine Analogs as Heat Shock Protein 90 (HSP90) Inhibitors</span>. WO 03/037860,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=S.+R.+Kasibhatla&author=K.+Hong&author=L.+Zhang&author=M.+A.+Biamonte&author=M.+F.+Boehm&author=J.+Shi&author=J.+Fan&title=Preparation+of+Purine+Analogs+as+Heat+Shock+Protein+90+%28HSP90%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DPreparation%2520of%2520Purine%2520Analogs%2520as%2520Heat%2520Shock%2520Protein%252090%2520%2528HSP90%2529%2520Inhibitors%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span> </span><span class="NLM_article-title">Orally active purine-based inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=817-828&author=M.+A.+Biamonteauthor=J.+Shiauthor=K.+Hongauthor=D.+C.+Hurstauthor=L.+Zhangauthor=J.+Fanauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=A.+A.+Maldonadoauthor=J.+L.+Sensintaffarauthor=Y.-C.+Yangauthor=A.+Kamalauthor=R.+E.+Loughauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=G.+A.+Timonyauthor=M.+F.+Boehmauthor=S.+R.+Kasibhatla&title=Orally+active+purine-based+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0503087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503087%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DHurst%26aufirst%3DD.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DMaldonado%26aufirst%3DA.%2BA.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.-C.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DOrally%2520active%2520purine-based%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D817%26epage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Brazidec, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">7′-Substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5352</span><span class="NLM_x">–</span> <span class="NLM_lpage">5362</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051146h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5352-5362&author=L.+Zhangauthor=J.+Fanauthor=K.+Vuauthor=K.+Hongauthor=J.-Y.+Le+Brazidecauthor=J.+Shiauthor=M.+Biamonteauthor=D.+J.+Buschauthor=R.+E.+Loughauthor=R.+Greckoauthor=Y.+Ranauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=R.+Mansfieldauthor=G.+A.+Timonyauthor=E.+H.+Ulmauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehm&title=7%E2%80%B2-Substituted+benzothiazolothio-+and+pyridinothiazolothio-purines+as+potent+heat+shock+protein+90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm051146h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051146h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DVu%26aufirst%3DK.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DLe%2BBrazidec%26aufirst%3DJ.-Y.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DBiamonte%26aufirst%3DM.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DUlm%26aufirst%3DE.%2BH.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3D7%25E2%2580%25B2-Substituted%2520benzothiazolothio-%2520and%2520pyridinothiazolothio-purines%2520as%2520potent%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5352%26epage%3D5362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Evaluation of 8-arylsulfanyl, 8- arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2892</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049012b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2892-2905&author=L.+Llaugerauthor=H.+Heauthor=J.+Kimauthor=J.+Aguirreauthor=N.+Rosenauthor=U.+Petersauthor=P.+Daviesauthor=G.+Chiosis&title=Evaluation+of+8-arylsulfanyl%2C+8-+arylsulfoxyl%2C+and+8-arylsulfonyl+adenine+derivatives+as+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm049012b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049012b%26sid%3Dliteratum%253Aachs%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DEvaluation%2520of%25208-arylsulfanyl%252C%25208-%2520arylsulfoxyl%252C%2520and%25208-arylsulfonyl%2520adenine%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2892%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span> </span><span class="NLM_article-title">Novel, potent small-molecule inhibitors of the molecular chaperone HSP90 discovered through structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4212</span><span class="NLM_x">–</span> <span class="NLM_lpage">4215</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050355z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4212-4215&author=B.+W.+Dymockauthor=X.+Barrilauthor=P.+A.+Broughauthor=J.+E.+Cansfieldauthor=A.+Masseyauthor=E.+McDonaldauthor=R.+E.+Hubbardauthor=A.+Surgenorauthor=S.+D.+Roughleyauthor=P.+Webbauthor=P.+Workmanauthor=L.+Wrightauthor=M.+J.+Drysdale&title=Novel%2C+potent+small-molecule+inhibitors+of+the+molecular+chaperone+HSP90+discovered+through+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Potent Small-Molecule Inhibitors of the Molecular Chaperone Hsp90 Discovered through Structure-Based Design</span></div><div class="casAuthors">Dymock, Brian W.; Barril, Xavier; Brough, Paul A.; Cansfield, Julie E.; Massey, Andrew; McDonald, Edward; Hubbard, Roderick E.; Surgenor, Allan; Roughley, Stephen D.; Webb, Paul; Workman, Paul; Wright, Lisa; Drysdale, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4212-4215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The crystal structure of a previously reported screening hit 1 (CCT018159) bound to the N terminal domain of mol. chaperone Hsp90 has been used to design 5-amide analogs.  These exhibit enhanced potency against the target in binding and functional assays with accompanying appropriate cellular pharmacodynamic changes.  Compd. 11 (VER-49009) compares favorably with the clin. evaluated 17-AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZR4ICeTnHxbVg90H21EOLACvtfcHk0ljyz7uMSScA6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D&md5=3a854d5f6fd1eb0e292292b2a8d22401</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm050355z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050355z%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DNovel%252C%2520potent%2520small-molecule%2520inhibitors%2520of%2520the%2520molecular%2520chaperone%2520HSP90%2520discovered%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4212%26epage%3D4215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Hall, S.</span><span> </span><span class="NLM_article-title">Discovery and Pre-Clinical Profile of SNX-5422: An Orally Active Hsp90 Inhibitor in Phase 1 Trials for Solid and Hematological Tumors</span>. Presented at the AACR Annual Meeting,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract 2449.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+Hall&title=Discovery+and+Pre-Clinical+Profile+of+SNX-5422%3A+An+Orally+Active+Hsp90+Inhibitor+in+Phase+1+Trials+for+Solid+and+Hematological+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520Pre-Clinical%2520Profile%2520of%2520SNX-5422%253A%2520An%2520Orally%2520Active%2520Hsp90%2520Inhibitor%2520in%2520Phase%25201%2520Trials%2520for%2520Solid%2520and%2520Hematological%2520Tumors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Cysyk, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barchi, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strong, J. M.</span><span> </span><span class="NLM_article-title">Reaction of geldanamycin and C17-substituted analogs with glutathione: product implications and pharmacological implications</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx050237e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=376-381&author=R.+L.+Cysykauthor=R.+J.+Parkerauthor=J.+J.+Barchiauthor=P.+S.+Steegauthor=N.+R.+Hartmanauthor=J.+M.+Strong&title=Reaction+of+geldanamycin+and+C17-substituted+analogs+with+glutathione%3A+product+implications+and+pharmacological+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Ftx050237e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx050237e%26sid%3Dliteratum%253Aachs%26aulast%3DCysyk%26aufirst%3DR.%2BL.%26aulast%3DParker%26aufirst%3DR.%2BJ.%26aulast%3DBarchi%26aufirst%3DJ.%2BJ.%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DHartman%26aufirst%3DN.%2BR.%26aulast%3DStrong%26aufirst%3DJ.%2BM.%26atitle%3DReaction%2520of%2520geldanamycin%2520and%2520C17-substituted%2520analogs%2520with%2520glutathione%253A%2520product%2520implications%2520and%2520pharmacological%2520implications%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2006%26volume%3D19%26spage%3D376%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Yamaguchi, S.; Nakashima, T.; Kanda, Y.</span><span> </span><span class="NLM_article-title">Preparation of Benzenoid Ansamycin Derivatives as HSP90 Family Protein Inhibitors for Treatment of Tumor</span>. WO 2007/001049,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=S.+Yamaguchi&author=T.+Nakashima&author=Y.+Kanda&title=Preparation+of+Benzenoid+Ansamycin+Derivatives+as+HSP90+Family+Protein+Inhibitors+for+Treatment+of+Tumor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Benzenoid%2520Ansamycin%2520Derivatives%2520as%2520HSP90%2520Family%2520Protein%2520Inhibitors%2520for%2520Treatment%2520of%2520Tumor%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Zhang, M. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nur-E-Alam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vousden, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaitatzis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radzom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, C. J.</span><span> </span><span class="NLM_article-title">Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5494</span><span class="NLM_x">–</span> <span class="NLM_lpage">5497</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8006068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5494-5497&author=M.+Q.+Zhangauthor=S.+Gaisserauthor=M.+Nur-E-Alamauthor=L.+S.+Sheehanauthor=W.+A.+Vousdenauthor=N.+Gaitatzisauthor=G.+Peckauthor=N.+J.+Coatesauthor=S.+J.+Mossauthor=M.+Radzomauthor=T.+A.+Fosterauthor=R.+M.+Sheridanauthor=M.+A.+Gregoryauthor=S.+M.+Roeauthor=C.+Prodromouauthor=L.+Pearlauthor=S.+M.+Boydauthor=B.+Wilkinsonauthor=C.+J.+Martin&title=Optimizing+natural+products+by+biosynthetic+engineering%3A+discovery+of+nonquinone+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm8006068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006068%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BQ.%26aulast%3DGaisser%26aufirst%3DS.%26aulast%3DNur-E-Alam%26aufirst%3DM.%26aulast%3DSheehan%26aufirst%3DL.%2BS.%26aulast%3DVousden%26aufirst%3DW.%2BA.%26aulast%3DGaitatzis%26aufirst%3DN.%26aulast%3DPeck%26aufirst%3DG.%26aulast%3DCoates%26aufirst%3DN.%2BJ.%26aulast%3DMoss%26aufirst%3DS.%2BJ.%26aulast%3DRadzom%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DT.%2BA.%26aulast%3DSheridan%26aufirst%3DR.%2BM.%26aulast%3DGregory%26aufirst%3DM.%2BA.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DBoyd%26aufirst%3DS.%2BM.%26aulast%3DWilkinson%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DC.%2BJ.%26atitle%3DOptimizing%2520natural%2520products%2520by%2520biosynthetic%2520engineering%253A%2520discovery%2520of%2520nonquinone%2520Hsp90%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5494%26epage%3D5497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Agatsuma, T.; Saitoh, Y.; Yamashita, Y.; Mizukami, T.; Akinaga, S.; Gomi, K.; Akasaka, K.; Takahashi, I.</span><span> </span><span class="NLM_article-title">Preparation of Radicicol Derivatives as Tyrosine Kinase Inhibitors</span>. WO 96/33989,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=T.+Agatsuma&author=Y.+Saitoh&author=Y.+Yamashita&author=T.+Mizukami&author=S.+Akinaga&author=K.+Gomi&author=K.+Akasaka&author=I.+Takahashi&title=Preparation+of+Radicicol+Derivatives+as+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAgatsuma%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Radicicol%2520Derivatives%2520as%2520Tyrosine%2520Kinase%2520Inhibitors%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Ikuina, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amishiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakata, C.</span><span> </span><span class="NLM_article-title">Synthesis and antitumor activity of novel <i>O</i>-carbamoylmethyloxime derivatives of radicicol</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2534</span><span class="NLM_x">–</span> <span class="NLM_lpage">2541</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030110r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2534-2541&author=Y.+Ikuinaauthor=N.+Amishiroauthor=M.+Miyataauthor=H.+Narumiauthor=H.+Ogawaauthor=T.+Akiyamaauthor=Y.+Shiotsuauthor=S.+Akinagaauthor=C.+Murakata&title=Synthesis+and+antitumor+activity+of+novel+O-carbamoylmethyloxime+derivatives+of+radicicol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm030110r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030110r%26sid%3Dliteratum%253Aachs%26aulast%3DIkuina%26aufirst%3DY.%26aulast%3DAmishiro%26aufirst%3DN.%26aulast%3DMiyata%26aufirst%3DM.%26aulast%3DNarumi%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DMurakata%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520antitumor%2520activity%2520of%2520novel%2520O-carbamoylmethyloxime%2520derivatives%2520of%2520radicicol%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2534%26epage%3D2541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of HSP90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.2174%2F156802608784911644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18673171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVant7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=859-868&author=M.+J.+Drysdaleauthor=P.+A.+Brough&title=Medicinal+chemistry+of+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of Hsp90 inhibitors</span></div><div class="casAuthors">Drysdale, Martin J.; Brough, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">859-868</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp90) inhibitors are an increasingly interesting and important class of compds. where the first in class, natural product derived inhibitors such as 17-allylaminogeldanamycin (17-AAG), are entering late stage clin. development.  Recently the emergence of synthetic, small mol. inhibitors has been described and both NVP-AUY922 and BIIB021 have entered clin. development.  The medicinal chem. of these and other published small mol. Hsp90 inhibitors is described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_sn_Ez1pvv7Vg90H21EOLACvtfcHk0lgyFsc2b042dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVant7Y%253D&md5=3e85f368ba92e36692b957c6e73d44a8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F156802608784911644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608784911644%26sid%3Dliteratum%253Aachs%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26atitle%3DMedicinal%2520chemistry%2520of%2520HSP90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D859%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Shiau, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southworth, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agard, D. A</span><span> </span><span class="NLM_article-title">Structural analysis of <i>E. coli</i> hsp90 reveals dramatic nucleotide-dependent conformational rearrangements</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=329-340&author=A.+K.+Shiauauthor=S.+F.+Harrisauthor=D.+R.+Southworthauthor=D.+A+Agard&title=Structural+analysis+of+E.+coli+hsp90+reveals+dramatic+nucleotide-dependent+conformational+rearrangements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DSouthworth%26aufirst%3DD.%2BR.%26aulast%3DAgard%26aufirst%3DD.%2BA%26atitle%3DStructural%2520analysis%2520of%2520E.%2520coli%2520hsp90%2520reveals%2520dramatic%2520nucleotide-dependent%2520conformational%2520rearrangements%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D329%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Ali, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Crystal structure of an HSP90-nucleotide-p23/Sba1 closed chaperone complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1017</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1038%2Fnature04716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16625188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1agtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=1013-1017&author=M.+M.+Aliauthor=S.+M.+Roeauthor=C.+K.+Vaughanauthor=P.+Meyerauthor=B.+Panaretouauthor=P.+W.+Piperauthor=C.+Prodromouauthor=L.+H.+Pearl&title=Crystal+structure+of+an+HSP90-nucleotide-p23%2FSba1+closed+chaperone+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex</span></div><div class="casAuthors">Ali, Maruf M. U.; Roe, S. Mark; Vaughan, Cara K.; Meyer, Phillipe; Panaretou, Barry; Piper, Peter W.; Prodromou, Chrisostomos; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7087</span>),
    <span class="NLM_cas:pages">1013-1017</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hsp90 (heat shock protein of 90 kDa) is a ubiquitous mol. chaperone responsible for the assembly and regulation of many eukaryotic signaling systems and is an emerging target for rational chemotherapy of many cancers.  Although the structures of isolated domains of Hsp90 have been detd., the arrangement and ATP-dependent dynamics of these in the full Hsp90 dimer have been elusive and contentious.  Here we present the crystal structure of full-length yeast Hsp90 in complex with an ATP analog and the co-chaperone p23/Sba1.  The structure reveals the complex architecture of the closed' state of the Hsp90 chaperone, the extensive interactions between domains and between protein chains, the detailed conformational changes in the amino-terminal domain that accompany ATP binding, and the structural basis for stabilization of the closed state by p23/Sba1.  Contrary to expectations, the closed Hsp90 would not enclose its client proteins but provides a bipartite binding surface whose formation and disruption are coupled to the chaperone ATPase cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcaj34ODndPbVg90H21EOLACvtfcHk0lgyFsc2b042dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1agtLw%253D&md5=15ea0bcf7cbf297b3f4a7005c7798fb0</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnature04716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04716%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DM.%2BM.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DVaughan%26aufirst%3DC.%2BK.%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520an%2520HSP90-nucleotide-p23%252FSba1%2520closed%2520chaperone%2520complex%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D1013%26epage%3D1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=41-56&author=D.+E.+Dollinsauthor=J.+J.+Warrenauthor=R.+M.+Immorminoauthor=D.+T.+Gewirth&title=Structures+of+GRP94-nucleotide+complexes+reveal+mechanistic+differences+between+the+hsp90+chaperones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DWarren%26aufirst%3DJ.%2BJ.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructures%2520of%2520GRP94-nucleotide%2520complexes%2520reveal%2520mechanistic%2520differences%2520between%2520the%2520hsp90%2520chaperones%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D28%26spage%3D41%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Wandinger, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">The HSP90 chaperone machinery</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">18473</span><span class="NLM_x">–</span> <span class="NLM_lpage">18477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=18473-18477&author=S.+K.+Wandingerauthor=K.+Richterauthor=J.+Buchner&title=The+HSP90+chaperone+machinery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWandinger%26aufirst%3DS.%2BK.%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DThe%2520HSP90%2520chaperone%2520machinery%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D18473%26epage%3D18477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladbury, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Identification and structural characterization of the ATP/ADP-binding site in the HSP90 molecular chaperone</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS0092-8674%2800%2980314-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=9230303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaK2sXkslShtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=65-75&author=C.+Prodromouauthor=S.+M.+Roeauthor=R.+O%27Brienauthor=J.+E.+Ladburyauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=Identification+and+structural+characterization+of+the+ATP%2FADP-binding+site+in+the+HSP90+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone</span></div><div class="casAuthors">Prodromou, Chrisostomos; Roe, S. Mark; O'Brien, Ronan; Ladbury, John E.; Piper, Peter W.; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-75</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hsp90 mol. chaperones in eukaryotic cells play essential roles in the folding and activation of a range of client proteins involved in cell cycle regulation, steroid hormone responsiveness, and signal transduction.  The biochem. mechanism of Hsp90 is poorly understood, and the involvement of ATP in particular is controversial.  Crystal structures of complexes between the n-terminal domain of the yeast Hsp90 chaperone and ADP ATP unambiguously identify a specific adenine nucleotide binding site homologous to the ATP-binding site of DNA gyrase B.  This site is the same as that identified for the antitumor agent geldanamycin, suggesting that geldanamycin acts by blocking the binding of nucleotides to Hsp90 and not the binding of incompletely folded client polypeptides as previously suggested.  These results finally resolve the question of the direct involvement of ATP in Hsp90 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFYXzazhDOZLVg90H21EOLACvtfcHk0li9iZblt_Spgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslShtLc%253D&md5=54dd6b1b47538c3fe4eca43904850df6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980314-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980314-1%26sid%3Dliteratum%253Aachs%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DO%2527Brien%26aufirst%3DR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DIdentification%2520and%2520structural%2520characterization%2520of%2520the%2520ATP%252FADP-binding%2520site%2520in%2520the%2520HSP90%2520molecular%2520chaperone%26jtitle%3DCell%26date%3D1997%26volume%3D90%26spage%3D65%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Meyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS1097-2765%2803%2900065-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=12667448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVWkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=647-658&author=P.+Meyerauthor=C.+Prodromouauthor=B.+Huauthor=C.+Vaughanauthor=S.+M.+Roeauthor=B.+Panaretouauthor=P.+W.+Piperauthor=L.+H.+Pearl&title=Structural+and+functional+analysis+of+the+middle+segment+of+hsp90%3A+implications+for+ATP+hydrolysis+and+client+protein+and+cochaperone+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional analysis of the middle segment of Hsp90: Implications for ATP hydrolysis and client protein and cochaperone interactions</span></div><div class="casAuthors">Meyer, Philippe; Prodromou, Chrisostomos; Hu, Bin; Vaughan, Cara; Roe, S. Mark; Panaretou, Barry; Piper, Peter W.; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">647-658</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activation of client proteins by the Hsp90 mol. chaperone is dependent on binding and hydrolysis of ATP, which drives a mol. clamp via transient dimerization of the N-terminal domains.  The crystal structure of the middle segment of yeast Hsp90 reveals considerable evolutionary divergence from the equiv. regions of other GHKL protein family members such as MutL and GyrB, including an addnl. domain of new fold.  Using the known structure of the N-terminal nucleotide binding domain, a model for the Hsp90 dimer has been constructed.  From this structure, residues implicated in the ATPase-coupled conformational cycle and in interactions with client proteins and the activating cochaperone Aha1 have been identified, and their roles functionally characterized in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqewICLgiRIuLVg90H21EOLACvtfcHk0li9iZblt_Spgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVWkt7w%253D&md5=b1635443b8c376b1159ec1353472bf13</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900065-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900065-0%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DVaughan%26aufirst%3DC.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DStructural%2520and%2520functional%2520analysis%2520of%2520the%2520middle%2520segment%2520of%2520hsp90%253A%2520implications%2520for%2520ATP%2520hydrolysis%2520and%2520client%2520protein%2520and%2520cochaperone%2520interactions%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26spage%3D647%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span> </span><span class="NLM_article-title">Modulation of Akt kinase activity by binding to HSP90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">10832</span><span class="NLM_x">–</span> <span class="NLM_lpage">10837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10832-10837&author=S.+Satoauthor=N.+Fujitaauthor=T.+Tsuruo&title=Modulation+of+Akt+kinase+activity+by+binding+to+HSP90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DN.%26aulast%3DTsuruo%26aufirst%3DT.%26atitle%3DModulation%2520of%2520Akt%2520kinase%2520activity%2520by%2520binding%2520to%2520HSP90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D10832%26epage%3D10837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiau, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agard, D. A.</span><span> </span><span class="NLM_article-title">The crystal structure of the carboxy-terminal dimerization domain of htpG, the <i>Escherichia coli</i> HSP90, reveals a potential substrate binding site</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1087-1097&author=S.+F.+Harrisauthor=A.+K.+Shiauauthor=D.+A.+Agard&title=The+crystal+structure+of+the+carboxy-terminal+dimerization+domain+of+htpG%2C+the+Escherichia+coli+HSP90%2C+reveals+a+potential+substrate+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26atitle%3DThe%2520crystal%2520structure%2520of%2520the%2520carboxy-terminal%2520dimerization%2520domain%2520of%2520htpG%252C%2520the%2520Escherichia%2520coli%2520HSP90%252C%2520reveals%2520a%2520potential%2520substrate%2520binding%2520site%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D1087%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Minami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahara, I.</span><span> </span><span class="NLM_article-title">The carboxy-terminal region of mammalian HSP90 is required for its dimerization and function in vivo</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=8289821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaK2cXhvVGlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=1459-1464&author=Y.+Minamiauthor=Y.+Kimuraauthor=H.+Kawasakiauthor=K.+Suzukiauthor=I.+Yahara&title=The+carboxy-terminal+region+of+mammalian+HSP90+is+required+for+its+dimerization+and+function+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The carboxy-terminal region of mammalian HSP90 is required for its dimerization and function in vivo</span></div><div class="casAuthors">Minami, Yasufumi; Kimura, Yoko; Kawasaki, Hiroshi; Suzuki, Koichi; Yahara, Ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1459-64</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">The majority of mouse HSP90 exists as α-α and β-β homodimers.  Truncation of the 15-kDa carboxy-terminal region of mouse HSP90 by digestion with the Ca2+-dependent protease m-calpain caused dissocn. of the dimer.  When expressed in a reticulocyte lysate, the full-length human HSP90α formed a dimeric form.  A plasmid harboring human HSP90α cDNA was constructed so that the carboxy-terminal 49 amino acid residues were removed when translated in vitro.  This carboxy-terminally truncated human HSP90α was found to exist as a monomer.  In contrast, loss of the 118 amino acid residues from the amino terminus of human HSP90α did not affect its in vitro dimerization.  Introduction of an expression plasmid harboring the full-length human HSP90α complements the lethality caused by the double mutations of two HSP90-related genes, hsp82 and hsc82, in a haploid strain of Saccharomyces cerevisiae.  The carboxy-terminally truncated human HSP90α neither formed dimers in yeast cells nor rescued the lethal double mutant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm54tIR10nNLVg90H21EOLACvtfcHk0ljVQx75M_AAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhvVGlsbc%253D&md5=151905625b933abd7e18dea113da7eb7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinami%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DKawasaki%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DYahara%26aufirst%3DI.%26atitle%3DThe%2520carboxy-terminal%2520region%2520of%2520mammalian%2520HSP90%2520is%2520required%2520for%2520its%2520dimerization%2520and%2520function%2520in%2520vivo%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1994%26volume%3D14%26spage%3D1459%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Richter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainzl, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">Intrinsic inhibition of the HSP90 ATPase activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">11301</span><span class="NLM_x">–</span> <span class="NLM_lpage">11311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1074%2Fjbc.M510142200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16461354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFWjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=11301-11311&author=K.+Richterauthor=S.+Moserauthor=F.+Hagnauthor=R.+Friedrichauthor=O.+Hainzlauthor=M.+Hellerauthor=S.+Schleeauthor=H.+Kesslerauthor=J.+Reinsteinauthor=J.+Buchner&title=Intrinsic+inhibition+of+the+HSP90+ATPase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic Inhibition of the Hsp90 ATPase Activity</span></div><div class="casAuthors">Richter, Klaus; Moser, Sandra; Hagn, Franz; Friedrich, Rainer; Hainzl, Otmar; Heller, Markus; Schlee, Sandra; Kessler, Horst; Reinstein, Jochen; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">11301-11311</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mol. chaperone Hsp90 is required for the folding and activation of a large no. of substrate proteins.  These are involved in essential cellular processes ranging from signal transduction to viral replication.  For the activation of its substrates, Hsp90 binds and hydrolyzes ATP, which is the key driving force for conformational conversions within the dimeric chaperone.  Dimerization of Hsp90 is mediated by a C-terminal dimerization site.  In addn., there is a transient ATP-induced dimerization of the two N-terminal ATP-binding domains.  The resulting ring-like structure is thought to be the ATPase-active conformation.  Hsp90 is a slow ATPase with a turnover no. of 1 ATP/min for the yeast protein.  A key question for understanding the mol. mechanism of Hsp90 is how ATP hydrolysis is regulated and linked to conformational changes.  In this study, we analyzed the activation process structurally and biochem. with a view to identify the conformational limitations of the ATPase reaction cycle.  We showed that the first 24 amino acids stabilize the N-terminal domain in a rigid state.  Their removal confers flexibility specifically to the region between amino acids 98 and 120.  Most surprisingly, the deletion of this structure results in the complete loss of ATPase activity and in increased N-terminal dimerization.  Complementation assays using heterodimeric Hsp90 show that this rigid lid acts as an intrinsic kinetic inhibitor of the Hsp90 ATPase cycle preventing N-terminal dimerization in the ground state.  On the other hand, this structure acts in concert with the 24 N-terminal amino acids of the other N-terminal domain to form an activated ATPase and thus regulates the turnover no. of Hsp90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU8XaKrwQtkrVg90H21EOLACvtfcHk0ljVQx75M_AAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFWjtr4%253D&md5=a25cf0f740198a58603f724d3158f79c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M510142200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M510142200%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DMoser%26aufirst%3DS.%26aulast%3DHagn%26aufirst%3DF.%26aulast%3DFriedrich%26aufirst%3DR.%26aulast%3DHainzl%26aufirst%3DO.%26aulast%3DHeller%26aufirst%3DM.%26aulast%3DSchlee%26aufirst%3DS.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DReinstein%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DIntrinsic%2520inhibition%2520of%2520the%2520HSP90%2520ATPase%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D11301%26epage%3D11311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Wegele, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">Hsp70 and HSP90, a relay team for protein folding</span> <span class="citation_source-journal">Rev. Physiol. Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1007%2Fs10254-003-0021-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=14740253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFWqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2004&pages=1-44&author=H.+Wegeleauthor=L.+Mullerauthor=J.+Buchner&title=Hsp70+and+HSP90%2C+a+relay+team+for+protein+folding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp70 and Hsp90 - a relay team for protein folding</span></div><div class="casAuthors">Wegele, H.; Mueller, L.; Buchner, J.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews of Physiology, Biochemistry and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-44</span>CODEN:
                <span class="NLM_cas:coden">RPBEA5</span>;
        ISSN:<span class="NLM_cas:issn">0303-4240</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Mol. chaperones are a functionally defined set of proteins which assist the structure formation of proteins in vivo.  Without certain protective mechanisms, such as binding nascent polypeptide chains by mol. chaperones, cellular protein concns. would lead to misfolding and aggregation.  In the mammalian system, mol. chaperones Hsp70 and Hsp90 are involved in the folding and maturation of key regulatory proteins, like steroid hormone receptors, transcription factors, and kinases, some of which are involved in cancer progression.  Hsp70 and Hsp90 form a multichaperone complex, in which both are connected by a 3rd protein called Hop.  The connection of and the interplay between the 2 chaperone machineries is of crucial importance for cell viability.  This review provides a detailed view of the Hsp70 and Hsp90 machineries, their cofactors, and their mode of regulation.  It summarizes the current knowledge in the field, including the ATP-dependent regulation of the Hsp70/Hsp90 multichaperone cycle and elucidates the complex interplay and their synergistic interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjgKipZ7s6ZbVg90H21EOLACvtfcHk0ljVQx75M_AAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFWqtrg%253D&md5=4095fcaa6fe7424050fabee5200b37b3</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs10254-003-0021-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10254-003-0021-1%26sid%3Dliteratum%253Aachs%26aulast%3DWegele%26aufirst%3DH.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DHsp70%2520and%2520HSP90%252C%2520a%2520relay%2520team%2520for%2520protein%2520folding%26jtitle%3DRev.%2520Physiol.%2520Biochem.%2520Pharmacol.%26date%3D2004%26volume%3D151%26spage%3D1%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Onuoha, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulstock, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossmann, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. E.</span><span> </span><span class="NLM_article-title">Structural studies on the co-chaperone Hop and its complexes with HSP90</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2008&pages=732-744&author=S.+C.+Onuohaauthor=E.+T.+Coulstockauthor=J.+G.+Grossmannauthor=S.+E.+Jackson&title=Structural+studies+on+the+co-chaperone+Hop+and+its+complexes+with+HSP90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnuoha%26aufirst%3DS.%2BC.%26aulast%3DCoulstock%26aufirst%3DE.%2BT.%26aulast%3DGrossmann%26aufirst%3DJ.%2BG.%26aulast%3DJackson%26aufirst%3DS.%2BE.%26atitle%3DStructural%2520studies%2520on%2520the%2520co-chaperone%2520Hop%2520and%2520its%2520complexes%2520with%2520HSP90%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D379%26spage%3D732%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Ballinger, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span> </span><span class="NLM_article-title">Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4535</span><span class="NLM_x">–</span> <span class="NLM_lpage">4545</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1128%2FMCB.19.6.4535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=10330192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADyaK1MXjt1yisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=4535-4545&author=C.+A.+Ballingerauthor=P.+Connellauthor=Y.+Wuauthor=Z.+Huauthor=L.+J.+Thompsonauthor=L.+Y.+Yinauthor=C.+Patterson&title=Identification+of+CHIP%2C+a+novel+tetratricopeptide+repeat-containing+protein+that+interacts+with+heat+shock+proteins+and+negatively+regulates+chaperone+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions</span></div><div class="casAuthors">Ballinger, Carol A.; Connell, Patrice; Wu, Yaxu; Hu, Zhaoyong; Thompson, Larry J.; Yin, Li-Yan; Patterson, Cam</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4535-4545</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The chaperone function of the mammalian 70-kDa heat shock proteins Hsc70 and Hsp70 is modulated by phys. interactions with four previously identified chaperone cofactors: Hsp40, BAG-1, the Hsc70-interacting protein Hip, and the Hsc70-hsp90-organizing protein Hop.  Hip and Hop interact with Hsc70 via a tetratricopeptide repeat domain.  In a search for addnl. tetratricopeptide repeat-contg. proteins, the authors have identified a novel 35-kDa cytoplasmic protein, carboxyl terminus of Hsc70-interacting protein (CHIP).  CHIP is highly expressed in adult striated muscle in vivo and is expressed broadly in vitro in tissue culture.  Hsc70 and Hsp70 were identified as potential interaction partners for this protein in a yeast two-hybrid screen.  In vitro binding assays demonstrated direct interactions between CHIP and both Hsc70 and Hsp70, and complexes contg. CHIP and Hsc70 were identified in immunoppts. of human skeletal muscle cells in vivo.  Using glutathione S-transferase fusions, the authors found that CHIP interacted with the carboxy-terminal residues 540 to 650 of Hsc70, whereas Hsc70 interacted with the amino-terminal residues 1 to 197 (contg. the tetratricopeptide domain and an adjacent charged domain) of CHIP.  Recombinant CHIP inhibited Hsp40-stimulated ATPase activity of Hsc70 and Hsp70, suggesting that CHIP blocks the forward reaction of the Hsc70-Hsp70 substrate-binding cycle.  Consistent with this observation, both luciferase refolding and substrate binding in the presence of Hsp40 and Hsp70 were inhibited by CHIP.  Taken together, these results indicate that CHIP decreases net ATPase activity and reduces chaperone efficiency, and they implicate CHIP in the neg. regulation of the forward reaction of the Hsc70-Hsp70 substrate-binding cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryOQ7k2PDUhLVg90H21EOLACvtfcHk0ljVQx75M_AAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjt1yisL8%253D&md5=d1baaf9ca0c3d91a169fcb31e3dec763</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1128%2FMCB.19.6.4535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.19.6.4535%26sid%3Dliteratum%253Aachs%26aulast%3DBallinger%26aufirst%3DC.%2BA.%26aulast%3DConnell%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DThompson%26aufirst%3DL.%2BJ.%26aulast%3DYin%26aufirst%3DL.%2BY.%26aulast%3DPatterson%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520CHIP%252C%2520a%2520novel%2520tetratricopeptide%2520repeat-containing%2520protein%2520that%2520interacts%2520with%2520heat%2520shock%2520proteins%2520and%2520negatively%2520regulates%2520chaperone%2520functions%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D4535%26epage%3D4545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Connell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinger, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohfeld, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span> </span><span class="NLM_article-title">The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1038%2F35070170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11146632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslGqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=93-96&author=P.+Connellauthor=C.+A.+Ballingerauthor=J.+Jiangauthor=Y.+Wuauthor=L.+J.+Thompsonauthor=J.+Hohfeldauthor=C.+Patterson&title=The+co-chaperone+CHIP+regulates+protein+triage+decisions+mediated+by+heat-shock+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins</span></div><div class="casAuthors">Connell, Patrice; Ballinger, Carol A.; Jiang, Jihong; Wu, Yaxu; Thompson, Larry J.; Hohfeld, Jorg; Patterson, Cam</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-96</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To maintain quality control in cells, mechanisms distinguish among improperly folded peptides, mature and functional proteins, and proteins to be targeted for degrdn.  The mol. chaperones, including heat-shock protein Hsp90, have the ability to recognize misfolded proteins and assist in their conversion to a functional conformation.  Disruption of Hsp90 heterocomplexes by the Hsp90 inhibitor geldanamycin leads to substrate degrdn. through the ubiquitin-proteasome pathway, implicating this system in protein triage decisions.  We previously identified CHIP (carboxyl terminus of Hsc70-interacting protein) to be an interaction partner of Hsc70 (ref. 4).  CHIP also interacts directly with a tetratricopeptide repeat acceptor site of Hsp90, incorporating into Hsp90 heterocomplexes and eliciting release of the regulatory cofactor p23.  Here we show that CHIP abolishes the steroid-binding activity and transactivation potential of the glucocorticoid receptor, a well-characterized Hsp90 substrate, even though it has little effect on its synthesis.  Instead, CHIP induces ubiquitination of the glucocorticoid receptor and degrdn. through the proteasome.  By remodelling Hsp90 heterocomplexes to favor substrate degrdn., CHIP modulates protein triage decisions that regulate the balance between protein folding and degrdn. for chaperone substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLcICHJwNISLVg90H21EOLACvtfcHk0lhjHK5-5rhwJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslGqsQ%253D%253D&md5=575a74b738bee74e5e5d4d9a27bc6a04</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2F35070170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35070170%26sid%3Dliteratum%253Aachs%26aulast%3DConnell%26aufirst%3DP.%26aulast%3DBallinger%26aufirst%3DC.%2BA.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DThompson%26aufirst%3DL.%2BJ.%26aulast%3DHohfeld%26aufirst%3DJ.%26aulast%3DPatterson%26aufirst%3DC.%26atitle%3DThe%2520co-chaperone%2520CHIP%2520regulates%2520protein%2520triage%2520decisions%2520mediated%2520by%2520heat-shock%2520proteins%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2001%26volume%3D3%26spage%3D93%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Meacham, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyr, D. M.</span><span> </span><span class="NLM_article-title">The Hsp70 co-chaperone CHIP targets immature CFTR for proteasomal degradation</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1038%2F35050509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11146634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslGqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=100-105&author=G.+C.+Meachamauthor=C.+Pattersonauthor=W.+Zhangauthor=J.+M.+Youngerauthor=D.+M.+Cyr&title=The+Hsp70+co-chaperone+CHIP+targets+immature+CFTR+for+proteasomal+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation</span></div><div class="casAuthors">Meacham, Geoffrey C.; Patterson, Cam; Zhang, Wenyue; Younger, J. Michael; Cyr, Douglas M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-105</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The folding of both wild-type and mutant forms of the cystic-fibrosis transmembrane-conductance regulator (CFTR), a plasma-membrane chloride-ion channel, is inefficient.  Most nascent CFTR is retained in the endoplasmic reticulum and degraded by the ubiquitin proteasome pathway.  Aberrant folding and defective trafficking of CFTRΔF508 is the principal cause of cystic fibrosis, but how the endoplasmic-reticulum quality-control system targets CFTR for degrdn. remains unknown.  CHIP is a cytosolic U-box protein that interacts with Hsc70 through a set of tetratricorepeat motifs.  The U-box represents a modified form of the ring-finger motif that is found in ubiquitin ligases and that defines the E4 family of polyubiquitination factors.  Here the authors show that CHIP functions with Hsc70 to sense the folded state of CFTR and targets aberrant forms for proteasomal degrdn. by promoting their ubiquitination.  The U-box appeared essential for this process because overexpression of CHIPΔU-box inhibited the action of endogenous CHIP and blocked CFTR ubiquitination and degrdn.  CHIP is a co-chaperone that converts Hsc70 from a protein-folding machine into a degrdn. factor that functions in endoplasmic-reticulum quality control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR2XvF2JH4WLVg90H21EOLACvtfcHk0lhjHK5-5rhwJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslGqtw%253D%253D&md5=65875810d882127157d1c23452e2b327</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2F35050509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050509%26sid%3Dliteratum%253Aachs%26aulast%3DMeacham%26aufirst%3DG.%2BC.%26aulast%3DPatterson%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYounger%26aufirst%3DJ.%2BM.%26aulast%3DCyr%26aufirst%3DD.%2BM.%26atitle%3DThe%2520Hsp70%2520co-chaperone%2520CHIP%2520targets%2520immature%2520CFTR%2520for%2520proteasomal%2520degradation%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2001%26volume%3D3%26spage%3D100%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Murata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span> </span><span class="NLM_article-title">CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1093%2Fembo-reports%2Fkve246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11743028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Ciug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=1133-1138&author=S.+Murataauthor=Y.+Minamiauthor=M.+Minamiauthor=T.+Chibaauthor=K.+Tanaka&title=CHIP+is+a+chaperone-dependent+E3+ligase+that+ubiquitylates+unfolded+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein</span></div><div class="casAuthors">Murata, Shigeo; Minami, Yasufumi; Minami, Michiko; Chiba, Tomoki; Tanaka, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1133-1138</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The ubiquitin-proteasome system catalyzes the immediate destruction of misfolded or impaired proteins generated in cells, but how this proteolytic machinery recognizes abnormality of cellular proteins for selective elimination remains elusive.  Here, we report that the C-terminus of Hsc70-interacting protein (CHIP) with a U-box domain is an E3 ubiquitin-ligase collaborating with mol. chaperones Hsp90 and Hsc70.  Thermally denatured firefly luciferase was multiubiquitylated by CHIP in the presence of E1 and E2 (Ubc4 or UbcH5c) in vitro, only when the unfolded substrate was captured by Hsp90 or Hsc70 and Hsp40.  No ubiquitylating activity was detected in CHIP lacking the U-box region.  CHIP efficiently ubiquitylated denatured luciferase trapped by the C-terminal region of Hsp90, which contains a CHIP binding site.  CHIP also showed self-ubiquitylating activity independent of target ubiquitylation.  Our results indicate that CHIP can be regarded as "a quality-control E3" that selectively ubiquitylates unfolded protein(s) by collaborating with mol. chaperones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRqke0yhJ4NbVg90H21EOLACvtfcHk0lhjHK5-5rhwJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Ciug%253D%253D&md5=06a57e11ed0a550cf5a2392dd58b94f2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1093%2Fembo-reports%2Fkve246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fembo-reports%252Fkve246%26sid%3Dliteratum%253Aachs%26aulast%3DMurata%26aufirst%3DS.%26aulast%3DMinami%26aufirst%3DY.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26atitle%3DCHIP%2520is%2520a%2520chaperone-dependent%2520E3%2520ligase%2520that%2520ubiquitylates%2520unfolded%2520protein%26jtitle%3DEMBO%2520Rep.%26date%3D2001%26volume%3D2%26spage%3D1133%26epage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Dai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonough, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madamanchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span> </span><span class="NLM_article-title">CHIP activates HSF1 and confers protection against apoptosis and cellular stress</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5446</span><span class="NLM_x">–</span> <span class="NLM_lpage">5458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=5446-5458&author=Q.+Daiauthor=C.+Zhangauthor=Y.+Wuauthor=H.+McDonoughauthor=R.+A.+Whaleyauthor=V.+Godfreyauthor=H.+H.+Liauthor=N.+Madamanchiauthor=W.+Xuauthor=L.+Neckersauthor=D.+Cyrauthor=C.+Patterson&title=CHIP+activates+HSF1+and+confers+protection+against+apoptosis+and+cellular+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMcDonough%26aufirst%3DH.%26aulast%3DWhaley%26aufirst%3DR.%2BA.%26aulast%3DGodfrey%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DH.%2BH.%26aulast%3DMadamanchi%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DCyr%26aufirst%3DD.%26aulast%3DPatterson%26aufirst%3DC.%26atitle%3DCHIP%2520activates%2520HSF1%2520and%2520confers%2520protection%2520against%2520apoptosis%2520and%2520cellular%2520stress%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D5446%26epage%3D5458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Obermann, W. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sondermann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">In vivo function of HSP90 is dependent on ATP binding and ATP hydrolysis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1998&pages=901-910&author=W.+M.+J.+Obermannauthor=H.+Sondermannauthor=A.+A.+Russoauthor=N.+P.+Pavletichauthor=F.+U.+Hartl&title=In+vivo+function+of+HSP90+is+dependent+on+ATP+binding+and+ATP+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObermann%26aufirst%3DW.%2BM.%2BJ.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DIn%2520vivo%2520function%2520of%2520HSP90%2520is%2520dependent%2520on%2520ATP%2520binding%2520and%2520ATP%2520hydrolysis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1998%26volume%3D143%26spage%3D901%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandon, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalusa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2850</span><span class="NLM_x">–</span> <span class="NLM_lpage">2860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2850-2860&author=S.+A.+Ecclesauthor=A.+Masseyauthor=F.+I.+Raynaudauthor=S.+Y.+Sharpauthor=G.+Boxauthor=M.+Valentiauthor=L.+Pattersonauthor=A.+D.+Brandonauthor=S.+Gowanauthor=F.+Boxallauthor=W.+Aherneauthor=M.+Rowlandsauthor=A.+Hayesauthor=V.+Martinsauthor=F.+Urbanauthor=K.+Boxallauthor=C.+Prodromouauthor=L.+Pearlauthor=K.+Jamesauthor=T.+P.+Matthewsauthor=K.+M.+Cheungauthor=A.+Kalusaauthor=K.+Jonesauthor=E.+McDonaldauthor=X.+Barrilauthor=P.+A.+Broughauthor=J.+E.+Cansfieldauthor=B.+Dymockauthor=M.+J.+Drysdaleauthor=H.+Finchauthor=R.+Howesauthor=R.+E.+Hubbardauthor=A.+Surgenorauthor=P.+Webbauthor=M.+Woodauthor=L.+Wrightauthor=P.+Workman&title=NVP-AUY922%3A+a+novel+heat+shock+protein+90+inhibitor+active+against+xenograft+tumor+growth%2C+angiogenesis%2C+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DPatterson%26aufirst%3DL.%26aulast%3DBrandon%26aufirst%3DA.%2BD.%26aulast%3DGowan%26aufirst%3DS.%26aulast%3DBoxall%26aufirst%3DF.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DRowlands%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DUrban%26aufirst%3DF.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DKalusa%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DNVP-AUY922%253A%2520a%2520novel%2520heat%2520shock%2520protein%252090%2520inhibitor%2520active%2520against%2520xenograft%2520tumor%2520growth%252C%2520angiogenesis%252C%2520and%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2850%26epage%3D2860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Barta, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenks, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabasz, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span> </span><span class="NLM_article-title">Discovery of benzamide tetrahydro-4<i>H</i>-carbazol-4-ones as novel small molecule inhibitors of HSP90</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3517</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2Fj.bmcl.2008.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18511277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFSns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3517-3521&author=T.+E.+Bartaauthor=J.+M.+Vealauthor=J.+W.+Riceauthor=J.+M.+Partridgeauthor=R.+P.+Faddenauthor=W.+Maauthor=M.+Jenksauthor=L.+F.+Gengauthor=G.+J.+Hansonauthor=K.+H.+Huangauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=J.+Ottoauthor=S.+E.+Hall&title=Discovery+of+benzamide+tetrahydro-4H-carbazol-4-ones+as+novel+small+molecule+inhibitors+of+HSP90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90</span></div><div class="casAuthors">Barta, Thomas E.; Veal, James M.; Rice, John W.; Partridge, Jeffrey M.; Fadden, R. Patrick; Ma, Wei; Jenks, Matthew; Geng, Lifeng; Hanson, Gunnar J.; Huang, Kenneth H.; Barabasz, Amy F.; Foley, Briana E.; Otto, James; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3517-3521</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Hsp90 maintains the conformational stability of multiple proteins implicated in oncogenesis and has emerged as a target for chemotherapy.  We report here the discovery of a novel small mol. scaffold that inhibits Hsp90.  X-ray data show that the scaffold binds competitively at the ATP site on Hsp90.  Cellular proliferation and client assays demonstrate that members of the series are able to inhibit Hsp90 at nanomolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC-Wjx_IUjKbVg90H21EOLACvtfcHk0lgXuyPBiYtLPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFSns74%253D&md5=f965e9a2cfd0d44a57bb1949cd87de63</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%2BF.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520benzamide%2520tetrahydro-4H-carbazol-4-ones%2520as%2520novel%2520small%2520molecule%2520inhibitors%2520of%2520HSP90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3517%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span> </span><span class="NLM_article-title">Structure−activity relationships in purine-based inhibitor binding to HSP90 isoforms</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2Fj.chembiol.2004.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=15217611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=775-785&author=L.+Wrightauthor=X.+Barrilauthor=B.+Dymockauthor=L.+Sheridanauthor=A.+Surgenorauthor=M.+Beswickauthor=M.+Drysdaleauthor=A.+Collierauthor=A.+Masseyauthor=N.+Daviesauthor=A.+Finkauthor=C.+Fromontauthor=W.+Aherneauthor=K.+Boxallauthor=S.+Sharpauthor=P.+Workmanauthor=R.+E.+Hubbard&title=Structure%E2%88%92activity+relationships+in+purine-based+inhibitor+binding+to+HSP90+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms</span></div><div class="casAuthors">Wright, Lisa; Barril, Xavier; Dymock, Brian; Sheridan, Louisa; Surgenor, Allan; Beswick, Mandy; Drysdale, Martin; Collier, Adam; Massey, Andy; Davies, Nick; Fink, Alex; Fromont, Christophe; Aherne, Wynne; Boxall, Kathy; Sharp, Swee; Workman, Paul; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-785</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the chaperone protein HSP90 is a potential strategy for treatment of cancers.  We have detd. structures of the HSP90α N-terminal domain complexed with the purine-based inhibitor, PU3, and analogs with enhanced potency both in enzyme and cell-based assays.  The compds. induce upregulation of HSP70 and downregulation of the known HSP90 client proteins Raf-1, CDK4, and ErbB2, confirming that the mols. inhibit cell growth by a mechanism dependent on HSP90 inhibition.  We have also detd. the first structure of the N-terminal domain of HSP90β, complexed with PU3.  The structures allow a detailed rationale to be developed for the obsd. affinity of the PU3 class of compds. for HSP90 and also provide a structural framework for design of compds. with improved binding affinity and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Z11Wd4hiXrVg90H21EOLACvtfcHk0li7ry_sUjp6vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D&md5=dd2146dba0f4b3198d5bc7023e645812</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DSheridan%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBeswick%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DCollier%26aufirst%3DA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DN.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520in%2520purine-based%2520inhibitor%2520binding%2520to%2520HSP90%2520isoforms%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D775%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Fritz, C. C.; Ge, J.; Hafeez, N.; Tillotson, B.; Depew, K.; Coco, J.; Basuki, J.; Lim, A.; Patterson, J.; Porter, J. R.; Palombella, V.; Normant, E.</span> (Infinity Pharmaceuticals) <span> </span><span class="NLM_article-title">Comparison of the Cellular and Biochemical Properties of Ansamycin and Non-Ansamycin Based Inhibitors</span>. Presented at the AACR-EORTC Meeting, Geneva,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=C.+C.+Fritz&author=J.+Ge&author=N.+Hafeez&author=B.+Tillotson&author=K.+Depew&author=J.+Coco&author=J.+Basuki&author=A.+Lim&author=J.+Patterson&author=J.+R.+Porter&author=V.+Palombella&author=E.+Normant&title=Comparison+of+the+Cellular+and+Biochemical+Properties+of+Ansamycin+and+Non-Ansamycin+Based+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DFritz%26aufirst%3DC.%2BC.%26atitle%3DComparison%2520of%2520the%2520Cellular%2520and%2520Biochemical%2520Properties%2520of%2520Ansamycin%2520and%2520Non-Ansamycin%2520Based%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">McCollum, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">TenEyck, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensgard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morlan, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballman, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlichman, C.</span><span> </span><span class="NLM_article-title">P-Glycoprotein-mediated resistance to HSP90-directed therapy is eclipsed by the heat shock response</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">7419</span><span class="NLM_x">–</span> <span class="NLM_lpage">7427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=7419-7427&author=A.+K.+McCollumauthor=C.+J.+TenEyckauthor=B.+Stensgardauthor=B.+W.+Morlanauthor=K.+V.+Ballmanauthor=R.+B.+Jenkinsauthor=D.+O.+Toftauthor=C.+Erlichman&title=P-Glycoprotein-mediated+resistance+to+HSP90-directed+therapy+is+eclipsed+by+the+heat+shock+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCollum%26aufirst%3DA.%2BK.%26aulast%3DTenEyck%26aufirst%3DC.%2BJ.%26aulast%3DStensgard%26aufirst%3DB.%26aulast%3DMorlan%26aufirst%3DB.%2BW.%26aulast%3DBallman%26aufirst%3DK.%2BV.%26aulast%3DJenkins%26aufirst%3DR.%2BB.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DErlichman%26aufirst%3DC.%26atitle%3DP-Glycoprotein-mediated%2520resistance%2520to%2520HSP90-directed%2520therapy%2520is%2520eclipsed%2520by%2520the%2520heat%2520shock%2520response%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D7419%26epage%3D7427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nguyen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mixon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrump, D. S.</span><span> </span><span class="NLM_article-title">Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin</span> <span class="citation_source-journal">J. Thorac. Cardiovasc. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1999&pages=908-915&author=D.+M.+Nguyenauthor=A.+Chenauthor=A.+Mixonauthor=D.+S.+Schrump&title=Sequence-dependent+enhancement+of+paclitaxel+toxicity+in+non-small+cell+lung+cancer+by+17-allylamino+17-demethoxygeldanamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DMixon%26aufirst%3DA.%26aulast%3DSchrump%26aufirst%3DD.%2BS.%26atitle%3DSequence-dependent%2520enhancement%2520of%2520paclitaxel%2520toxicity%2520in%2520non-small%2520cell%2520lung%2520cancer%2520by%252017-allylamino%252017-demethoxygeldanamycin%26jtitle%3DJ.%2520Thorac.%2520Cardiovasc.%2520Surg.%26date%3D1999%26volume%3D118%26spage%3D908%26epage%3D915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit72b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nguyen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabibi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrump, D. S.</span><span> </span><span class="NLM_article-title">Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis</span> <span class="citation_source-journal">Ann. Thorac. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72b&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2FS0003-4975%2801%2902787-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72b&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=11515869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72b&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A280%3ADC%252BD3MvntFamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2001&pages=371-378&author=D.+M.+Nguyenauthor=D.+Lorangauthor=G.+A.+Chenauthor=J.+H.+Stewartauthor=E.+Tabibiauthor=D.+S.+Schrump&title=Enhancement+of+paclitaxel-mediated+cytotoxicity+in+lung+cancer+cells+by+17-allylamino+geldanamycin%3A+in+vitro+and+in+vivo+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72bR"><div class="casContent"><span class="casTitleNuber">72b</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis</span></div><div class="casAuthors">Nguyen D M; Lorang D; Chen G A; Stewart J H 4th; Tabibi E; Schrump D S</div><div class="citationInfo"><span class="NLM_cas:title">The Annals of thoracic surgery</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">371-8; discussion 378-9</span>
        ISSN:<span class="NLM_cas:issn">0003-4975</span>.
    </div><div class="casAbstract">BACKGROUND:  It has previously been demonstrated that 17-allylamino geldanamycin (17-AAG) enhances paclitaxel-mediated cytotoxicity and downregulates vascular endothelial factor expression in non-small cell lung cancer.  This project was designed to evaluate the tumoricidal and antiangiogeneic effects of 17-AAG and paclitaxel in H358 non-small cell lung cancer cells grown as xenografts in nude mice.  METHODS:  In vitro cytotoxic drug combination effects were evaluated by (4, 5-dimethylthiazo-2-yl)-2, 5-diphenyl tetrazolium bromide-based proliferation assays.  The combinations of 17-AAG and paclitaxel were administered intraperitoneally in nude mice bearing H358 tumor xenografts.  Tumor volumes were measured weekly.  Tumor expression of erbB2, vascular endothelial cell growth factor, von Willebrand factor (tumor microvasculature), and activated caspase 3 (apoptosis) were determined by immunohistochemistry.  RESULTS:  Five- to 22-fold enhancement of paclitaxel cytotoxicity was achieved by paclitaxel + 17-AAG combination that was paralleled with marked induction of apoptosis.  This combination treatment profoundly suppressed tumor growth and significantly prolonged survival of mice bearing H358 xenografts.  Immunohistochemical staining of tumor tissues indicated profound reduction of vascular endothelial cell growth factor expression associated with reduction of microvasculature in tumors treated with 17-AAG.  Apoptotic cells were more abundant in tumors treated with 17-AAG + paclitaxel than in those treated with 17-AAG or paclitaxel alone.  CONCLUSIONS:  Concurrent exposure of H358 cells to 17-AAG and paclitaxel resulted in supraadditive growth inhibition effects in vitro and in vivo.  Analysis of molecular markers of tumor tissues indicated that therapeutic drug levels could be achieved with this chemotherapy regimen leading to significant biological responses.  Moreover, 17-AAG-mediated suppression of vascular endothelial cell growth factor production by tumor cells may contribute to the antitumor effects of this drug combination in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6lhdZxuooAFQKX3ooHxWjfW6udTcc2eYsV9t__5qZtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvntFamtQ%253D%253D&md5=fa80347b05cd34e1586c8c4003fcb863</span></div><a href="/servlet/linkout?suffix=cit72b&amp;dbid=16384&amp;doi=10.1016%2FS0003-4975%2801%2902787-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-4975%252801%252902787-4%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DD.%2BM.%26aulast%3DLorang%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DG.%2BA.%26aulast%3DStewart%26aufirst%3DJ.%2BH.%26aulast%3DTabibi%26aufirst%3DE.%26aulast%3DSchrump%26aufirst%3DD.%2BS.%26atitle%3DEnhancement%2520of%2520paclitaxel-mediated%2520cytotoxicity%2520in%2520lung%2520cancer%2520cells%2520by%252017-allylamino%2520geldanamycin%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520analysis%26jtitle%3DAnn.%2520Thorac.%2520Surg.%26date%3D2001%26volume%3D72%26spage%3D371%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit72c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormerod, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rienzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, A. L.</span><span> </span><span class="NLM_article-title">Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72c&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1535-7163.MCT-05-0445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72c&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16731752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72c&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVWnurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1197-1208&author=N.+Sainauthor=B.+Krishnanauthor=M.+G.+Ormerodauthor=A.+De+Rienzoauthor=W.+M.+Liuauthor=S.+B.+Kayeauthor=P.+Workmanauthor=A.+L.+Jackman&title=Potentiation+of+paclitaxel+activity+by+the+HSP90+inhibitor+17-allylamino-17-demethoxygeldanamycin+in+human+ovarian+carcinoma+cell+lines+with+high+levels+of+activated+AKT"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72cR"><div class="casContent"><span class="casTitleNuber">72c</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT</span></div><div class="casAuthors">Sain, Nivedita; Krishnan, Bhavani; Ormerod, Michael G.; De Rienzo, Assunta; Liu, Wai M.; Kaye, Stanley B.; Workman, Paul; Jackman, Ann L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1197-1208</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activation of the phosphatidylinositol-3-kinase (PI3K)/AKT survival pathway is a mechanism of cytotoxic drug resistance in ovarian cancer, and inhibitors of this pathway can sensitize to cytotoxic drugs.  The HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) depletes some proteins involved in PI3K/AKT signaling, e.g., ERBB2, epidermal growth factor receptor (EGFR), and phosphorylated AKT (p-AKT).  17-AAG and paclitaxel were combined (at a fixed 1:1 ratio of their IC50) in four ovarian cancer cell lines that differ in expression of p-AKT, EGFR, and ERBB2.  The EGFR-overexpressing A431 and KB epidermoid cell lines were also included.  Combination indexes (CI) were calcd. using the median-effect equation and interpreted in the context of 17-AAG-mediated inhibition of PI3K signaling.  Synergy was obsd. in IGROV-1- and ERBB2-overexpressing SKOV-3 ovarian cancer cells that express a high level of constitutively activated p-AKT [CI at fraction unaffected (fu)0.5 = 0.50 and 0.53, resp.].  Slight synergy was obsd. in A431 cells (moderate p-AKT/overexpressed EGFR; CI at fu0.5 = 0.76) and antagonism in CH1 (moderate p-AKT), HX62 cells (low p-AKT), and KB cells (low p-AKT/overexpressed EGFR; CI at fu50 = 3.0, 3.5, and 2.0, resp.).  The obsd. effects correlated with changes in the rate of apoptosis induction.  17-AAG induced a decrease in HSP90 client proteins (e.g., C-RAF, ERBB2, and p-AKT) or in downstream markers of their activity (e.g., phosphorylated extracellular signal-regulated kinase or p-AKT) in SKOV-3, IGROV-1, and CH1 cells at IC50 concns.  A non-growth-inhibitory concn. (6 nmol/L) reduced the phosphorylation of AKT (but not extracellular signal-regulated kinase) and sensitized SKOV-3 cells to paclitaxel.  In conclusion, 17-AAG may sensitize a subset of ovarian cancer to paclitaxel, particularly those tumors in which resistance is driven by ERBB2 and/or p-AKT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOIHecJVgN37Vg90H21EOLACvtfcHk0liguXn1QvanKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVWnurc%253D&md5=7c6d1770fb9e7a92c31e3379ac8e93a4</span></div><a href="/servlet/linkout?suffix=cit72c&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0445%26sid%3Dliteratum%253Aachs%26aulast%3DSain%26aufirst%3DN.%26aulast%3DKrishnan%26aufirst%3DB.%26aulast%3DOrmerod%26aufirst%3DM.%2BG.%26aulast%3DDe%2BRienzo%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%2BM.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJackman%26aufirst%3DA.%2BL.%26atitle%3DPotentiation%2520of%2520paclitaxel%2520activity%2520by%2520the%2520HSP90%2520inhibitor%252017-allylamino-17-demethoxygeldanamycin%2520in%2520human%2520ovarian%2520carcinoma%2520cell%2520lines%2520with%2520high%2520levels%2520of%2520activated%2520AKT%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1197%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olshen, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to taxol</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">2139</span><span class="NLM_x">–</span> <span class="NLM_lpage">2144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2139-2144&author=D.+B.+Solitauthor=A.+D.+Bassoauthor=A.+B.+Olshenauthor=H.+I.+Scherauthor=N.+Rosen&title=Inhibition+of+heat+shock+protein+90+function+down-regulates+Akt+kinase+and+sensitizes+tumors+to+taxol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DBasso%26aufirst%3DA.%2BD.%26aulast%3DOlshen%26aufirst%3DA.%2BB.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%252090%2520function%2520down-regulates%2520Akt%2520kinase%2520and%2520sensitizes%2520tumors%2520to%2520taxol%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D2139%26epage%3D2144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">McCollum, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukasiewicz, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">TenEyck, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingle, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlichman, C.</span><span> </span><span class="NLM_article-title">Cisplatin abrogates the geldanamycin-induced heat shock response</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3256</span><span class="NLM_x">–</span> <span class="NLM_lpage">3264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1535-7163.MCT-08-0157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18852129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ensb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=3256-3264&author=A.+K.+McCollumauthor=K.+B.+Lukasiewiczauthor=C.+J.+TenEyckauthor=W.+L.+Lingleauthor=D.+O.+Toftauthor=C.+Erlichman&title=Cisplatin+abrogates+the+geldanamycin-induced+heat+shock+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Cisplatin abrogates the geldanamycin-induced heat shock response</span></div><div class="casAuthors">McCollum, Andrea K.; Lukasiewicz, Kara B.; TenEyck, Cynthia J.; Lingle, Wilma L.; Toft, David O.; Erlichman, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3256-3264</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Benzoquinone ansamycin antibiotics such as geldanamycin (GA) bind to the N-terminal ATP-binding domain of heat shock protein (Hsp) 90 and inhibit its chaperone functions.  Despite in vitro and in vivo studies indicating promising antitumor activity, derivs. of GA, including 17-allylaminogeldanamycin (17-AAG), have shown little clin. efficacy as single agents.  Thus, combination studies of 17-AAG and several cancer chemotherapeutics, including cisplatin (CDDP), have begun.  In colony-forming assays, the combination of CDDP and GA or 17-AAG was synergistic and caused increased apoptosis compared with each agent alone.  One measurable response that results from treatment with Hsp90-targeted agents is the induction of a heat shock factor-1 (HSF-1) heat shock response.  Treatment with GA + CDDP revealed that CDDP suppresses up-regulation of HSF-1 transcription, causing decreased levels of stress-inducible proteins such as Hsp27 and Hsp70.  However, CDDP treatment did not prevent trimerization and nuclear localization of HSF-1 but inhibited DNA binding of HSF-1 as shown by chromatin immunopptn.  Melphalan, but not camptothecin, caused similar inhibition of GA-induced HSF-1-mediated Hsp70 up-regulation.  3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt cell survival assays revealed that deletion of Hsp70 caused increased sensitivity to GA (Hsp70+/+ IC50 = 63.7 ± 14.9 nmol/L and Hsp70-/- IC50 = 4.3 ± 2.9 nmol/L), which confirmed that a stress response plays a crit. role in decreasing GA sensitivity.  Our results suggest that the synergy of GA + CDDP is due, in part, to CDDP-mediated abrogation of the heat shock response through inhibition of HSF-1 activity.  Clin. modulation of the HSF-1-mediated heat shock response may enhance the efficacy of Hsp90-directed therapy. [Mol Cancer Ther 2008;7(10):3256-64].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCuOuzH7bdybVg90H21EOLACvtfcHk0liguXn1QvanKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ensb%252FN&md5=acf49aa902d3b1da677842424dc40c8d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0157%26sid%3Dliteratum%253Aachs%26aulast%3DMcCollum%26aufirst%3DA.%2BK.%26aulast%3DLukasiewicz%26aufirst%3DK.%2BB.%26aulast%3DTenEyck%26aufirst%3DC.%2BJ.%26aulast%3DLingle%26aufirst%3DW.%2BL.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DErlichman%26aufirst%3DC.%26atitle%3DCisplatin%2520abrogates%2520the%2520geldanamycin-induced%2520heat%2520shock%2520response%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D3256%26epage%3D3264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Duus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahar, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozpuyan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izban, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Masri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maududi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alkan, S.</span><span> </span><span class="NLM_article-title">Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma</span> <span class="citation_source-journal">Leuk. Lymphoma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1369</span><span class="NLM_x">–</span> <span class="NLM_lpage">1378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1080%2F10428190500472123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16923571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWksbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=1369-1378&author=J.+Duusauthor=H.+I.+Baharauthor=G.+Venkataramanauthor=F.+Ozpuyanauthor=K.+F.+Izbanauthor=H.+Al-Masriauthor=T.+Maududiauthor=A.+Toorauthor=S.+Alkan&title=Analysis+of+expression+of+heat+shock+protein-90+%28HSP90%29+and+the+effects+of+HSP90+inhibitor+%2817-AAG%29+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma</span></div><div class="casAuthors">Duus, J.; Bahar, H. I.; Venkataraman, G.; Ozpuyan, F.; Izban, K. F.; Al-Masri, H.; Maududi, T.; Toor, A.; Alkan, S.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1369-1378</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Heat shock protein 90 (HSP90) is required for structural folding and maintenance of conformational integrity of various proteins, including several assocd. with cellular signaling.  Recent studies utilizing 17-allylamino-17-demethoxygeldanamycin (17-AAG), an inhibitor of HSP90, demonstrated an antitumor effect in solid tumors.  To test whether HSP90 could be targeted in multiple myeloma (MM) patients, we first investigated expression of HSP90 by immunofluorescence and flow cytometric anal. in a myeloma cell line (U266) and primary myeloma cells.  Following demonstration of HSP90 expression in myeloma cells, archival samples of 32 MM patients were analyzed by immunoperoxidase staining.  Myeloma cells in all patients showed strong cytoplasmic expression of HSP90 in all samples and 55% also demonstrated concurrent nuclear immunopositivity.  Treatment of U266 and primary MM cells with 17AAG resulted in significantly increased apoptosis compared to untreated control cells.  Anal. of anti-apoptotic BCL2 family proteins and akt in MM cells incubated with 17AAG revealed down-regulation of BCL-2, BCL-XL, MCL-1 and akt.  Furthermore, although a low concn. of bortezomib resulted in no cell death, a combination of 17AAG and bortezomib treatment revealed a synergistic apoptotic effect on the U266 cell line.  These data suggest that targeted inhibition of HSP90 may prove to be a valid and innovative strategy for the development of future therapeutic options for MM patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUx9uyCQeSJ7Vg90H21EOLACvtfcHk0li8ZHBPsARDIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWksbvE&md5=b88b14273842d7de01cceaedf60604eb</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1080%2F10428190500472123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428190500472123%26sid%3Dliteratum%253Aachs%26aulast%3DDuus%26aufirst%3DJ.%26aulast%3DBahar%26aufirst%3DH.%2BI.%26aulast%3DVenkataraman%26aufirst%3DG.%26aulast%3DOzpuyan%26aufirst%3DF.%26aulast%3DIzban%26aufirst%3DK.%2BF.%26aulast%3DAl-Masri%26aufirst%3DH.%26aulast%3DMaududi%26aufirst%3DT.%26aulast%3DToor%26aufirst%3DA.%26aulast%3DAlkan%26aufirst%3DS.%26atitle%3DAnalysis%2520of%2520expression%2520of%2520heat%2520shock%2520protein-90%2520%2528HSP90%2529%2520and%2520the%2520effects%2520of%2520HSP90%2520inhibitor%2520%252817-AAG%2529%2520in%2520multiple%2520myeloma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2006%26volume%3D47%26spage%3D1369%26epage%3D1378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Raja, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clubb, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega-Cava, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakku-Reddi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naramura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, H.</span><span> </span><span class="NLM_article-title">A combination of trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1640</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1535-7163.MCT-07-2409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18769124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1630-1640&author=S.+M.+Rajaauthor=R.+J.+Clubbauthor=M.+Bhattacharyyaauthor=M.+Dimriauthor=H.+Chengauthor=W.+Panauthor=C.+Ortega-Cavaauthor=A.+Lakku-Reddiauthor=M.+Naramuraauthor=V.+Bandauthor=H.+Band&title=A+combination+of+trastuzumab+and+17-AAG+induces+enhanced+ubiquitinylation+and+lysosomal+pathway-dependent+ErbB2+degradation+and+cytotoxicity+in+ErbB2-overexpressing+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells</span></div><div class="casAuthors">Raja, Srikumar M.; Clubb, Robert J.; Bhattacharyya, Mitra; Dimri, Manjari; Cheng, Hao; Pan, Wei; Ortega-Cava, Cesar; Lakku-Reddi, Alagarsamy; Naramura, Mayumi; Band, Vimla; Band, Hamid</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1630-1640</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">ErbB2 (or Her2/Neu) overexpression in breast cancer signifies poorer prognosis, yet it has provided an avenue for targeted therapy as demonstrated by the success of the humanized monoclonal antibody Trastuzumab (Herceptin).  Resistance to Trastuzumab and eventual failure in most cases, however, necessitate alternate ErbB2-targeted therapies.  HSP90 inhibitors such as 17-allylaminodemethoxygeldanamycin (17-AAG), potently downregulate the cell surface ErbB2.  While the precise mechanisms of Trastuzumab or 17-AAG action remain unclear, ubiquitinylation-dependent proteasomal or lysosomal degrdn. of ErbB2 appears to play a substantial role.  As Trastuzumab and 17-AAG induce the recruitment of distinct E3 ubiquitin ligases, Cbl and CHIP resp., to ErbB2, we hypothesized that 17-AAG and Trastuzumab combination could induce a higher level of ubiquitinylation and downregulation of ErbB2 as compared to single drug treatments.  We present biochem. and cell biol. evidence that combined 17-AAG and Trastuzumab treatment of ErbB2-overexpressing breast cancer cell lines leads to enhanced ubiquitinylation, downregulation from the cell surface and lysosomal degrdn. of ErbB2.  Importantly, combined 17-AAG and Trastuzumab treatment induced synergistic growth arrest and cell death specifically in ErbB2-overexpressing but not in ErbB2-low breast cancer cells.  Our results suggest the 17-AAG and Trastuzumab combination as a mechanism-based combinatorial targeted therapy for ErbB2-overexpressing breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Pmjyyf8L7LVg90H21EOLACvtfcHk0lg18zvcLPYOxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktL3L&md5=d7b9f1a2ad114b19bacf6eebb0b8c2ac</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2409%26sid%3Dliteratum%253Aachs%26aulast%3DRaja%26aufirst%3DS.%2BM.%26aulast%3DClubb%26aufirst%3DR.%2BJ.%26aulast%3DBhattacharyya%26aufirst%3DM.%26aulast%3DDimri%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DOrtega-Cava%26aufirst%3DC.%26aulast%3DLakku-Reddi%26aufirst%3DA.%26aulast%3DNaramura%26aufirst%3DM.%26aulast%3DBand%26aufirst%3DV.%26aulast%3DBand%26aufirst%3DH.%26atitle%3DA%2520combination%2520of%2520trastuzumab%2520and%252017-AAG%2520induces%2520enhanced%2520ubiquitinylation%2520and%2520lysosomal%2520pathway-dependent%2520ErbB2%2520degradation%2520and%2520cytotoxicity%2520in%2520ErbB2-overexpressing%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1630%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Banerji, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimshaw, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic−pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models</span> <span class="citation_source-journal">Clin. Cancer. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">7023</span><span class="NLM_x">–</span> <span class="NLM_lpage">7032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1078-0432.CCR-05-0518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=16203796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKiurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=7023-7032&author=U.+Banerjiauthor=M.+Waltonauthor=F.+Raynaudauthor=R.+Grimshawauthor=L.+Kellandauthor=M.+Valentiauthor=I.+Judsonauthor=P.+Workman&title=Pharmacokinetic%E2%88%92pharmacodynamic+relationships+for+the+heat+shock+protein+90+molecular+chaperone+inhibitor+17-allylamino%2C+17-demethoxygeldanamycin+in+human+ovarian+cancer+xenograft+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic-Pharmacodynamic Relationships for the Heat Shock Protein 90 Molecular Chaperone Inhibitor 17-Allylamino, 17-Demethoxygeldanamycin in Human Ovarian Cancer Xenograft Models</span></div><div class="casAuthors">Banerji, Udai; Walton, Michael; Raynaud, Florence; Grimshaw, Rachel; Kelland, Lloyd; Valenti, Melani; Judson, Ian; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">19, Pt. 1</span>),
    <span class="NLM_cas:pages">7023-7032</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To establish the pharmacokinetic and pharmacodynamic profile of the heat shock protein 90 (HSP90) inhibitor 17-allylamino, 17-demethoxygeldanamycin (17-AAG) in ovarian cancer xenograft models.  Exptl. Design: The effects of 17-AAG on growth inhibition and the expression of pharmacodynamic biomarkers c-RAF-1, CDK4, and HSP70 were studied in human ovarian cancer cell lines A2780 and CH1.  Corresponding expts. were conducted with established tumor xenografts.  The variability and specificity of pharmacodynamic markers in human peripheral blood lymphocytes (PBL) were studied.  Results: The IC50 values of 17-AAG in A2780 and CH1 cells were 18.3 nmol/L (SD, 2.3) and 410.1 nmol/L (SD, 9.4), resp.  Pharmacodynamic changes indicative of HSP90 inhibition were demonstrable at greater than or equal the IC50 concn. in both cell lines.  Xenograft expts. confirmed tumor growth inhibition in vivo.  Peak concns. of 17-AAG achieved in A2780 and CH1 tumors were 15.6 and 16.5 μmol/L, resp., and there was no significant difference between day 1 and 11 pharmacokinetic profiles.  Reversible changes in pharmacodynamic biomarkers were shown in tumor and murine PBLs in both xenograft models.  Expression of pharmacodynamic markers varied between human PBLs from different human volunteers but not within the same individual.  Pharmacodynamic biomarker changes consistent with HSP90 inhibition were shown in human PBLs exposed ex vivo to 17-AAG but not to selected cytotoxic drugs.  Conclusion: Pharmacokinetic-pharmacodynamic relationships were established for 17-AAG.  This information formed the basis of a pharmacokinetic-pharmacodynamic-driven phase I trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5wCR9QLU4krVg90H21EOLACvtfcHk0lg18zvcLPYOxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKiurjP&md5=1ef1b18dcf4f131d622d5189dff681d2</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0518%26sid%3Dliteratum%253Aachs%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DWalton%26aufirst%3DM.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DGrimshaw%26aufirst%3DR.%26aulast%3DKelland%26aufirst%3DL.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DJudson%26aufirst%3DI.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DPharmacokinetic%25E2%2588%2592pharmacodynamic%2520relationships%2520for%2520the%2520heat%2520shock%2520protein%252090%2520molecular%2520chaperone%2520inhibitor%252017-allylamino%252C%252017-demethoxygeldanamycin%2520in%2520human%2520ovarian%2520cancer%2520xenograft%2520models%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2005%26volume%3D11%26spage%3D7023%26epage%3D7032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Development and application of HSP90 inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2Fj.drudis.2007.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18190862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVWhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=38-43&author=D.+B.+Solitauthor=G.+Chiosis&title=Development+and+application+of+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78aR"><div class="casContent"><span class="casTitleNuber">78a</span><div class="casTitle"><span class="NLM_cas:atitle">Development and application of Hsp90 inhibitors</span></div><div class="casAuthors">Solit, David B.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">38-43</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 has emerged as an important target in several diseases.  The present review will discuss our understanding of the role played by Hsp90 in regulating and maintaining the transformed phenotype in cancers and neurodegenerative diseases, as well as recent findings on its roles in fungal and viral infections.  It will also update the reader on the preclin. development and clin. translation of Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobKuG3vjpdrLVg90H21EOLACvtfcHk0lg18zvcLPYOxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVWhug%253D%253D&md5=a4fa749f37fe96d9f323d437e9afded6</span></div><a href="/servlet/linkout?suffix=cit78a&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2007.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2007.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520and%2520application%2520of%2520HSP90%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D38%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit78b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharaj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Targeting HSP90: small-molecule inhibitors and their clinical development</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1016%2Fj.coph.2008.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18644253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=370-374&author=T.+Taldoneauthor=A.+Gozmanauthor=R.+Maharajauthor=G.+Chiosis&title=Targeting+HSP90%3A+small-molecule+inhibitors+and+their+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78bR"><div class="casContent"><span class="casTitleNuber">78b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90: small-molecule inhibitors and their clinical development</span></div><div class="casAuthors">Taldone, Tony; Gozman, Alexander; Maharaj, Ronnie; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-374</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 multichaperone complex has important roles in the development and progression of malignant transformation.  Several small-mol. inhibitors of Hsp90 of diverse chemotypes have shown potent antitumor activity in a wide-range of malignancies, and are currently in clin. or late-stage preclin. investigation.  This review intends to update the reader on advances made over the past two years in the clin. development of Hsp90 inhibitors in advanced cancers.  It will refer to the two 17-AAG formulations, tanespimycin and IPI-504, and to synthetic small mols., among which are the purine-scaffold Hsp90 inhibitor CNF2024/BIIB021, the isoxazole deriv. VER-52296/NVP-AUY922, and the carbazol-4-one benzamide deriv. SNX-5422, and will present our current knowledge on their clin. performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaxbcGVj_eb7Vg90H21EOLACvtfcHk0lg18zvcLPYOxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7J&md5=2f471b76eec1e93de88ecaa46865db6d</span></div><a href="/servlet/linkout?suffix=cit78b&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DGozman%26aufirst%3DA.%26aulast%3DMaharaj%26aufirst%3DR.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DTargeting%2520HSP90%253A%2520small-molecule%2520inhibitors%2520and%2520their%2520clinical%2520development%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D370%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percy, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikorski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slovin, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLaCruz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span> </span><span class="NLM_article-title">Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span> <span class="citation_source-journal">Clin. Cancer. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">–</span> <span class="NLM_lpage">1782</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1078-0432.CCR-06-1863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=17363532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1775-1782&author=D.+B.+Solitauthor=I.+Percyauthor=C.+Kopilauthor=R.+Sikorskiauthor=M.+J.+Morrisauthor=S.+F.+Slovinauthor=W.+K.+Kellyauthor=A.+DeLaCruzauthor=T.+Curleyauthor=G.+Hellerauthor=S.+Larsonauthor=L.+Schwartzauthor=M.+J.+Egorinauthor=N.+Rosenauthor=H.+I.+Scher&title=Phase+I+trial+of+17-allylamino-17-demethoxygeldanamycin+in+patients+with+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span></div><div class="casAuthors">Solit, David B.; Ivy, S. Percy; Kopil, Catherine; Sikorski, Rachel; Morris, Michael J.; Slovin, Susan F.; Kelly, W. Kevin; DeLaCruz, Anthony; Curley, Tracy; Heller, Glenn; Larson, Steven; Schwartz, Lawrence; Egorin, Merrill J.; Rosen, Neal; Scher, Howard I.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1775-1782</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To define the max. tolerated dose (MTD), toxicities, and pharmacokinetics of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when administered using continuous and intermittent dosing schedules.  Patients with progressive solid tumor malignancies were treated with 17-AAG using an accelerated titrn. dose escalation schema.  The starting dose and schedule were 5 mg/m2 daily for 5 days with cycles repeated every 21 days.  Dosing modifications based on safety, pharmacodynamic modeling, and clin. outcomes led to the evaluation of the following schedules: daily x 3 repeated every 14 days; twice weekly (days 1, 4, 8, and 11) for 2 wk every 3 wk; and twice weekly (days 1 and 4) without interruption.  During cycle 1, blood was collected for pharmacokinetic and pharmacodynamic studies.  Fifty-four eligible patients were treated.  The MTD was schedule dependent: 56 mg/m2 on the daily x 5 schedule; 112 mg/m2 on the daily x 3 schedule; and 220 mg/m2 on the days 1, 4, 8, and 11 every-21-day schedule.  Continuous twice-weekly dosing was deemed too toxic because of delayed hepatotoxicity.  Hepatic toxicity was also dose limiting with the daily x 5 schedule.  Other common toxicities encountered were fatigue, myalgias, and nausea.  This latter adverse effect may have been attributable, in part, to the DMSO-based formulation.  Concns. of 17-AAG above those required for activity in preclin. models could be safely achieved in plasma.  Induction of a heat shock response and down-regulation of Akt and Raf-1 were obsd. in biomarker studies.  The MTD and toxicity profile of 17-AAG were schedule dependent.  Intermittent dosing schedules were less toxic and are recommended for future phase II studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGKeAL9KtMGbVg90H21EOLACvtfcHk0lgLJAFqv1K75Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtL4%253D&md5=7de014104bbd48f42ec8faac2e8d92ed</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1863%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DPercy%26aufirst%3DI.%26aulast%3DKopil%26aufirst%3DC.%26aulast%3DSikorski%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DSlovin%26aufirst%3DS.%2BF.%26aulast%3DKelly%26aufirst%3DW.%2BK.%26aulast%3DDeLaCruz%26aufirst%3DA.%26aulast%3DCurley%26aufirst%3DT.%26aulast%3DHeller%26aufirst%3DG.%26aulast%3DLarson%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DL.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DScher%26aufirst%3DH.%2BI.%26atitle%3DPhase%2520I%2520trial%2520of%252017-allylamino-17-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520cancer%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1775%26epage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Banerji, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scurr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judson, I.</span><span> </span><span class="NLM_article-title">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino,17-demethoxygeldanamycin in patients with advanced malignancies</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4152</span><span class="NLM_x">–</span> <span class="NLM_lpage">4161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1200%2FJCO.2005.00.612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=15961763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=4152-4161&author=U.+Banerjiauthor=A.+O%E2%80%99Donnellauthor=M.+Scurrauthor=S.+Paceyauthor=S.+Stapletonauthor=Y.+Asadauthor=L.+Simmonsauthor=A.+Maloneyauthor=F.+Raynaudauthor=M.+Campbellauthor=M+Waltonauthor=S.+Lakhaniauthor=S.+Kayeauthor=P.+Workmanauthor=I.+Judson&title=Phase+I+pharmacokinetic+and+pharmacodynamic+study+of+17-allylamino%2C17-demethoxygeldanamycin+in+patients+with+advanced+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies</span></div><div class="casAuthors">Banerji, Udai; O'Donnell, Anne; Scurr, Michelle; Pacey, Simon; Stapleton, Sarah; Asad, Yasmin; Simmons, Laura; Maloney, Alison; Raynaud, Florence; Campbell, Maeli; Walton, Michael; Lakhani, Sunil; Kaye, Stanley; Workman, Paul; Judson, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4152-4161</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To study the toxicity and pharmacokinetic-pharmacodynamic profile of 17-allylamino, 17-demethoxygeldanamycin (17-AAG) and to recommend a dose for phase II trials.  Patients and Methods: This was a phase I study examg. a once-weekly dosing schedule of 17-AAG.  Thirty patients with advanced malignancies were treated.  Results: The highest dose level reached was 450 mg/m2/wk.  The dose-limiting toxicities (DLTs) encountered were grade 3 diarrhea in three patients (one at 320 mg/m2/wk and two at 450 mg/m2/wk) and grade 3 to 4 hepatotoxicity (AST/ALT) in one patient at 450 mg/m2/wk.  Two of nine DLTs were at the highest dose level.  Two patients with metastatic melanoma had stable disease and were treated for 15 and 41 mo, resp.  The dose vs. area under the curve-relationship for 17-AAG was linear (r2 = .71) over the dose range 10 to 450 mg/m2/wk, with peak plasma concns. of 8,998 μg/L (std. deviation, 2,881) at the highest dose level.  After the demonstration of pharmacodynamic changes in peripheral blood leukocytes, pre- and 24 h post-treatment, tumor biopsies were performed and demonstrated target inhibition (c-RAF-1 inhibition in four of six patients, CDK4 depletion in eight of nine patients and HSP70 induction in eight of nine patients) at the dose levels 320 and 450 mg/m2/wk.  It was not possible to reproducibly demonstrate these changes in biopsies taken 5 days after treatment.  Conclusion: It has been possible to demonstrate that 17-AAG exhibits a tolerable toxicity profile with therapeutic plasma concns. and target inhibition for 24 h after treatment and some indications of clin. activity at the dose level 450 mg/m2/wk.  We recommend this dose for phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaKgFbodgT_bVg90H21EOLACvtfcHk0lgLJAFqv1K75Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1elsrY%253D&md5=6ba10e24a68a1d9bd09d87239eea1ca6</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.00.612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.00.612%26sid%3Dliteratum%253Aachs%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DA.%26aulast%3DScurr%26aufirst%3DM.%26aulast%3DPacey%26aufirst%3DS.%26aulast%3DStapleton%26aufirst%3DS.%26aulast%3DAsad%26aufirst%3DY.%26aulast%3DSimmons%26aufirst%3DL.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DWalton%26aufirst%3DM%26aulast%3DLakhani%26aufirst%3DS.%26aulast%3DKaye%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DJudson%26aufirst%3DI.%26atitle%3DPhase%2520I%2520pharmacokinetic%2520and%2520pharmacodynamic%2520study%2520of%252017-allylamino%252C17-demethoxygeldanamycin%2520in%2520patients%2520with%2520advanced%2520malignancies%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D4152%26epage%3D4161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span>30% propylene glycol, 20% cremophor EL, 50% ethanol to a concentration of 10 mg/mL in the vial, 200 mg/vial.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=30%25+propylene+glycol%2C+20%25+cremophor+EL%2C+50%25+ethanol+to+a+concentration+of+10+mg%2FmL+in+the+vial%2C+200+mg%2Fvial."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopeck, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cropp, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannah, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudis, C. A.</span><span> </span><span class="NLM_article-title">Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer. A dose-escalation study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5410</span><span class="NLM_x">–</span> <span class="NLM_lpage">5417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1200%2FJCO.2007.11.7960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18048823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVCisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=5410-5417&author=S.+Modiauthor=A.+T.+Stopeckauthor=M.+S.+Gordonauthor=D.+Mendelsonauthor=D.+B.+Solitauthor=R.+Bagatellauthor=W.+Maauthor=J.+Whelerauthor=N.+Rosenauthor=L.+Nortonauthor=G.+F.+Croppauthor=R.+G.+Johnsonauthor=A.+L.+Hannahauthor=C.+A.+Hudis&title=Combination+of+trastuzumab+and+tanespimycin+%2817-AAG%2C+KOS-953%29+is+safe+and+active+in+trastuzumab-refractory+HER-2-overexpressing+breast+cancer.+A+dose-escalation+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: a phase I dose-escalation study</span></div><div class="casAuthors">Modi, Shanu; Stopeck, Alison T.; Gordon, Michael S.; Mendelson, David; Solit, David B.; Bagatell, Rochelle; Ma, Weining; Wheler, Jennifer; Rosen, Neal; Norton, Larry; Cropp, Gillian F.; Johnson, Robert G.; Hannah, Alison L.; Hudis, Clifford A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5410-5417</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: This phase I study examd. whether a heat shock protein (Hsp) 90 inhibitor tanespimycin (17-AAG; KOS-953) could be administered safely in combination with trastuzumab at a dose that inhibits Hsp90 function in vivo in lymphocytes.  Patients and Methods: Patients with an advanced solid tumor progressing during std. therapy were eligible.  Patients were treated with weekly trastuzumab followed by i.v. tanespimycin, assessed in escalating dose levels.  Results: Twenty-five patients were enrolled onto four tanespimycin dose levels: 225 (n = 4), 300 (n = 3), 375 (n = 8), and 450 mg/m2 (n = 10).  Dose-limiting toxicity (DLT) was obsd. at the third and fourth cohort (1 patient each): more than 2-wk delay for grade 4 fatigue/grade 2 nausea and anorexia (375 mg/m2); more than 2-wk delay for thrombocytopenia (450 mg/m2).  Drug-related grade 3 toxicity included emesis, increased ALT, hypersensitivity reactions (two patients each), and drug-induced thrombocytopenia (n = 1).  Common mild to moderate toxicities included fatigue, nausea, diarrhea, emesis, headache, rash/pruritus, increased AST/ALT, and anorexia.  Pharmacokinetic anal. demonstrated no difference in tanespimycin kinetics with or without trastuzumab.  Pharmacodynamic testing showed reactive induction of Hsp70 (a marker of Hsp90 inhibition) in lymphocytes at all dose levels.  Antitumor activity was noted (partial response, n = 1; minor response, n = 4; stable disease ≥ 4 mo, n = 4).  Tumor regressions were seen only in patients with human epidermal growth factor receptor 2 (HER-2)-pos. metastatic breast cancer.  Conclusion: Tanespimycin plus trastuzumab is well tolerated and has antitumor activity in patients with HER-2+ breast cancer whose tumors have progressed during treatment with trastuzumab.  These data suggest that Hsp90 function can be inhibited in vivo to a degree sufficient to cause inhibition of tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMOMgqgGMiFbVg90H21EOLACvtfcHk0lhI9B8bQF0DNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVCisQ%253D%253D&md5=a99de102e2458d4428b39a239a06ada4</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.11.7960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.11.7960%26sid%3Dliteratum%253Aachs%26aulast%3DModi%26aufirst%3DS.%26aulast%3DStopeck%26aufirst%3DA.%2BT.%26aulast%3DGordon%26aufirst%3DM.%2BS.%26aulast%3DMendelson%26aufirst%3DD.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DWheler%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DCropp%26aufirst%3DG.%2BF.%26aulast%3DJohnson%26aufirst%3DR.%2BG.%26aulast%3DHannah%26aufirst%3DA.%2BL.%26aulast%3DHudis%26aufirst%3DC.%2BA.%26atitle%3DCombination%2520of%2520trastuzumab%2520and%2520tanespimycin%2520%252817-AAG%252C%2520KOS-953%2529%2520is%2520safe%2520and%2520active%2520in%2520trastuzumab-refractory%2520HER-2-overexpressing%2520breast%2520cancer.%2520A%2520dose-escalation%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D5410%26epage%3D5417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span>48th ASH Meeting, Orlando, FL, December 2006.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=48th+ASH+Meeting%2C+Orlando%2C+FL%2C+December+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><a href="http://clinicaltrial.gov/ct/show/NCT00319930" class="extLink">http://clinicaltrial.gov/ct/show/NCT00319930</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fclinicaltrial.gov%2Fct%2Fshow%2FNCT00319930."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayzel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span> </span><span class="NLM_article-title">Development of 17-allylamino-17-demethoxygeldanamycin hydroquionone hydrochloride (IPI-504), an anti-cancer agent directed against HSP90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17408</span><span class="NLM_x">–</span> <span class="NLM_lpage">17413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17408-17413&author=J.+R.+Sydorauthor=E.+Normantauthor=C.+S.+Pienauthor=J.+R.+Porterauthor=J.+Geauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=J.+Hudakauthor=J.+Pattersonauthor=C.+Pendersauthor=M.+Pinkauthor=M.+A.+Readauthor=J.+Sangauthor=C.+Woodwardauthor=Y.+Zhangauthor=D.+S.+Grayzelauthor=J.+Wrightauthor=J.+A.+Barrettauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=J.+K.+Tong&title=Development+of+17-allylamino-17-demethoxygeldanamycin+hydroquionone+hydrochloride+%28IPI-504%29%2C+an+anti-cancer+agent+directed+against+HSP90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DHudak%26aufirst%3DJ.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DPenders%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGrayzel%26aufirst%3DD.%2BS.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26atitle%3DDevelopment%2520of%252017-allylamino-17-demethoxygeldanamycin%2520hydroquionone%2520hydrochloride%2520%2528IPI-504%2529%252C%2520an%2520anti-cancer%2520agent%2520directed%2520against%2520HSP90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17408%26epage%3D17413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span>Presented at the ASCO Annual Meeting,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Presented+at+the+ASCO+Annual+Meeting%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span>Infinity Press Release, April 15,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Infinity+Press+Release%2C+April+15%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Glaze, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiseman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holleran, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, J. E.</span><span> </span><span class="NLM_article-title">Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1007%2Fs00280-005-1000-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=15986212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=637-647&author=E.+R.+Glazeauthor=A.+L.+Lambertauthor=A.+C.+Smithauthor=J.+G.+Pageauthor=W.+D.+Johnsonauthor=D.+L.+McCormickauthor=A.+P.+Brownauthor=B.+S.+Levineauthor=J.+M.+Coveyauthor=M.+J.+Egorinauthor=J.+L.+Eisemanauthor=J.+L.+Holleranauthor=E.+A.+Sausvilleauthor=J.+E.+Tomaszewski&title=Preclinical+toxicity+of+a+geldanamycin+analog%2C+17-%28dimethylaminoethylamino%29-17-demethoxygeldanamycin+%2817-DMAG%29%2C+in+rats+and+dogs%3A+potential+clinical+relevance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance</span></div><div class="casAuthors">Glaze, Elizabeth R.; Lambert, Amy L.; Smith, Adaline C.; Page, John G.; Johnson, William D.; McCormick, David L.; Brown, Alan P.; Levine, Barry S.; Covey, Joseph M.; Egorin, Merrill J.; Eiseman, Julie L.; Holleran, Julianne L.; Sausville, Edward A.; Tomaszewski, Joseph E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">637-647</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: 17-DMAG is a hydrophilic deriv. of the mol. chaperone inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17-AAG; NSC-330507), which is currently being evaluated for the treatment of cancer in clin. trials. 17-DMAG offers a potential advantage over 17-AAG because its aq. soly. eliminates the need for complicated formulations that are currently used for administration of 17-AAG.  In addn., 17-DMAG undergoes only limited metab. compared to 17-AAG.  The present results are from preclin. toxicity studies evaluating 17-DMAG in rats and dogs.  Methods: Doses of 0, 2.4, 12 and 24 mg/m2 per day were administered to rats, while dogs received doses of 0, 8 or 16 mg/m2 per day.  In both species, 17-DMAG was administered i.v. (slow bolus for rats; 1-h infusion for dogs) daily for 5 days.  An addnl. cohort of dogs received 16 mg/m2 per day orally for 5 days.  Clin. observations were noted, and std. hematol. and clin. chem. parameters were monitored.  Selected tissues were evaluated microscopically for drug-related lesions.  Tissue and plasma 17-DMAG concns. were measured by HPLC/MS at selected time-points on days 1 and 5.  Results: Daily i.v. administration of 17-DMAG at doses of 24 mg/m2 per day in rats or 16 mg/m2 per day in dogs produced lethality on day 6, approx. 24 h following the last dose.  Body wt. loss was common in rats and dogs.  Drug-related gastrointestinal, bone marrow and hepatic toxicities were also common in rats and dogs.  Dogs also exhibited signs of renal and gallbladder toxicity.  Plasma concns. of 17-DMAG increased proportionately with dose in rats and disproportionately with dose in dogs.  In rat tissues, however, only fourfold to sixfold increases in 17-DMAG concns. were obsd. with a tenfold increase in dose.  The highest concns. of 17-DMAG were found in the liver of rats, with progressively lower concns. in the spleen, lung, kidney and plasma.  Regardless of the route of administration, higher drug concns. were present in plasma (rat and dog) and tissue (rat) samples obtained on day 5 compared to those obtained on day 1.  Although plasma concns. decreased with time, 17-DMAG was still detected in dog plasma for at least 24 h after drug administration.  Conclusions: With the recent approval of 17-DMAG for clin. use, the data generated from these preclin. studies will provide guidance to clinicians as they administer this drug to their patients.  The MTD of 17-DMAG was 12 mg/m2 per day in rats and 8 mg/m2 per day in dogs; therefore, the recommended starting dose for phase I trial is 1.3 mg/m2 per day for 5 days.  Gastrointestinal and bone marrow toxicity were dose-limiting in rats, and gastrointestinal, renal, gallbladder and bone marrow toxicity were dose-limiting in dogs.  All adverse effects were fully reversible in surviving animals after treatment was complete.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWkzP-n-oIFbVg90H21EOLACvtfcHk0lhI9B8bQF0DNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7bP&md5=62fe4552e57e6e2b86326d57d4ab8ff2</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1007%2Fs00280-005-1000-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-005-1000-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlaze%26aufirst%3DE.%2BR.%26aulast%3DLambert%26aufirst%3DA.%2BL.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DPage%26aufirst%3DJ.%2BG.%26aulast%3DJohnson%26aufirst%3DW.%2BD.%26aulast%3DMcCormick%26aufirst%3DD.%2BL.%26aulast%3DBrown%26aufirst%3DA.%2BP.%26aulast%3DLevine%26aufirst%3DB.%2BS.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DEiseman%26aufirst%3DJ.%2BL.%26aulast%3DHolleran%26aufirst%3DJ.%2BL.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DTomaszewski%26aufirst%3DJ.%2BE.%26atitle%3DPreclinical%2520toxicity%2520of%2520a%2520geldanamycin%2520analog%252C%252017-%2528dimethylaminoethylamino%2529-17-demethoxygeldanamycin%2520%252817-DMAG%2529%252C%2520in%2520rats%2520and%2520dogs%253A%2520potential%2520clinical%2520relevance%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D56%26spage%3D637%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Lancet, J.; Gojo, I.; Baer, M.; Burton, M.; Klein, M.; Nowadly, C.; Gorre, M.; Zhong, Z.; Johnson, R. G.; Hannah, A. L.</span><span> </span><span class="NLM_article-title">Phase 1, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of of the Hsp-90 Inhibitor, KOS-1022 (17-DMAG), in Patients with Refractory Hematological Malignancies</span>. Presented at the ASCO Annual Meeting,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>Abstract 2081.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+Lancet&author=I.+Gojo&author=M.+Baer&author=M.+Burton&author=M.+Klein&author=C.+Nowadly&author=M.+Gorre&author=Z.+Zhong&author=R.+G.+Johnson&author=A.+L.+Hannah&title=Phase+1%2C+Pharmacokinetic+%28PK%29+and+Pharmacodynamic+%28PD%29+Study+of+of+the+Hsp-90+Inhibitor%2C+KOS-1022+%2817-DMAG%29%2C+in+Patients+with+Refractory+Hematological+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLancet%26aufirst%3DJ.%26atitle%3DPhase%25201%252C%2520Pharmacokinetic%2520%2528PK%2529%2520and%2520Pharmacodynamic%2520%2528PD%2529%2520Study%2520of%2520of%2520the%2520Hsp-90%2520Inhibitor%252C%2520KOS-1022%2520%252817-DMAG%2529%252C%2520in%2520Patients%2520with%2520Refractory%2520Hematological%2520Malignancies%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span>P = phospholipon 90G (phospholipid surfactant). M = miglyol 812N (short chain triglyceride). S = soybean oil (long chain triglyceride). E = emulsion.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=P+%3D+phospholipon+90G+%28phospholipid+surfactant%29.+M+%3D+miglyol+812N+%28short+chain+triglyceride%29.+S+%3D+soybean+oil+%28long+chain+triglyceride%29.+E+%3D+emulsion."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Cheung, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of HSP90 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3338</span><span class="NLM_x">–</span> <span class="NLM_lpage">3343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3338-3343&author=K.+J.+Cheungauthor=T.+P.+Matthewsauthor=K.+Jamesauthor=M.+G.+Rowlandsauthor=K.+J.+Boxallauthor=S.+Y.+Sharpauthor=A.+Maloneyauthor=S.+M.+Roeauthor=C.+Prodromouauthor=L.+H.+Pearlauthor=G.+W.+Aherneauthor=E.+McDonaldauthor=P.+Workman&title=The+identification%2C+synthesis%2C+protein+crystal+structure+and+in+vitro+biochemical+evaluation+of+a+new+3%2C4-diarylpyrazole+class+of+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DK.%2BJ.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DBoxall%26aufirst%3DK.%2BJ.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DThe%2520identification%252C%2520synthesis%252C%2520protein%2520crystal%2520structure%2520and%2520in%2520vitro%2520biochemical%2520evaluation%2520of%2520a%2520new%25203%252C4-diarylpyrazole%2520class%2520of%2520HSP90%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3338%26epage%3D3343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalusa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1198</span><span class="NLM_x">–</span> <span class="NLM_lpage">1211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1535-7163.MCT-07-0149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=17431102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFanu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1198-1211&author=S.+Y.+Sharpauthor=C.+Prodromouauthor=K.+Boxallauthor=M.+V.+Powersauthor=J.+L.+Holmesauthor=G.+Boxauthor=T.+P.+Matthewsauthor=K.+J.+Cheungauthor=A.+Kalusaauthor=K.+Jamesauthor=A.+Hayesauthor=A.+Hardcastleauthor=B.+Dymockauthor=P.+A.+Broughauthor=X.+Barrilauthor=J.+E.+Cansfieldauthor=L.+Wrightauthor=A.+Surgenorauthor=N.+Foloppeauthor=R.+E.+Hubbardauthor=W.+Aherneauthor=L.+Pearlauthor=K.+Jonesauthor=E.+McDonaldauthor=F.+Raynaudauthor=S.+Ecclesauthor=M.+Drysdaleauthor=P.+Workman&title=Inhibition+of+the+heat+shock+protein+90+molecular+chaperone+in+vitro+and+in+vivo+by+novel%2C+synthetic%2C+potent+resorcinylic+pyrazole%2Fisoxazole+amide+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues</span></div><div class="casAuthors">Sharp, Swee Y.; Prodromou, Chrisostomos; Boxall, Kathy; Powers, Marissa V.; Holmes, Joanna L.; Box, Gary; Matthews, Thomas P.; Cheung, Kwai-Ming J.; Kalusa, Andrew; James, Karen; Hayes, Angela; Hardcastle, Anthea; Dymock, Brian; Brough, Paul A.; Barril, Xavier; Cansfield, Julie E.; Wright, Lisa; Surgenor, Allan; Foloppe, Nicolas; Hubbard, Roderick E.; Aherne, Wynne; Pearl, Laurence; Jones, Keith; McDonald, Edward; Raynaud, Florence; Eccles, Sue; Drysdale, Martin; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1198-1211</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Although the heat shock protein 90 (HSP90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) shows clin. promise, potential limitations encourage development of alternative chemotypes.  We discovered the 3,4-diarylpyrazole resorcinol CCT018159 by high-throughput screening and used structure-based design to generate more potent pyrazole amide analogs, exemplified by VER-49009.  Here, we describe the detailed biol. properties of VER-49009 and the corresponding isoxazole VER-50589.  X-ray crystallog. showed a virtually identical HSP90 binding mode.  However, the dissocn. const. (Kd) of VER-50589 was 4.5±2.2 nmol/L compared with 78.0±10.4 nmol/L for VER-49009, attributable to higher enthalpy for VER-50589 binding.  A competitive binding assay gave a lower IC50 of 21±4 nmol/L for VER-50589 compared with 47±9 nmol/L for VER-49009.  Cellular uptake of VER-50589 was 4-fold greater than for VER-49009.  Mean cellular antiproliferative GI50 values for VER-50589 and VER-49009 for a human cancer cell line panel were 78±15 and 685±119 nmol/L, resp., showing a 9-fold potency gain for the isoxazole.  Unlike 17-AAG, but as with CCT018159, cellular potency of these analogs was independent of NAD(P)H:quinone oxidoreductase 1/DT-diaphorase and P-glycoprotein expression.  Consistent with HSP90 inhibition, VER-50589 and VER-49009 caused induction of HSP72 and HSP27 alongside depletion of client proteins, including C-RAF, B-RAF, and survivin, and the protein arginine methyltransferase PRMT5.  Both caused cell cycle arrest and apoptosis.  Extent and duration of pharmacodynamic changes in an orthotopic human ovarian carcinoma model confirmed the superiority of VER-50589 over VER-49009.  VER-50589 accumulated in HCT116 human colon cancer xenografts at levels above the cellular GI50 for 24 h, resulting in 30% growth inhibition.  The results indicate the therapeutic potential of the resorcinylic pyrazole/isoxazole amide analogs as HSP90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdCmDXnfwFjrVg90H21EOLACvtfcHk0ljParLfaJv82A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFanu7Y%253D&md5=58678b76ed7fbda4d21942c69346946c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0149%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DCheung%26aufirst%3DK.%2BJ.%26aulast%3DKalusa%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHardcastle%26aufirst%3DA.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520the%2520heat%2520shock%2520protein%252090%2520molecular%2520chaperone%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520novel%252C%2520synthetic%252C%2520potent%2520resorcinylic%2520pyrazole%252Fisoxazole%2520amide%2520analogues%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1198%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radimerski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span> </span><span class="NLM_article-title">NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">R33</span><div class="note"><p class="first last"> (12 pages)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=R33&author=M.+R.+Jensenauthor=J.+Schoepferauthor=T.+Radimerskiauthor=A.+Masseyauthor=C.+T.+Guyauthor=J.+Brueggenauthor=C.+Quadtauthor=A.+Bucklerauthor=R.+Cozensauthor=M.+J.+Drysdaleauthor=C.+Garcia-Echeverriaauthor=P.+Chene&title=NVP-AUY922%3A+a+small+molecule+HSP90+inhibitor+with+potent+antitumor+activity+in+preclinical+breast+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DRadimerski%26aufirst%3DT.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DGuy%26aufirst%3DC.%2BT.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DQuadt%26aufirst%3DC.%26aulast%3DBuckler%26aufirst%3DA.%26aulast%3DCozens%26aufirst%3DR.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DChene%26aufirst%3DP.%26atitle%3DNVP-AUY922%253A%2520a%2520small%2520molecule%2520HSP90%2520inhibitor%2520with%2520potent%2520antitumor%2520activity%2520in%2520preclinical%2520breast%2520cancer%2520models%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2008%26volume%3D10%26spage%3DR33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Sessa, C.; Sharma, S.; Britten, C.; Vogelzang, N.; Bhalla, K.; Mita, M.; Pluard, T.; Stiegler, P.; Quadt, C.; Shapiro, G. I.</span><span> </span><span class="NLM_article-title">A Phase I Dose-Escalation Study of AUY922, a Novel HSP90 Inhibitor, in Patients with Advanced Solid Malignancies</span>. Presented at the ASCO Annual Meeting,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Abstract 3532.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+Sessa&author=S.+Sharma&author=C.+Britten&author=N.+Vogelzang&author=K.+Bhalla&author=M.+Mita&author=T.+Pluard&author=P.+Stiegler&author=C.+Quadt&author=G.+I.+Shapiro&title=A+Phase+I+Dose-Escalation+Study+of+AUY922%2C+a+Novel+HSP90+Inhibitor%2C+in+Patients+with+Advanced+Solid+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSessa%26aufirst%3DC.%26atitle%3DA%2520Phase%2520I%2520Dose-Escalation%2520Study%2520of%2520AUY922%252C%2520a%2520Novel%2520HSP90%2520Inhibitor%252C%2520in%2520Patients%2520with%2520Advanced%2520Solid%2520Malignancies%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Ida, S.; Motwani, M.; Jensen, M.; Wang, J.; Huseinovic, N.; Stiegler, P.; Wang, X.; Quadt, C.</span><span> </span><span class="NLM_article-title">Pharmacodynamics and Pharmacokinetics of AUY922 in a Phase I/II Study of Patients with Solid Tumors</span>. Presented at the ASCO Annual Meeting,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Abstract 3533.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Ida&author=M.+Motwani&author=M.+Jensen&author=J.+Wang&author=N.+Huseinovic&author=P.+Stiegler&author=X.+Wang&author=C.+Quadt&title=Pharmacodynamics+and+Pharmacokinetics+of+AUY922+in+a+Phase+I%2FII+Study+of+Patients+with+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DIda%26aufirst%3DS.%26atitle%3DPharmacodynamics%2520and%2520Pharmacokinetics%2520of%2520AUY922%2520in%2520a%2520Phase%2520I%252FII%2520Study%2520of%2520Patients%2520with%2520Solid%2520Tumors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Chandarlapaty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawai, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silinski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D. B.</span><span> </span><span class="NLM_article-title">SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm9004708&amp;key=10.1158%2F1078-0432.CCR-07-1667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm9004708&amp;key=18172276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm9004708&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslGq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=240-248&author=S.+Chandarlapatyauthor=A+Sawaiauthor=Q.+Yeauthor=A.+Scottauthor=M.+Silinskiauthor=K.+Huangauthor=P.+Faddenauthor=J.+Partridgeauthor=S.+Hallauthor=P.+Steedauthor=L.+Nortonauthor=N.+Rosenauthor=D.+B.+Solit&title=SNX2112%2C+a+synthetic+heat+shock+protein+90+inhibitor%2C+has+potent+antitumor+activity+against+HER+kinase-dependent+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase-Dependent Cancers</span></div><div class="casAuthors">Chandarlapaty, Sarat; Sawai, Ayana; Ye, Qing; Scott, Anisa; Silinski, Melanie; Huang, Ken; Fadden, Pat; Partdrige, Jeff; Hall, Steven; Steed, Paul; Norton, Larry; Rosen, Neal; Solit, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-248</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The heat shock protein 90 (Hsp90) chaperone plays an important role in transformation by regulating the conformational maturation and stability of oncogenic kinases and transcription factors.  Ansamycins, such as 17-(allylamino)-17-demethoxygeldanmycin (17-AAG), inhibit Hsp90 function; induce the degrdn. of Hsp90 client proteins such as HER2, and have shown activity in early clin. trials.  However, the utility of these drugs has been limited by their hepatotoxicity, poor soly., and poorly tolerated formulations.  Exptl. Design: We detd. the pharmacodynamic and antitumor properties of a novel, synthetic Hsp90 inhibitor, SNX-2112, in cell culture and xenograft models of HER kinase-dependent cancers.  RESULTS: We show in a panel of tumor cell lines that SNX-2112 and its prodrug SNX-5542 are Hsp90 inhibitors with properties and potency similar to that of 17-AAG, including: degrdn. of HER2, mutant epidermal growth factor receptor, and other client proteins, inhibition of extracellular signal-regulated kinase and Akt activation, and induction of a Rb-dependent G1 arrest with subsequent apoptosis.  SNX-5542 can be administered to mice orally on a daily schedule.  Following oral administration, SNX-5542 is rapidly converted to SNX-2112, which accumulates in tumors relative to normal tissues.  A single dose of SNX-5542 causes HER2 degrdn. and inhibits its downstream signaling for up to 24 h, and daily dosing results in regression of HER2-dependent xenografts.  SNX-5542 also shows greater activity than 17-AAG in a non-small cell lung cancer xenograft model expressing mutant EGFR.  CONCLUSIONS: These results suggest that Hsp90 inhibition with SNX-2112 (delivered as a prodrug) may represent a promising therapeutic strategy for tumors whose growth and survival is dependent on Hsp90 clients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqER6BYKwq_PLVg90H21EOLACvtfcHk0ljK_Z-rMgiclA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslGq&md5=d0aff2ef77885c47803acd1d6cb446c5</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1667%26sid%3Dliteratum%253Aachs%26aulast%3DChandarlapaty%26aufirst%3DS.%26aulast%3DSawai%26aufirst%3DA%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DSilinski%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DFadden%26aufirst%3DP.%26aulast%3DPartridge%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DS.%26aulast%3DSteed%26aufirst%3DP.%26aulast%3DNorton%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DSolit%26aufirst%3DD.%2BB.%26atitle%3DSNX2112%252C%2520a%2520synthetic%2520heat%2520shock%2520protein%252090%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520activity%2520against%2520HER%2520kinase-dependent%2520cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D240%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Okawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabasz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiziltepe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enatsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">846</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=846-855&author=Y.+Okawaauthor=T.+Hideshimaauthor=P.+Steedauthor=S.+Valletauthor=S.+Hallauthor=K.+Huangauthor=J.+Riceauthor=A.+Barabaszauthor=B.+Foleyauthor=H.+Ikedaauthor=N.+Rajeauthor=T.+Kiziltepeauthor=H.+Yasuiauthor=S.+Enatsuauthor=K.+C.+Anderson&title=SNX-2112%2C+a+selective+Hsp90+inhibitor%2C+potently+inhibits+tumor+cell+growth%2C+angiogenesis%2C+and+osteoclastogenesis+in+multiple+myeloma+and+other+hematologic+tumors+by+abrogating+signaling+via+Akt+and+ERK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkawa%26aufirst%3DY.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DBarabasz%26aufirst%3DA.%26aulast%3DFoley%26aufirst%3DB.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DKiziltepe%26aufirst%3DT.%26aulast%3DYasui%26aufirst%3DH.%26aulast%3DEnatsu%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DSNX-2112%252C%2520a%2520selective%2520Hsp90%2520inhibitor%252C%2520potently%2520inhibits%2520tumor%2520cell%2520growth%252C%2520angiogenesis%252C%2520and%2520osteoclastogenesis%2520in%2520multiple%2520myeloma%2520and%2520other%2520hematologic%2520tumors%2520by%2520abrogating%2520signaling%2520via%2520Akt%2520and%2520ERK%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D846%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1byq" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1byq','PDB','1byq'); return false;">PDB: 1byq</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1osf" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1osf','PDB','1osf'); return false;">PDB: 1osf</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1bgq" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1bgq','PDB','1bgq'); return false;">PDB: 1bgq</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uym" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1uym','PDB','1uym'); return false;">PDB: 1uym</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2vci" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2vci','PDB','2vci'); return false;">PDB: 2vci</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3d0b" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3d0b','PDB','3d0b'); return false;">PDB: 3d0b</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2bz5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2bz5','PDB','2bz5'); return false;">PDB: 2bz5</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9004708&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm9004708%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-1" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9004708" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679901577f3a3cfa","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
